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TBE Tris / borate / EDTA buffer (Ix):
0.089 M Tris base, 0.089 M ortho-boric acid, 2 mM EDTA
TE 10 mM Tris.Cl, 1 mM EDTA
TEE trypanosome lytic factor
TREU Trypanosomiasis Research Edinburgh University
UTR
VAT
untranslated region 
variable antigen type
VSG variant surface glycoprotein
X-Gal 5-bromo-4-chioro-3-indolyl-p-D-galactoside
ZMG Zimmerman postfusion medium supplemented with glucose 
132 mM NaCl, 8 mM Na2HP0 4 , 1.5 mM KH2PO4, 0.5 mM 
magnesium acetate, 0.09 mM calcium acetate [pH 7.0], 1% glucose
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A b st r a c t
African trypanosomes evade tfie mammalian host immune system for prolonged periods by 
periodically switching the protective Variant Surface Glycoprotein (VSG) coat expressed 
on their cell surface. Recombination reactions, which introduce novel VSG gene copies 
into specialised expression sites, constitute the principal mechanism of this antigenic 
variation process. Since VSG genes occupy cassettes with common upstream and 
downstream sequences it is hypothesised that VSG switching reactions occur primarily by 
homologous recombination. It has previously been shown that at least some of the VSG 
switching reactions are either catalysed or regulated by RAD51, a fundamental component 
of the homologous recombination machinery in eukaryotes.
In order to investigate further the factors regulating antigenic variation we have 
characterised several components of the highly conserved post-replicative mismatch repair 
(MMR) system in T. brucei. The nuclear MMR system recognises mispaired bases in 
heteroduplex recombination intermediates preventing recombination between divergent 
DNA molecules, and thereby confining such reactions to highly homologous sequences. In 
yeast and mammals this system is composed of three homologues of the bacterial MutS 
enzyme and tliree bacterial MutL-related enzymes. We have identified five single-copy 
genes putatively encoding three MutS homologues and two MutL homologues, suggesting 
that most of the components of eukaryotic MMR are conserved in trypanosomes.
Knockout mutants have been generated in two of the genes, MSH2 and MLHl, to 
investigate the activities of MMR in this organism. Both M5772-deficient and MLHl- 
deficient trypanosomes exhibit mierosatellite instability, a mutator phenotype, and 
tolerance to the methylating agent MNNG, demonstrating that these genes encode 
components of an active MMR system in T. brucei. Moreover, deletion of MSH2 
increases the frequency of recombination between 3% divergent sequences, revealing that 
MMR is also involved in the regulation of recombination in this organism. Despite this, no 
effect on the frequency or mechanisms used in antigenic variation was observed in either 
MSH2 or MLHl mutants, suggesting that MMR has little or no influence on this process, 
and that perhaps the homologous recombination reactions underlying antigenic variation 
proceed by a mechanism distinct from general recombination.
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C h a p t e r  1
Introduction
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1.1 General introduction
The Kinetoplastida are an order of unicellular flagellated protozoa that diverged early in 
eukaryotic evolution (Sogin et a l, 1986; Sogin, 1989). They possess many unique genetic 
and metabolic features, including an organelle containing kinetoplast (mitochondrial)
DNA, after which they are named. However, they also retain many of the characteristics 
conserved throughout the eukaryotic lineage. Within this order are the Trypanosomatidae, 
a family that boasts many vertebrate parasites (Maslov et a l, 2001). Trypanosoma brucei 
belongs to a group named the African Trypanosomes, which are mostly found in sub- 
Saharan and equatorial Africa. They are extracellular parasites that proliferate in the 
lymphatic and vascular systems of their mammalian host, causing interstitial inflammation 
and neerosis within the capillaries of major organs (Vickerman, 1985). The resulting 
parasitaemia typically produces sub-clinical infections within the reservoir of African 
game. However, in imported breeds of domestic cattle severe malnutrition and possibly 
death, in the form of a disease called nagana, occurs. In humans, the equivalent disease is 
called sleeping sickness, because the parasites also cause disorders of the central nervous 
system. Several morphologically indistinguishable sub-species of differing infectivity 
exist T. b. brucei is believed to be non-infective to man because of a non-immune high- 
density lipoprotein called trypanosome lytic factor (TLF) found in human serum which 
lyses the parasites (Hajduk e ta l ,  1992; Smith e ta l, 1995; Smith and Hajduk, 1995). 
However, T. b. rhodesiense and T b. gambiense are extremely virulent in humans, causing 
the acute and chronie forms of sleeping sickness respectively, and are generally fatal if left 
untreated. The factor which allows T b. rhodesiense to avoid killing by TLF is the product 
of the serum resistance-associated {SRA) gene, although its mode of aetion has yet to be 
determined (Pays et a l, 2001). The mechanism conferring TLF resistance to 
T, b. gambiense is unknown.
The developmental cycle of T. brucei, shown in Figure 1.1, requires both a mammalian 
host and an insect vector of the genus Glossina, or tsetse fly (Vickerman et a l, 1988). 
During this cycle, the parasite undergoes a number of highly co-ordinated and functionally 
organised differentiation events, and alternates between proliferative and non-dividing 
stages. The replicative stages proliferate by repeated mitotic division and are responsible 
for establishing and maintaining infection in their environment, whereas the non-dividing 
stages are pre-adapted to transmit the infection to the next host or vector (Shapiro et a l , 
1984; Matthews and Gull, 1997).
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Non-dividing metacyclic trypomastigotes, which develop in the salivary gland of the tsetse 
fly, are introduced into the mammal when an infective tsetse fly feeds (Barry and 
McCulloch, 2001). There they differentiate into the rapidly proliferating long slender 
bloodstream form, which is adapted for growth within the mammal, scavenging glucose 
from the host’s blood serum and relying on aerobic glycolysis within specialised organelles 
called glycosomes (Priest and Hajduk, 1994). The resultant parasitaemia does not, 
however, normally kill the host as it is attenuated in two main ways. Firstly, the host 
immune response clears the majority of the parasites, and secondly, the long slender form 
ceases to divide at high cell densities (Pays et a l, 2001). Cessation of the mitotic cell 
cycle and differentiation into the non-proliferative short stumpy bloodstream form is 
indueed by a low molecular weight factor, secreted by the long slender stage, which 
operates through a cyclic adenosine monophosphate (cAMP) signal transduction pathway 
(Hamm et a l, 1990; Vassella et a l, 1997). The short stumpy bloodstream cells are pre­
adapted to the conditions within the tsetse fly gut and show signs of mitochondrial 
reactivation (Vickerman, 1985).
Metacyclic cells and both bloodstream forms possess a densely packed surface coat 
composed of Variant Surface Glycoprotein (VSG) (Cross, 1975). In excess of 10  ^copies 
of a single VSG species are expressed at the cell surface (Cross, 1996), and these 
molecules, which are present as dimers, define the variable antigen type (VAT) (Barry, 
1997a; Barry and McCulloch, 2001). While VSG molecules are highly immunogenic, they 
function to protect the underlying invariant antigens from immune recognition and prevent 
the action of non-specific immune pathways through steric hindrance (Overath et a l ,
1994). The ability of the bloodstream forms to evade the host immune system therefore 
relies on their capacity to periodically change this coat by a process known as antigenic 
variation. Each VSG coat is encoded by a distinct VSG gene and studies have suggested 
that T. brucei possesses a repertoire of approximately 1000 different VSGs (Van der Ploeg 
et a l, 1982). Immune evasion is dependent upon the parasite’s ability to express a novel 
VSG, thereby switching the VSG coat exposed at the cell surface. VSG sequences are 
extremely variable so that the host immune system is likely to be unfamiliar with all the 
exposed epitopes in the new VSG coat (Blum et a l, 1993). Once infected, a host is often 
infected for life, although there are reported cases where the parasite eventually exhausts 
its VSG repertoire, and under these conditions the host can clear the infection in a 
phenomenon known as ‘self-cure’ (Nantulya et a l, 1984; Barry, 1986b; Nantulya et a l, 
1986).
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When a tsetse fly takes a blood meal from the infected host, only the short stumpy 
bloodstream forms survive as they are pre-adapted to the environment within the fly 
(Vassella et a l, 2000). These differentiate into procyclic trypomastigotes in the posterior 
midgut of the fly and undergo a switch to mitochondrial respiration using proline as the 
main energy source (Vickerman et a l, 1988; Priest and Hajduk, 1994). The VSG coat is 
shed and replaced by an invariant coat called procyclin, which is carbohydrate-rich (Roditi 
and Pearson, 1990). The procyclin coat comprises two distinct proteins, EP procyclin and 
GPEET procyclin, which are named after their characteristic internal repeat motifs (using 
the single letter amino acid code; Ruepp et a l, 1997). These proteins are induced early in 
differentiation, although EP expression is maintained while GPEET expression is repressed 
as established procyclic forms develop (Vassella et a l, 2000). Knockout studies have 
revealed that the EP and GPEET procyclins are not functionally equivalent, although the 
role of the procyclin coat is still under debate (Ruepp et a l,  1997). It is possible, however, 
that these proteins are required to avoid the proteolytic activities prominent in the fly’s gut 
(Barry, 1997a).
The procyclic cells differentiate through a series of developmental stages, including the 
non-dividing mesocyclic form, while migrating from the midgut into the foregut, then 
through the oesophagus until they reach the salivary glands (Van Den Abbeele et a l ,
1999). At this point, they differentiate into the epimastigote form which attaches to the 
microvilli of the salivary gland. Here they develop into nascent metacyclic cells, at which 
point they cease to divide, regain the VSG eoat, the glycosomes enlarge and mitochondrial 
functions are repressed (Vickerman et a l, 1988). The cells detach from the microvilli to 
become free metacyclic trypomastigotes in the salivary gland space before entering the 
mammal when the tsetse fly feeds, and so beginning the life cycle again.
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Figure 1.1 The life cycle of Trypanosoma brucei
The different life cycle stages shown are scanning electron micrographs, reproduced to 
scale. Stages capable of replication are denoted by curved arrows, while straight arrows 
indicate differentiation and progression through the life cycle. An erythrocyte is shown 
next to the long slender bloodstream form for comparison. Epimastigote stage cells are 
shown as a cluster on the salivary gland epithelium where they grow as a dense monolayer 
(After Barry and McCulloch, 2001).
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1.2 Antigenic variation
Enhanced phenotypic variation is a collective term encompassing several distinct 
mechanisms, including antigenic variation, -which have evolved independently in a broad 
variety of pathogenic microorganisms. These phenomena enhance propagation or prolong 
survival of the micropathogens in the host, and ultimately promote transmission to new 
hosts (Barry and McCulloch, 2001). Although these events are generally random, the 
genomes of many of the organisms undergoing these processes are organised so that these 
events are more likely to occur, often at high frequencies (greater than 10'  ^events per 
generation; Henderson et a l, 1999). Phenotypic variation thereby generates a 
heterogeneous population capable of exploiting more diverse opportunities.
For viruses, evasion of the host immune system is the primary advantage of phenotypic 
variation, with the best characterised examples being those of the influenza virus and 
human immunodeficiency virus 1 (HIVl). Phenotypic variation in influenza virus alters 
the capsid haemagglutinin protein which is required for binding host cell receptors, but 
which also elicits the host immune response. Antigenic drift, which involves the 
accumulation of point mutations and therefore amino acid replacements in the 
haemagglutinin protein, allows the virus to initiate new rounds of infection in previously 
exposed populations (Gorman et a l, 1992). However, influenza pandemics arise due to a 
more fundamental change termed antigenic shift, which occurs less frequently and involves 
genetic reassortment between two viruses infecting the same host, leading to the 
development of a virus expressing a serologically distinct haemagglutinin coat (Fanning 
and Taubenberger, 1999).
In HIV 1, the two main conserved regions required for viral attachment to CD4+ host cells 
are the CD4 receptor and the chemokine co-receptor, which are both present on the 
homotrimeric gpl20 envelope glycoprotein (Kwong e ta l ,  1998; Wyatt e ta l ,  1998). The 
CD4 binding site of gpl20 is located in a deeply recessed groove that renders it 
inaccessible to antibodies. The chemokine co-receptor, however, is protected by three 
variable loops which undergo antigenic variation, thereby hiding the receptor site from the 
immune system while allowing host cell binding. This can be considered a form of 
intramolecular steric hindrance where variable sequences shield the underlying sequences 
from immune recognition.
Phenotypic variation in bacteria is achieved by a host of different mechanisms, and is not 
limited solely to pathogenic species. Most commonly affected by these processes are
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surface structures such as fimbriae, flagella, lipopolysaccharide (LPS) and outer membrane 
pro teins, which alter how the organism interacts with its environment or host. Two broad 
categories of phenotypic variation can be distinguished in bacteria. Firstly, processes 
which cause expression of a particular factor to be switched on or off are termed phase 
variation. For example, while slnouded by a surface capsule, meningococci are able to 
evade the host immune system. However, upon switching to the alternative state, they 
become able to invade host cells (Bucci et a l, 1999). The second, more complex form of 
phenotypic variation found in bacteria is known as antigenic variation, a phenomenon 
which allows the organism to switch between the expression of a number of alternative 
surface phenotypes. This strategy allows the pathogen to evade the specific response of 
the host immune system and prolong infection over long periods. Borrelia hermsii is a 
tick-bome spirochaete which causes relapsing fever, a disease characterised by a cyclic rise 
and fall in body temperature. Each relapse population of spirochaetes expresses an 
antigenically distinct surface lipoprotein that is encoded by a separate gene, and at least 25 
of these genes can be expressed alternately from a single expression site (Barbour, 2002). 
Thus, although the host immune response clears the cell population expressing one 
lipoprotein, another population expressing a different lipoprotein continues to multiply. A 
similar system for the antigenic variation of surface lipoproteins has been described in the 
Lyme-disease spirochaete, B. burgdorferi (Zhang et a l, 1997).
A number of strategies for antigenic variation are also successfully utilised by unicellular 
eukaryotic parasites. African trypanosomes, including T. brucei, are able to repeatedly 
replace the VSG coat expressed at their cell surface using both recombinational and 
transcriptional switching mechanisms (see section 1.3). In fact, the similarities between 
the systems executing antigenic variation in trypanosomes and Borrelia spp. are striking, at 
both the genetic and phenotypic levels. Antigenic variation has also been described in the 
opportunistic fungal pathogen Pneumocystis carinii, which encodes a large number of 
major surface glycoprotein (MSG) genes that can be introduced into the expression site by 
recombination (Stringer and Keely, 2001). Furthermore, the intestinal parasite, Giardia 
lamblia, also possesses a considerable potential to alter the variant-specific surface protein 
(VSP) coat which covers its entire cell surface, using a system which resembles the 
transcriptional switching mechanism of T. brucei (Svard et a l, 1998).
Antigenic variation is not limited solely to extracellular pathogens whose surface is in 
direct contact with the host immune system, as the intraerythrocytic parasites Plasmodium 
falciparum and Babesia bovis have also evolved systems which enable them to vary the 
antigens they express on the surface of their host cells (Barbour and Restrepo, 2000).
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However, the functions of these proteins are more complex than the simple role in immune 
evasion required of the surface antigens of extracellular parasites. For instance, members 
of the PfEMPl protein family, encoded by the var genes of P. falciparum, are receptors 
which concentrate into knob-like protrusions on the surface of the parasitised cell. These 
receptors bind host molecules on endothelial cells, thereby sequestering infected 
erythrocytes from immune surveillance at sites such as the spleen (Gardner et a i, 1996; 
Wahlgren et a l,  1999). Two other protein families, encoded by the r if  and stevor genes, 
are also thought to undergo antigenic variation in P. falciparum, although the functions of 
these antigens have yet to be hilly elucidated (Beeson and Brovm, 2002).
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1.3 Antigenic variation in T, brucei
Since the advent of molecular biology, researchers have been studying the mechanisms 
involved in antigenic variation (reviewed in Donelson, 1995; Cross, 1996; Barry, 1997b; 
Borst et a l,  1998; Pays and Nolan, 1998; Barry and McCulloch, 2001). Until recently, 
most of this research was conducted using monomorphic lines of trypanosomes developed 
from a number of stocks with differing genetic backgrounds by prolonged, often rapid 
syringe passing of T. brucei through laboratory animals (Barry and McCulloch, 2001). 
These cell lines are unable to differentiate from long slender to short stumpy forms, at least 
in the case of strain MITat 1.2a S427 because they have lost the ability to signal a response 
to the stumpy induction factor (Vassella et a l, 1997). Consequently, they reach high 
parasitaemias in vivo, and can readily grown in vitro. Non-adapted, or pleomorphic, 
trypanosomes continue to generate short stumpy forms both in vitro and in vivo and are 
readily able to establish tsetse fly infections. Monomorphic lines have been shown to 
switch at a low frequency of 10’^  to 10'  ^ switches/cell/generation (Lamont et a l, 1986). In 
contrast, in pleomorphic lines the switch rate is at least 10'  ^ switches/cell/generation and 
can be as high as 10'  ^switches/cell/generation (Turner and Barry, 1989; Turner, 1997).
The basis for this switching difference is unknown, but may be connected to changes in 
cell cycle control, or could indicate that monomorphic cells are deficient in a switch- 
promoting function, such as an endonuclease that promotes homologous recombination 
(Barry, 1997b). One advantage of the switch deficiency in monomorphic cells is it has 
allowed researchers to elucidate that several mechanisms enable T. brucei to express a 
novel VSG, and thereby a novel surface coat (see below). Such studies would have been 
seriously hampered by the inherent instability of VSG gene expression in pleomorphic 
cells. However, recent data have suggested that monomorphic and pleomorphic cells differ 
in their usage of the described switching mechanisms, highlighting the need for further 
research into the genetic controls of antigenic variation in both these cell lines (Barry, 
1997b; Robinson et a l, 1999). It should also be noted that the rates of underlying VSG 
activation are probably underestimated by methodologies recording phenotypic switching 
only, since a trypanosome population can contain individual cells expressing the same VSG 
which arose via multiple independent gene rearrangement events (Timmers et a l, 1987).
VSG genes are only expressed when present in specialised telomeric locations called VSG 
expression sites (Figure 1.2; Pays et a l,  2001). In a given cell only a single expression site 
is transcriptionally active at a time, ensuring that a homogeneous VSG coat is expressed at 
the cell surface. Expression sites comprise stage-specific transcription units which are 
thought to be transcribed by RNA polymerase I, the enzyme also responsible for
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transcribing the ribosomal DNA and the procyclin loci (Barry and McCulloch, 2001; 
Navarro and Gull, 2001). Two types of expression site have been described. These are 
known as metacyclic expression sites (MESs), so named because they are expressed within 
the metacyclic developmental stage, and bloodstream expression sites (BBSs), which are 
expressed in both long slender and short stumpy cells within the mammal. All expression 
sites are telomeric, and the VSG gene is invariably found directly adjacent to the telomeric 
repeats ((CCCTAA)n; Van der Ploeg et a l, 1984). Both the MESs and BES^ are present on 
all size classes of chromosome except the minichromosomes. MESs are generally about 
4-6 kb in length and there an estimated 27 such loci within a cell (Figure 1.2b; Turner et 
a l, 1988). These loci are the only known protein-coding monocistrons in trypanosomes, 
the VSG being the single transcribed gene (Barry and McCulloch, 2001). Other features 
characteristic of MESs include a poorly conserved promoter region (Bringaud et a l, 2001) 
and a small number of 70-bp repeats (typically 1 or 2 repeat units) found upstream of the 
VSG, although some MESs lack these repeats (Lenardo et a l, 1984). The metacyclic 
population of a tsetse fly salivary gland is heterogeneous, consisting of a mixture of 
variable antigenic types (VATs), thereby creating a diversity which should maximise 
infection of new hosts and circumvent the problem of existing anti-VSG antibodies in 
previously infected hosts (Barry et a l, 1998). This is achieved by each metacyclic cell 
randomly selecting and activating a single MES.
Metacyclic cells introduced into a mammalian host quickly re-enter the cell cycle and 
differentiate into the long slender proliferative bloodstream form. Within a few days these 
cells switch their VSG coat and initiate transcription from one of approximately 20 BBSs 
(Figure 1.2a; Pays et a l, 2001; Vanhamme et a l, 2001). These loci are large polycistronic 
transcription units, up to 65 kb in size, and the overall structure, and indeed sequence, of 
these sites appears to be largely conserved. BBSs are demarcated at their 5 ’ end by a large 
array of 50-bp repeats located upstream of the BBS promoter, while a number of non-KSG 
expression site-associated genes {ESAGs) are located downstream of the promoter. The 
functions of a number of the ESAGs have been elucidated; for instance, ESAG6 and 
ESAG7 encode a heterodimeric receptor for the uptake of host transferrin (Salmon et a l, 
1994; Steverding et a l, 1994), while ESAG4 encodes an adenylate cyclase (Paindavoine et 
a l, 1992). However, many of the ESAG gene products have yet to be assigned a function, 
nor is it known why it is necessary that these genes be co-expressed with the VSG. 
Separating the final ESAG and the VSG is a large ‘barren’ region composed of degenerate 
70-bp repeats, believed to facilitate recombinational VSG switching (see below).
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Since the VSG coat present on the trypanosome cell surface is highly immunogenic, the 
parasite must alter the active VSG gene to express a novel surface coat in order to avoid the 
host immune system and maintain infection. For this reason the T. brucei genome encodes 
an estimated 1000 VSG genes, although many of these may be damaged or incomplete 
(Van der Ploeg et a l, 1982). The majority of these genes are thought to reside in large 
arrays within chromosome-internal locations, and are termed basic-copy (BC) genes, while 
most of the remaining VSGs are found in telomeric regions, especially those of the 100 or 
so mini-chromosomes (Gull et a l, 1998). The remaining VSGs are located within the 
MESs and BESs. VSGs can be considered as occupying cassettes with common upstream 
and downstream sequences. At the 5’ end, the majority of VSGs are flanked by runs of 
imperfect 70-bp repeats (Liu et a l, 1983; Aline et a l, 1985). BC genes possess a small 
number of such repeats, between 1 and 10, while mini-chromosomal telomeric VSGs have 
been shown to have more. As described above, within BESs the ‘barren’ region may 
contain hundreds of these repeats spanning several kilobases upstream of the VSG. The 
ESAGs also provide many kilobases of homology between BESs (Thi et a l, 1991; Xong et 
a l, 1998). Downstream, at the 3’ end of all VSGs, are the highly conserved 
carboxyterminal coding regions followed by the 3’ untranslated regions. For 
mini-chromosomal telomeric and expression site VSGs the telomeric hexanucleotide 
repeats also provide several kilobases of homology (Aline et a l, 1985; Aline and Stuart, 
1989). These cassettes possess the features of functional units designed to undergo 
homologous recombination, and it is hypothesised that the homologous recombination 
machinery underlies a number of the reported VSG switching mechanisms (see below and 
section 1.4).
Currently, there are five main mechanisms reported for antigenic variation in T. brucei 
(Figures 1.3, 1.4, 1.5, 1.6 and 1.7). The first mechanism is termed expression-linked copy 
(ETC) formation, and comprises the first of two forms of duplicative transposition (Figure 
1.3). During this mechanism a chromosome-internal VSG gene is copied and inserted into 
the active BES. The VSG that previously occupied the BES is deleted, and the new VSG 
copy, or EEC, is expressed (Michels et a l, 1983; Pays et a l, 1983b). Since this 
mechanism shares similarities with gene conversion reactions found in all organisms, 
which are mediated by cellular DNA recombination enzymes (see section 1.4), it is 
possible these same enzymes assist in EEC formation. This is the only mechanism 
allowing the activation of BC genes, which account for the majority of silent VSGs and 
which cannot be expressed unless transposed into the active BES. Numerically, this must 
be an important mechanism for antigenic variation. EEC formation occurs readily in both 
monomorphic and pleomorphic lines of trypanosomes, and is mediated by a recombination
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reaction that relies upon the regions of homology which flank the VSGs and form the gene 
cassette. In most cases, imperfect 70-bp repeats delineate the upstream limit for 
recombination (Campbell et a l, 1984; De Lange et a l, 1985; Florent et a l, 1987; Lee and 
Van der Ploeg, 1987), as is true for every reported case in pleomorphic lines so far 
(Matthews et a l, 1990). However, in monomorphic lines, the region of transposition can 
extend to other homologous sequences (Michiels et a l, 1983; Pays et a l, 1983b; Lee and 
Van der Ploeg, 1987) and deletion of the 70-bp repeats from the active ES have been 
shown not to affect EEC formation (McCulloch et a l, 1997). These data have led to the 
suggestion that EEC formation occurs by general homologous recombination in 
monomorphic trypanosomes and that these cell lines are deficient in another, dedicated 
system for duplicative transposition which operates in pleomorphic cells (BaiTy, 1997b).
The second fomi of duplicative transposition is called telomere conversion, and occurs 
when a VSG is copied from the telomere of a chromosome and inserted into the active ES 
(Figure 1.4). Again, the VSG originally found in the BES is deleted. While exhibiting 
many similarities with EEC formation, telomere conversion differs because the transposed 
region can terminate downstream of the end of the VSG gene cassette, within subtelomeric 
regions of homology (De Lange et a l, 1983; Bernards et a l, 1984) or even the 
hexanucleotide telomeric repeats at the end of the chromosome (De Lange et a l, 1983). In 
fact, some telomere conversions may simply copy the entire donor telomere into the BES 
(De Lange et a l, 1983), This mechanism is highly significant in antigenic variation, as it 
is probably the main route for mini-chromosomal VSG gene activation, both in 
monomorphic and pleomorphic trypanosomes.
Telomere reciprocal recombination is the third form of recombination-dependent antigenic 
variation in trypanosomes (Figure 1.5). This mechanism involves the exchange of 
telomeric regions containing VSG genes between chromosomes, and is mediated by a 
simple genetic cross-over event (Barry, 1997b). It does not involve gene conversion, and 
the VSG within the active site is not deleted. To effect an antigenic switch this genetic 
exchange must introduce a novel VSG gene into the active BES, and the previously 
expressed VSG is moved to a silent telomere. For this process, the position of genetic 
exchange may be within the 70-bp repeats (Pays et a l, 1985a) or further upstream within 
the BES (Pays et a l, 1983a; Shea et a l, 1986). Until recently only two cases of this 
mechanism had been reported. However, Rudenko et al (1996) found more examples, and 
suggested that this may be a major mechanism of antigenic switching in monomorphic 
lines. Nevertheless, since this mechanism has not so far been observed in pleomorphic
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cells, it is likely that this type of antigenic variation is simply the result of random mitotic 
cross-over events.
The final recombination-dependent VSG switching mechanism is mosaic gene formation 
(Figure 1.6). Using this process, which is also called segmental gene conversion, novel 
VSGs can be generated by chance recombination between two or more VSG genes 
(reviewed in Barbet and Kamper, 1993). Segmental gene conversion was originally 
reported to involve the retention of the 3’ coding sequence of the VSG initially in the BES, 
while the upstream region was replaced by a fragment of a novel gene (Pays et al., 1983a). 
Later, mosaic gene fonnation was reported between members of the same VSG gene family 
(Pays et a l, 1985b), and more recently it has been shown that many mosaic genes are 
constructed from fragments of pseudogenes (Roth et a l, 1986; Thon et a l, 1990). The 
nature of this mechanism suggests that such events are likely to be rare. However, if a 
chronically infected host eventually develops immunity against all the readily expressed 
VSGs in the repertoire, no other VATs can survive and the products of this mechanism may 
then be detected. It seems likely that this mechanism is also unregulated, and relies upon 
chance homologies within the recombining VSG genes.
The fifth mechanism allowing the expression of a novel VSG in T. brucei is termed in situ 
transcriptional switching (Figure 1.7). This type of antigenie variation involves the 
transcriptional activation of one of the silent BESs along with the concomitant silencing of 
the active BES, thereby switching between the two VSGs that occupy those particular sites 
and enabling the cell to express a new surface coat. In monomorphic cells in situ 
switching is often the most commonly observed mechanism of antigenic variation 
(McCulloch et a l, 1997; McCulloch and Barry, 1999). However, pleomorphic cells rarely 
seem to utilise this mechanism, perhaps because it can only be used to activate the VSGs 
which happen to occupy the BESs (Robinson et a l, 1999). It has been known for many 
years that only a single expression site can be active at a time, and many theories have 
been advanced over the years to explain this phenomenon (reviewed in Barry and 
McCulloch, 2001). However, the recent discovery of a subnuclear structure associated 
with expression of the active BES by RNA polymerase I appears to have solved the 
problem (Navarro and Gull, 2001). This structure, termed the expression site body (ESB), 
is present only in the bloodstream form, and appears to be a coherent structure inside 
which the active BES is located and transcribed. Inactive BESs are not associated with this 
transcriptional body. Since the ESB recruits RNA polymerase I for transcription, it is 
likely to share some features with the nucleolus but is nevertheless entirely separate 
(Chaves et a l, 1998; Navarro and Gull, 2001). These results suggest a model in which
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BES recruitment and activation relies on interaction with the ESB, and where inactive 
BESs are excluded from the structure while it is occupied by the active BES. This is 
supported by evidence showing that two BESs cannot be fully active at the same time, and 
that attempts to force cells to express two sites simultaneously, using antibiotic selection, 
appears to cause the cells to switch rapidly back and forth between the two sites (Chaves et 
a l, 1999). Although the mechanism ensuring that only one BES occupies the ESB at a 
time remains unknown, it may rely on some conserved feature of the expression site, since 
the sequences of BESs, outwith the VSGs, have been shown to be around 90% identical 
(Xong et a l, 1998; Navarro and Gull, 2001). Furthermore, this model suggests that in situ 
switching would proceed by a process which caused the interaction between the active BES 
and ESB to become unstable, and an inactive BES could then move to occupy the ESB, 
resulting in displacement of the active BES by an inactive one. How this is co-ordinated, 
and whether it is related to DNA replication, recombination or chromatin remodelling, 
remains unclear (Navarro and Gull, 2001).
A sixth mechanism which has been proposed involves the accumulation of point mutations 
during the generation of a copy of a previously expressed VSG gene sequence (Donelson, 
1995). However, all the exposed epitopes encoded by the VSG would have to be altered 
from the progenitor sequence for the cell to avoid destruction by the host immune system, 
and it is difficult to see how such a high rate of point mutation could be achieved.
Explanations for many aspects of antigenic variation in T. brucei remain elusive, and 
almost nothing is known about the genes in trypanosomes that regulate it. The reduction in 
switch rate in monomorphic lines has prompted the suggestion that an active mechanism 
for antigenic variation exists that is diminished or absent in these cell lines (Barry, 1997b). 
Since the switch rate is comparable to that expected by background mutation alone, it is 
possible switching occurs in monomorphic cells by random homologous recombination, 
and that pleomorphic cells possess a dedicated pathway for VSG recombination. 
Trypanosomes do possess pathways to ensure VSGs are expressed in a loose hierarchy, 
leading to the appearance of VATs in a semi-definable order (Gray, 1965; Capbem et a l, 
1977; Barry, 1986a; Thon et a l, 1990), so preventing the exhaustion of the whole VSG 
repertoire within the early waves of parasitaemia. This hierarchy appears to be based on 
the probability of activation of VSG genes in a variety of locations and under a number of 
circumstances (Barry and McCulloch, 2001). For instance, VSGs are more frequently 
activated when present in telomeric rather than chromosome-internal locations (Liu et a l , 
1985; Robinson et a l, 1999). In pleomorphic trypanosomes, duplication is by far the 
predominant switching mechanism, while in situ switching events are rare (Robinson et a l ,
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1999). It follows that telomere reciprocal recombination and mosaic gene formation 
events would be less frequent still. At the head of the hierarchy are the telomeric VSGs, 
perhaps because the flanking regions of these genes are likely to share longer stretches of 
homology with the active BES, thereby increasing the probability of successful gene 
conversion.
38
Figure 1.2 VSG expression sites in trypanosomes
(A) Bloodstream expression sites {BESs) are large polycistronic transcription units up to 
about 60 kb in length (Pays et a i,  2001). The expression site promoter (shown as a flag) 
drives transcription of up to a dozen non-VSG expression site-associated genes (ESAGs; 
shown in yellow), as well as the VSG gene (shown in red) which is found at the terminus of 
the BES, proximal to the telomeric repeats (shown as black arrowheads). Separating the 
ESAGs and VSG gene are a large array of 70-bp repeats (shown as vertical black and white 
stripes), while the 5’ boundary of the BES is delimited by an array of 50-bp repeats (shown 
as green ovals). (B) Metacyclic expression sites (MESs) are monocistronic transcription 
units approximately 4-6 kb in length which contain only a VSG gene and a small number of 
70-bp repeats upstream of the telomeric repeats (Barry and McCulloch, 2001).
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Figure 1.3 Expression linked copy (ELC) formation
A simplified scheme showing the replacement of the VSG (shown in red) in the active BES 
(indicated by a dashed arrow) by a novel inactive chromosome-internal VSG (shown in 
blue) using homologous sequences present in the 70-bp repeats (shown as vertical black 
and white stripes) and downstream of the VSGs. The BES promoter is depicted as a flag. 
The expressed VSG is destroyed and replaced by a copy of the inactive VSG (ELC) which 
is then transcribed.
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Figure 1.4 Telomere conversion
A simplified scheme showing the replacement of the VSG (shown in red) in the active BES 
(indicated by a dashed arrow) by a novel inactive telomeric VSG (shown in blue) using 
5’ homologous sequences present in the 70-bp repeats (shown as vertical black and white 
stripes) or between the upstream regions of two expression sites; the 3’ conversion limit 
may lie in homologous sequences downstream of the VSGs, or conversion may copy the 
entire donor telomere into the BES. The BES promoter is depicted as a flag. The 
expressed VSG is destroyed and replaced by a copy of the inactive VSG which is then 
transcribed.
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Figure 1.5 Telomere reciprocal recombination
A simplified scheme showing crossing-over between the active BES (indicated by a dashed 
arrow) and an inactive BES. During this process the expressed VSG (shown in red) is 
exchanged for a novel inactive VSG (shown in blue) which is then transcribed. These 
events utilise homologous sequences upstream of the VSGs, either within the 70-bp repeats 
(shown as vertical black and white stripes) or between the upstream regions of two BESs. 
The BES promoter is depicted as a flag.
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Figure 1.6 Mosaic gene formation
A simplified scheme showing recombination between homologous sequences present 
within an inactive or damaged VSG within an inactive BES (shown in red) with another 
inactive or damaged VSG (shown in blue). This process may result in the generation of a 
novel VSG (shown in red/blue) within the inactive BES. Activation of this BES (indicated 
by a dashed arrow) results in the expression of a novel VSG. The BES promoter is depicted 
as a flag.
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Figure 1.7 In situ transcriptional switching
A simplified scheme showing the inactivation of the active BES (indicated by a dashed 
arrow) containing the expressed VSG (shown in red), along with the simultaneous 
activation of an inactive BES containing a novel VSG (shown in blue). The BES promoters 
are shown as flags and the 70-bp repeats as vertical black and white stripes.
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1.4 DNA recombination and antigenic variation
DNA recombination has been recognised as one of the primary forces underlying antigenic 
variation in T. brucei (McCulloch and Barry, 1999). At present, very little is known about 
the recombination machineiy possessed by trypanosomes, although recent work suggests 
that multiple pathways of recombination and DNA break repair may be present (see 
below), mirroring the situation in other eukaryotes.
Extensive research into the recombination and DNA break repair pathways of yeast and 
mammals has revealed that DNA recombination is usually initiated by the presence of a 
double-strand break (DSB) or free double-strand end (free end). These lesions can arise by 
the direct action of ionising radiation and some chemicals, by the action of endonucleases 
during events such as meiosis or mating type switching in Saccharomyces cerevisiae, or 
perhaps most importantly, during DNA replication when a replication fork encounters a 
single-strand break (a nick) or collides with a protein that terminates replication (Haber, 
1999; Karran, 2000; Cromie et a l, 2001). If such lesions remain unrepaired they may lead 
to chromosome loss and ultimately cell death, while imprecise repair can result in 
mutations and chromosomal rearrangements (van Gent et a l, 2001). For these reasons, 
eukaryotes have evolved an impressive array of DSB-repair pathways.
Two general types of DSB repair can be distinguished in eukaryotes; non-homologous end 
joining (NHEJ) in which the broken ends are directly rejoined to one another; and 
homologous recombination (HR), where an intact double-strand DNA molecule acts as a 
template to repair the broken molecule. HR can in fact be sub-divided into several 
pathways, including gene conversion and break-induced replication (BIR), in which an 
intact homologous chromosome or sister cliromatid is used as a template for repair, and 
single-strand annealing (SSA) where complementary regions flanking both ends of the 
DSB are joined to repair the lesion (Figure 1.8; Pâques and Haber, 1999). These 
mechanisms have been conserved tlrroughout evolution, and adapted to accommodate the 
demands of increasingly complex organisms and their environments. Many of the proteins 
central to these processes in S. cerevisiae have homologues in other eukaryotes, although 
the relative contribution of NHEJ and HR varies between lower and higher eukaryotes. 
Moreover, within an organism the choice of repair pathway may also be influenced by the 
phase of the cell cycle, the nature of the lesion to be repaired and, in multicellular 
organisms, the cell type and stage of development (reviewed in Pâques and Haber, 1999; 
Pastink and Lohman, 1999; Haber, 2000; Karran, 2000; Cromie et a l,  2001). 
Supplementary to their role in genome maintenance, these repair pathways are also utilised
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during processes which generate genetic diversity; for instance, genetic exchange during 
meiosis (Pâques and Haber, 1999), or V(D)J recombination during the generation of B and 
T cell lineages (Featherstone and Jackson, 1999).
NHEJ is the most prevalent form of non-homologous, or illegitimate, DSB repair, and 
requires little or no base-pairing to join the DNA ends (Figure 1.8a; Moore and Haber, 
1996; Jeggo, 1998). In mammalian cells, this process begins with the assembly of the 
multiprotein complex, DNA-dependent protein kinase (DNA-PK). Both of the DNA ends 
are bound by heterodimers composed of the KU70 and KU80 proteins, which recruit and 
activate the catalytic subunit of DNA-PK (DNA-PKcs). The DNA-PK complex then 
recruits DNA ligase IV and XRCC4 (X-ray cross-complementing 4), which together 
accomplish the ligation step. The same core proteins are required during NHEJ in 
S. cerevisiae, although no homologue of DNA-PKcs has been identified in this organism.
A further difference lies in the involvement of the RAD50-MRE11-containing complex in 
NHEJ in S. cerevisiae (Moore and Haber, 1996), while the absence of MREl 1 has little 
effect on the vertebrate system (Yamaguchi-Iwai et a l , 1999). Whilst KU70/80-dependent 
NHEJ is the best characterised reaction, genetic evidence in yeast has suggested that forms 
of NHEJ can occur in KU70/80 mutants, albeit less efficiently, and with different reaction 
requirements (Pâques and Haber, 1999; Manolis et a l, 2001).
In S. cerevisiae, DSB repair by HR relies upon the RAD52 epistasis group proteins, 
including RAD50, RAD51, RAD52, RAD54, RAD57, RAD59, MREl 1 and XRS2, and 
homologues of the majority of these proteins have been identified in mammalian cells 
(Pâques and Haber, 1999). A number of distinct mechanisms of HR have been described 
in eukaryotes to explain experimental observations gathered using a variety of assay 
methods, and to provide a framework for further study. However, in vivo it is unlikely that 
these repair pathways are as clearly delineated. Within the cell, molecular cross-talk 
between the pathways may generate flexibility, allowing HR to repair a broad spectrum of 
lesions using different combinations of the RAD52-group proteins.
The simplest HR pathway, SSA, is dependent on the presence of direct repeats on both 
sides of the DSB (Figure 1.8b; Pâques and Haber, 1999). In S. cerevisiae, after 5’ to 3’ 
resection of both ends of the break by the RAD50-MRE11-XRS2 complex, or perhaps by 
other nuclease activities, these regions of homology are exposed and can anneal together to 
form a joint molecule. This process appears to be facilitated by RAD52, since it is capable 
of promoting the annealing of complementary single strands in vitro (Mortensen et a l , 
1996; Shinohara et a l, 1998), but other RAD52-group members in S. cerevisiae do not
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seem to be required (Pastink and Lohman, 1999). The single-stranded non-homologous 
tails are then removed by the RADI-RAD 10 endonuclease working in conjunction with the 
mismatch repair heterodimer MSH2-MSH3 (see section 1.6). Repair DNA synthesis is 
followed by ligation to complete the repair. The SSA repair process results in deletion of 
the sequence between the two repeats along with one of the repeat regions. SSA has been 
observed between molecules containing as little as 30 bp of complementary sequence, 
although the efficiency of the process is greatly enhanced where 200-400 bp of 
homologous sequence are available (Sugawara et a l , 2000), and repair events resulting in 
the deletion of as much as 15 kb have been reported (Sugawara and Haber, 1992). SSA 
also occurs in mammalian cells, and although little is known about the genetic 
requirements of this process, it is assumed that the mammalian counterparts of the 
RAD50-MRE11-XRS2 nuclease and RADI-RAD 10 endonuclease complexes are involved 
(Karran, 2000).
Gene conversion, or the nonreciprocal transfer of DNA from one molecule to its 
homologue, is the most extensively studied form of HR, and is thought to occur by two 
pathways: gene conversion involving Holliday junctions (Figure 1.8d; Szostak et a l, 1983) 
and synthesis-dependent strand annealing (SDSA; Figure 1.8e; Nassif et a l,  1994). The 
pathways share many mechanistic features, and the early stages of these repair events 
appear to be identical (Pâques and Haber, 1999). As in SSA, the ends of the DSB are 
resected, probably by the RAD50-MRE11-XRS2 complex, to generate 3’ single-stranded 
tails. RAD51 protein polymerises onto the single-stranded tails to form a nucleoprotein 
filament that searches for homologous duplex DNA. Upon successful completion of this 
search, DNA strand exchange forms a joint molecule between the homologous intact 
duplex DNA and the damaged DNA. The formation of RAD51 nucleoprotein filaments is 
facilitated by the co-ordinated action of RAD52, the RAD55-RAD57 heterodimer and 
replication protein A (RPA; Sung, 1994; Sung, 1997; Shinohara and Ogawa, 1998); the 
strand exchange reaction is promoted by RAD54 (Petukhova et a l,  1998). Repair DNA 
synthesis requires DNA polymerase and accessory factors, but the identity of the 
polymerases involved remains unclear. The two models differ mainly in the methods used 
to resolve the strand exchange recombination intermediates, prior to repair completion by 
DNA ligase. In gene conversion involving Holliday junctions, the 3’ ends are thought to 
invade the homologous template and initiate new DNA synthesis, leading to the formation 
of two four-stranded branched structures called Holliday junctions. Theoretically, these 
Holliday junctions should be cleaved by resolvases, analogous to RuvC or RusA in 
eubacteria (Connolly et a l, 1991; Chan et a l, 1997). So far, only one candidate resol vase, 
active in the nuclei of eukaryotes, has been identified. This protein, called MUS81,
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cleaves Holliday junctions in vitro (Chen et a l, 2001), but is thought to use a novel 
enzymatic strategy, dissimilar from those of the eubacterial enzymes, and it does not seem 
to possess all the expected properties of a eukaryotic Holliday junction resol vase (Haber 
and Heyer, 2001). A complex of unknown composition which can cleave Holliday 
junctions in a manner similar to that of RuvC has also been identified in mammalian cell 
extracts (Constantinou et a l, 2001). Other Holliday junction resolvases have also been 
identified in the mitochondria of budding yeast and fission yeast (Kleff et a l, 1992; White 
and Lilley, 1997). Gene conversion is not associated with crossing-over if both Holliday 
junctions are cleaved in the same direction. Alternatively, if the crossed strands of one 
Holliday junction are cleaved, while the non-crossed strands of the other Holliday junction 
are cut, then gene conversion is associated with the crossing-over of flanking markers. The 
second gene conversion model, SDSA, does not involve Holliday junctions. Instead, the 
newly synthesised DNA strands are returned to the broken molecule after displacement 
from the template, after which the two newly synthesised strands can anneal to each other. 
DNA synthesis then fills any gaps remaining in the broken molecule to complete the 
repair. This process is not associated with the crossing-over of markers flanking the DSB.
The final HR pathway, BIR, has been postulated to explain the observation of very long 
gene conversion tracts, in some cases up to 400kb in length (Figure 1.8c; Esposito, 1978; 
Pâques and Haber, 1999; Kraus et a l,  2001). Very little is known about the mechanism or 
the components involved in this type of repair, although evidence implicates a number of 
the RAD52-group proteins along with the replication machinery. BIR appears to be 
initiated in a similar manner to gene conversion, with the 3’ end of the single-stranded tail 
invading intact homologous duplex and forming a joint molecule. The 3’ end then 
probably initiates both leading- and lagging-strand synthesis to form a true replication fork. 
As in replication, this fork is able to synthesise many kilobases of DNA, explaining the 
large conversion tracts observed as a result of this repair mechanism. This recombination- 
induced replication process may also result in DNA synthesis extending the length of 
whole chromosome arms, with synthesis proceeding to the end of the telomere.
The majority of VSG switching events in T. brucei involve DNA rearrangements, and as 
discussed in section 1.3, VSG genes occupy cassettes with common upstream and 
downstream sequences, suggesting that homologous recombination underlies these events. 
In recent years, homologues of a number of proteins central to the recombination pathways 
of other eukaryotes have been identified in trypanosomes, and functional analyses of these 
genes has begun to shed light on the recombination mechanisms available to this organism. 
The first recombinase gene characterised in T. brucei encodes a homologue of the highly
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conserved RAD51 protein (McCulloch and Barry, 1999). RAD51 proteins bind both 
single- and double-stranded DNA to form nucleoprotein filaments in the presence of ATP 
(Benson et a l,  1994). These proteins display ATPase activity in the presence of single­
stranded DNA, and upon binding, RAD51 can catalyse the transfer of a single-stranded 
DNA tail into intact duplex DNA, to generate homology-dependent strand-exchange 
intermediates in which the single-stranded DNA is annealed with the complementary 
strand of the duplex DNA, and the non-eomplementary strand is displaced (Sung, 1994; 
Baumann et a l, 1996). Homozygous T. brucei RAD51 mutants exhibited an increased 
sensitivity to the radiomimetic alkylating agent methyl methanesulphonate (MMS) and a 
reduced efficiency of integration of DNA constructs following transformation, both 
phenotypes consistent with the loss of a component of the HR machinery. Analysis of the 
role of RAD51 in VSG switching revealed a complex phenotype: the mutants switched 
their VSG coats at a reduced overall frequency relative to wild-type cells, but interestingly 
this was due to down-regulation of both recombinational switching and in situ 
transcriptional switching. Switching events of both types were still detectable in the 
homozygous mutants, however, indicating that /MD57-independent pathways of 
switching, and therefore DNA recombination, exist in T. brucei. Recent investigations into 
this residual recombination activity, using DNA transformation, have revealed that 
trypanosomes contain at least two, and perhaps three, pathways of homologous 
recombination (Conway et a l, 2002b).
More recently, the roles of the KU70 and M R E ll genes have been investigated in 
trypanosomes. KU70 associates with KU80 to form a heterodimer which is essential for 
efficient and accurate NHEJ (Featherstone and Jackson, 1999). The primary function of 
the KU70/80 heterodimer is to bind DNA ends and recruit factors, such as DNA-PKcs, 
which repair the DSB (Featherstone and Jackson, 1999). MREl 1 forms a complex with 
RAD50, and either XRS2 in yeast, or NBSl in mammals (D'Amours and Jackson, 2002). 
This complex is required for the nucleolytic processing of DSBs in HR and possibly 
NHEJ, and is thought to play a structural role which may facilitate both strand exchange 
and end-joining reactions (Furuse et a l, 1998; Pauli and Gellert, 1998; Pauli and Gellert, 
2000; Hopfner et a l, 2002). The MREl 1 complex has also been associated with DNA 
damage sensing and signalling activities (D'Amours and Jackson, 2002; Hopfner et a l , 
2002). KU70 mutant trypanosomes showed no increase in sensitivity to the cytotoxic 
effects of MMS compared with wild-type cells, indicating that NHEJ plays a minor role in 
DSB repair in the parasite (Conway et a l, 2002a). Similarly, M R E ll mutant 
trypanosomes showed no increased sensitivity to MMS compared to wild-type cells, but 
did display an increase in sensitivity to the radiomimetic drug bleomycin, which
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predominantly causes single- and double-strand DNA breaks, suggesting that M R E ll is 
involved in DSB repair (Robinson et a l, 2002). However, given that M R E ll only appears 
to be involved in the repair of lesions created after treatment with bleomycin, but not 
MMS, it appears that M R E ll is only involved in the repair of a sub-set of DNA damage, 
whereas RAD51 has a more widespread function. Large scale genome rearrangements 
were also detected in M R E ll mutants after prolonged passage in vitro. Furthermore, 
M R E ll mutation has been shown to have a direct effect on recombination, as a 3- to 4-fold 
reduction in the frequency of integration of homologous targeting constructs was observed 
in M RE ll mutants compared with wild-type cells. This reduction in integration efficiency 
is approximately half that seen in RAD51 mutant trypanosomes (McCulloch and Barry,
1999). In addition, M RE ll mutants were seen to integrate the DNA constructs into two 
available homologous locations, a different pattern of recombination compared with 
wild-type cells, but comparable to RAD51 mutant cell lines (McCulloch and Barry, 1999; 
Robinson et al., 2002). A possible explanation for these observations is that resection of 
the ends of DSBs occurs much less efficiently in M REll mutant trypanosomes, so the 
3’ single-stranded tails generated by this process are shorter than in wild-type cells, 
perhaps forcing M R E ll mutant cells to repair the break using the RAD51-independent 
homologous recombination pathway (Conway et a l, 2002b). Despite these alterations to 
recombination in trypanosomes, M R E ll mutants, like KU70 mutants, displayed no 
changes in either the frequency of, or mechanisms used, during VSG switching (Conway et 
al., 2002a; Robinson et al., 2002). It remains unclear what this tells us about either the 
initiating event in VSG switching, or the recombination pathway that is used.
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Figure 1.8 Pathways of double-strand break (DSB) repair
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1.5 Mismatch repair in eukaryotes
Given the conflicting evidence of RAD51 and MREl 1 involvement in VSG switching, it 
remains unclear exactly what form of VSG recombination reaction(s) are used. The 
involvement of RAD51 is compatible with the molecular data suggesting that homologous 
recombination is involved. Nevertheless, the MREl 1 data illustrate that we still need to 
understand the genetic controls that operate on this process. The post-replicative mismatch 
repair system is an important metabolic pathway first described in prokaryotes (Cox,
1976). This mechanism functions mainly to recognise and correct base-base mispairs and 
misalignments that arise as a result of DNA damage or replication errors, but significantly 
it also regulates homologous recombination, at least between divergent DNA sequences. 
This makes it an attractive system to examine in the context of T. brucei VSG switching.
Although the best-researched mismatch repair (MMR) systems are the MutHLS-dependent 
pathways of Escherichia coli and Salmonella typhimurium (Modrich, 1991), work in 
eukaryotes has revealed extensive sequence conservation between the functional 
homologues of the principal polypeptides involved (Eisen, 1998; Culligan et aL, 2000). 
Such homology suggests the fundamental components of MMR have been conserved 
throughout evolution and adapted to the requirements of increasingly complex genomes 
(Fishel and Kolodner, 1995; Fishel and Wilson, 1997). These major components fall into 
two main categories: MutS homologues (MSH) and MutL homologues (MLH), which are 
related to the bacterial MutS and MutL proteins respectively (Figure 1.9). MutS family 
members typically exhibit 20-30% amino acid identity and the family has been divided 
into two main lineages on the basis of phylogenetic analysis of the highly conserved ATP 
binding domain: MutS-I, which encompasses the proteins involved in MMR; and MutS-II, 
where the eukaryotic proteins are required during meiotic crossing over and chromosome 
segregation (the bacterial homologues have yet to be assigned a function; Eisen, 1998). 
MutS-I homologues generally possess four conserved subdomains: a putative ATP binding 
site (Gorbalenya and Koonin, 1990) and a helix-turn-helix motif towards the C-terminal 
end (Biswas et al., 2001), as well as a middle conserved domain (Culligan et a l, 2000) and 
an N-terminal mismatch interacting domain (Maikov et a l, 1997; Culligan et a l, 2000; 
Schofield et a l,  2001). MutS-II proteins also possess the ATP-binding site and helix-tum- 
helix motif, and some possess the middle conserved domain; they lack the N-terminal 
domain, however (Eisen, 1998; Culligan et a l, 2000). MutL-related proteins also possess 
a putative ATP binding site found in a conserved region of approximately 300 residues at 
their amino-terminus (Bergerat et a l, 1997; Mushegian et a l, 1997; Ban and Yang, 1998;
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Dutta and Inouye, 2000), while the rather diverse carboxy-terminal region is responsible 
for dimer formation (Pang et a l, 1997; Schâr et a l, 1997; Kondo et a l, 2001).
The MutHLS or MMR system in Escherichia coli has been reviewed by Modrich, 1991; 
Fishel and Kolodner, 1995; Kolodner, 1996; Modrich and Lahue, 1996; Jiricny, 1998; 
Buermeyer et a l, 1999; Harfe and Jinks-Robertson, 2000 (Figure 1.10). In this system, the 
MutS homodimer recognises and binds base-base mispairs and small insertion-deletion 
loops (IDLs). The MutS-DNA complex is then bound by a homodimer of MutL. MutL is 
thought to function as a molecular matchmaker, interacting with and modulating the 
activities of other proteins involved in MMR. MutL recruits MutH, an endonuclease 
which nicks the unmethylated strand at a hemimethylated GATC site. Excision from the 
nick past the mismatch and resynthesis of the unmethylated strand to complete the repair 
can be bi-directional, and requires the co-ordinated activities of any of a number of single­
strand-specific exonucleases including Exol, ExoVII, ExoX or RecJ, as well as UvrD 
(MutU) helicase II, single-strand binding protein (SSB), DNA polymerase III holoenzyme 
and DNA ligase. The use of dam méthylation to distinguish between parental and newly 
replicated DNA appears to be unique to gram negative bacteria, and since no homologues 
of MutH have been identified outside this group, other organisms must possess different 
mechanisms of signal transduction and strand discrimination (Jiricny, 1998; Buermeyer et 
a l, 1999; Kolodner and Marsischky, 1999; Harfe and Jinks-Robertson, 2000).
Although the model for MMR in eukaryotes is far from complete, it is thought to have 
evolved from an ancestral system also related to the MutHLS system in bacteria (Eisen, 
1998; Culligan et a l, 2000). In S. cerevisiae, six MSH genes and four MLH genes have 
been described (Kolodner and Marsischky, 1999). Furthermore, there has been extensive 
progress in identifying and understanding the proteins involved in mammalian MMR since 
the discovery that hereditary nonpolyposis colorectal carcinoma (HNPCC), a common 
form of inherited cancer predisposition syndrome, is caused by mutations in some of the 
genes encoding components of the MMR system (Peltomaki et a l,  1997).
Of the six MSH genes found in S, cerevisiae, MSH2-6 encode proteins that act on nuclear 
DNA, and homologues of each have been found in a large array of eukaryotes. However, 
MSHl, which is required for the stability of the mitochondrial genome, has so far only 
been identified in S. cerevisiae, Schizosaccharomyces pombe and Arabidopsis thaliana 
(Reenan and Kolodner, 1992a; Reenan and Kolodner, 1992b; Culligan and Hays, 2000). Of 
the five nuclear homologues, three (MSH2, MSH3 and MSH6) are involved in mismatch 
repair (Johnson et a l, 1996b; Marsischky et a l, 1996), whereas the remaining two (MSH4
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and MSH5) facilitate crossing-over during meiotic recombination (Ross-Macdonald and 
Roeder, 1994; Hollingsworth et a l, 1995). MSHl, MSH2, MSH3 and MSH6 are members 
of the MutS-I lineage whereas MSH4 and MSH5 have been classified as MutS-II proteins 
(Eisen, 1998). Orthologues of MSH2, MSH3 and MSH6 have been described in both 
mammals and plants, and in fact, plants possess an extra MutS homologue, MSH7, which 
also appears to function in MMR (Culligan and Hays, 2000; Dong et a l, 2002).
In contrast to bacteria, eukaryotic MutS homologues have evolved to form heterodimers 
(with the exception of MSHl; Nakagawa et a l, 1999). An explanation for this may have 
been uncovered by structural studies of MutS homodimers in E. coli and Thermus 
aquaticus which revealed that while the protein subunits are identical, together they form 
structural heterodimers by adopting different conformations upon mismatch binding 
(Lamers et a l, 2000; Obmolova et a l, 2000), In eukaryotes, the possession of multiple 
MutS-I homologues allowed the evolution of distinct heterodimers which may have 
broadened the range of mismatches the cell is able to detect and repair. In yeast and 
mammals, MSH2 forms complexes with MSH3 and MSH6 (Figure 1.11; Acharya et a l, 
1996; laccarino et a l, 1996; Marsischky et a l,  1996). These heterodimers are also present 
in plants, and are joined by a third as MSH2 also interacts with MSH7 (Culligan and Hays, 
2000). Interactions between MSH4 and MSH5 have also been documented in yeast 
(Pochart et a l, 1997), but discussion of the activities of this heterodimer is outwith the 
scope of this work.
Evidence from in vitro binding assays and mutation spectra suggest that MSH2 is 
necessary for the repair of all types of mismatches. The MSH2-MSH6 heterodimer (also 
known as the MutSa complex in mammals and plants) is believed to recognise and bind 
base-base mispairs preferentially, while the MSH2-MSH3 complex (MutS(3 in mammals 
and plants) is primarily involved in the repair of IDLs (Acharya et a l,  1996; Habraken et 
a l, 1996; Johnson et a l, 1996b; Marsischky et a l, 1996; Sia et a l,  1997b; Earley and 
Crouse, 1998; Genschel et a l, 1998). In plants, the MSH7 protein is closely related to 
MSH6 and forms the heterodimer MSH2-MSH7, or MutSy (Culligan and Hays, 2000).
In vitro studies indicate that the spectrum of mismatches recognised by MSH2-MSH7 may 
be similar to that of MSH2-MSH6. However, the affinity of the MSH2-MSH7 
heterodimer for the mismatches tested was lower than that of the MSH2-MSH6 
heterodimer for the same mispairs. This may suggest that MSH2-MSH7 is required for the 
repair of specialised DNA lesions or mispairs in specialised contexts (Culligan and Hays, 
2000). The in vivo activities of MSH2-MSH7 have yet to be investigated. MSH2-MSH6
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and MSH2-MSH3 appear to be partially redundant in function as they compete for the 
repair of small 1- to 2-nucleotide loops (Acharya et a l, 1996; Johnson et a l,  1996b; 
Marsischky et a l, 1996; Greene and Jinks-Robertson, 1997; Genschel et a l, 1998;
Culligan and Hays, 2000). Furthermore, MSH2-MSH6 is considered to be the 
predominant complex during post-replicative mismatch repair, as studies of the protein 
levels within MMR-proficient human cells revealed it to be in excess over MSH2-MSH3 
(Drummond et a l, 1997; Genschel et a l, 1998; Marra et a l, 1998). Such studies have yet 
to be performed in yeast and plants.
As previously stated, the eukaryotic MutS homologues involved in nuclear MMR possess 
four conserved domains. The best studied of these is the highly conserved ATP-binding 
domain which contains the four motifs characteristic of the ABC ATPase superfamily 
(I, II, III and IV; Gorbalenya and Koonin, 1990; Holland and Blight, 1999). In this 
superfamily, motif I corresponds to the ‘Walker A’ consensus sequence which is required 
to bind the phosphoryl moeity of ATP or GTP (also known as the P-loop), and motif III 
corresponds to the ‘Walker B’ site which is required for Mg^^ binding (Walker et a l, 1982; 
Gorbalenya and Koonin, 1990). Purified bacterial, yeast and human MutS homologues 
have been shown to possess an intrinsic low level ATP hydrolysis (ATPase) activity 
(Haber and Walker, 1991; Chi and Kolodner, 1994; Alani et a l, 1997b; Gradia et a l,
1997) which is essential for the correct functioning of these proteins in MMR. Genetic 
analyses of wwf&related genes from bacteria and S. cerevisiae revealed that mutations 
within the P-loop resulted in decreased in vitro ATPase activity, and over-expression of the 
mutant alleles led to dominant negative mutator phenotypes (Haber and Walker, 1991; 
Alani et a l, 1997b; laccarino et a l, 1998; Studamire et a l, 1998). In in vitro DNA 
binding assays, addition of ATP to reactions containing mismatched substrates abolished 
MSH2-MSH6 mismatch binding (Drummond et a l, 1995; Gradia et a l, 1997). This 
ATP-dependent mismatch release probably results from the translocation of the 
heterodimer away from the mismatch and off the free ends of the bound DNA molecule.
In similar experiments, where the ends of the DNA substrates were physically blocked by 
biotin-streptavidin complexes, or indeed where the DNA substrates were circular, this 
ATP-induced release of MSH2-MSH6 was prevented (Gradia et a l, 1999). It has been 
suggested that MSH2-MSH6 functions as a molecular switch similar to G protein 
signalling pathways (Gradia et a l, 1997; Fishel, 1998; Gradia et a l, 1999; Fishel et a l,
2000). In this model, the MSH2-MSH6 heterodimer hydrolyses ATP to form the 
mismatch-binding competent ADP-bound form. Recognition of a mismatch induces 
ADP-ATP exchange which results in the formation of a freely diffusible clamp which is 
stably associated with DNA. The clamp dissociates from the mismatch and is capable of
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rapidly diffusing away in either a 5' or 3' direction, allowing a further MSH2-MSH6 
complex to bind the mismatch. This hypothesis accounts both for the bidirectionality of 
MMR, and affords a possible mechanism of signal transduction to activate the repair 
machinery. The target of the MSH2-MSH6 sliding clamp is unknovm, but both 
proliferating cell nuclear antigen (PCNA) and exonuclease 1 (EXOl) are attractive 
candidates (see below; Gradia et a l,  1999). It is likely that the other eukaryotic 
MutS-related heterodimers involved in MMR function in a similar manner given the high 
level of conservation of their ATP-binding domains.
The second conserved domain found towards the C-terminus is the helix-turn-helix motif. 
This region is required for dimérisation of the MutS homologues as revealed by structural 
studies of bacterial MutS (Lamers et a l, 2000; Obmolova et a l, 2000). Mutation of the 
helix-turn-helix motif of both MutS and MSH2 not only leads to loss of dimérisation but 
also loss of mismatch binding and ATP hydrolysis (Alani, 1996; Alani et a l, 1997b; 
Biswas et a l, 2001). This can be explained by the structural data which reveals that both 
the ATP-binding site and the DNA binding site of MutS are composed of domains derived 
from both subunits (Lamers et a l, 2000; Obmolova et a l, 2000). If this is also the case in 
eukaryotes, disruption of dimérisation would also affect both the ATPase and mismatch 
recognition activities of the MSH2-containing heterodimers.
The middle conserved domain is the third region of conservation found in the MutS 
homologues (Culligan et a l, 2000). Three dimensional structural analysis of 
Homo sapiens MSH2 indicates that this domain lies on the surface of the molecule (de Las 
Alas et a l, 1998), and a dominant negative phenotype is observed upon mutation of a 
highly conserved arginine in this region of E. coli MutS (R305H) (Wu and Marinus, 1994). 
While the middle domain is probably not directly involved in heterodimer formation 
(Alani, 1996; Guerrette et a l, 1998), it may have a role in mediating interactions with 
other components of the MMR system, for instance members of the MutL family of 
proteins.
The final conserved region found in MutS homologues involved in MMR is the N-terminal 
mismatch interacting domain. Within the N-terminal domain of E. coli MutS and 
T, aquaticus MutS, there is a conserved Phe-X-Glu DNA binding motif, where the 
glutamic acid residue hydrogen bonds with either an unpaired thymidine or the thymidine 
of a G-T mismatch (Lamers et a l, 2000; Schofield et a l, 2001). This motif is also present 
in MSH6 and MSH7 homologues from A. thaliana, H  sapiens and S. cerevisiae, 
suggesting this motif is common to proteins binding base-base mismatches and small IDLs
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(Acharya et a l, 1996; Marsischky et a l, 1996; Culligan and Hays, 2000; Culligan et a l,
2000). MSH3 orthologues, which are involved in the repair of larger IDLs do not possess 
the conserved Phe-X-Glu motif, although they do show sequence conservation within this 
region (Culligan et a l, 2000). A similar situation is observed within the MSH2 
orthologues.
Analysis of genetic and protein-protein interactions suggests that eukaryotic MMR is 
fundamentally similar to the bacterial system, and that a heterodimer of MutL homologues 
interacts with an MSH2-containing heterodimeric complex bound to mismatched DNA 
(Figure 1.12) (Jiricny, 1998; Buermeyer a/., 1999; Kolodner and Marsischky, 1999; 
Nakagawa et a l,  1999; Harfe and Jinks-Robertson, 2000). Four genes possessing the 
regions of homology characteristic of MutL-family members have been cloned in 
S. cerevisiae', these are designated MLHl, MLH2, MLH3 and PMSl (named for the 
phenotype of post-meiotic segregation). Four MutL homologues have so far been described 
in mammals; MLHl, MLH3, PMSl and PMS2. The closest mammalian homologue of 
S. cerevisiae PMS1 is PMS2, but it is unclear as to whether mammalian PMS1 is more 
closely related to S. cerevisiae PMSl or MLH2 (Lipkin et a l, 2000). Currently only 
MLHl has been described in^ . thaliana, although studies of MMR in plants are still in 
their infancy (Jean et a l, 1999).
MLHl has been identified as the common subunit of three MutL-related complexes in 
yeast, associating with PMSl, MLH2 and MLH3 (see Figure 1.11) (Wang et a l, 1999). In 
yeast, MLHl mutants, MLHl PMSl double mutants and MSH2 mutants all exhibit a 
similar level of phenotypic deficiency in assays examining the repair of replication errors, 
indicating that the MLHl and PMSl proteins are necessary during the repair of such errors 
(Strand et a l, 1993; Prolla et a l,  1994a; Greene and Jinks-Robertson, 1997). MLHl-PMSl 
(MLH1-PMS2 in mammals, where it is also called MutLa) is known to form mismatch- 
dependent ternary complexes with both MSH2-MSH6 and MSH2-MSH3 and so plays an 
important role in the repair of both base-base mispairs and IDLs (Habraken et a l, 1997; 
Habraken et a l, 1998; Blackwell et a l, 2001). The MLH1-MLH3 heterodimer is reported 
to interact with MSH2-MSH3 only, probably to promote the repair of specific insertion- 
deletion mispairs (Flores-Rozas and Kolodner, 1998), but it is also thought to complex 
with the MSH4-MSH5 heterodimer to facilitate crossing-over during meiosis (Wang et a l , 
1999). The MLH1-MLH2 complex has only recently been described, and MLH2 mutants 
are resistant to cisplatin and related anticancer drugs thereby implying a role in processing 
some types of DNA damage (Durant et a l, 1999).
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As for MutL in E. coli, the MLH-related heterodimers in eukaryotes are believed to act as 
"coupling" factors in the assembly of higher order complexes during MMR, or indeed 
during meiotic crossing-over (Buermeyer et a l, 1999). Consistent with this idea are the 
findings that MLHl interacts with proteins which are thought to be involved in the 
downstream processing and repair of mismatches, including PCNA and EXOl (see below). 
It is also probable that the MutL homologues enhance mismatch recognition, as it is known 
that MutL increases the efficiency of mismatch recognition by MutS (Drotschmann et a l ,
1998) and similar results have been reported for yeast MLHl-PMSl (Habraken et a l,
1997).
As described above, MutL-related proteins possess two characteristic conserved domains, 
an ATP-binding domain and a dimérisation domain. The ATP-binding domain is highly 
conserved between the MutL homologues and is a member of the recently described 
GHKL ATPase/kinase superfamily (Bergerat et a l, 1997; Mushegian et a l, 1997; Ban and 
Yang, 1998; Dutta and Inouye, 2000). The best researched member of the MLH family,
E, coli MutL, possesses a weak ATPase activity which is required to transduce the signal 
from MutS to factors which effect the repair of the mismatch (Aronshtam and Marinus, 
1996; Ban and Yang, 1998; Ban et a l, 1999; Spampinato and Modrich, 2000). Weak 
ATPase activities have also been demonstrated in S. cerevisiae MLHl and PMSl and 
amino acid substitutions within the conserved ATP-binding motifs of these proteins result 
in a reduction in ATP-binding and hydrolysis and lead to mutator phenotypes in vivo (Pang 
et a l, 1997; Tran and Liskay, 2000; Hall et a l, 2002). Further to this, it has been 
demonstrated that S. cerevisiae MLHl binds ATP more efficiently than PMSl, suggesting 
that MLHl binds ATP first, resulting in a conformational change allowing PMSl to bind 
ATP, and allowing the heterodimer to modulate interactions with other MMR components 
(Hall et a/., 2002).
The second domain present in MutL homologues is required for dimérisation and is found 
in the C-terminal portion of these proteins (Pang et a l, 1997; Guerrette et a l, 1999; Kondo 
et a l , 2001). This domain is poorly conserved between the paralogous MutL-related 
protein sub-families, but well-conserved regions can be identified between orthologues 
(Pang et a l,  1997; Lipkin et a l, 2000). For instance, yeast PMSl shares the sequence 
PWNCPHGRPTMRH with its orthologue human PMS2, but not with its paralogues, yeast 
MLHl or human PMSl (Pang et a l, 1997). Deletion studies show that proteins which lack 
this domain cannot interact with their normal MutL-related binding partners (Pang et a l , 
1997; Guerrette et a l, 1999; Kondo et a l, 2001). Furthemiore, mutational studies of the 
dimérisation domains of human MutL homologues revealed that a number of mutations
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reported in HNPCC kindreds caused a strong reduction in heterodimerisation, explaining 
the MMR-deficiency in these patients (Guerrette et a i, 1999).
A final conserved motif, which is present only in orthologues of MLHl, has been termed 
the carboxy-terminal homology (CTH) motif (Pang et a l,  1997). This domain is essential 
for mismatch repair function in S. cerevisiae MLHl, and mutations in this motif resulted in 
strong mutator phenotypes, but did not affect interaction with PMSl (Pang et a l, 1997). 
However, the exact role of this motif in the functioning of MLHl has not yet been 
elucidated.
The proteins involved in DNA strand discrimination, and excision and resynthesis of the 
nascent strand have yet to be frilly characterised in eukaryotes (Figure 1.12), but it is 
expected that many of the activities required to complete MMR in bacteria will also be 
necessary in eukaryotes. As described above, in E. coli strand discrimination is achieved 
by the endonuclease MutH, which introduces a nick in the nascent strand at hemi­
methylated GATC sequence (Modrich and Lahue, 1996). Eukaryotes do not possess dam 
méthylation, but it is hypothesised that single-strand breaks and strand discontinuities 
created during replication are utilised to distinguish the nascent strand, since in vitro repair 
of mismatched plasmid substrates containing a single-strand break occurs on the nicked 
strand (Holmes et a l, 1990; Thomas et a l, 1991; Buermeyer et a l,  1999). PCNA, an 
essential factor in DNA replication, forms a ring shaped trimeric complex which encircles 
DNA and tethers DNA polymerase to the template (Warbrick, 2000). It also functions as a 
sliding platform which can mediate interactions between several different proteins at once, 
as well as with DNA (Jonsson and Hubscher, 1997; Kelman, 1997; Kelman and Hurwitz,
1998). There is mounting evidence to suggest that PCNA may also mediate interactions 
between the mismatch recognition complex and the replication machinery, thereby 
facilitating strand discrimination (Figure 1.12). Consistent with this suggestion is the 
finding that human MSH3 and MSH6 colocalise with PCNA to replication foci 
(Kleczkowska et a l, 2001). Moreover, both yeast and human MSH3 and MSH6 have 
been shown to interact with PCNA as part of a heterodimer with MSH2 (Johnson et a l , 
1996a; Clark et a l, 2000; Flores-Rozas et a l, 2000; Kleczkowska et a l, 2001), and 
conserved PCNA-binding sites have been found at the extreme N-termini of MSH3 and 
MSH6 homologues from yeast and humans (Clark et a l , 2000; Warbrick, 2000). This 
motif is also present in MSH3, MSH6 and MSH7 from A. thaliana, although it is absent 
from the MSH2, MLHl and PMSl orthologues in all these species (Kleczkowska et a l,
2001). It has also been shown that interaction with PCNA is strongly reduced where the 
PCNA binding sites of MSH3 and MSH6 contain mutations (Clark et a l,  2000;
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Kleczkowska et a l, 2001), and that interaction with this replication factor enhances the 
mispair binding of the MSH2-MSH6 heterodimer (Flores-Rozas et a l,  2000). The 
importance of these interactions for functional mismatch repair is underlined by in vivo 
studies of the yeast MSH3 and MSH6 proteins which revealed that mutations in the PCNA 
binding site led to a mutator phenotype (Clark et a l, 2000; Flores-Rozas et a l, 2000). It 
has been suggested that these phenotypes arise due to defects in the strand discrimination 
process, an idea supported by the finding that some mutations in S. cerevisiae pol30 (the 
gene encoding PCNA in this organism) cause mutator phenotypes epistatic to 
MMR-inactivating mutations (Chen et a l, 1999). Interaction with PCNA is not limited to 
the MutS homologues, however, as MLHl has also been shown to bind PCNA, although 
the region of the MLHl protein involved in this interaction has not been identified (Umar 
et a l, 1996). Furthermore, a complex containing MSH2, M LHl, PMS2 and PCNA was 
co-immunoprecipitated in the presence of DNA and ATP from nuclear extracts of 
MMR-proficient human cells, but not from MLHl-deficient human cells (Gu et a l, 1998). 
Recently, it has been shown that ternary complexes composed of MSH2-MSH6 and 
M LHl-PMSl, while stable in the presence of mismatched DNA and ATP, are disrupted by 
the addition of PCNA, indicating that this protein not only interacts with these complexes, 
but may induce translocation of the complex away from the mismatch in order to recruit 
downstream factors required for mismatch correction (Bowers et a l , 2001). In addition to 
the role of PCNA during the early stages of MMR, Gu et aL (1998) suggested that this 
replication factor might also be required during the DNA resynthesis step, as unrepaired 
molecules and repair intermediates that were blocked at the step of DNA resynthesis by 
limiting amounts of PCNA were converted to full-length products in the presence of excess 
PCNA. While these data suggest a central role for PCNA in MMR, evidence indicates that 
other replication factors such as replication protein A (RPA) and replication factor C 
(RFC) are also required (Lin et a l, 1998; Xie et a l, 1999). Indeed, recently it has been 
suggested that RPA may be required to protect single-stranded regions of the template 
DNA strand from nuclease degradation (Ramilo et a l , 2002), thereby ensuring that the 
template strand is suitable for repair DNA synthesis and echoing one of the roles of single­
strand binding protein (SSB) in E. coli (Meyer and Laine, 1990).
As in bacteria, a number of exonucleases have also been implicated in eukaryotic MMR. 
EXOl has been reported to interact with MSH2, MSH3 and MLHl in vitro, and studies 
show that EXOl and the MutLa complex can be co-immunoprecipitated from human 
extracts (Tishkoff et a l, 1997; Schmutte et a l, 1998; Schmutte et a l,  2001). Mutations in 
EXOl caused a weak mutator phenotype in both budding and fission yeast and analysis
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showed that MSH2 was epistatic over EXOl (Tishkoff et a l, 1997; Rudolph et a l, 1998). 
It has also been suggested that the 3'-5' exonuclease functions of both DNA polymerases 
delta (Pol Ô) and epsilon (Pol c) are partially redundant with the 5'-3' activity of EXOl, as 
combined inactivation of these three exonuclease activities give rise to a mutation rate 
similar to that seen in MMR-deficient yeast cells (Tran et a l, 1999). Further to this, 
human extracts depleted of Pol 5 are defective in the repair DNA synthesis step of 
mismatch correction, but this defect is alleviated by addition of this enzyme, implicating 
this DNA polymerase in the reaction (Longley et a l, 1997). It is also noteworthy that 
Pol 5 has been reported to interact with PCNA (Prelich et a l, 1987), again suggesting an 
association between the MMR system and the replication machinery.
Our understanding of the eukaryotic MMR system still remains incomplete (Figure 1.12), 
and, as yet, no eukaryotic helicase(s) or DNA ligase(s) have been implicated in MMR. It 
is possible that a number of helicases can function in eukaryotic MMR, and that this 
functional redundancy has masked the identities of these components. Another possibility 
is that eukaryotic MMR may involve exonucleases which work on double-stranded DNA 
(for instance EXOl), thereby removing the need for helicase activity (Harfe and Jinks- 
Robertson, 2000). It is also possible that functional redundancy has prevented the 
identification of the ligase which completes the MMR reaction, although the most 
attractive candidate is DNA ligase I (Marra and Schar, 1999).
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Figure 1.9 The proteins involved in the post-replicative mismatch repair (MMR) 
pathway
a) The MutS homologues involved in MMR possess four conserved subdomains (shown in 
red): a mismatch interacting domain (Maikov et a l, 1997; Schofield et a l, 2001), a middle 
conserved domain (Culligan et a l, 2000), an ATP binding domain (Gorbalenya and 
Koonin, 1990) and a helix-turn-helix motif (Biswas et a l, 2001). b) MutL-related peptides 
contain a highly conserved ATP binding domain (Bergerat et a l, 1997; Mushegian et a l, 
1997; Ban and Yang, 1998; Dutta and Inouye, 2000) and a more diffuse region of 
conservation required for dimer formation (shown in blue; Pang et a l,  1997; Schâr et al., 
1997; Kondo et a l, 2001). The amino- and carboxy-termini are designated N and C 
respectively.
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Figure 1.10 The mechanism of E. coli methyl-directed MMR
MMR is initiated when a MutS homodimer binds a mispair. The subsequent binding of the 
MutL homodimer is required to recruit the MutH endonuclease, which nicks the newly- 
replicated unmethylated strand at a hemi-methylated GATC site, located either 5’ or 3’ of 
the mismatch. This is followed by an excision step which requires the activity of helicase 
II to displace the newly-replicated DNA strand, as well as one of a number of single­
stranded exonucleases to digest the displaced strand leaving a gap in the DNA. Excision 
from the nick to the mismatch may occur in either a 5’ to 3’ direction, performed by 
ExoVII or RecJ, or a 3’ to 5’ direction, using Exol or ExoX. Resynthesis to fill in the 
resulting gap requires the DNA polymerase III holoenzyme complex, SSB and DNA 
ligase. In this system, MMR is coupled to DNA replication, so that mismatches formed 
during DNA replication can be repaired using the methylated parental strands as templates, 
thereby reducing misincorporation errors. (Adapted from Grilley et a i,  1993)
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Figure 1.11 Interactions between MutS- and MutL-related proteins during 
mismatch repair in Saccharomyces cerevisiae
Depending on the type of mismatch, the distorted heteroduplex is bound by either 
MSH2-MSH6, in the case of a base-base mispair or small insertion/deletion loop (IDL), or 
MSH2-MSH3 where a larger IDL is detected. The MSH2-containing heterodimer/DNA 
complex is then bound by a MutL-related heterodimer; in yeast this is usually 
MLHl-PMSl, however, some specific IDLs may induce binding of MLH1-MLH3 to the 
MSH2-MSH3 complex. (Adapted from Kolodner and Marsischky, 1999)
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Figure 1.12 A scheme for eukaryotic mismatch repair
Initially, a mismatch is recognised by an MSH2-containing heterodimer (shown in red), 
which, in turn, is bound by an MLHl-containing heterodimer (shown in blue). Formation 
of this ternary-complex is believed to enable the recruitment of factors required for strand 
discrimination and excision of the mismatch, followed by resynthesis and ligation of the 
nascent strand. A number of the components required during this process have yet to be 
identified. (Adapted from Buermeyer et al., 1999)
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1.6 Mismatch repair in DNA recombination
Recombination between divergent (homeologous) DNA sequences has been found to occur 
at a reduced frequency when compared with recombination between homologous 
sequences (Evans and Alani, 2000; Harfe and Jinks-Robertson, 2000). During the 
formation of heteroduplex joints between independent but complementary single-stranded 
parental DNA molecules, mispaired bases arise where the two single strands differ in 
sequence. Where very high levels of sequence divergence are encountered, stably 
base paired strand exchange intermediates seem to be unable to form, thereby preventing 
recombination. However, even a single mismatched base-pair serves to inhibit 
recombination, indicating that an active anti-recombination system also exists (Datta et a l , 
1996; Datta et a l, 1997). MutS- and MutL-related proteins, interacting with mispaired 
bases in strand exchange intermediates, form the basis of this activity, since the frequency 
of recombination between homeologous substrates is often greatly elevated in 
MMR deficient cell lines (Shen and Huang, 1989; Alani et a l, 1994; Selva et a l, 1995; 
Datta et a l, 1996; Datta et a l, 1997; Evans and Alani, 2000). During heteroduplex 
formation mismatches are processed by components of the MutHLS system in bacteria, 
and evidence from yeast and mammalian cells suggests that the barrier to recombination 
imposed by mismatch repair is conserved throughout evolution (Rayssiguier et a l, 1989; 
de Wind et a l, 1995; Selva et a l, 1995; Datta et a l, 1996).
One function of the MMR anti-recombination activity is likely in spéciation, acting as a 
genetic barrier that prevents recombination between the genomes of closely related species 
(Rayssiguier et a l, 1989; Hunter et a l, 1996; Stambuk and Radman, 1998; Vulic et a l, 
1999). For example, the bacterial species, E. coli and Salmonella typhimurium, cannot 
normally undergo successful mating. If MMR mutants are crossed, however, this barrier is 
alleviated (Rayssiguier et a l, 1989). In fact, over 1% of cells in wild populations of 
pathogenic E. coli or Salmonella enterica may be MMR-deficient, posing the question 
whether these cells enhanee transmission of antibiotic resistance and virulence genes 
between bacterial populations through interspecies mating (LeClerc et a l,  1996). The 
anti-recombination activities of MMR may also enhance genome stability by inhibiting 
gene amplification, recombination between diverged repetitive sequences, and gross 
chromosomal rearrangements, thereby protecting against tumour formation in mammals 
(Harfe and Jinks-Robertson, 2000; Lin et a l, 2001; Myung et a l, 2001; Pastink et a l, 
2001).
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Two general models have been proposed to explain how eomponents of the MMR 
machinery act to down-regnlate homeologous recombination (Rayssiguier et a l,  1989).
The heteroduplex destruetion model suggests that MMR-direeted exeision leads to the 
generation of multiple single-strand breaks which destroy the recombination intermediate. 
In contrast, the non-destructive heteroduplex rejection model suggests that the MMR 
proteins act to reverse the formation of mismatch-containing heteroduplex DNA. The 
finding that mitotie recombination between 94%-identical substrates generated gene 
conversion tracts which were significantly longer in MMR-defective yeast strains when 
compared with wild-type strains is consistent with either of these models (Chen and Jinks- 
Robertson, 1998; Nicholson et a l , 2000). However, it has been reported that MMR 
activity does not greatly affect the transformation efficiency of plasmids containing a 
preformed heteroduplex region into E. coli, arguing against the ereation of DNA breaks by 
the heteroduplex destruction model (Westmoreland et a l , 1997). Further evidence 
supporting the heteroduplex rejection model includes the finding that E. coli MutS and 
MutL proteins reduce both the rate and extent of RecA-mediated branch migration in vitro 
when the recombining heteroduplexes contain mismatches (Worth et a l, 1994; Worth et 
a l,  1998). These experiments also indicated that inhibition of homeologous recombination 
required the ATPase activity of the MutS protein (Worth et a l,  1998). More recently, 
MutS and MutL have also been shown to inhibit RuvAB-dependent stimulation of 
RecA-promoted branch migration through regions containing sequence heterologies 
(Fabisiewicz and Worth, 2001).
The meehanism of heteroduplex rejection is unknown, although several explanations have 
been suggested. Firstly, either reverse branch migration or immediate resolution of the 
recombination intermediate may result from a direct interaction between MMR proteins 
and the recombination machinery upon detection of mismatch-containing heteroduplex 
DNA (Alani et a l, 1994). Alternatively, rejection of the donor strand could result from 
unwinding of mismatched heteroduplex molecules by an MMR-associated helicase activity 
(Claverys and Lacks, 1986; Zahrt and Maloy, 1997). This hypothesis is supported by 
evidence indicating that MMR regulates homeologous recombination in E. coli at two 
stages, including an early stage which requires the UvrD helicase and the RecBCD 
nuclease, and a late MutH-dependent stage (Stambuk and Radman, 1998).
As stated above, a single mismatch is sufficient to activate the MMR-dependent 
anti-recombination mechanism, and further mismatches have a cumulative negative effect 
on the frequency of recombination (Datta et a l, 1997; Chen and Jinks-Robertson, 1999). 
As the level of sequence heterology between the substrate molecules inereases, the
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probability of the recombination intermediate avoiding detection by the MMR system 
decreases, and Avhere the sequences are diverged by several pereent the presence of 
additional mismatches fails to induce further anti-recombination activity. Furthermore, the 
overall rates of recombination between identical DNA sequences are also increased in 
MMR-defieient cells, although exactly why this should be so is not clear (Datta et a l , 
1997). One explanation might be that mispairs are formed during the early steps of 
homology searching, and these are resolved as longer strand exchange intermediates are 
formed.
Studies of mitotic recombination in yeast have revealed that MSH2, MSH3, MSH6,
MLHl, PMSl, RADI, RADIO and EXOl all inhibit recombination in the presence of 
mismatches (Chen and Jinks-Robertson, 1999; Nicholson et a l,  2000). In general, the 
MSH2-MSH3 and MSH2-MSH6 heterodimers appear to recognise a similar spectrum of 
mismatches during both recombination and replication (Nicholson et a l, 2000). The 
greatest increases in homeologous recombination rates, relative to wild-type strains, are 
seen in MSH2 mutants. MSH6 mutants seem unable to inhibit recombination between 
sequences containing base-base mispairs and 1-nucleotide loops, while mMSHS mutants 
recombination rates increase between sequences containing IDLs of up to 18-nucIeotides, 
but also, surprisingly, some types of base-base mispair. Disruption of MLHl, PMSl or 
MLHl PMSl all lead to similar inereases in homeologous recombination rates, suggesting 
that the peptides operate as a heterodimer (Nieholson et a l , 2000). However, 
reeombination rates are lower in these backgrounds than in MSH2 mutant strains, 
indicating that MSH2 is involved in blocking recombination by a pathway independent of 
these proteins, and that mismatch binding alone is suffieient to elicit some anti­
recombination activity (Chen and Jinks-Robertson, 1999; Nicholson et a l, 2000). It 
should be noted, however, that the roles of MLH2 and MLH3 in repressing recombination 
between divergent sequences have yet to be assessed. Further evidence indicates that 
disruption of either RADI or RADIO also increases homeologous recombination to rates 
similar to those seen in MSH3 mutants (Nicholson et a l, 2000). Since other nucleotide 
excision repair (NER) proteins do not seem to affect recombination between divergent 
sequenees, it is thought that the RADI-RAD 10 endonuclease is acting outside its role in 
NER. Finally, EXOl has also been reported to play a minor role in the inhibition of 
homeologous recombination (Nicholson et a l, 2000). Epistasis analysis indicates that 
PMSl, RADI and EXOl act in different pathways or complexes to inhibit homeologous 
reeombination. Furthermore, while the effects of MSH6 and PMSl deletion mutations 
were epistatic, the effects of MSH3 and PMSl deletion mutations were not, suggesting that 
the anti-recombination activity of MSH3 does not rely on interaction with the
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MLHl-PMSl heterodimer and may involve other factors such as the RADI-RAD 10 
endonuclease or EXOl (Nieholson et a l, 2000). Current evidence suggests that the roles 
of MMR proteins in prevention of homeologous recombination are more complex than in 
post-replicative mismatch repair, and further research should elucidate the differences 
between these two mechanisms, leading to a more eomplete model for inhibition of 
homeologous recombination in eukaryotes.
In addition to their roles in mismatch correction and homeologous recombination, the 
MMR proteins are also required to facilitate the processing of recombination intermediates 
during homologous recombination. Evidence shows that MSH2 can bind a variety of DNA 
structures, including Holliday junctions and Y-structures as well as a diverse array of 
mismatches (Alani et a l, 1997a; Sugawara et a l,  1997; Marsischky et a l, 1999).
Moreover, when MSH2 is complexed with either MSH6 or MSH3 another level of 
specificity is added allowing different heterodimers to act upon different types of 
recombination intermediate (Figures 1.13 and 1.14). In& cerevisiae the MSH2-MSH3 
heterodimer, along with the RADI-RAD 10 endonuclease, is known to be required for the 
processing of non-homologous ends during gene eonversion and single-strand annealing 
(Figure 1.13 and 1.14); MSH6, MLHl and PMSl are not required during these events 
(Saparbaev et a l, 1996; Sugawara et a l, 1997). Indeed, the yeast MSH2 protein has been 
reported to loealise to sites near double-strand breaks possessing non-homologous ends in 
vivo (Evans et a l,  2000). Additional studies have suggested that MSH2 and RADIO 
interact with each other directly (Bertrand et a l , 1998). It has been hypothesised that 
during this process MSH2-MSH3 binds to the non-homologous single-stranded DNA at 
the end of the annealed region, thus stabilising the recombination intermediate, and 
allowing the RADI-RAD 10 endonuelease to locate and cleave the non-homologous tail 
(Sugawara et a l, 1997). Finally, MSH2-MSH6 has been found to bind Holliday junctions 
with an affinity and specificity that is at least as high as it has for mispaired bases, as well 
as enhancing their cleavage by phage resolution enzymes (Figure 1.13 and 1.14; 
Marsischky et a l, 1999). The structural features which cause MSH2-MSH6 to recognise 
and bind Holliday junctions have yet to be elucidated.
69
Figure 1.13 Activities of MutS-related proteins during homologous recombination
in Saccharomyces cerevisiae
Different recombination intermediates have been found to interact with different mismatch 
repair components. The MSH2-MSH6 heterodimer has been shown to associate with 
Holliday junctions (Marsischky et a i,  1999). 3'-tailed DNA structures (created during 
single-strand annealing and gene conversion events) are believed to interact with the 
MSH2-MSH3 heterodimer which then recruits the RADI-RAD 10 endonuclease complex 
acting outside its role in the nucleotide excision repair pathway (Sugawara et a l,  1997).
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Figure 1.14 A scheme for DNA recombination and the roles of MutS and MutL 
homologues in Saccharomyces cerevisiae
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1.7 Aims of this thesis
At the outset of this thesis it was unknown whether T. brucei possessed a functional MMR 
system, or whether MMR proteins regulated recombination between divergent sequences 
in this organism. However, it was hypothesised that, if present, the components of MMR 
might be involved in the regulation of antigenic variation in this organism. The primary 
aim of this thesis was to establish whether the T. brucei genome encodes components of a 
functional post-replicative nuclear MMR system, and to determine the roles of this system 
in both DNA recombination and antigenic variation in trypanosomes.
Initially we attempted to identify any highly conserved mutS- and mwf^Z-related genes 
present in T. brucei using both molecular biology techniques, such as PCR amplification 
with degenerate primers, and a computational approach involving searching of the genome 
sequencing databases using the protein sequences of MutS and MutL family members from 
other organisms. Putative MMR components were identified only as gene fragments, and 
so cloning methods were needed to recover the complete genes in order to assign identities 
based on the similarity of the predicted polypeptide sequences to MutS- and MutL-related 
proteins from other eukaryotes.
Those genes encoding putative homologues of MSH2 and M LHl, whieh are, respectively, 
the primary components of the MutS- and MutL-related heterodimers in eukaryotes, were 
chosen for functional analysis. To this end, homozygous knockout mutants were generated 
for each gene, and their roles in MMR confirmed by examining their sensitivities to the 
alkylating agent A-methyl-A^-nitro-A-nitrosoguanidine (MNNG), and their ability to 
correct replication slippage events which result in a mutator phenotype termed 
microsatellite instability. To assess the roles of the putative MSH2 and MLHl genes in 
trypanosome antigenic variation, a VSG switching assay described in McCulloch et al. 
(1997) was adopted. Finally, an assay to elucidate the role of MMR in trypanosome 
homologous and homeologous recombination was developed, and tested in both MSH2 
mutants and wild-type T. brucei.
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C h a p t e r  2
Materials and Methods
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2.1 Trypanosome strains, cell culture and transformation
2.1.1 Trypanosome strains
Three Trypanosoma brucei cell lines were utilised in this study. Clones derived from 
Trypanosoma brucei MITat (Moltino Institute -  Trypanozoan antigen type) 1.2a S427 
were used in the studies on monomorphic bloodstream form trypanosomes. The ILTat 
(I.L.R.A.D. -  International Laboratory for Research in Animal Diseases -  Trypanozoan 
antigen type) 1.2 and TREU (Trypanosomiasis Research Edinburgh University) 927/4 cell 
lines were used solely in molecular studies.
2.1.2 Routine culture of trypanosomes
In vitro cell culture of bloodstream form trypanosomes was performed using HMI-9 
culture medium (Hirumi and Hirumi, 1989) at 37°C.
2.1.3 Transformation and cloning of trypanosomes
Bloodstream form trypanosomes were transformed by electroporation of cells with 
approximately 5 pg of plasmid DNA that had been digested with the relevant restriction 
enzymes, phenol-chloroform extracted and then ethanol precipitated. Electroporation of 
5 x 10  ^cells was perfoimed in 0.5 ml of Zimmerman postfusion medium (132 mM NaCl,
8 mM Na2HP0 4 , 1.5 mM KH 2PO4, 0.5 mM magnesium acetate, 0.09 mM calcium acetate 
[pH 7.0]) supplemented with 1% glucose (ZMG). All electroporation of cells was 
performed using a Bio-Rad Gene Puiser II set at 1.4 kV and 25-pF capacitance (giving a 
delivered voltage of 1.40 to 1.60 kV and a time constant of 0.40 to 0.60 ms). Cells were 
allowed to recover for 18 h in HMI-9 before transformants were selected using the 
relevant antibiotic. Transformants were either selected on semi-solid agarose plates 
(Carruthers and Cross, 1992), where 1x10^ cells were spread on plates containing the 
relevant antibiotic, or 1 x 10  ^or 5 x 10  ^cells were diluted into 18 ml HMI-9, containing 
the relevant antibiotic(s) and spread in 1.5 ml samples over 12 wells of a 24-well tissue 
culture plate. Typically, transformants grew out after 7 to 14 days.
Bloodstream form trypanosomes were cloned in one of two ways. Firstly, by plating 100 
cells on semi-solid agarose plates (Carruthers and Cross, 1992), containing the relevant 
antibiotic(s). Clones typically grew out after 7 to 14 days. Secondly by diluting 20 to 30
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cells in 20 ml of HMI-9 containing the relevant antibiotic(s), and plating 200 pi samples 
over a 96-well culture dish. Clones typically grew out after 5-7 days.
2.1.4 Stabilate manufacture and growth
Cryogenically frozen stocks of trypanosomes (‘stabilates’) were prepared from 
bloodstream form cultures grown to approximately 2.5 x 10*^  cells.ml'^ by mixing with 
100% glycerol, to give a 1 ml sample containing 10% glycerol. Stabilates were frozen to 
-70”C for 24 h before being transferred to liquid nitrogen for storage. When a stabilate was 
required for culture it was thawed rapidly at 3TC  and transferred to a culture flask 
containing 10 ml of culture medium.
2.2 Standard molecular biology techniques
2.2.1 General PCR
Amplification of template using Tag DNA polymerase was performed in 1 x buffer IV 
with separate MgCl] (all reagents supplied by Advanced Biotechnologies), producing 
products with single 3 ’ deoxyadenosine residues at either end owing to the nontemplate- 
dependent terminal transferase activity of the enzyme. Pfu polymerase was used to 
amplify high fidelity PCR products with blunt termini in 1 x Pfu buffer (Stratagene). 
Herculase Enhanced DNA polymerase is based on Pfu polymerase with a small amount of 
Tag polymerase added (Stratagene); it therefore yields high fidelity products with a 
mixture of blunt termini and termini with single 3’ deoxyadenosine overhangs and was 
used in 1 x Herculase buffer. An extension time of 1 min.kb'^ was allowed for both Tag 
polymerase and Herculase polymerase, whilst 2 min.kb'^ was allowed for Pfu polymerase. 
Each primer was added to a final concentration of 200 nM (Sigma Genosys), and 5-20 ng 
of template DNA was used. Deoxynucleotides (dATP, dCTP, dGTP and dTTP) were 
added to a final concentration of 400 pM in total (100 pM each) (Amersham Pharmacia 
Biotech). Reactions were performed in thin-walled 200 pi microeppendorf tubes (Perkin- 
Elmer), and were overlaid with a drop of mineral oil (Sigma) when thermal cycling was 
performed in a Robocycler 96 or Robocycler Gradient 96 (Stratagene), but this was 
unnecessary when using a PCR Sprint (Hybaid). The reaction conditions for each 
individual PCR are described in the relevant sections and include the following details: the 
primers and polymerase used, the template and Mg^ "*" concentrations, the cycling 
conditions, and the final reaction volume.
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2.2.2 Restriction digestion
Restriction digestion reactions were usually performed in a final volume of 20 pi 
containing 1 x reaction buffer and 20-40 U enzyme (all reagents supplied by New England 
Biolabs). For double digestions the most compatible reaction buffer was chosen and equal 
amounts of the two enzymes were added. Reactions were incubated for 2 h at the optimal 
temperature for the enzyme. Each reaction contained 200-600 ng DNA. Where greater 
amounts of DNA needed to be digested several reactions were set up, and normally 
combined either by gel purification and pooling or by phenol/chloroform extraction, 
ethanol precipitation and pooling.
2.2.3 General gel electrophoresis
Samples of DNA were typically electrophoresed on 0.6 to 1.0% agarose gels (Gibco BRL, 
Life Technologies) made with either 1 x TAE buffer or 0.5 x TBE buffer containing 
0.2 pg.ml'^ EtBr at 20 to 100 kV for 1 to 18 h, using a commercial 1 kb ladder as a size 
marker (Gibco BRL, Life Technologies). Gels were then visualised under UV.
2.2.4 Ligation of PCR products
PCR products with blunt termini were purified using the Strataprep PCR purification kit 
and cloned into PCR-Script Amp SK(+) plasmids (all reagents supplied by Stratagene, 
following the manufacturer’s protocols). In most cases the inserts were amplified using 
Pfu polymerase or Herculase polymerase. However, in some instances Taq polymerase­
generated PCR products, which possess 3’ terminal adenine residues, were ‘polished’ by 
the addition of Pfu polymerase after purification (using reagents supplied with the 
PCR-Script Amp Cloning Kit, Stratagene, following the manufacturer’s protocol). 
Ligations were performed at room temperature for 1 h. For each cloning attempt a range 
of different insert:vector ratios were prepared to maximise the likelihood of a successful 
ligation. The PCR Script system relies on the addition of Srfl, which is an infrequently 
cleaving restriction enzyme which cuts in the plasmid multiple cloning site to generate 
blunt termini, into the ligation mix. Any plasmid which religates without an insert will be 
restricted by Srfi, thereby enhancing the overall yield of correct ligations.
PCR products generated using Taq polymerase were cloned directly into pCR2.1-T0P0 
(Invitrogen, according to the manufacturer’s instructions). Ligations were performed at 
room temperature for 5 to 30 min. The TOPO TA cloning system relies on vector with an
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Open multiple cloning site possessing single 3’-thymidine overhangs at both termini which 
are covalently bound to Topoisomerase I by phospho-tyrosyl bonds between the DNA and 
the enzyme. When an insert possessing 3’-adenine overhangs (i.e. a Taq PCR product) is 
introduced, the 5’-hydroxyl groups of the insert molecule can attack the phospho-tyrosyl 
bonds, thereby releasing the topoisomerase and ligating the insert to the vector.
2.2.5 Ligation of restricted DNA fragments
The treatment of DNA fragments after restriction digestion depended on the type of 
cloning involved. For ligations involving compatible restriction sites in the vector, 20 U of 
Calf Intestinal Phosphatase (CIP; Roche) was added to restriction digestion reactions of 
vector DNA and incubated for 5 min at room temperature to remove the 5 ’ terminal 
phosphates and prevent religation of the vector prior to purification. Where 5’ 
overhanging restriction sites needed to be made blunt for ligating non-compatible ends, the 
20 pi restriction digestion reaction was supplemented with 0.5 pi 10 x digestion buffer,
1 pi of lOmM dNTPs (containing dATP, dCTP, dGTP and dTTP at 2.5 mM each),
5 U DNA polymerase I largeTragment (Klenow, New England Biolabs) and 2.5 pi distilled 
H2O to bring the volume of the restriction digestion up to 25 pi, before incubation at 37°C 
for 30 min. Subsequently, 20 U of CIP was added to reactions containing vector DNA and 
incubated at room temperature for 5 min before purification, while insert DNA was 
purified immediately after digestion without further modification.
After restriction digestion and treatment with modifying enzymes, the DNA fragment of 
interest was, in most cases, separated on a 0.6% agarose gel, excised using a scalpel and 
purified using the QIAquick gel extraction kit (QIAGEN, following the manufacturer’s 
protocol). However, since restriction digestion of lambda clones produces a large number 
of fragments, and gel extraction results in the loss of approximately 50% of the sample, 
sub-cloning of lambda fragments relied on the ‘shotgun’ approach, whereby all the 
fragments generated in the restriction digestion were added to the ligation mix, and 
plasmids containing the h'agment of interest were retrieved after transformation of the 
ligation mix. Therefore, restriction digestions of lambda clones were phenol-chloroform 
extracted and then chloroform extracted (in both cases, the extractions were centrifuged at 
10 000 g for 10 min). Afterwards 1/20 volume of 3 M sodium acetate was added to the 
aqueous phase and the DNA was ethanol precipitated by adding 2 volumes of 99% ethanol, 
incubating at -20°C for at least 30 min before centrifugation at 10 000 g for 30 min to 
pellet the DNA. The ethanol was then aspirated, and the pellet washed with 1 volume of
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70% ethanol before a similar centrifugation for 5 min. Finally the 70% ethanol was 
removed and the pellet air-dried for 5 min before resuspension in an appropriate volume of 
distilled H2O.
For each cloning attempt a range of different insert:vector ratios were prepared to increase 
the probability of a successful ligation. Both cohesive-end and blunt-end ligations were 
performed in a final volume of 10|ul, using 400 U T4 DNA ligase (New England Biolabs). 
Ligations were incubated at room temperature for 3-4 h.
2.2.6 Transformation and plasmid retrieval
After ligation, 5 jul of the ligation mix was added to a 50 pi aliquot of competent cells 
(previously thawed on ice), mixed gently, and incubated on ice for 30 min. The cells were 
then heat shocked at 42°C for 47 s, and chilled immediately on ice for 2 min. After 
cooling, 150 pi of L-broth was added before the cells were incubated at 37°C for 1 h.
After this ‘recovery step’, the cells were spread on selective L-agar plates containing 
50 pg.ml'^ ampicillin (Sigma), which were incubated for 16-18 h at 37°C. For ligations 
where constructs with and without inserts could be distinguished by blue/white colony 
colour due to active/inactive (3-galactosidase, the plates were also supplemented with 
0.125 mM IPTG (Boerhinger Mannheim) and 0,05 mM X-Gal (Boehringer Mannheim). 
Plasmids were transformed into either XL 1-Blue MRF’ supercompetent cells (Stratagene), 
XL 10-Gold Kan ultracompetent cells (Stratagene), or TOPI OF’ competent cells 
(Invitrogen).
Single transformed colonies were inoculated into 5 ml L-broth (supplemented with 
ampicillin to a final concentration of 50 pg.mF*) and grown at 37°C for 16-18 h. The 
plasmids were then retrieved from 3 ml of this culture using the QIAprep miniprep kit 
(QIAGEN, following the manufacturer’s protocol). The insert size and orientation were 
then confirmed by restriction digestion of 250 ng plasmid using enzymes chosen according 
to their position in the predicted restriction map for the plasmid. Where large amounts of a 
plasmid were required for later manipulations, a single colony was inoculated into 200 ml 
of L-broth supplemented with 50 jug.mf^ ampicillin, and incubated at 37°C for 16-18 h. 
The plasmids were then retrieved from 100 ml of TOPI OF’ cell culture or 200 ml of 
XL 1-Blue MRF’ or XL 10-Gold Kan cell culture using the QIAGEN plasmid maxiprep kit 
(according to the manufacturer’s protocol).
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2.3 Genomic DNA isolation and Southern analysis
2.3.1 Standard genomic DNA preparations
A maximum of 1 x 10  ^trypanosomes were centrifuged at 1620 g  and the supernatant 
decanted. The cells were resuspended in 0.5 ml digestion buffer (100 mM NaCl, 1 mM 
EOT A, 50 mM Tris.HCl (pH 8.0)) supplemented with SDS to 1% and Proteinase K to 
10 pg.ml'* and incubated at 37° for 18 h. The genomic DNA was phenol/chloroform 
extracted twice; the phases were separated by centrifugation at 10,000 g  for 10 min. To 
ensure minimal shearing, wide-bore disposable plastic pipettes were used to aspire the 
aqueous phase. Afterwards, the DNA was ethanol precipitated by gentle mixing with 
2 volumes of 99% ethanol. The suspension was allowed to stand at room temperature for 
30 min before centrifugation at 10,000 g  for 30 min. The pellet was drained and washed 
with 70% ethanol to remove salts, then drained and air-dried before resuspension in TE 
buffer to a final concentration to 2 |ug.pf’.
2.3.2 Digestion of genomic DNA
Usually 2 pg of genomic DNA prepared as described above was digested in a 20 pi 
reaction containing 1 x reaction buffer and 20-40 U of restriction enzyme.
2.3.3 Southern blotting
Restriction digestions of genomic DNA were electrophoresed on 0.6% agarose gels made 
with either 1 x TAE buffer or 0.5 x TBE buffer at between 15-30 kV for 18 h, post-stained 
with EtBr and visualised. The gels were then immersed in 0.125 M HCl for 30 min, rinsed 
in H2O, immersed in denaturing solution (0.5 M NaOH, 1.5 M NaCl) for 30 mins, rinsed in 
H2O, immersed in neutralisation solution (1 M Tris-HCl pH 8.0, 1.5 M NaCl) for 30 min 
and finally rinsed with H2O. The DNA was then transferred to a positively charged nylon 
membrane (Hybond-N or Hybond-XL, Amersham Pharmacia Biotech; or Roche) by 
capillary blotting using 20 x SSC as the transfer buffer (Sambrook and Russell, 2001), 
typically for 18 h. The DNA was then crosslinked to the nylon membrane by exposure to 
1200J UV light using a UV Stratalinker 2400 (Stratagene).
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2.4 RNA isolation and reverse transcription PCR
2.4.1 RNA isolation
Total RNA was isolated from between 4 x 10  ^to 1 x 10  ^cells using 1 ml TRIzol reagent 
(GibCO BRL, Life Technologies). Cells were pelleted by centrifugation at 1620 g, and 
lysed in TRIzol reagent by repetitive pipetting. The lysed samples were incubated at room 
temperature for 5 min before 200 pi of chloroform was added. The tubes were shaken 
vigorously for 15 s and then incubated at room temperature for 2-3 min, before the samples 
were centrifuged at 12 000 g for 15 min at 4°C. The colourless upper aqueous phase was 
removed to a fresh tube, and the RNA precipitated by the addition of 500 pi of 
iso-propanol. Samples were incubated at room temperature for 10 min, before the RNA 
was pelleted by centrifugation at 12 000 g for 10 min at 4°C. The supernatant was 
removed and the pellet washed once with 1 ml 75% ethanol, air-dried and dissolved in 
20 pi DEPC-treated H2O.
2.4.2 Reverse transcription and cDNA synthesis
Total RNA was treated with DNase I (amplification grade; Invitrogen Life Technologies, 
according to the manufacturer’s protocol) to remove genomic DNA contamination. 
Afterwards, cDNA was generated by reverse transcription using Superscript II Reverse 
Transcriptase, and the Superscript first-strand synthesis system for RT-PCR with the 
random hexamer primers provided for generating the first-strand of DNA (Invitrogen Life 
Technologies, according to the manufacturer’s protocol). Target cDNA was then 
amplified using 5 U Taq polymerase with 2 mM MgCb, 400 pM dNTPs (lOOpM each), 
200 nM sense primer, 200 nM antisense primer, and 2 pi of cDNA (from the first-strand 
reaction) in a final volume of 50 pi, under the following cycling conditions: 94°C for 
5 min, 30 cycles of 94°C for 1 min, 55°C for 1 min and 72°C for 1 min, with a final step of 
72°C for 10 min. Amplification of the internal fragment 0ÏMSH2 used the MSH2D5 and 
MSH2U2 primers (all primer sequences shown in Table 2.1). The primers MSH8D3 and 
MSH8\Jl or MSH8D6 and MSH8\]1 were used to amplify the internal fragment of MSH8, 
while the primers E'coRISL(l) and MSHSUl or MSH8\J^ were used to confirm 5’ splicing 
of this gene. MLHl was amplified using the MLH1\J\ and MLH1D6 primers. PMSl was 
amplified using the following primers: PMS1\J\ and PMSIDI. A control amplification of 
the 5’ end of the gene encoding the large subunit of RNA polymerase I using the primer 
pair Poll 5’ and Poll 3’ was perfoiined to assess the integrity of the cDNA (Rudenko et a l.
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1996). The presence or absence of mRNA encoding a given protein in wild-type 
trypanosomes was confirmed using cDNA generated from both MITat 1.2 bloodstream 
forms and procyclic cells.
2.5 Manufacture of radiolabelled probes and DNA hybridisation
2.5.1 Radiolabelled probes
The majority of the probes used in this study were PCR amplified from MITat 1.2 gDNA 
or from plasmids containing the antibiotic resistance genes. These fragments were then gel 
purified using the QIAGEN gel extraction kit (following the manufacturer’s protocol). 
Radiolabelling was perfoimed using the Prime-It II Random Primer Labelling Kit 
(Stratagene). Initially, 10 pi of random 9-mer oligonucleotides (27 ODunits.mf^) were 
mixed with 200 ng of template DNA and sterile, distilled water to a total reaction volume 
of 36 pi. The DNA was denatured by heating to 95°C for 5 min, and cooled to room 
temperature before brief centrifugation. Subsequently, 10 pi 5 x primer buffer, 3 pi a-^^P 
labelled dCTP and 1 pi Klenow (5 U.uf*) were added in order, mixed, and incubated at 
37°C for 10 min. This mixture was then briefly centrifuged before purification of the 
probes from the unincorporated nucleotides using MicroSpin S-200 HR columns 
(Amersham Pharmacia Biotech, following the manufacturer’s protocol). After 
purification, the probes were denatured at 95 °C for 5 min immediately prior to use.
2.5.2 Hybridisation
Nylon filters were hybridised to radioactive probes in glass hybridisation tubes. Where 
several nylon filters were to undergo hybridisation simultaneously in the same tube they 
were placed between two sheets of hybridisation mesh (Amersham, Life Technologies), 
before being transferred to a glass hybridisation tube. Approximately 50 ml of Church- 
Gilbert solution (0.342 M Na2HP0 4 , 0.158 M NaH2P0 4 .2H2 0 ), 0.257 M SDS and 1 mM 
EDTA) was added and the filters were pre-hybridised by rotation at 65°C for a minimum 
of 3 h in a hybridisation oven. After addition of the purified, denatured probe the 
hybridisation was incubated at 65°C in the oven for at least 18 h. Afterwards, the filters 
were washed to high stringency in the oven at 65°C with the following series of solutions; 
100 ml 2 X SSC, 0.1% SDS (twice -  initially for 5 min then again for 30 min); and 100 ml 
0.2 X SSC, 0.1% SDS (for 30 min). The filters were then heat-sealed in plastic and 
visualised in one of two ways: filters were either placed next to medical photographic film
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(Konica Medical Corporation) in an autoradiography cassette at -70°C for 15 min to 
7 days, or next to a phosphoimaging plate (Fujifilm) in an autoradiography cassette for 
15 min to 24 hours, exposure time depending of the expected strength of the signal in both 
cases. The photographic film was developed using an M35-M X-OMAT Processor 
(Kodak), and phosphoimages were read using a Typhoon 8600 Variable Mode Imager 
(Molecular Dynamics).
2.5.3 Stripping of nylon filters
Nylon filters were stripped with a boiling solution of 0.4 M NaOH, 0.1% SDS. The 
solution was poured onto the filters in a heat resistant container and allowed to cool to 
room temperature. The filters were then rinsed in 2 x SSC before re-use. Following 
stripping the filters were placed next to a phosphoimaging plate for 24 h to ensure that the 
procedure had been successful.
2,6 Screening of the ILTat 1.2 genomic lambda library and mapping of clones
2.6.1 Preparation of phage-lambda plating bacteria
A single colony of E. coli LE392 (Promega) was inoculated into 10 ml L-broth 
supplemented with 0.2% maltose and incubated at 37°C for 18 h. The ODeoo of a 1/10 
dilution of the culture was measured and the amount of culture which would give a final 
concentration of 2.0 ODgoo in 10 ml was centrifuged at 4000 g for 10 min at room 
temperature. The supernatant was aspirated and the cell pellet resuspended in 10 ml of 
10 mM MgS0 4 . This suspension of plating bacteria was stored at 4°C for up to 3 weeks.
2.6.2 Plating of phage-lambda
For the primary sereen, an ILTat 1.2 genomic bacteriophage-lambda library was diluted to
1.5 X 10  ^pfu.mf' (a kind gift of Nils Burman; the library was generated using ILTat 1.2 
genomic DNA which had undergone a partial restriction digestion with Sau3A which was 
cloned into \hcXhol site of the LambdaGEM-12 vector). Phage suspension and plating 
bacteria were mixed in a 1:1 ratio (300 |ul each for a primary screen or 100 pi each for later 
screens), and incubated at 37°C for 30 min. Next, top agarose (6.5 ml for a primary screen 
or 2.5 ml for a later sereen), was mixed with the phage-bacteria suspension and poured 
onto a bottom agar plate (14 cm diameter plate for a primary screen or 8 cm diameter plate 
for a later screen). The top agarose was allowed to solidify for 5 min, before the plate was
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inverted and incubated at 37°C for 18 h. For this protocol, bottom agar plates were dried 
and pre-waraied to 37°C, while top agarose was pre-heated to 48°C, After incubation 
phage plates were stored at 4°C. For secondary and tertiary and quaternary screens, the 
same procedure was followed using tenfold serial dilutions (1 x 10 ,^ 1 x 10"^  and 1x10^) of 
isolated phage plaques,
2.6.3 Transfer of phage to nylon filters
Phage plates were placed at 4°C for at least 1 h to allow the agarose to solidify before the 
transfer. A nylon filter (Hybond-N, Amersham Phannacia Biotech) was placed onto the 
surface of the agar for 1 min. During this time, the filter was stabbed assymetrically in 
3 places with a needle and syringe containing electrophoresis loading dye, leaving a mark 
in the agar where the hole was made and allowing later orientation. The filter was 
removed and a replica filter was placed on the agar surface for 3 min, while the needle was 
used to puncture the filter in the same places as the original filter. The position of the 
holes was also marked on the underside of the petri dish. The filters were allowed to dry, 
plaque side up, for 20 min. The filters were then incubated, plaque side up, for 2 min in 
the following solutions in order: Southern dénaturation solution, Southern neutralisation 
solution, and 2 x SSC (see section 2.2.3). The filters were then allowed to dry, and the 
DNA was crosslinked to the nylon filters by exposure to 1200J UV light using a UV 
Stratalinker 2400.
2.6.4 Isolation of target phage-lambda clones
The nylon filters were then hybridised with radiolabelled probes as described in section
2.5. The filters were visualised by autoradiography, and then the duplicate filters were 
examined for hybridisation. Where the probe had hybridised to the same place on both 
filters, the autoradiograph was aligned with the phage plate and the target plaque 
identified. A plug of agar encompassing such a plaque was then transferred to 250 jul of 
phage suspension buffer. This suspension was then used as the inoculum for a further 
round of phage plating as in section 2.6.2. The screening process was repeated until every 
plaque on the agar plate hybridised to the probe showing the suspension to be clonal.
2.6.5 Liquid lysis of phage-lambda clones
A well-isolated phage plaque from the final screening plate was transferred to 100 |al 
phage suspension buffer and left for 1 h at 37°C for use as the inoculum for liquid lysis of
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the clone. A single colony of LE392 was inoculated into 5 ml L-broth supplemented with 
10 mM MgS0 4  and 0.2% Maltose and incubated at 37°C for 18 h. 500 pi of this culture 
was added to the tube containing the clonal target phage plug and incubated for 20 min at 
37°C. The phage-bacteria suspension was then used to inoculate 100 ml of L-broth 
supplemented with 10 mM MgS0 4  and pre-waiTned to 37°C. The culture was shaken at 
37°C until lysis occurred (usually 6-7 h), then 500pl of chloroform was added and the 
culture shaken for a further 15 min. After lysis the culture was centrifuged at 8 000 g for 
10 min to remove the cellular debris. The supernatant was transferred to a sterile tube,
200 pi of chlorofonn was added and the suspension was stored at 4°C for 18 h. The target 
phage were isolated from the supernatant using LambdaSorb Phage Adsorbant (Promega), 
and the DNA was purified and resuspended in TE buffer (5 pi of TE buffer per 10 ml 
supernatant, according to Promega’s protocol).
2.6.6 Restriction mapping of phage-lambda clones
Approximately 600 ng of phage DNA was added to each restriction digestion performed as 
described in section 2.2.2. For each gene, a range of single and double digestions were 
performed on each lambda clone, using the enzymes suggested by the available gene 
sequence data and the results of the genomic Southerns. The restriction digestion reactions 
were separated on a 0.6% agarose gel in TAE buffer, visualised and Southern blotted. The 
results of the Southern analyses, the sequence of the lambda arms and the available 
sequence data for the gene in question allowed restriction maps of the lambda clones to be 
developed. Examination of these maps revealed restriction fragments which were likely to 
contain the entire ORF of the gene as well as processing flanks. These restriction 
digestions were then repeated and the fragment of interest cloned as described in section
2.2.5.
2.7 Sequencing
In a thin-walled microeppendorf tube, 500 ng of plasmid DNA (prepared using the 
QIAprep miniprep kit) was mixed with 3.2 pinoles of primer and 8 pi ABI PRISM dGTP 
BigDye terminator ready reaction solution (Applied Biosystems) in a final volume of 
20 pi. Thermal cycling was then perfoimed with a hot start in a PCR Sprint at 96°C for 
4 min followed by 25 cycles of 96°C for 10 s, 50°C for 5 s and 60°C for 4 min.
Afterwards, the solution was transfen*ed to a 0.5 ml eppendorf tube and mixed with 6 pi of 
3 M sodium acetate and 150 pi of 95% ethanol. After incubation at room temperature for
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15 min, the DNA was pelleted by centrifugation at 10 000 g for 20 min. The supernatant 
was aspirated and the pellet washed with 250 pi 70% ethanol and dried in a Robocycler 96 
at 90°C for 1 min. Automated sequencing was then performed by either the Molecular 
Biology Support Unit (MBSU) of the University of Glasgow, or Oswel Research Products 
at the University of Southampton.
2.8 Data mining the National Center for Biotechnology Information (NCBI)
database, the T, briicei and other sequencing databases, multiple alignment of 
polypeptide sequences and gap comparisons
2.8.1 NCBI data retrieval
The MutS/MSH and MutL/MLH protein sequences were obtained from the protein 
database of the National Center for Biotechnology Infoimation (NCBI) 
(http://www.ncbi.nlm.nih.gov/). The mismatch repair protein homologues used during this 
study (and their accession numbers) are as follows: MutS from Escherichia coli 
(AAC75775); MSHl (NP Ol 1988) from Saccharomyces cerevisiae; homologues of the 
S. cerevisiae MSH2 protein (CAA99102) 'moXwàmg Arahidopsis thaliana (024617), 
Drosophila melanogaster (SPELl -  P43248), Encephalitozoon cuniculi (CAD26200), 
Homo sapiens (NP 000242), Mus musculus (AAA75027), Neurospora crassa 
(AAB84225), Schizosaccharomycespombe (CAA07342), Xenopus laevis (S53609),
T. hrucei (AAK08648), Trypanosoma cruzi (AAG00261) and Zea mays (Q9XGC9); 
homologues of the S. cerevisiae MSH3 protein (CAA42247) from A. thaliana 
(CAA07684), H  sapiens (NP_002430), 6'. pombe (SWI4 - CAB52164), and T. brucei (no 
accession number); MSH4 (BAA09235) and MSH5 (CAA98728) from S. cerevisiae; 
homologues of the S. cerevisiae MSH6 protein (CAA87671) from A. thaliana 
(CAB53337), D. melanogaster (Q9VUM0), E. cuniculi (CAD25790) and H. sapiens 
(NP_000170); MSH7 from ri. thaliana (AAP06013) and Z. mays (MUS2 -  CAB42555); 
MSH8 from T. brucei (AAK51796); MutL fr'om E. coli (AAC77127); homologues of the 
S. cerevisiae y ilM l  protein (CAA89803) fromZ. thaliana (NP_192653), D. melanogaster 
(AAF59117), E. cuniculi (CAD26547), H. sapiens (NP 000240) and T. brucei 
(AAK29067); homologues of the S. cerevisiae PMSl protein (CAA95956) from 
A. thaliana (AALOl 156), D. melanogaster (PMS2 - AAF58142), E. cuniculi (CAD26036),
H. sapiens (PMS2 - NP 000526) and T. brucei (AAK08649); the S. cerevisiae MLH2 
protein (CAA97559); the S. cerevisiae MLH3 protein (CAA97869); and the PMSl 
(XP_010779) and MLH3 (NP 055196) proteins from H. sapiens.
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2.8.2 Multiple alignment of polypeptide sequences
Multiple alignment of polypeptide sequences was performed using several programs 
including: the PileUp program from the GCG Wisconsin Package (Wisconsin Package 
Version 10.0, Genetics Computer Group (GCG), Madison, Wise.); CLUSTAL X (version
1.8; Thompson et a l, 1997); and Multalin available on the server of the Institut National de 
la Recherche Agronomique (http://prodes.toulouse.inra.ff/multalin/ multalin.html) (Corpet, 
1988).
2.8.3 Pairwise comparisons
Pairwise comparisons were performed using the Gap paii*wise comparison program of the 
GCG Wisconsin Package to assess the percentage similarities and identities between two 
sequences. The full length protein sequences were compared using the program’s default 
settings.
2.8.4 Data mining the T. brucei sequencing databases
Preliminary multiple aligmiients of the MutS, MSH2, MSH3, MSH6, MutL, MLHl and 
PMSl sequences (see section 2.8.1) were perfoimed using PileUp. The regions of 
conservation between the orthologous sequences included in each alignment were 
identified using output fiom the BOXSHADE server (http://www.ch.embnet.org/software/ 
BOX_form.html) using the RTF_new output foimat and the ffaetion of sequences (that 
must agree for shading) set between 0.5 to 1.0.
BLAST searches of the TIGR (http://www.tigr.org/tdb/mdb/tbdb/seq_search.html) and 
Sanger (http://www.sanger.ac.ulc/Projects/T_brucei/Toolkit/blast_server.shtml) T. brucei 
genome sequencing databases using the MutS- and MutL-related sequences from E. coli,
S. cerevisiae, H. sapiens and A. thaliana allowed identification of clones encoding 
homologous sequences in T. brucei. Data retrieved from the T. brucei databases were then 
used in further BLAST searches of the TIGR and Sanger servers as described above to find 
any overlapping sequences. This process was repeated with each sequence until no further 
overlapping sequences could be identified. All sequences retrieved from the T. brucei 
databases were then aligned into contigs using the Fragment Assembly series of programs 
provided by the GCG Wisconsin Package. The contiguous sequences were then used to 
BLAST search the NCBI database (http://www.ncbi.nlm.nih.gov/BLAST/) to assess their 
similarities with known proteins.
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Large contiguous sequences retrieved from the Sanger database were analysed using the 
Nucleotide Identification (NIX) server (http://www.hgmp.mrc.ac.uk/Registered/ 
webapp/nix/) provided by the UK Human Genome Mapping Project Resource Centre.
This server is an integrated interface allowing the user to run a number of programs which 
predict sequence features (eg. exons) and perfoim BLAST searches, with an output which 
allows the user to easily compare the results of the different programs against eachother. 
The T. brucei sequences analysed were input into the NIX server as genomic bacterial 
sequences (because T. brucei transcribes polycistronic mRNA and lacks introns). The NIX 
outputs presented in this study only show the results of selected programs: the BLAST 
search outputs from EMBL, TrEMBL and SwissProt; the gene prediction program 
HMMGene; and the exon prediction program Fex.
2.8.5 Data mining the sequencing databases of other unicellular parasitic organisms
BLAST searching of genome sequencing databases (Table 2.2) available for Babesia 
bovis, Encephalitozoon cuniculi, Entamoeba histolytica, Giardia lamblia, Leishmania 
major, Plasmodium falciparum, Theileria annulata. Toxoplasma gondii, and Trypanosoma 
cruzi was perfoimed using the MutS- and MutL-related sequences from A. thaliana,
S. cerevisiae and T. brucei to identify similar sequences in these organisms. Data retrieved 
from these databases were then used to BLAST search the NCBI database to assess their 
similarities with laiown proteins, and putative protein identities were assigned solely on 
this basis. Also, the NCBI protein database (http://www.ncbi.nlm.nih.gov/) was searched 
for published MutS and MutL homologous sequences in these organisms.
2.9 Isolation of the complete coding sequences of three MutS homologues from
T, brucei
2.9.1 MSH2
Degenerate PCR primers were designed against the ATP-binding motif of MSH2 
{MSH2 5’(1) and MSH2 3’(1); all primer sequences shown in Table 2.1). PCR was 
performed using 20 ng of MITat 1.2 gDNA, 5 U Taq polymerase, 2 mM MgCb and 2 pM 
of each primer in a final volume of 50 pi, with an initial 5 min dénaturation at 94°C, 
followed by 30 cycles of 94°C for 1 min, 48°C for 2 min, and 72°C for 1 min, followed a 
final 5 min extension at 72°C. A 315 bp product was generated and cloned into 
pBluescript II KS (Stratagene), which upon sequencing was predicted to encode the 
expected region of T brucei MSH2. This plasmid was restriction-digested using EcoBl
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and BanïHl, and the fragment encoding the ATP-binding domain of MSH2 was purified as 
described in section 2.2.5. This fragment was then used as a probe for a MITat 1.2 and 
ILTat 1.2 genomic Southern and also as a probe to screen an ILTat 1.2 genomic lambda 
library. Several lambda clones were identified, restriction-digested and Southern blotted.
A 4.5kb EcoBl fragment that contained the complete MSH2 ORF was cloned into 
pBluescript II KS to create the plasmid pJBlOO and the sequence was determined on both 
strands using the following primers: T3, T7, MSH2E>\, MSH2D2, MSH2D3, MSH2D4, 
MSH2D5, MSH2VI, MSH2F2, MSH2F3, MSH2F4, MSH231, MSH232, MSH2J3, MSH2J4, 
MSH2UI, MSH21J2, MSH2U3, MSH21J4, MSH2XJ5, and MSH2U6. The sequence predicts 
a polypeptide 951 amino acids in length, as well as the 5’ and 3’ untranslated regions of the 
gene (accession number AY026905).
2,9,2 MSH8
PCR primers were designed from two contiguous sequences identified by the procedure 
described in section 2.8.4 {MSH8 5’ and MSH8 3’; all primer sequence shown in Table 
2.1). PCR was perfoimed with an initial 5 min dénaturation at 94°C followed by 30 cycles 
of 94°C for 1 min, 55°C for 1 min, and 72°for 5 min, followed a final 10 min extension at 
72°C, using 20 ng MITat 1.2 gDNA, 5 U Taq polymerase and 2 mM MgCh in a final 
volume of 50 pi. The 2.0 kb product was ‘polished’ with Pfu polymerase and cloned into 
pPCR-Script Amp SK(+), creating the plasmids pJB301.1 and pJB301.2, and the sequence 
of the two independently derived clones was detennined on both strands using custom 
designed primers. From this sequence, two oligonucleotides {MSH8D3 and MSH8\J\) 
were designed to PCR amplify a 540 bp fragment for use as a probe for a MITat 1.2 and 
ILTat 1.2 genomic Southern. The reaction conditions were similar to above except that 
thermal cycling was performed for 5 min at 94°C, 30 eycles of 94°C for 1 min, 55°C for 
1 min and 72°C for 2 min, followed by a final extension step of 10 min at 72°C.
Several months later, further searching of the T. brucei sequencing databases was 
performed using the sequence derived from pJB301 revealing further contiguous sequence. 
Oligonucleotides directed against these sequences allowed PCR using 2.5 U Herculase 
polymerase with othei-wise similar conditions to those used to generate the PCR product 
cloned to give pJB301. Two products were generated: the first 2.9 kb in length (using 
primers MSH8 UP(1) and MSH8U3) and the second 2.2 kb in length (using primers 
MSH8Y>3 and MSH8 DN(1)). Two independent PCR reactions were cloned into 
pPCR-Script Amp SK(+) for each product, generating the plasmids pJB302 and pJB303 
respectively, and the sequence of each deteimined as above. The 2.9 kb and 2.2 kb
products encoded the N-tenninal and C-teiTninal regions of MSH8 respectively. 
Sequencing of the locus encoding MSH8 required the following oligonucleotides: T3, T7, 
M13 For, M13 Rev, M SH 8m ,M SH 8m , M SH Sm , M SH 8m , MSH8D5, MSH8D6, 
MSH8D1, M SH 8m , MSH8\]\, MSH8\J1, MSH8\J3, M SH 8m , MSH8\25, MSH8\J6, 
MSH8\]1, MSH8\5^, and MSH8\]9. Contiguous sequence derived from all three MSH8 
sequences revealed an ORF encoding a polypeptide 997 amino acids in length (accession 
number AF350880).
Expression of the gene and the 5’-splicing of the gene were confirmed by RT-PCR as 
described in section 2.4.
2.9.3 MSH3
A recent BLAST search of the Sanger 71 brucei genome sequencing database using the 
71 brucei MSH8 polypeptide sequence identified a large contig (TRYP9.0.000864) 
encoding another MutS homologue from T. brucei. The hypothetical ORF 
(TRYP9.0.000864 4) encoding this polypeptide was used to BLAST search the NCBI 
database in order to assess its similarity to known sequences (see section 2.8.4). This 
approach suggested the ORF encoded an MSH3 homologue.
2.10 Isolation of the complete coding sequences of two MutL homologues from
71 brucei
2.10.1 MLHl
PCR primers were designed from three contiguous sequences identified by the procedure 
described in section 2.8.4 {MLHl 5’(1) and MLHl 3’(1); all primer sequences shown in 
Table 2.1). PCR was perfoimed with an initial 5 min dénaturation step of 94°C, followed 
by 30 cycles of 94°C for 1 min, 50°C for 1 min and 72°C for 5 min, with a final step of 
72°C for 10 min using 20 ng MITat 1.2 gDNA, 5 U Taq polymerase and 2 mM MgCb in a 
final volume of 50 pi. A 2.9 kb product was generated using these primers showing that 
the three contigs composed parts of the same gene. A further set of oligonucleotides 
{MLH1\J\ and MLH1D6) were designed from the contig sequence in order to amplify a 
427 bp product, predicted to encode the ATP binding domain of MLHl, for use as a probe 
for both a MITat 1.2 and ILTat 1.2 genomic Southern and an ILTat 1.2 genomic lambda 
library. The reaction conditions were similar to those used above except that thermal 
cycling was performed for 5 min at 94°C, with 30 cycles of 94°C for 1 min, 55°C for 1 min
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and 72°C for 2 min, followed by a final extension step of 10 min at 72°C. Several lambda 
clones were isolated and a 4.0 kb Acc651 (Kpnl) fragment that contained the complete 
MLHl ORF was cloned into pBluescript II KS, generating the plasmid pJB200. The 
sequence was generously detennined by T. I. Harvey on both strands by sequencing using 
the following primers: T3, T7, M L H im ,M L H im , M L H im , M L H im , M L H im ,  
MLH1D6, M LH IW , MLHIDS, M LH lU l, M LHW 2, MLH1U3, MLH1V4, MLH1V5, 
MLH1U6, and M LHIVI. The sequence predicts a polypeptide 887 amino acids in length, 
along with 5’ and 3’ untranslated regions (accession number AF346620).
2.10.2 PM Sl
PCR primers were designed from three contiguous sequences identified by the procedure 
described in section 2.8.4 {PMSl 3’(2) and PMSl 5’(2) or PMS1\L2\ all primer sequences 
shown in Table 2.1). PCR using primers PMSl 5’(2) and PMSl 3’(2) was performed with 
an initial 5 min dénaturation at 94°C, followed by 30 cycles of 94°C for 1 min, 55°C for 
1 min, and 72°for 4 min, followed a final 10 min extension at 72°C, using 20 ng MITat 1.2 
gDNA, 5 U Taq polymerase and 2 mM MgCb in a final volume of 50 pi. PCR using these 
primers generated a 2.7 kb product confinning that the contigs were part of the same gene. 
PCR using the primers PMS1M2 and PMSl 3’(2) generated a 460 bp product for use as a 
probe for both a MITat 1.2 and ILTat 1.2 genomic Southern and an ILTat 1.2 genomic 
lambda library. The reaction conditions were similar to those used above except that the 
thermal cycling was performed using an initial 5 min dénaturation at 94°C, followed by 
30 cycles of 94°C for 1 min, 50°C for 1 min, and 72°for 1 min, followed a final 10 min 
extension at 72°C. Several lambda clones were isolated and a 5.5kb EcoBl fragment that 
contained the complete PMSl ORF was cloned into pBluescript II KS, generating the 
plasmid pJB400. The library screening and sub-cloning and sequencing were generously 
performed by T. I. Harvey. The sequence was determined on both strands by sequencing 
with the following custom designed primers: T3, T7, PMSIDI, PMS1T>2, PMS1T>3, 
P M S im , P M S im , P M S im , P M s m i, P M S im ,P M S i\i2 , p m s i \l3, P M S im , 
PMS1\]5, and PMS1\L6. The sequence encodes a polypeptide 788 amino acids in length 
(accession number AY026906).
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2.11 Generation and analysis of T. brucei mismatch repair knock-out cell lines
2.11.1 MSH2
T. brucei MSH2 Icnockout constructs were designed to contain 430bp of 5’ sequence and 
370bp of 3’ sequence, which act as targeting sequences for replacement of the entire MS7/2 
ORF. The MSH2 flanldng sequences were amplified by PCR fi'om 20 ng MITat 1.2 gDNA 
with 1.25 U Pfu polymerase supplemented with 2 mM MgS0 4  in a final volume of 50 pi, 
with an initial 5 min dénaturation at 94°C followed by 30 cycles of 94”C for 1 min, 50°C 
for 1 min, and 72° for 1 min, followed a final 10 min extension at 72°C. The 5’ flank was 
amplified using the primers MSH2 5’(A) and MSH2 5’(B), while for the 3’ flank the 
primers MSH2 3’(A) and MSH2 3’(B) were used (primer sequences shown in Table 2.1). 
Both flanks were cloned simultaneously into pBluescript II KS. These targeting flanks 
were separated by one of two antibiotic resistance cassettes, containing either the 600 bp 
puromycin-N-acetyltransferase ORF {PUR) or the 400 bp blasticidin-S-deaminase ORF 
{BSD) (both gifts of M. Cross), flanked by 230 bp of p-a tubulin and 330 bp of a-P tubulin 
processing signals. After integration, the resistance genes are expressed by endogenous 
MSH2 transcription, since the Imockout cassettes contain no promoter elements. Cloning 
of the resistance cassettes between the MSH2 targeting sequences generated the constructs 
AMSH2::PUR and AMSH2::BSD respectively. The plasmids were digested with ATzoI and 
Notl prior to being transfonned into T. brucei as described in section 2.1.3. Transformants 
were selected with 1.0 pg.mf' puromycin dihydrochloride (Calbiochem) or 2.5 pg.m f’ 
blasticidin S hydrochloride (Calbiochem).
Correct integration of the constructs into the MSH2 locus was determined in three ways. 
Firstly, gDNA from the transformants was digested with Sad, Southern blotted and probed 
with the 430 bp MSH2 5’ integration flank described above, to determine that the MSH2 
wild-type allele was removed from the genome in the blasticidin and puromycin double 
resistant clones. In both digestions a 5.8 kb fragment was detected in the wild-type and 
heterozygous mutants, conesponding to the intact wild-type MSH2 locus. This fragment 
was absent in the homozygous knockout clones. The probe also hybridised to 2.85 kb and 
2.65 kb fragments corresponding to the AMSH2::PUR and AMSH2::BSD alleles 
respectively. Secondly, to show that no copies of the MSH2 ORF existed with the MSH2 
homozygous mutant cell lines, PCR was performed on 20 ng gDNA isolated from the 
transformants using internal primers complementary to the MSH2 ORF {MSH2D5 and 
MSH2\]2\ sequences shown in Table 2.1), using 5 U Taq polymerase and 2 mM MgCl] in
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a final volume of 50 pi with an initial 5 min dénaturation at 94°C followed by 30 cycles of 
94°C for 1 min, 55°C for 1 min, and I T  for 1 min, followed a final 10 min extension at 
72°C in a PCR Sprint. A control amplification of the 5’ end of the gene encoding the large 
subunit of RNA polymerase I using the primer pair Poll 5’ and Poll 3’ was performed to 
assess the integrity of the gDNA (Rudenlco et a l, 1996). Finally, total RNA from the 
MSH2 knockout mutants was prepared with TRIzol and cDNA was synthesised as 
described in section 2.4. RT-PCR was perfonned to detennine whether or not intact MSH2 
mRNA was present in the transformants.
2.11.2 MLHl
The MLHl Icnock-out constructs were generated and utilised as described for the MSH2 
knockout constructs, with the following modifications. The T. brucei MLHl targeting 
sequences were designed to replace the entire MLHl ORF using 413 bp of 5’ flank and 
520 bp of 3’ flank. These were amplified from 20 ng of MITat 1.2 gDNA by PCR using 
2.5 U of Herculase polymerase in a final volume of 50 pi with the following cycling 
conditions: 94°C for 5 min, 30 cycles of 94°C for 45 s, 55°C for 45 s and 72°C for 30 s, 
followed by 72°C for 10 min. The 5’ flanlc was amplified using the primers MLHl 5’(A) 
and MLHl 5’(B), while the 3’ flank was amplified with the primers MLHl 3’(A) and 
MLHl 3’(B) (sequences shown in Table 2.1). Cloning of the resistance cassettes between 
the M L/// targeting sequences generated the AMLH1::PUR and AMLHl ::BSD constructs 
respectively.
Correct integration of the constructs into the MLHl locus was determined in three ways. 
Firstly, in order to determine that the MLHl wild-type allele was removed from the 
genome in the blasticidin and puromycin double resistant clones, gDNA from the 
transformants was digested with Kpnl, Southern blotted and probed with the 415 bp MLHl 
5’ integration flanlc described above. In both digestions a 4.5 kb fragment corresponding 
to the intact wild-type MLHl locus was detected in the wild-type and heterozygous 
mutants. This fragment was absent in the homozygous Imockout clones. The probe also 
hybridised to 1.3 kb and 1.1 kb fragments con'esponding to the AMLHl::PUR and 
AMLHl ::BSD alleles respectively. Secondly, PCR was performed on 20 ng gDNA 
isolated from the transformants using internal primers complementary to the MLHl ORF 
{MLH1\]\ and MLH1D6; sequences shown in Table 2.1), using 5 U Taq polymerase and 
2 mM MgCb in a final volume of 50 pi with an initial 5 min dénaturation at 94°C followed 
by 30 cycles of 94°C for 1 min, 55°C for 1 min, and 72° for 1 min, followed a final 10 min
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extension at 72°C in a PCR Sprint, to show that no copies of the MLHl ORF existed with 
the MLHl homozygous mutant cell lines. In order to assess the integrity of the gDNA, a 
control amplification of the 5’ end of the gene encoding the large subunit of RNA 
polymerase I using the primer pair Poll 5’ and Poll 3’ was performed (Rudenko et a l, 
1996). Finally, total RNA from the MLHl Imockout mutants was prepared with TRIzol 
and cDNA was synthesised as described in section 2.4. RT-PCR was performed to 
determine whether or not intact MLHl mRNA was present in the transformants,
2.12 Re-expressing a copy of the wild-type MSH2 allele in the homozygous 
knock-outs
The T. brucei MSH2 re-expression construct was based on the MSH2 lambda sub-clone 
pJBlOO. An antibiotic resistance cassette containing the 400 bp bleomycin resistance 
protein {BLE) ORF, flanked at the 5 ’ end by 400 bp of processing flank from the actin 
locus and at the 3’ end by 330 bp of a-p tubulin intergenic sequence, was cloned into the 
multiple cloning site downstream of the 3’ end of the MSH2 3’ processing flank in pJBlOO. 
This cloning generated the construct AMSH2::MSH2-BLE. The targeting flanks used by 
this construct to replace either the MSH2::PUR or MSH2::BLE alleles are the MSH2 
5’ flank and the a-p tubulin intergenic sequence. As this re-expression cassette contains 
no promoter element, both MSH2 and the resistance gene will be expressed by endogenous 
MSH2 transcription, thereby returning MSH2 to a noimal level of expression.
The plasmid was digested with Hindlll prior to being transformed into T. brucei as 
described in section 2.1.3. Transformants were selected with 2.5 pg.mf^ phleomycin 
(Cayla). Con*ect integration of the construct into the MSH2 locus was determined as 
described in section 2.11.1. Where con*ect integration had occurred Southern analysis 
detected a 6.2 kb band con'esponding to the MSH2::MSH2-BLE allele.
2.13 Measuring the growth rates of trypanosome mutant cell lines
In vitro growth rates were measured for each 3174 MSH2 or MLHl transformant by 
diluting mid-log phase trypanosomes to a concentration of 1 x 10  ^cells.ml"^ in 2.5 ml of 
culture medium in 6-well culture dishes. Cell concentrations were measured at 24 h 
intervals thereafter with a haemocytometer (Sigma).
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2.14 Measuring cell survival following treatment with Æ-methyl-Æ'-nitro-7V- 
nitrosoguanidine (MNNG)
Recently cloned bloodstream form trypanosomes (see section 2.1.3) were grown to 
mid-log phase before being diluted to 10 cells.mf* and plated across 96-well plates at 
200 pi per well. For each of three repetitions, one culture dish for each 3174 MSH2 or 
MLHl transfonnant was plated at each drug concentration. MNNG (Aldrich Chemical 
Company) was dissolved to 5 mg.mf' in 100% DMSO before dilution into HMI-9. The 
following drug concentrations were used independently: 0, 0.25, 0.5, 0.75 and 1.0 pg.ml"  ^
in HMI-9. Plates were incubated for 12 days before wells were scored for cell survival.
The results have been depicted as an average percentage survival without standard error 
bars as the thi*ee repetitions for each cell line were performed simultaneously using the 
same mid-log phase cell culture (see sections 4.2.6 and 4.3.5 and Figures 4.8 and 4.31).
2.15 Generation and analysis of trypanosomes that have nndergone antigenic 
variation
The isolation of VSG-switched variants utilised the approach described in McCulloch et al. 
(1997) with some modifications. A number of ICR mice were intraperitoneally injected 
with between 2x10^ and 4 x 10  ^3174 trypanosomes (which are wild-type at both the 
MSH2 and MLHl loci; McCulloch et al., 1997) growing on hygromycin B (5.0 pg.ml’^ ; 
Roche) and G418 (2.5 pg.m f'; Sigma Cell Culture). The infections were cured 3-4 days 
later by injection with cymelarsan (Rhone Merieux; 5 mg.kg"' body weight) to generate 
mice immunised against the VSG221 coat. The immunised mice were used between 7 and 
35 days post-curing. To select for switched variants, the 3174 MSH2 or MLHl 
transfoimants were passaged from medium containing hygromycin and G418 into 
non-selective medium at a density of 2 x 10  ^cells.mf' and grown for nine generations 
(approximately 72 h) until they reached densities of 2 x lO'^  to 3 x 10  ^cells.mf'. The 
trypanosomes were counted, and 4x10^ cells of each transformant were centrifuged at 
580 g, resuspended in 300pl of HMI-9 and then intraperitoneally injected into an 
immunised mouse. Twenty-four liours later the mice were bled by cardiac puncture. 
Switched variants were isolated from 0.4 ml of blood as described by Rudenko et al.
(1996) and were immediately cloned after dilution into 20ml HMI-9; this volume was 
spread over a 96-well culture dish. Typically, a single trypanosome would grow out to a 
visible population after 5 to 7 days. We have assumed that all the cell populations double
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every 8 hours in order to calculate the VS G switching frequencies from the numbers of 
clones that grew out.
To assay for the drug sensitivity of the switched variant clones, approximately 2x10' '  cells 
were passaged from the 96-well dish into 1 ml of HMI-9 medium alone, or supplemented 
with either hygromycin B (5.0 pg.ml ' ) or G418 (2.5 pg.mf'). Growth was scored 7 days 
later. Small-scale genomic DNA preparations for the PCR assays were made from 3x10^ 
to 5 X 10  ^cells as described in section 2.3.1. The presence or absence of the hygromycin 
phosphotransferase, neomycin phosphotransferase, and VSG221 genes was assessed by 
PCR using the following primer pairs: Hygro 5’ and Hygro 3’, Neo 5’ and Neo 3%
VSG221 5’ and VSG221 3’ (sequences shown in Table 2.1). The integrity of the DNA 
was assessed by a control amplification of the 5’ end of the gene encoding the large 
subunit of RNA polymerase I using the primer pair ( Poll 5’ and Poll 3’ -  for sequences 
see Table 2.1; Rudenko et a l, 1996) as described in section 2.4.2. PCR amplification in a 
final volume of 25 pi was perfonned using 5 U of Taq polymerase with 2 mM MgCb in a 
Robocycler 96; the reaction used 1/50 of the total DNA prepared as above and involved an 
initial 5 min dénaturation at 94°C followed by 30 cycles of 94°C for 1 min, 55°C for 1 min 
and 72°C for 1 min and finally 10 min at 72°C.
2.16 Assay for microsatellite instability in the 71 brucei mismatch repair mutants
Trypanosomes were cloned by the 96-well plate method described in section 2.1.3. For 
each 3174 MSH2 or MLHl transformant 10 clones (200 pi culture) were passaged into 
25 ml HMI-9 each and grown to a density of 1.5 x lO'’ to 4.5 x 10  ^cells.mf'. Genomic 
DNA was prepared from each culture as detailed in section 2.3.1, and diluted in distilled 
H2O to 5 ng.pf ' for use as template to PCR amplify the chosen microsatellite loci. PCR 
amplification was performed using a Robocycler 96, using the following reagents in a final 
volume of 20 pi: either 0.5 U Herculase polymerase in 1 x Herculase buffer with 
5 ng template DNA, 400 nM of each primer (all primer sequences shown in Table 2.1), and 
125 pM each of dATP, dCTP, dGTP and dTTP; or 0.5 U Taq polymerase in 45mM 
Tris.HCl pH 8.8, 11 mM (Nfl4)2S0 4 , 4.5 mM MgCb, 6.7 mM 2-mercaptoethano 1, 4.4 pM 
EDTA, 113 pg.mf' BSA, with 1 mM each of dATP, dCTP, dGTP, and dTTP, 5 ng 
template DNA, and 400 nM of each primer. Microsatellite JS-2 (Hope et a l, 1999) was 
amplified by 28 cycles of 96°C for 50 s, 58°C for 50 s and 70°C for 50 s using the primers 
JS-2A and JS-2B with Herculase polymerase for the MSH2 transformant samples and Taq 
polymerase for the MLHl transformant samples, before analysis by electrophoresis on a
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3% NuSieve GTG agarose gel (FMC BioProdiicts). Ail other microsatellite loci were 
amplified using Taq polymerase and separated on 4% NuSieve gels to estimate the dilution 
factor for later analysis. Electrophoresis was performed in 0.5 x TBE buffer containing 
0.2 pg.m f' EtBr at 150 kV for 2.5-4.0 h, using Superladder-Low 20 bp ladder as a size 
marker (Advanced Biotechnologies). Microsatellite PLC (A. MacLeod, S. McLellan, 
C.M.R. Turner and A. Tait, personal communication) was amplified by 27 cycles of 95°C 
for 50 s, 58°C for 50 s and 70°C for 50 s using the primers PLCG and PLCH3. 
Microsatellite ChrII-6 (A. MacLeod, A. Tweedie and A. Tait, personal communication) 
was amplified by 30 cycles of 95°C for 50 s, 52°C for 50 s and 72°C for 2 min using the 
primers ChrII-6A and ChrII-6B. Microsatellites Chii-7 and ChrI-15 (A. MacLeod,
A. Tweedie, A. Tait, personal communication) were amplified by 28 cycles of 95°C for 
50 s, 54°C for 50 s and 68°C for 50 s using the primers ChrI-7A and ChrI-7B, and 
ChrI-15A and Chii-15B, respectively. The wild-type PCR products were cloned into 
pCR2.1-TOPO for micro satellites PLC, ClirII-6, ClirI-7 and ChrI-15 and sequenced on 
both strands. One primer flom each pair for each microsatellite was labelled with the 
fluorescent dye 6-carboxyfluorescein (6-FAM; Sigma Genosys) for detection with an 
automated DNA sequencer. Microsatellites PLC, ChrII-6, ChrI-7, and ChrI-15 were 
analysed by GeneScan analysis as follows. The PCR products were diluted 1/5 to 1/50 in 
H2O and 1 pi of each was run on a 36 cm acrylamide-urea gel (5% polyacrylamide, 6 M 
urea and 1 x TBE buffer for 3 h at 3 000 V and 51°C). N, N, N% N ’-tetramethyl-6- 
carboxyrhodamine (TAMRA)-labelled GeneScan size standard (Applied Biosystems) was 
loaded into each well along with the PCR products. Signals were read with an automatic 
sequencer (ABI 377; Applied Bio systems), and the data were stored and analysed with 
GeneScan software (version 3.1.2; Applied Biosystems) by the local Southern sizing 
method. The aciylamide gel electrophoresis and reading of the fluorescent signals were 
performed by the Molecular Biology Support Unit (MBSU) of the University of Glasgow. 
Where possible, the PCR products generated from the microsatellite loci given above were 
cloned into pCR2.1-T0P0 (Invitrogen; see section 2.2.4), and sequenced in order to 
determine the sequence of the alleles present in the 3174 MSH2 and MLHl wild-type 
trypanosomes. The results have been tabulated as a qualitative assessment of the presence 
or absence of microsatellite length changes (see sections 4.2.7 and 4.3.6).
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2.17 Assay for the frequency of integration of homologous and homeologous 
cassettes into trypanosome mismatch repair mutants
2.17.1 Generation of phleomycin resistance cassettes with homologous and 
homeologous integration flanks derived from the hygromycin 
phosphotransferase ORF
The hygromycin phosphotransferase {HYG) ORF present in the plasmid pHygro-Tub, was 
used as a template for the amplification of targeting flanks derived from the wild-type HYG 
gene by PCR using the primers HYGYor and HYGRsw (all primer sequences shown in 
Table 2.1). All reactions were performed in a PCR Sprint, using 2 ng of template and the 
following cycling conditions: 94°C for 10 min, 30 cycles of 94°C for 1 min, 65°C for 
1 min and 72°C for 1 min, followed by a final step of 72°C for 10 min. High fidelity 
amplification of the targeting flanks was performed using 2.5 U Herculase polymerase in a 
final volume of 50 pi to generate flanks which were perfectly homologous to the HYG 
template. A random mutagenesis approach was utilised to generate flanks homeologous 
(non-identical) to the HYG template. Two nucleotide analogues, dPTP and 8-oxo-dGTP 
(both supplied by Amersham Phaimacia Biotech), were added to a standard Taq 
polymerase amplification reaction (25 pi, containing 5 U Taq and 2 mM MgCh) to a final 
concentration of 100 pM each. Taq polymerase incorporates dPTP in place of dTTP, and 
with a lower efficiency dCTP, while 8-oxo-dGTP is incorporated in place of dTTP only 
(Zaccolo et a l, 1996). At the end of cycles 5, 10, 15, 20, 25, and 30, Ipl of the reaction 
mix was removed and used a template for a standard Taq polymerase amplification, 
required to remove the mismatches present in the PCR products prior to cloning. The six 
resulting Taq PCR products and the high-fidelity Herculase PCR product were cloned into 
pCR2.1-TOPO, and clones were restriction-digested withZ^cI and Ndel to ensure the 
presence of these sites within the plasmid. A number of clones derived from each PCR 
product were sequenced on both strands with the following primers: M l3 For, M l3 Rev, 
HYGDl, HYGD2, and HYGUl. Furthermore, pHygro-Tub was sequenced using the 
primers HYGDl, HYGD2, HYGUl, ResFor and ResRev. Selection of clones was governed 
by the level of mutation which they had incorporated. The clones chosen were as follows: 
pHYGOI (1%) and pHYG03 (3%) (all percentages rounded to the nearest integer) and 
pHYGWT, which sequencing revealed to be 100% identical to the HYG template.
The HYG integration flanks were separated by an antibiotic resistance cassette containing 
the BLE ORF, flanked at the 5 ’ end by 400 bp of processing flank from the actin locus and
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at the 3’ end by 400 bp of processing flank from the calmodulin locus. The resistance gene 
will be expressed by endogenous tubulin transcription since the cassette contains no 
promoter element. Cloning of the resistance cassette between the HYG targeting sequences 
generated the constructs HYGWT::BLE, HYG01::BLE and HYG03::BLE. The plasmids 
were digested with Ascl and resuspended to 1 |ig.|ur' in distilled H2O prior to 
transformation into T. brucei.
2.17.2 Generation of a trypanosome cell line containing a single copy of the HYG 
ORF
The plasmid pHygro-Tub which contains the HYG ORF flanked by 230 bp of p-a tubulin 
and 300 bp of a-p tubulin targeting flanks was digested with YTzoI andXbal prior to being 
transformed into T. brucei MITat 1.2a S427 as described into section 2.1.3. Integration of 
this cassette replaces an a  tubulin gene. As the resistance cassette does not contain a 
promoter element the HYG gene will be expressed by endogenous tubulin transcription. 
Transformants were selected at 5 jug.mf' hygromycin B.
Correct integration of the cassette into the tubulin locus was determined by Southern 
analysis. Genomic DNA from the transformants was digested with Kpnl, Southern blotted 
and probed with the HYG ORF generated by PCR with Herculase polymerase in section 
2.17.1. In the Kpnl digestion a 2.9 kb fragment was detected where the cassette had 
integrated correctly. The resulting cell line, HTUB, was then used to generate both 
heterozygous and homozygous MSH2 knock-out mutants as described in section 2.11.1.
2.17.3 Assay to determine the frequency of construct integration
Electroporation of 2.5 x 10  ^cells of each HTUB MSH2 transformant was performed in 
0.5 ml ZMG medium with 6 pg of HYG::BLE construct as described in section 2.1.3. For 
each transformation 1.5 x 10  ^cells were diluted into 36 ml HMI-9, containing 2.5 jug.mf* 
phleomycin and spread in 1.5 ml samples over a 24-well tissue culture plate. Three 
repetitions were performed for each of the constructs, HYGWT::BLE, HYG01::BLE and 
HYG03::BLE, in each of the HTUB cell lines. Plates were incubated at 37°C for 7 days 
before wells were scored for cell growth.
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Table 2.1 Oligonucleotides used in this study
Primer Name Primer Sequence
BLEYoy 5’-GGACCTCGTGGAGGACG-3 ’
ChrI-7A 5 ’-CCTGTTGGCCGCATTATTCGATGC-3 ’ ; 
labelled with 6-FAM
ChrI-7B 5 ’-TGAGGAAGTGAGGGGAGACGGAAG-3 ’
ChrI-15A 5 ’-TGGCTAGTTACACTGTAGTTCTCC-3 ’ ; 
labelled with 6-FAM
Chi'I-15B 5 ’-CCACAACCACTCCTTGATATTCAC-3 ’
ChrII-6A 5 ’-GTTGTGTGAGCAACGCAAGGGCGG-3 ’ ; 
labelled with 6-FAM
ChrII-6B 5’-TATAACAACAGGTGAAGGAGAGGG-3’
FcoRISL(l) 5 ’-CCGAATTCGTTTCTGTACTATATTG-3 ’ : 
EcoRI sequence underlined
HYGDl 5 ’-CAAGACCTGCCTGAAACC-3 ’
HYGDl 5 ’ -TTCCC AAT ACGAGGTCGC-3 ’
HYGYov 5 ’-AAGGCGCGCCAGCCTGAACTCACCGCGACG-3 ’ : 
Ascl sequence underlined
HYGKqv 5 ’-ATGGCGCGCCCTCCGGATCGGACGATTGCG-3 ’ : 
Ascl sequence underlined
Hygro 5’ 5’-ATGAAAAGCCTGAACTCACC-3’
Hygro 3’ 5 ’-CTATTCCTTTGCCCTCGGAC-3 ’
HYGUl 5’-CATCAGCTCATCGAGAGC-3’
JS-2A 5 ’ -GATTGGCGC A AC AACTTTC AC ATACG-3 ’
JS-2B 5’-CCCTTTCTTCCTTGGCCATTGTTTTACTAT-3’
Ml 3 For 5’-GTAAAACGACGGCCAG-3 ’
Ml 3 Rev 5’-GGAAACAGCTATGAC-3’
MLH l 3’(1) 5 ’-AAGGATCCGCTC AGCAACGCTCGAAGACC-3 ’ : 
BamHl sequence underlined
MLH l 3’(A) 5 ’-GGTCTAGAGATATCCTCTTCTTTCTGTCGTGG-3 ’ :
Xbal sequence underlined and EcoRW sequence double underlined
MLH l 3’(B) 5 ’-AACTCGAGAGGAAACAAGCCACAAACACGCCG-3 ’ : 
Xhol sequence underlined
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Table 2.1 continued
Primer Name Primer Sequence
MLHl 5’(1) 5 ’ -CCGAATTC AATTCGGAC ATAATGTTCGC-3 ’ : 
EcoRi sequence underlined
MLHl 5’(A) 5 ’-GGGAATTCTCTTAGATATGGGTATGC-3 ’ : 
EcoYl sequence underlined
MLHl 5’(B) 5 ’-GGTCTAGAAAATGTGTGAAAGAGCGG-3 ’ ; 
Xbal sequence underlined
MLHim 5’-AAGCGAGACAGAAGAGAACC-3’
M LHim 5’-AGTTTGTGATGTACCCGCGCG-3’
MLHim 5’-GGCTTCGGCATCAGTCACGG-3’
M LHim 5’-GGCACAGCAGAGAGAGAGG-3 ’
MLH1D5 5’-CGAACGAAGACAAACACGG-3’
MLH1D6 5’-CCAGCAACACTACCATCG-3’
MLHIDI 5’-GAGTGAATCTGCCGAATATCC-3’
M LHim 5’-CCATCAGCACTGATTTCC-3’
MLHim 5 ’ -GC ATTC AGGTGGTTGTTC AGG-3 ’
M LHim 5’-AGTGTACAGTGGTGTGTTGG-3 ’
M LHim 5 ’ -TGGTGGTGTGGCTGCTGTGG-3 ’
M LHim 5’-GAGGATGGTGAAGAAGTGG-3 ’
MLHim 5’-GGAAATCAGTGCTGATGG-3’
M LHim 5’-CGCGGGTACATCACAAACTGC-3’
M LHim 5’-ATGCACACCAACAGACCG-3’
MSH2V{\) 5 ’-CCGGATCCDATIGCCCAIGCIARNCCRAA-3 ’ : 
BamYll sequence underlined
MSH2 5 \ \ ) 5 ’ -CCGAATTC ATHRTIACIGGICCN AA YATG-3 ’ : 
EcoRl sequence underlined
MSH2 3’ (A) 5 ’-GGAAGCTTGATATCTGGTGGAGGTGTGAGA AGG-3 ’ : 
Hindlll sequence underlined and EcoRX sequence double 
underlined
MSH2 3’(B) 5 ’-AACTCGAGCGAGGTACTGAAGTAAGG-3 ’ : 
Xhol sequence underlined
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Table 2.1 continued
Primer Name Primer Sequence
MSH2 5’(A) 5’-GTGAATTCGCACAGATGTGGAATGAGGG-3 ’ ; 
EcoYl sequence underlined
MSH2 5’(B) 5’-CCAAGCTTGTTAACTTGCTGACTACACACCCG-3’; 
Hindlll sequence underlined and Hpal sequence double 
underlined
MSH2DX 5 ’-CCGAATTCGGAGGTAAGTCAACTTTCATG-3 ’. 
EcoRl sequence underlined
MSH2D2 5 ’ -GGAGC ATTGGTGTTTGTGTCG-3 ’
MSH2D3 5 ’ -GCTACGGATTGTACGTGGC-3 ’
MSH2D4 5’-GCTGAGCGAGCAGTATAAGG-3’
MSH2D5 5’-GCTGATCACGCAGGTACTGC-3’
MSH2FI 5 ’ -GTTGTGTC AGTTATGTGG AGGG-3 ’
MSH2Y2 5 ’ -CG AGTCCTTTCTTCTGTGCC-3 ’
MSH2F3 5’-ATACGACCGACAGACGAGCG-3’
MSH2F4 5’-AAAGCCTTCTAGAATCCGCC-3’
MSH2n 5’-CAAGAGAGAAAGGGACTGGG-3’
MSH232 5 ’-GTTGTGTCATTTCGTGG-3 ’
MSH233 5 ’-AAGCTGCTGTCGTGCCCGCC-3 ’
MSH234 5 ’-ATCGAATGGATCTATGGCGG-3 ’
MSH2U\ 5 ’ -CCGGATCCTCCATCGTACGTTGACGTCC-3 ’ ; 
BamUl sequence underlined
M SH 2m 5 ’ -CCTTATACTGCTCGCTC AGC-3 ’
MSH2U3 5 ’-GCAGTACCTGCGTGATCAGC-3 ’
MSH2U4 5’-TCAATAACCACACTCCC-3’
M SH 2m 5 ’ -C AC AGAAG A AAGG ACTCGG-3 ’
MSH2U6 5’-CAGCGTCATCAGAGGAGG-3’
MSH8 5^ 5’-TACGAACGTCGCGAAGACCC-3’
MSH8 3^ 5’-CGAGCTCCAGAGACTTAACC-3’
M SH8m 5’-CGAGCACTCGTACTTCCG-3’
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Table 2.1 continued
Primer Name Primer Sequence
MSH8D2 5 ’ - AGCTGCTGAGGTGTC AGGGG-3 ’
MSH8D3 5 ’ -C AGTGGTGTCGCTACTTGC-3 ’
M SH Sm 5 ’-CCTTCTACTCTTCTCTACCC-3 ’
MSH8D5 5’-GTGTCATCACTACAAGCCGG-3’
MSH8D6 5’-TACGACCAAGATGCCGC-3’
MSH8D1 5 ’-CGAATGGCAAGGAGAGCG-3 ’
M SH 8m 5’-CCATTGCGAGTTTCTGCG-3’
MSH8 DN(1) 5 ’ -C ACCTTCTCC ATCGCCTCC-3 ’
MSH8UI 5’-GGTAGAGAAGAGTAGAAGGG-3’
MSH81J2 5’-GCATAGACGTAGCAAACACTGG-3’
MSH8U3 5 ’-GACACACGCTGAAGTACGGG-3 ’
MSH8V4 5’-GATGCTTCTTGTACTGCACG-3’
MSH81J5 5 ’-CGGAAGTACGAGTGCTCG-3 ’
MSH8\J6 5 ’ -CCTCCTTTA AGCTCCTCTCC-3 ’
MSHSUl 5’-GCTGATCATCATGGGATCGG-3’
M SH 8m 5’-ACAAAGAGCGAAAGGC-3’
MSH8U9 5’-GGGTGAGATCATGAAAGC-3 ’
M SH 8lJ?i\) 5’-TGGTGCTTTCTAAGGGTCGG-3’
Neo 5’ 5’-TTGCACGCAGGTTCTCCG-3’
Neo 3’ 5 ’ -GA ACTCGTC A AGAAGGCG-3 ’
PLCG 5 ’ -CA ACGACGTTGGA AGAGTGTG AAC-3 ’ ; 
labelled with 6-FAM
PLCH3 5 ’ - CCACTGACCTTTCATTTGATCGCTTTC-3 ’
PMSJ y  (2) 5’-ATGACGAGCATTAGGTTCCG-3’
PMSl 5’(2) 5’-TACGACTCGATGTGGAGC-3’
P M S im 5’-GGTTGGTGGTGCTGGTTGG -3’
P M S im 5’-GCACCAGCAACTTATTGG-3’
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Table 2.1 continued
Primer Name Primer Sequence
P M s im 5’-CAGCAAGGGCTCGCTGGG-3’
P M S im 5’-GCTTCGCCACGAAAACCC-3’
P M S im 5 ’ -C AATGGTGCACGTGTGGG-3 ’
P M s im 5’-TTCGACACCTTTGCCTCG-3’
P M SIW 5 ’ -TAGTTGCC ATTGAGTGCC-3 ’
P M s im 5’-CCTTCTTCCTGCATGTCAGC-3’
P M s im 5 ’-GTTGCTGGTGCTATCAGTGC-3 ’
P M s im 5’-GGTCTTTCGTCGCAGGC-3 '
P M s im 5’-GCTCACGTTGTATTTGGG-3’
P M s im 5’-GTCGCTTTTTCTACACGG-3 ’
P M s im 5 ’-GATGGACTAAAGAAGACG-3 ’
Poll 5’ 5 ’-CAGGAGGATCGTTCGGCACCTTGGC-3 ’
Poll 3’ 5 ’-CATGCGCCTGTGGTTCAGCATAGC-3 ’
ResFor 5’-TTCGTAAGTGGTGGTGG-3’
ResRev 5 ’ -GGAGAGAGAGA AAGAGG-3 ’
T3 5’-AATTAACCCTCACTAAAGGG-3 ’
T7 5 ’ -TAATACGACTC ACTATAGGG-3 ’
VSG221 5’ 5 ’-CCGAATTCCGCATGCCTTCCAATCAGGAGGC-3 ’ ; 
vgcoRI sequence underlined
VSG221 3’ 5 ’-CGCGGATCCGCTGTATCGGCGACAACTGCAG-3 ’ : 
Bam\l\ sequence underlined
103
I
bJDI
g3z!»0>801t
3
I
IH
Ph
a
(D
tJÛ
c <u , GO
CD
I a
ai■§Ck
2no
'S
IuW)•IIc/5
Io
II S
00 
H
m
c/5
<o
O
d)
0) "P
H
0  
•S1
oo(N
Ig
IISSoaII
I
§I
c§
i>IIU  <u
OO <3
1 1§(L) .%
ILs i i
I
01
oOo(N
1| lÜ T3u  I
cd DO Ph O
fS c3II
œ
I
f iII
73 ^II
P4!j
& .8
c/3
W Ph
HJ•I
rP dJ[—I
4
Jdi
a  ffl
I1
a
o
I
f i t
Ii
I
« 8IIJU cd
1 1 1
#54|
9  g
}I
II| iI% 00.SIÜ 3
l i<u S
g g
c/5
IIg
104
3Iw
«N
I
O<uI è
IIc / 5
I ftX) Q(L)
I!
I
Îo
gIII
I
(u d>IIIIII
egO t3 H §
<D
<UI
I!
%I&
g " g  g*
!
105
C h a p t e r  3
Identification of three putative MutS 
homologues and two putative MutL 
homologues from T. brucei
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3.1 Cloning and characterisation of a putative MutS Homologue 2 (MSH2) 
orthologue in T, brucei
3.1.1 Introduction
The amino acid sequences of MutS homologues from a diverse range of organisms have 
been shown to be highly conserved, especially over the ATP-binding domain and the helix- 
turn-helix motif (Eisen, 1998; Culligan et a i,  2000). The primary MutS homologue 
involved in eukaryotic MMR is MSH2, as this protein is required for all nuclear MMR 
reactions to proceed (Harfe and Jinks-Robertson, 2000). Orthologues of MSH2 can be 
distinguished from other eukaryotic mismatch-interacting MutS-related proteins by the 
closer proximity of their mismatch interacting domains to their N-termini (except T. brucei 
MSH8; see below). Furthermore, MSH2 orthologues evolved from a common ancestor 
(Eisen, 1998; Culligan et a l ,  2000) and this is reflected in multiple alignments of MutS 
homologues, which reveal that there is a greater similarity between the ATP-binding 
domains of MSH2 proteins than there is between MSH2 orthologues and other MutS 
homologues (data not shown). Knowledge of the characteristics of MSH2 orthologues in 
other eukaryotes allowed the isolation of a gene from T. brucei which putatively encodes a 
homologue of MSH2.
3.1.2 Identification of a putative T. brucei MSH2 orthologue by degenerate PCR
The putative T. brucei MSH2 gene was initially identified by degenerate PCR using 
primers directed against the highly-conserved ATP-binding motif. A GCG pileup 
alignment of MSH2 polypeptides from a number of representative eukaryotes revealed 
several candidate regions which could be back-translated allowing the design of suitable 
degenerate primers. The 5’ primer {MSH2 5’(1)) was designed to recognise a short motif 
known to be present in most MSH2, MSH3 and MSH6 homologues (Figure 3.1). However, 
to increase the likelihood of amplifying MSH2 rather than any other homologue, the 
3’ primer (MSH2 3’ (1)) was designed to recognise a short motif specific to MSH2. PCR 
amplification from MITat 1.2 genomic DNA using these primers at 2 pM each (see section 
2.9.1) produced a 315 bp product which was cloned and sequenced (Figure 3.2). From the 
sequence data it was evident that this product encoded the predicted region of a putative 
MSH2 homologue (Figure 3.9).
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3.1.3 Cloning of the complete ORF of the putative T. brucei MSH2 gene from a 
genomic lambda library
The clone of the 315 bp degenerate PCR product was then restriction-digested with EcoBl 
and BamRl and the sequence encoding the ATP-binding domain used as a probe to screen 
an ILTat 1.2 genomic lambda library in order to recover the complete MSH2 gene 
sequence. As described in Materials and Methods (see section 2.6), the library was put 
through four rounds of screening, and a single clonal plaque (designated Plaque 1) was 
recovered. DNA was prepared from this phage clone and mapped by restriction digestion. 
Initially, the DNA was singly digested to assess which restriction enzymes produced 
fragments of a suitable size for cloning. Southern analysis of the products of these 
digestions revealed that EcoBl, Sad  and Sail gave fragments of between 4.0 and 8.0 kb 
which could therefore potentially encode the entire ORF of MSH2 (Figure 3.3). 
Furthermore, Sacll cut twice within the sequence amplified in the degenerate PCR and 
gave two informative bands on a Southern blot, allowing orientation of the restriction 
fragments as one is brighter since it is complementary to a larger region of the probe (the 
third fragment was too short for the probe to illuminate). The phage DNA was then double 
digested using and either EcoRl, Sad  or Sail. The products of these digestions were 
then Southern blotted and the results analysed (Figure 3.4). Although the Sad i and EcoRl 
double digestion appeared to be partial, in the Southern blot the probe seemed to have 
hybridised only to bands of the expected size. The final restriction map of Plaque 1 was 
compiled using the restriction digestion data, the known sequence of the bacteriophage-A, 
arms, and the short sequence identified by degenerate PCR (Figure 3.5). Analysis of these 
data revealed that the 4.5 kb EcoRl fragment should contain the entire putative MSH2 ORF 
along with its processing flanks. DNA from Plaque 1 was therefore digested with EcoBl 
and ‘shot-gun’ cloned into pBluescript II KS. From the resulting sub-clones one (pJBlOO) 
that contained a 4.5 kb insert was chosen for sequencing. This revealed an ORF encoding 
a putative polypeptide 951 amino acids in length, as well the 5’ and 3’ processing flanks 
required for splicing of the mRNA. A sequence map of the 4.5 kb insert is shovm in 
Appendix 1.
3.1.4 Southern analysis of the putative T. brucei MSH2 locus
Both MITat 1.2 and ILTat 1.2 genomic DNA were restriction-digested with a panel of 
enzymes to analyse the genomic environment of the putative T. brucei MSH2 ORF. The 
restriction digestions were separated by agarose gel electrophoresis, Southern blotted, and 
then probed with the same probe as was used in section 3.1.3, revealing the gene to be
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present in single copy within the T. brucei genome (Figure 3.6). Unfortunately, the EcoRM 
restriction digestion of both types of genomic DNA appeared to be partial, and in the lane 
containing the ILTat 1.2 Sali digestion there was an air bubble in the agarose. Despite this, 
the restriction pattern in both the MITat 1.2 and ILTat 1.2 digestions were identical and it 
can be concluded that the genomic environment of this gene is the same in both strains of 
T. brucei. In each genomic digestion the probe hybridised to fragments of the same size as 
in the lambda digestions, thereby confirming the map of clone Plaque 1 (Figure 3.5).
3.1.5 Analysis of the expression of the putative T. brucei MSH2 gene
The expression of the putative MSH2 gene was investigated by RT-PCR using gene- 
internal primers specific to the MSH2 ORF {MSH2D5 and MSH2\J2\ see Appendix 1 and 
section 2.4.2). The integrity of the cDNA was confirmed using primers specific to the 
large subunit of T. brucei RNA polymerase I (Poll 5’ and Poll 3’; see Figure 3.7; Rudenko 
et a l , 1996), and it is apparent that the putative MSH2 gene is expressed in both procyclic 
and bloodstream stage cells. No conclusions can be drawn about the level of expression of 
the gene in the different life cycle stages since, under the conditions used, RT-PCR is not 
quantitative.
3.1.6 Pairwise comparison of the putative T, brucei MSH2 polypeptide with other 
MutS homologues
A conceptual translation of the putative T. brucei MSH2 ORF was compared with a range 
of MutS homologues from E. coli, A. thaliana, H  sapiens, and S. cerevisiae using the 
GCG gap program. The results of these pairwise alignments are shown in Table 3.1. A 
graphical representation of these data shows that the putative T. brucei MSH2 polypeptide 
shares between 5.5 and 13.0% greater identity (or 6.0 and 12.0% greater similarity) with 
the MSH2 orthologues than with the MSH3 or MSH6 homologues shown (Figure 3.8). 
While similarity does not necessarily equate to homology, this evidence suggests that the 
T, brucei gene encodes an orthologue of MSH2.
3.1.7 Multiple alignment of the putative J. brucei MSH2 polypeptide with 
eukaryotic MSH2 orthologues
A global multiple alignment of the putative T. brucei MSH2 polypeptide with a number of 
eukaryotic MSH2 orthologues was produced with CLUSTAL X (Thompson et a l, 1997) 
using the default settings (Figure 3.9). The alignment shows diffuse conservation
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throughout the polypeptides, including the N-terminal mismatch-interacting domain 
(Maikov et a l , 1997; Culligan et a/., 2000; Schofield et a l ,  2001), the middle conserved 
domain (Culligan et a l , 2000) and the helix-tum-helix motif (Add et a l ,  1999; Biswas et 
a l , 2001). A region of high identity corresponds to the ATP binding domain (Gorbalenya 
and Koonin, 1990). The putative T. brucei MSH2 shows conservation across the four 
functional domains characteristic of MSH2 orthologues, but is divergent compared with 
the other MSH2 orthologues shown, especially over the N-terminal region required for 
interaction with mismatches. From this alignment, the putative T. brucei MSH2 appears to 
contain three insertions of 8, 14 and 10 amino acids between the N-terminal mismatch- 
interacting domain and middle conserved domain and a 12 amino acid insertion between 
the middle conserved and ATP-binding domains. Since the function of the amino acid 
residues which lie between the conserved domains is unknown and the 3-dimensional 
structure of MSH2 has not been solved, the functional implications of these insertions, if 
any, cannot be predicted.
3.1.8 The genomic environment of the putative T, brucei MSH2 ORF in TREU 927/4
Recent searching of the Sanger T, brucei genome sequence database revealed a large 
contig, TRYPl 0.0.001883 (29,749 bp), composed of 324 reads from chromosome X, 
which encodes the putative MSH2 gene. While this sequence is unfinished, it can be 
concluded that the putative MSH2 gene is present on chromosome X. Comparison of the 
putative MSH2 ORFs from ILTat 1.2 and TREU 927/4 shows the nucleotide sequences 
differ at 15 positions, and this is reflected in the conceptual translations of the ORFs as the 
two polypeptide sequences differ by 5 amino acid residues (data not shown). Although 
some of these changes may be sequencing artefacts, they have affected amino acid residues 
which are not conserved between the MSH2 orthologues shown in the alignment in Figure 
3.9, If these changes do reflect real differences between the two trypanosome cell lines, 
they are unlikely to impact upon the function of the protein as the residues affected are 
unlikely to have catalytic roles. Further analysis of the contig sequence (see section 2.8.4) 
reveals that the putative MSH2 gene is approximately 8.6 kb downstream of a hypothetical 
ORF which bears homology to a T, brucei flagellar antigen (Figure 3.10). The contig 
sequence also contains a number of other hypothetical ORFs, but BLAST searches of 
nucleotide and protein databases retrieve only insignificant alignments.
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Figure 3.1 Design of degenerate PCR primers to amplify an MSH2 orthologue 
from r. brucei
A GCG pileup of a portion of the sequence of the MSH2 orthologues from A. thaliana 
(Ath), S. cerevisiae (See), S. pombe (Spo), H. sapiens (Hsa) and N. crassa (Ncr) is shown. 
The pileup was shaded using the BOXSHADE server (http://www.ch.embnet.org/software/ 
BOX_form.html) and identical residues are boxed in black, conserved residues in grey. 
Only the sequences around the ATP-binding domain are shown. Residues marked with an 
asterisk were back-translated to generate degenerate primers to PCR amplify the 
intervening MSH2 gene sequence; blue asterisks correspond to primer MSH2 5'(1), and red 
to primer MSH2 3’(1).
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F i g u r e  3 . 2  D e g e n e r a t e  P C R  o f  M S H 2
Primers MSH2 5’(1) and MSH2 3’(1) were used with MITat 1.2 genomic DNA for PCR. 
Control reactions were performed with both primers in the absence of T. brucei DNA 
template (A), the MSH2 5’(1 ) primer only (B), and the MSH2 3’(1 ) primer only (C). Lane 
D shows the reaction containing both primers and template.
B D
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Figure 3.3 Restriction mapping of Plaque 1 - single digestions
(A) DNA isolated from the genomic lambda clone Plaque 1 was digested with the enzymes 
shown and separated on a 0.6% agarose gel. (B) A Southern blot of the restriction 
digestions shown in (A) probed with a 315 bp degenerate PCR product amplified from the 
putative T. brucei MSH2 gene.
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Figure 3.4 Restriction mapping of Plaque 1 - double digestions
(A) DNA isolated from the genomic lambda clone Plaque 1 was digested with the enzymes 
shown and separated on a 0.6% agarose gel. (B) A Southern blot of the restriction 
digestions shown in (A) probed with a 315 bp degenerate PCR product amplified from the 
putative T. brucei MSH2 gene.
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Figure 3.5 Restriction map of the putative T. brucei MSH2 lambda clone Plaque 1
A restriction enzyme map of Plaque 1, a lambda clone encoding the putative T. brucei 
MSH2 gene, which was retrieved from the ILTat 1.2 genomic lambda library (not to scale). 
The putative MSH2 ORF is denoted by hatched shading. The probe region is shown as a 
black box with the primers MSH2 5’ (1) and MSH2 3’(1) (shown as black half arrows) 
which were used to produce the probe fragment indicated above and below. Restriction 
enzyme sites are shown as coloured bars, with the resulting fragments indicated below: 
S'acII (red); EcoRl (blue); Sad  (purple); Sail (green).
MSH2
SP6 MSH2 5\\)^  T7f  I ^ m m \----------
.Si/fll (5.3 kb) Sad \ (6.0 kb)
/ùï>Rl (4.5 kb)
.SV/rl (5.5 kb)
■SV//I (7.2 kb
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Figure 3.6 Genomic Southern blot probed for the putative T. brucei MSH2 gene
A Southern blot of MITat 1.2 and ILTat 1.2 genomic DNA which was restriction-digested 
with the enzymes shown, separated on a 1.0% agarose gel, probed with a 315 bp 
degenerate PCR product amplified from the putative T. brucei MSH2 gene and washed to 
0.2 X SSC, 0.1% SDS at 65°C.
MITat 1.2 ILTat 1.2
kb
8.0  —7.0 —
6.0 —
5.0 —
4.0 —
r
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1 1
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Figure 3.7 Analysis of the expression of the putative T. brucei MSH2 gene
RT-PCR was performed on both bloodstream and procyclic form total RNA isolated from 
MITat 1.2. Internal primers complementary to the putative T. brucei MSH2 gene were 
used and the integrity of the RNA was confirmed using primers directed against the large 
subunit of T. brucei RNA polymerase I (Rudenko et a i, 1996). For both genes RT positive 
(RT+), RT negative (RT-) and no template (NT) reactions were performed.
RNA
POLI MSH2
RNA
POLI MSH2
4- I 4- IH H H E—' H HX X ^  X  X "Z,
Bloodstream
Form
Procyclic
Form
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T a b l e  3 . 1  P a i r w i s e  c o m p a r i s o n  o f  t h e  p u t a t i v e  T .  b r u c e i  M S H 2  p o l y p e p t i d e  w i t h  a  
r a n g e  o f  M u t S  h o m o l o g u e s
Pairwise gap alignments were performed using the GCG gap program. The full length 
putative T. brucei MSH2 polypeptide sequence was compared against the full length 
polypeptide sequences for a range of MutS homologues. For each alignment the 
percentage identity and similarity between the two proteins was calculated.
M utS hom ologue
T. b ru c e i  M SH2
% Identity % Sim ilarity
E. coli MutS 29.14 38.57
A. thaliana MSH2 35.43 46.68
H. sapiens MSH2 35.27 45.91
S. cerevisiae MSH2 32.28 44.43
A. thaliana MSH3 24.14 34.59
H. sapiens MSH3 24.94 36.36
S. cerevisiae MSH3 22.38 35.06
T. brucei MSH3 26.15 34.58
A. thaliana MSH6 26.42 36.17
H. sapiens MSH6 26.80 36.31
S. cerevisiae MSH6 26.33 38.11
A. thaliana MSH7 26.80 37.03
T. brucei MSH8 26.98 35.35
S. cerevisiae MSHl 27.38 37.98
S. cerevisiae MSH4 22.98 32.86
S. cerevisiae MSH5 22.74 35.12
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F i g u r e  3 . 8  A  g r a p h i c a l  r e p r e s e n t a t i o n  o f  t h e  s i m i l a r i t y  b e t w e e n  t h e  p u t a t i v e  
T .  b r u c e i  M S H 2  p o l y p e p t i d e  a n d  o t h e r  M u t S - r e l a t e d  p r o t e i n s
Pairwise alignments were performed as described in Table 3.1 to compare the putative 
T. brucei (Tbr) MSH2 polypeptide sequence with other MutS-related polypeptide 
sequences from: A. thaliana (Ath), E. coli (Eco), H. sapiens (Hsa) and S. cerevisiae (See). 
Percentage identity is shown in blue and percentage similarity in red.
I
ll
119
Figure 3.9 Global multiple alignment of the putative T. brucei MSH2 polypeptide
with a range of MSH2 orthologues
Multiple sequence alignment of the putative T. brucei MSH2 (TbrMSH2) polypeptide 
(shown in red) with homologues of MSH2 from other eukaryotes: A. thaliana MSH2 
(AthMSH2), D. melanogaster Spellchecker 1 (DmeMSH2), H. sapiens (HsaMSH2),
S. cerevisiae MSH2 (SceMSH2), and X. laevis MSH2 (XlaMSH2). Sequences were 
aligned using CLUSTAL X (Thompson et a i , 1997) and shaded using the BOXSHADE 
server (http://www.ch.embnet.org/software/BGX_foim.html): identical residues are shaded 
in black, and conserved residues in grey. MIS is the N-terminal mismatch interacting 
domain (shown in purple; Maikov et a i ,  1997; Culligan et a i ,  2000; Schofield et a i,
2001), MCD is the middle conserved domain (shown in turquoise; Culligan et a i , 2000), 
the peptides identified as I, II, III and IV are the conserved nucleotide binding motifs 
(shown in blue; Gorbalenya and Koonin, 1990) and HTH is the conserved helix-tum-helix 
motif (shown in green; Add et a i ,  1999; Biswas et a i ,  2001). The region identified 
beneath the T. brucei sequence corresponds to the region of the T. brucei MSH2 gene that 
was amplified by degenerate PCR and used as a probe (shown in orange).
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Figure 3.10 Analysis of the genomic environment of the putative T, brucei MSH2
gene
The nucleotide sequence of contig TRYPl 0.0.001883 was analysed using the Nucleotide 
Identification (NIX) server (http://www.hgmp.mrc.ac.uk/Registered/webapp/nix/) provided 
by the UK Human Genome Mapping Project Resource Centre. The output shows the 
results of selected programs which were used in the analysis. The sequence regions 
identified correspond to: (A) the T. brucei MSH2 ORF; (B) a hypothetical ORF bearing 
similarity to a T. brucei flagellar antigen; and (C) a number of hypothetical ORFs 
suggested by the HMMGene gene-prediction and Fex exon-prediction programs. The 
predicted direction of transcription is indicated by a black arrow.
I  m i l l  I
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3.2 Identification of two further putative MutS homologues, MSH3 and MSH8, in
T, brucei
3.2.1 Introduction
During nuclear mismatch repair in yeast and humans MSH2 forms a heterodimeric 
complex with another MutS homologue, either MSH3 or MSH6 (Acharya et a l ,  1996; 
Kolodner and Marsischky, 1999). This situation is more complicated in plants as another 
protein, called MSH7, which is closely related to MSH6 and which probably arose via 
duplication of this gene, has also been identified and forms a third heterodimer with MSH2 
in these organisms (Culligan and Hays, 2000). Furthermore, in eukaryotes such as 
D. melanogaster and C. elegans, for whom the complete genome sequence is available, no 
homologues of MSH3 have been identified and these organisms are thought to rely solely 
on the mismatch repair capabilities of the MSH2-MSH6 heterodimer (Sekelsky et a l, 
2000). As the sole partner for MSH2 in these organisms it is possible that MSH6 might 
fulfil at least some, if not all, of the roles that MSH3 performs in yeast and mammals. 
However, the functions of the MSH6 homologues in D. melanogaster and C. elegans have 
yet to be determined experimentally.
In the absence of functional data, putative homologues of MSH3, MSH6 and MSH7 can be 
distinguished from MSH2 orthologues as they possess N-terminal extensions upstream of 
the mismatch interacting domain (data not shown). It is also possible to distinguish 
between MSH3, MSH6 and MSH7 homologues as they vary greatly in length, and differ 
within the sequence of their mismatch interacting domains (see Figure 3.21). MSH3 and 
MSH7 proteins are generally 1000 to 1190 amino acids in length, whereas MSH6 proteins 
are usually between 1250 and 1370 amino acids in length (data not shown). However, the 
sequence of the mismatch interacting domain of MSH7 is similar to that of MSH6 
(Culligan and Hays, 2000). Knowledge of the characteristics of the MSH3/MSH6 
sub-family of MutS-related proteins allowed identification of two homologues from 
T. brucei, firstly a gene designated MSH8, and more recently a probable orthologue of 
MSH3.
3.2.2 Identification of a second putative MutS homologue by searching the T, brucei 
genome sequencing databases
Similarity searching of the TIGR and Sanger sequencing databases using the MSH3 and 
MSH6 polypeptide sequences from A, thaliana, H, sapiens and S. cerevisiae revealed a
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number of sequences bearing homology to these MutS-related proteins. Alignment of 
these sequences using the GCG fragment assembly programs produced two contigs which 
appeared to span the C-terminal half of the same gene because one of the contigs contained 
the Ml 3 forward sequence of TIGR clone 30114 and the other contained the Ml 3 reverse 
sequence (Figure 3.11). From the available sequence it was possible to assign the gene as 
a putative member of the MSH3/MSH6 sub-family, but as the sequence was incomplete, no 
further conclusions could be dravm.
3.2.3 Cloning and sequencing of the complete ORF of the putative J. brucei MSH8 
gene
PCR primers {MSH8 5’ and MSH8 3’) were designed from these contigs which would 
amplify the majority of the available gene sequence. PCR was performed on MITat 1.2 
genomic DNA with high fidelity polymerase (see section 2.9.2) and generated a product 
approximately 2.0 kb in length (Figure 3.12). This product was cloned into pPCR-Script 
Amp SK (+) (the resulting plasmid was called pJB301), and sequencing revealed an 
incomplete ORF 631 amino acids in length.
The sequence generated above was used to search the T. brucei sequencing databases at 
regular intervals in an attempt to identify further homologous sequences recently added to 
the databases. After several months, a number of shotgun clone sequences became 
available which aligned with the sequence of the 2.0 kb PCR product (Figure 3.13). Where 
available, the sequence from the opposite end of these clones would therefore have to lie 
either upstream or downstream of the known sequence for MSH8. The Ml 3 forward 
sequence of clone 109F12 allowed the design of a primer (MSH8 UP(1)) which, when used 
with a primer complementary to the sequence of the 2.0 kb PCR product (MSH8U3), 
would amplify the 5’ end of the gene. Furthermore, the Ml 3 reverse sequence of clone 
90D12 revealed that the MSH8 gene was upstream of T. brucei HSP60 (Bringaud et al., 
1995). A primer directed against this sequence {MSH8 DN(1)) used in conjunction with a 
primer complementary to the sequence of the 2.0 kb PCR product (MSH8D3) would 
amplify the 3’ end of the gene and confirm this linkage. Using these two sets of primers, 
two overlapping PCR products were amplified from MITat 1.2 genomic DNA (see section 
2.9.2): the first, approximately 2.9 kb in length, corresponded to the 5’ end of the gene 
(MSH8 Upstream), and the second, approximately 2.2 kb in length, contained the sequence 
of the 3’ end of the gene (MSH8 Downstream; Figure 3.14). These products were cloned 
into pPCR-Script Amp SK(+) (generating the plasmids pJB302 and pJB303 respectively). 
The plasmids were sequenced and the data assembled with the sequence of the original
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2.0 kb PCR product using the GCG package. A single contig resulted which upon 
translation revealed an ORF 997 amino acids in length, along with 5’ and 3’ processing 
flanks. The HSP60 start codon was located approximately 1.0 kb downstream of the 
MSH8 stop codon. A sequence map of the MSH8 gene is shown in Appendix 2.
3.2.4 Southern analysis of the putative T. brucei MSH8 locus
Both MITat 1.2 and ILTat 1.2 genomic DNA were restriction-digested with a panel of 
enzymes to analyse the genomic environment of the putative T. brucei MSH8 ORF. The 
restriction digestions were separated by agarose gel electrophoresis and Southern blotted. 
PCR primers were designed from the sequence encoding the ATP-binding domain 
{MSH8D3 and MSH8\}\ \ see section 2.9.2) and used to amplify a 540 bp product from 
MITat 1.2 genomic DNA (Figure 3.15). This PCR product was then used as a probe for the 
Southern blot. This hybridisation revealed the gene to be present in single copy in the 
T. brucei genome (Figure 3.16). Furthermore, since the restriction pattern in both the 
MITat 1.2 and ILTat 1.2 digestions were identical it can be concluded that the genomic 
environment of this gene is the same in these strains of T. brucei.
3.2.5 Analysis of the expression of the putative T. brucei MSH8 gene
The expression of the putative MSH8 gene was investigated by RT-PCR using gene- 
internal primers specific to the MSH8 ORF {MSH8D3 and MSH8UI; see section 2.4.2).
The integrity of the cDNA was confirmed as described in section 3.1.5. The results 
demonstrate that the putative MSH8 gene is expressed in both bloodstream and procyclic 
form cells (Figure 3.17). Since non-quantitative RT-PCR was performed no conclusions 
about the level of expression in the different life cycle stages can be drawn.
3.2.6 Identification of a third putative MutS homologue by searching of the 
J. brucei genome sequencing databases
As the T. brucei genome sequencing databases are under continual development, BLAST 
searching of these resources has been performed at regular intervals to investigate whether 
any further mismatch repair proteins have come to light. In the last month of my Ph.D. 
(January 2001), a BLAST search of the Sanger database using the putative T. brucei MSH8 
polypeptide sequence identified a contig forming part of chromosome IX which encodes a 
hypothetical ORF whose conceptual translation bears strong sequence similarity to MSH3 
fi'om M  musculus and H. sapiens. This hypothetical ORF (TRYP9.0.000864 4) encodes a
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polypeptide 935 amino acids in length which possesses the four conserved domains 
characteristic of a MutS homologue involved in nuclear MMR (see Figures 1.9 and 3.21). 
Although the chromosome IX sequence released by Sanger is unfinished and therefore may 
contain errors, this contig, TRYP9.0.000864, is 12,066 bp in length and composed of 
127 reads, suggesting extensive overlaps between the constituent sequence fragments. 
Furthermore, investigation of the conceptual translation of the hypothetical ORF suggests 
that the sequence is in frame throughout its length and that the putative MSH3 polypeptide 
sequence encoded is likely to be correct. Therefore, for the purposes of this analysis the 
sequence of the hypothetical MSH3 ORF will be considered correct. A sequence map of 
this hypothetical ORF is shown in Appendix 3.
3.2.7 Pairwise comparison of the putative 71 brucei MSH3 and MSH8 polypeptides 
with other MutS homologues
Using the GCG gap program conceptual translations of the putative T. brucei MSH8 and 
MSH3 ORFs were compared with a range of MutS homologues from E. coli, A. thaliana,
H  sapiens, and S. cerevisiae. The results of these pairwise alignments are shown in 
Table 3.2. The data are represented in the form of a graph in Figure 3.18 for MSH8 and in 
Figure 3.19 for MSH3. Analysis of these data reveals that the putative T. brucei MSH8 
polypeptide shares between 3.5 and 6.0% greater identity (or 1.5 and 8.0% greater 
similarity) with the MSH6 and MSH7 homologues shown than it does with either the 
MSH2 or MSH3 homologues used in the analysis. Before the discovery of the putative 
T. brucei MSH3, the overall levels of similarity suggested that the MSH8 gene encoded a 
member of the MSH3/MSH6 sub-family of MutS homologues, but the data was 
inconclusive as to whether it was an orthologue of MSH6 or a composite protein 
encompassing the functions of both MSH6 and MSH3. Since the putative T. brucei MSH3 
polypeptide shares between 1.0 and 6.0% greater identity (or 4.0 and 8.5% greater 
similarity) with MSH3 than with either MSH2, MSH6 or MSH7 homologues from other 
eukaryotes (Figure 3.19), it can be concluded that this gene probably encodes the 
orthologue of MSH3 in T. brucei. This new data from T. brucei and extrapolation from the 
MMR systems of S. cerevisiae and H. sapiens suggests that MSH8 is an orthologue of 
MSH6 as this would fulfil the requirements for MMR in these organisms. However,
MSH8 is truncated in comparison with MSH6 orthologues from other eukaryotes (see 
sections 3.2.1, 3.2.8 and 3.2.9), and it may not therefore perform the same functions. 
Furthermore, plants possess a third member of the MSH3/MSH6 subfamily, MSH7, and 
since the genome sequence for T. brucei is not yet complete it is possible that another
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MutS-related gene bearing a greater similarity to MSH6 will come to light in the future. It 
is for these reasons we have chosen the nomenclature MSH8, rather than MSH6 or MSH7.
3.2.8 Investigation of the 5’ splicing of the putative T, brucei MSH8 mRNA
As discussed in section 3.2.7, the predicted T, brucei MSH8 polypeptide is truncated in 
comparison with homologues of MSH6 at only 997 amino acids in length. Therefore, in 
order to confirm the conceptual translation of the putative MSH8 gene, RT-PCR was 
performed (see section 2.4.2) using a primer directed against the conserved splice acceptor 
sequence trans-spliced onto all mature mRNAs in T. brucei (£coRISL(l); Ullu et a l ,  1996) 
and primers complementary to the 5’ end of the MSH8 gene {MSH8\]1 and MSH8U%\ 
Figure 3.20). The integrity of the cDNA was confirmed using primers complementary to 
the MSH8 ORF (MSH8D6 and MSH81J6). Amplification from cDNA generated from 
MITat 1.2 bloodstream form total RNA using the MSH8D6 and MSH8U6 gene-intemal 
primers produced two products: a larger specific product (approximately 600 bp) 
confirming transcription of the MSH8 gene; and a smaller non-specific product 
(approximately 350 bp). The primers EcoRISL(l) and MSH8U7 gave a single specific 
band of the expected size (approximately 600 bp), while amplification using jEcoRISL(I) 
and MSH8U^ gave three bands. The product generated by RT-PCR using the primers 
EcoRISL(l) and MSH8U1 was cloned, and sequencing confirmed that the hypothesised 
splice acceptor site was correct, lying 72 bp upstream of the predicted start codon. MSH8 
likely forms part of a multi-gene transcription unit, and so the products generated in the 
EcoRISL(l) and MSH8U^ RT-PCR probably arose from splicing events further upstream 
of the MSH8 splice acceptor site (see Appendix 2). These results suggest that the proposed 
start codon is correct and that the MSH8 polypeptide is indeed truncated and no longer 
than 997 amino acids.
3.2.9 Multiple alignment of the putative T. brucei MSH3 and MSH8 polypeptides 
with eukaryotic MSH3, MSH6 and MSH7 homologues
Global multiple alignment of the MSH3, MSH6 and MSH7 orthologues ffom/4. thaliana, 
K  sapiens and S. cerevisiae together with the putative T. brucei MSH3 and MSH8 
polypeptides was performed using the CLUSTAL X program (Figure 3.21; Thompson et 
a l , 1997). The multiple alignment parameters used were as follows: gap opening penalty 
(12.00), gap extension penalty (2.0), delay divergent sequences (40%) and the protein 
weight matrix used was the gonnet series. In comparison with the putative T. brucei 
MSH3 and MSH8 polypeptides, the MSH3, MSH6 and MSH7 proteins from other
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eukaryotes all possess N-terminal extensions, the longest of which belong to the MSH6 
orthologues, and which show virtually no sequence conservation. The first region of 
conservation between these MutS homologues corresponds to the N-terminal mismatch 
recognition domain (Maikov et a l ,  1997; Culligan et a l, 2000), where the putative 
T, brucei MSH3 polypeptide shows greater similarity to the MSH3 orthologues, whereas 
the putative T. brucei MSH8 polypeptide is more similar to the MSH6 and MSH7 
homologues shown. Within the N-terminal mismatch interacting domain a conserved 
Phe-X-Glu DNA binding motif (Schofield et a l, 2001) can be identified in the MSH6 and 
MSH7 homologues shown. This motif is also present in the T  brucei MSH8 polypeptide 
but not in T, brucei MSH3. The middle-conserved domain which is thought to have a role 
in protein-protein interactions shows a similar pattern of conservation (Culligan et a l , 
2000), although both MSH3 from A. thaliana and the putative T. brucei MSH8 
polypeptides possess insertions of approximately 25 amino acids in this region. The 
C-terminal half of the alignment shows a diffuse conservation between the polypeptides, 
except across the ATP-binding domain where the levels of similarity are very high 
(Gorbalenya and Koonin, 1990), From this alignment, it can be deduced that the putative 
T. brucei MSH3 polypeptide is more similar to the MSH3 orthologues from other 
eukaryotes. However, while the putative T. brucei MSH8 polypeptide would appear to 
belong to the MSH6 sub-family of MutS homologues it is impossible to designate it as an 
orthologue of either MSH6 or MSH7, or as yet another more divergent member of this 
family. From this alignment it is obvious that the T. brucei MSH3 and MSH8 polypeptide 
sequences are divergent compared with the sequences of the other members of the 
MSH3/MSH6 subfamily used in the analysis.
Recently, a conserved PCNA binding motif has been identified in MSH3, MSH6 and 
MSH7 proteins from A. thaliana, H. sapiens and S. cerevisiae (Culligan and Hays, 2000; 
Warbrick, 2000). This represents a fifth region of conservation in these MutS homologues, 
and it is normally found near the extreme N-terminus of these proteins. The consensus of 
this amino acid motif is Qxxhxxaa, where h indicates hydrophobic residues (commonly 
isoleucine or leucine) and a represents aromatic residues (usually phenylalanine; Flores- 
Rozas et a l , 2000). Figure 3.22 shows the best candidate motif sequences identified by 
manual local multiple alignment of a number of MSH3/MSH6 family members. 
Interestingly, the full consensus sequence appears to be absent from the T. brucei MSH3 
and MSH8 polypeptides, as well as the D, melanogaster MSH6 and Z mays MSH7 
proteins. It is possible to assign possible partial PCNA binding motifs in all these 
polypeptides, but whether these would be able to interact with PCNA is unknown. 
Furthermore, the position of the partial motifs in the T. brucei MSH3 and MSH8
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polypeptides is incorrect in comparison with the motifs found in other organisms. The 
MSH8 partial motif is located towards the N-terminus, but the amino acids residues 
involved form part of the conserved N-terminal mismatch interacting domain and are 
unlikely to be available for interactions with PCNA. The partial motif identified in 
T. brucei MSH3, on the other hand, is located between the N-terminal mismatch 
interacting domain and the middle-conserved domain, thereby disrupting the highly 
conserved domain organisation of the MSH3/MSH6 sub-family, again making it unlikely 
to be a functional PCNA binding domain.
3.2.10 The genomic environments of the putative T, brucei MSH8 and MSH3 genes in 
TREU 927/4
A recent BLAST search of the Sanger T. brucei genome sequencing database using the 
MSH8 ORF retrieved a large contig, TRY? 10.0.001896 (37,475 bp), composed of 461 
reads from chromosome X. Although the TREU 927/4 genome sequence is unfinished and 
preliminary it can be concluded that the putative MSH8 gene is present on chromosome X. 
A comparison of the conceptual translations of the putative MSH8 ORF from MITat 1.2 
and TREU 927/4 shows the sequences to differ at only 3 amino acid residues (data not 
shown). Similarly, the nucleotide sequences only differ at seven positions. Although these 
changes could be sequencing artefacts, if they are real differences between the two 
trypanosome stocks they are unlikely to be significant to the overall functioning of the 
protein because the amino acids residues affected are not conserved between members of 
the MSH3/MSH6 sub-family of proteins and so are unlikely to have a catalytic role.
Further analysis of the contig sequence (see section 2.8.4) confirmed that the putative 
MSH8 ORF is approximately 1.0 kb upstream of the HSP60 ORF (see section 3.2.3; 
Bringaud et a l , 1995), and reveals that another previously described T. brucei gene, 
encoding a T lymphocyte triggering factor (Vaidya et a l , 1997), is approximately 10.0 kb 
downstream from the gene (Figure 3.23). Upstream of the putative MSH8 ORF, but 
transcribed from the opposite strand and in the opposite direction, is a gene which has been 
identified as a CDC2-related protein kinase in T. brucei (Mottram and Smith, 1995). There 
are also a number of hypothetical ORFs whose functions cannot be predicted from the 
results of BLAST searches of nucleotide and protein databases.
During the BLAST search of the Sanger T. brucei genome sequencing database described 
above another contig was retrieved encoding a 12,066 bp region of chromosome IX 
(TRYP9.0.000864). Analysis of this contig revealed that it encoded a putative orthologue 
of MSH3, as described in section 3.2.6. Further analysis of the sequence encoded by this
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contig (see section 2.8.4) reveals that the putative MSH3 gene lies approximately 2.0 kb 
downstream of a hypothetical ORF encoding a probable glutaminyl-tRNA synthetase, and
4.6 kb downstream of another hypothetical ORF encoding a putative PCNA homologue in 
T. brucei (Figure 3.24). Also encoded within this contig sequence are a number of other 
hypothetical ORFs, but BLAST searches of the nucleotide and protein databases do not 
reveal any significant similarities to known sequences.
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Figure 3.12 PCR of a 2.0 kb region of the putative T. brucei MSH8 gene
Primers MSH8 5’ and MSH8 3’ were used with 20 ng of MITat 1.2 genomic DNA for 
PCR. Control reactions were performed with both primers in the absence of T. brucei 
DNA template (A), the MSH8 5’ primer only (B), and the MSH8 3’ primer only (C). Lane 
D shows the reaction containing both primers and template.
B D
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Figure 3.13 Strategy for PCR amplification of the putative T, brucei MSH8 ORF
A 2.0 kb fragment encoding the C-terminal end of MSH8 which was cloned and sequenced 
is shown in red. The expected T. brucei MSH8 ORF is shown in blue. Similarity 
searching of the trypanosome sequencing databases revealed further clones overlapping 
and extending the original 2.0 kb fragment and showed that MSH8 lies upstream of the 
HSP60 gene (Bringaud et a l, 1995); these sequences and the contigs they comprise are 
shown in purple for upstream sequence and green for downstream sequence. PCR primers 
(MSH8 UP(1), M SH8W , MSH8 DN(1) and MSH8D3', shown as black half-arrows) were 
designed from these sequences and used to amplify two overlapping PCR products: MSH8 
Upstream (shown in orange) and MSH8 Downstream (shown in black).
over page
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Figure 3.14 PCR of the upstream and downstream regions of the putative T, brucei
MSH8 gene
To amplify the sequence encoding the 5’ end of the MSHS gene the primers MSHS UP(1) 
and MSH8U3 were used with MITat 1.2 genomic DNA for PCR. Control reactions were 
performed with both primers in the absence of T. brucei DNA template (A), the 
MSH8 UP(1) primer only (B), and the MSH8\J3 primer only (C). Lane D shows the 
reaction containing both primers and template. Similarly, the primers MSH8D3 and 
MSH8 DN(1) were used to amplify the 3’ end of the gene. Lanes E, F and G show the 
control reactions performed with both primers in the absence of T. brucei DNA template, 
the MSH8D3 primer only, and the MSH8 DN(1) primer only respectively. Lane H shows 
the reaction containing both template and primers.
Upstream Downstream
A B c D E F G H
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Figure 3.15 PCR of 71 brucei MSH8 probe sequence
Primers MSH8D3 and MSH8\J\ were used with MITat 1.2 genomic DNA for PCR. 
Control reactions were performed with both primers in the absence of T. brucei DNA 
template (A), the MSH8X33 primer only (B), and the MSH8\}\ primer only (C). Lane D 
shows the reaction containing both primers and template.
B D
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Figure 3.16 Genomic Southern blot probed for the putative T. brucei MSH8 gene
A Southern blot of MITat 1.2 and ILTat 1.2 genomic DNA which was restriction-digested 
with the enzymes shown, separated on a 0.6% agarose gel, probed with a 540 bp PCR 
product amplified from the T. brucei MSHS gene and washed to 0.2 x SSC, 0.1% SDS at 
65°C.
MITat 1.2 ILTat 1.2
kb
7.0 —6.0 —5.0 —
4.0 —
3.0 —
2.0  —  
1.6  —  
1.0 —
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Figure 3.17 Analysis of the expression of the putative T. brucei MSH8 gene
RT-PCR was performed on both bloodstream and procyclic form total RNA isolated from 
MITat 1.2. Internal primers complementary to the putative T. brucei MSH8 gene were 
used and the integrity of the RNA was confirmed using primers directed against the large 
subunit of T. brucei RNA polymerase I (Rudenko et a i ,  1996). For both genes RT positive 
(RT+), RT negative (RT-) and no template (NT) reactions were run.
RNA
POLI MSH8
RNA
POLI MSH8
Bloodstream
Form
Procyclic
Form
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Table 3.2 Pairwise comparison of the putative T, brucei MSH8 and MSH3 
polypeptides with a range of MutS homologues
Using the GCG gap program, pairwise alignments between the full length putative MSHS 
polypeptide and a range of full length MutS-related protein sequences were performed. 
Similar alignments were also completed using the full length putative T. brucei MSH3 
polypeptide sequence. For each alignment the percentage identity and similarity between 
the two polypeptides was calculated.
M utS hom ologue
T, brucei M SH 8 r. brucei M SH 3
%
Identity
%
Sim ilarity
%
Identity
%
Sim ilarity
E, coli MutS 30.55 42.02 26.84 36.58
A. thaliana MSH2 29.36 38.60 25.42 34.26
H. sapiens MSH2 28.74 38.52 27.74 36.98
S. cerevisiae MSH2 25.00 35.34 24.97 35.34
T. brucei MSH2 26.98 35.35 26.15 34.58
A. thaliana MSH3 28.99 38.69 30.94 42.83
K  sapiens MSH3 27.77 38.52 30.72 42.49
S. cerevisiae MSH3 26.10 36.61 30.43 42.16
T. brucei MSH3 28.85 38.20 100.00 100.00
A, thaliana MSH6 32.07 42.17 28.35 38.36
H. sapiens MSH6 30.19 40.15 29.70 37.80
S. cerevisiae MSH6 32.51 43.61 25.81 37.10
A. thaliana MSH7 31.74 40.96 29.79 38.57
T. brucei MSHS 100.00 100.00 28.85 38.20
S, cerevisiae MSHl 25.84 35.51 27.08 36.93
S. cerevisiae MSH4 22.24 31.84 26.49 36.43
S. cerevisiae MSH5 21.71 32.57 24.42 36.89
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F i g u r e  3 . 1 8  A  g r a p h i c a l  r e p r e s e n t a t i o n  o f  t h e  s i m i l a r i t y  b e t w e e n  t h e  p u t a t i v e  
T .  b r u c e i  M S H S  p o l y p e p t i d e  a n d  o t h e r  M u t S - r e l a t e d  p r o t e i n s
Pairwise alignments were performed as described in Table 3.2 to compare the putative 
T. brucei (Tbr) MSHS polypeptide sequence with other MutS-related polypeptide 
sequences from: A. thaliana (Ath), E. coli (Eco), H. sapiens (Hsa) and S. cerevisiae (See). 
Percentage identity is shown in blue and percentage similarity in red.
I I I
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F i g u r e  3 . 1 9  A  g r a p h i c a l  r e p r e s e n t a t i o n  o f  t h e  s i m i l a r i t y  b e t w e e n  t h e  p u t a t i v e  
T .  b r u c e i  M S H 3  p o l y p e p t i d e  a n d  o t h e r  M u t S - r e l a t e d  p r o t e i n s
Pairwise alignments were performed as described in Table 3.2 to compare the putative 
T. brucei (Tbr) MSH3 polypeptide sequence with other MutS-related polypeptide 
sequences from: A. thaliana (Ath), E. coli (Eco), H. sapiens (Hsa) and S. cerevisiae (See). 
Percentage identity is shown in blue and percentage similarity in red.
Mh M»M8
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Figure 3.20 Analysis of the 5’ splicing of the putative T. brucei MSH8 gene
RT-PCR was performed on bloodstream form total RNA isolated from MITat 1.2. Internal 
primers complementary to the putative T. brucei MSHS gene {MSH8D6 and MSH8\J6) 
were used to confirm the integrity of the cDNA (shown in panel A). A primer 
complementary to the conserved T. brucei splice acceptor sequence (EcoRISL(l); Ullu et 
a i, 1996) was used in conjunction with internal primers specific to the MSHS ORF: 
MSHS\J1 (shown in panel B) or MSHS\J% (shown in panel C). For each set of primers RT 
positive (RT+), RT negative (RT-) and no template (NT) reactions were run.
B
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Figure 3.21 Global multiple alignment of the putative 71 brucei MSH3 and MSH8 
polypeptides with a range of MSH3, MSH6 and MSH7 orthologues
Multiple sequence alignment of the putative T. brucei (Tbr) MSH3 (shown in blue) and 
MSH8 (shown in red) polypeptides with homologues of MSH3, MSH6 and MSH7 from 
other eukaryotes: A. thaliana (Ath), H. sapiens (Hsa), and S. cerevisiae (See). Sequences 
were aligned using CLUSTAL X (Thompson et a l, 1997), and shaded using the 
BOXSHADE server (http://www.ch.embnet.org/software/BOX_form.html): identical 
residues are shaded in black, and conserved residues in grey. MIS is the N-terminal 
mismatch interacting domain (shown in purple; Maikov et a l , 1997; Culligan et a l , 2000; 
Schofield et a l , 2001), MCD is the middle conserved domain (shown in turquoise; 
Culligan et a l , 2000), the peptides identified as I, II, III and IV are the conserved 
nucleotide binding motifs (shown in green; Gorbalenya and Koonin, 1990) and HTH is the 
conserved helix-turn-helix motif (shovm in pink; Adé et a l , 1999; Biswas et a l ,  2001).
The region identified beneath the T. brucei MSH8 sequence corresponds to the region of 
the T. brucei MSH8 gene that was amplified and used as a probe (shown in orange).
HsaMSH3 1 ----------------------------------------------------------------------------------------------
AthMSH3 1 ----------------------------------------------------------------------------------------------
SceM SH3 1 ----------------------------------------------------------------------------------------------H ^3 *]  ^'—. —" — — — — ~ ~ — AM — AM m m—-
AthMSH6 1 ---------------------------------------------------------- MAPSRRQISGRSPLVNQQRQITSFFGKSASSSS
HsaMSH6 1 MSRQSTLYSFFPKSPALSDANKASARASREGGRAAAAPGASPSPGGDAAWSEAGPGPRPL
SceM SH6 1 ---------------------------------------------------------------------------------------------------------------------------------
AthMSH7 1 ----------------------------------------------------------------------------------------------
TbrMSHB 1 ----------------------------------------------------------------
HsaMSH3
AthMSH3
SceM SH3
TbrMSHS
AthMSH6
HsaMSH6
SceM SH 6
AthMSH7
TbrMSHS
1 --------------------------------------------------------------------------------------------------------------------------
1 --------------------------------------------------------------------------------------------------------------------------
1 --------------------------------------------------------------------------------------------------------------------------
3 4  SPSPSPSPSLSNKKTPKSNNPNPKSPSPSPSPPKKTPKLNPNPSSNLPARSPSPGPDTPS 
61 ARSASPPKAKNLNGGLRRSVAPAAPTSCDFSPGDLVWAKMEGYPWWPCLVYNHPFDGTFI 
1 ---------------------------------------------------------------------------MAPATPKTSKTAHFENGSTSSQKKM
HsaMSH3
AthMSH3
SceM SH3
TbrMSHS
AthMSHS
HsaMSH6
SceM SHS
AthMSH7
TbrMSHB
9 4 PVQSKFKKPLLVIGQTPS PPQ SWITYGDEWGKQVRVYWPLDKKWYDGSVTFYDKGE GK 
1 2 1  REKGKSVRVHVQFFDDSPTRGWVSKRLLKPYTGSKSKEAQKGGHFYSAKPEILRAMQRAD 
2 6 KQSSLLSFFSKQVPSGTPSKKVQKPTPATLENTATDKITKNPQGGKTGKLFVDVDEDNDL 
1 -----------------------------------------------MQRQRSILSFFQKPTAATTKGLVSGDAASGGGGSGGPR
1 ------------------------------------------------------------------------------------------------------------------
HsaMSH3 1 — MSRRKPASGGLAASSSAPARQAVLSRFFQSTGSLKSTSSSTGAADQVDPGAAAAAAPP
AthM SH3 1 ----------------------------------------------------------------------------------------------------------------------------------
SceM SH3 1 ----------------------------------------------------------------------------------------------------------------------------------
TbrMSHS 1 ---------------------------------------------------------------
AthMSHS 1 5 4  HWEYEDGEEESLDLGKEKTEWWGEKSGDRFNRLKRGASALRKWTDSDDDVEMGNVEE 
HsaMSHS 1 8 1  EALNKDKIKRLELAVCDEPSEPEEEEEMEVGTTYVTDKSEEDNEIESEEEVQPKTQGSRR 
SceM SHS 8 6  TIAEETVSTVRSDIMHSQEPQSDTMLNSNTTEPKSTTTDEDLSSSQSRRNHKRRVNYAES 
AthMSH7 3 9  FNVKEGDAKGDASVRFAVSKSVDEVRGTDTPPEKVPRRVLPSGFKPAESAGDASSLFSNI 
TbrMSHB 1 ----------------------------------------------------------------
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SceM SHS 2 3 2
T b rM S H S 95
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SceM SHS 3 7 0
AthMSH7 3 2 6
Tb rM SH B 1 0 4
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HsaMSHS 1124 TSLLH---------------------------------
AthMSHS 1048 KFALSEEDPWKAFEFLKHAWKIAGKIRLKPTCSF-----
SceM SHS 1046 IH ---------------------------------------------------------------------------
T b rM S H S  -----------------------------------------------------------------------------------
AthMSHS IS IO  CELHSMANTFLRLTN-----------------------------------------------HsaMSHS ---------------------------------------
SceMSHS 120S GLKNTKLGSGEGVIiNYDWNIKRNVIiKSLFSIIDDLQS
AthMSH? 1085 PIGEDDYDTLFCLWHEIKSSYCVPK-------------------------
Tb rM SH B  -----------------------------------------------------------------------------------
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Figure 3.22 Alignment of the conserved PCNA binding motifs present in the 
MSH3/MSH6 sub-family of MutS homologues
A manual local alignment of the putative T. brucei (Tbr) MSH3 and MSH8 polypeptides 
vrith homologues of MSH3, MSH6, and MSH7 from other eukaryotes: A. thaliana (Ath), 
D. melanogaster (Dme), H. sapiens (Hsa), S. cerevisiae (See), S. pombe (Spo) and Z  mays 
(Zma), Only sequences showing similarity to the consensus sequence of the conserved 
PCNA binding motif are shown (Flores-Rozas et a l , 2000). In the consensus line h 
indicates hydrophobic residues and a represents aromatic residues. Conserved residues are 
shown in bold.
Consensus Q x x h x x a aAthMSHS QQTISRFFHsaMSHS QAVLSRFF
SceMSHS QPTISRFFTbrMSHS IVEWLFYAthMSH6 QRQITSFF
DmeMSHG TNTLLNYF
HsaMSHG QSTLYSFF
SceMSH6 QSSLLSFFSpoMSHG QKTLFGFFAthMSH? QRSILSFFZmaMSH? YLSLAPYFTbrMSHS HYDWIFF
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Figure 3.23 Analysis of the genomic environment of the putative T. brucei MSH8
gene
The nucleotide sequence of contig TRYP 10.0.001896 was analysed using the Nucleotide 
Identification (NIX) server (http://www.hgmp.mrc.ac.uk/Registered/webapp/nix/) provided 
by the UK Human Genome Mapping Project Resource Centre. The output shows the 
results of selected programs which were used in the analysis. The sequence regions 
identified correspond to: (A) the T. brucei MSHS ORF; (B); the T. brucei HSP60 ORF 
(Bringaud et a l, 1995); (C) a T. brucei gene encoding a T lymphocyte triggering factor 
(Vaidya et a l, 1997); (D) a T. brucei gene encoding a CDC2-related protein kinase 
(Mottram and Smith, 1995); and (E) a number of hypothetical ORFs suggested by the 
HMMGene gene-prediction program. The predicted direction of transcription is indicated 
by black arrows.
E D ErS rS fS I
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Figure 3.24 Analysis of the genomic environment of the putative T. brucei MSH3
gene
The nucleotide sequence of contig TRYP9.0.000864 was analysed using the Nucleotide 
Identification (NIX) server (http://www.hgmp.mrc.ac.uk/Registered/webapp/nix/) provided 
by the UK Human Genome Mapping Project Resource Centre. The output shows the 
results of selected programs which were used in the analysis. The sequence regions 
identified correspond to: (A) the putative T. brucei MSH3 ORF; (B); a hypothetical ORF 
bearing similarity glutaminyl-tRNA synthetase; (C) a hypothetical ORF bearing similarity 
to proliferating cell nuclear antigen (PCNA); and (D) a hypothetical ORF suggested by the 
HMMGene gene-prediction and Fex exon-prediction programs. The predicted direction of 
transcription is indicated by a black arrow.
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3.3 Cloning and characterisation of a putative MutL Homologue 1 (MLHl) 
orthologue in T, brucei
3.3.1 Introduction
During MMR, the MutS-related proteins (discussed above) function in conjunction with 
MutL homologues (Kolodner and Marsischky, 1999). These proteins are also highly 
conserved at the amino acid level, especially across the ATP-binding domain and, to a 
lesser extent, over the region involved in dimer formation (Schar et a l ,  1997). The 
primary MutL homologue in eukaryotes is MLH l, since this protein is required in the 
formation of all MutL-related heterodimers and is therefore required for all nuclear MMR 
reactions to proceed (Wang et a l , 1999), In addition to the conserved ATP-binding and 
dimer formation domains, orthologues of MLHl possess a characteristic carboxy-terminal 
homology (CTH) domain which can be used to distinguish these proteins from other 
eukaryotic MutL homologues (Pang et a l, 1997). Knowledge of the characteristics of 
MutL-related proteins allows workers to identify putative MLHl orthologues and 
distinguish them from other MutL homologues. This approach allowed the isolation of a 
gene from T. brucei which putatively encodes an orthologue of MLHl.
3.3.2 Identilicatioii of the putative 71 brucei M LH l gene by searching the 71 brucei 
genome sequencing databases
BLAST searching of the 71 brucei genome sequencing databases using the MLHl 
polypeptide sequences from A. thaliana, H. sapiens and S. cerevisiae retrieved a number of 
clones bearing similarity to these proteins. These sequences were aligned using the GCG 
fragment assembly programs revealing three contigs: MLH l A  and MLHIB  comprised the 
N-terminal region of the gene and MLHIC appeared to encode the C-terminus (Figure 
3.25). MLH l A  and MLHIB  could be recognised as part of the same gene as they both 
contained sequence from the TIGR clone 2D6. A PCR was performed using MITat 1.2 
genomic DNA with primers complementary to regions just upstream and downstream of 
the predicted start and stop codons respectively {MLHl 5’(1) and MLH l 3%1); see section 
2.10.1) which gave a product 2.9 kb in length, confirming the linkage of these contigs 
(Figure 3.26).
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3.3.3 Cloning a complete ORF from a genomic lambda library putatively encoding
the r. brucei M LH l gene
PCR primers were designed from the sequence encoding part of the ATP binding domain 
of the putative MLH l gene {M LH llll and ML///D6; see section 2.10.1), and used to 
amplify a 472 bp product from MITat 1.2 genomic DNA (Figure 3.27). This product was 
then used as a probe to screen an ILTat 1.2 genomic library in order to recover the 
complete MLH l gene sequence, including upstream and downstream ORF-flanking 
regions. As described in Materials and Methods (section 2.6), the library was put through 
four rounds of screening, and a single clonal plaque (designated Plaque 6) was recovered. 
DNA was prepared from this phage clone for use in sub-cloning experiments.
Examination of the restriction sites within the available sequence for the putative MLH l 
gene (see Appendix 4) revealed that digestions with several restriction enzymes might 
potentially release fi'agments containing the entire ORF along with processing flanks 
which could be sub-cloned into pBluescript II KS, thereby avoiding the need for complex 
and time-consuming restriction mapping of the phage clone. MITat 1.2 genomic DNA was 
restriction-digested with a panel of enzymes and the products were Southern blotted to 
investigate the size of the fragments which hybridised to the probe for each digestion 
(Figure 3.28). A number of enzymes gave fragments between 4.0 and 8.0 kb {BarriRl, 
Hinàlll, Kpnl, Pvull and fecll) which could potentially encode the entire MLH l ORF. 
Unfortunately, the BamYil restriction digestion appeared to be partial, so this enzyme was 
ignored. Sail also gave a fragment within the desired size range; however, this enzyme 
gave two bands because it recognises a site within the region of the MLH l ORF to which 
the probe hybridised. From the Southern blot it was concluded that the 4.0 kb fragment 
released in the Kpnl digestion would be suitable for sub-cloning since the available 
sequence data for the putative MLH l gene showed that a Kpnl site was located 
approximately 480 bp upstream of the proposed start codon for the gene. Since MLH l 
ORFs are usually between 2.8 and 3.5 kb in length this fragment was expected to contain 
the entire ORF along with the 5’ and 3’ processing flanks.
DNA from Plaque 6 was digested with Acc6S\ (an isoschizomer oïKpn l which cleaves to 
give 5’ overhangs), and shot-gun cloned into pBluescript II KS. The resulting sub-clones 
were analysed and a clone containing the 4.0 kb fragment was chosen for sequencing. This 
plasmid (called pJB200) contained an ORF encoding a putative polypeptide 887 amino 
acids in length flanked by the 5 ’ and 3 ’ untranslated regions of the gene. A sequence map 
of the 4.0 kb insert is shown in Appendix 4.
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3.3.4 Southern analysis of the putative T. brucei MLHl locus
In order to investigate the genomic environment of the putative T. brucei MLH l ORF both 
MITat 1.2 and ILTat 1.2 genomic DNA were restriction-digested with a range of enzymes. 
The restriction digestions were separated by agarose gel electrophoresis, Southern blotted, 
and probed with the PCR product described in section 3.3.3. The pattern of hybridisation 
revealed the gene to be present in single copy in the T. brucei genome (Figure 3.29). 
Unfortunately, the Spel restriction digestion appeared to be partial and Sail digestion 
produced two bands as the enzyme recognises a site within the sequence used as the probe. 
Furthermore, it can be concluded that the genomic environment of this gene is the same in 
MITat 1.2 and ILTat 1.2 since the restriction pattern in both sets of digestions were 
identical.
3.3.5 Analysis of the expression of the putative T. brucei M LHl gene
The expression of the putative MLH l gene was investigated by RT-PCR using gene- 
internal primers specific to the MLH l ORF (MLH lUl and MLH1D6; see section 2.4.2 and 
Appendix 4) while the integrity of the cDNA used in the experiment was confirmed as 
described in section 3.1.5. The putative MLH l gene is expressed in both bloodstream and 
procyclic stage cells (Figure 3.30). No conclusions can be drawn about the levels of 
expression in the different life cycle stages since non-quantitative RT-PCR was used.
3.3.6 Pairwise comparison of the putative T, brucei MLHl polypeptide with other 
MutL homologues
Pairwise gap alignments were performed using the GCG gap program to compare a 
conceptual translation of the putative T, brucei MLHl ORF with a broad spectrum of 
MutL-related peptides from E. coli, A. thaliana, H  sapiens, and S. cerevisiae. Table 3.3 
and Figure 3.31 show the results of these pairwise alignments. These data indicate that the 
polypeptide is indeed a MutL homologue, bearing between 4.0 and 15.0% greater sequence 
identity (or 6.0 and 15.0% greater similarity) to the MLHl orthologues than to the PMSl 
orthologues shown. This evidence suggests that the gene encodes an orthologue of MLHl, 
although it must be noted that similarity does not necessarily equate to homology.
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3.3.7 Multiple alignment of the putative T, brucei MLHl polypeptide with
eukaryotic MLHl orthologues
A global multiple alignment of the putative 7! brucei MLHl polypeptide with MLHl 
orthologues from a range of eukaryotes was generated using CLUSTAL X (Thompson et 
a l, 1997) using the default parameters (Figure 3.32). The alignment shows a region of 
high identity corresponding to the ATP binding domain (Bergerat et a l , 1997; Mushegian 
et a l , 1997; Pang et a l, 1997; Ban and Yang, 1998; Dutta and Inouye, 2000). The diffuse 
conservation throughout the C-terminal half of the multiple alignment identifies the PMSl- 
interacting domain (Pang et a l , 1997; Kondo et a l, 2001). At the C-terminus a short motif 
which is also required for MMR activity shows high identity (Pang et a l , 1997). The 
7! brucei MLHl polypeptide is conserved across the three domains characteristic of MLHl 
orthologues from other eukaryotes. However, the polypeptide is divergent compared with 
the other proteins shown, especially over the region required for dimérisation. It should 
also be noted that this alignment suggests the T. brucei MLHl polypeptide possesses an 
85 amino acid insertion in comparison with the other MLHl orthologues shown.
However, this insertion is located within the central region of the polypeptide which has 
not been associated with any properties necessary for the functioning of M LH l.
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Figure 3.26 PCR of a 2.9 kb region of the putative T. brucei M LH l gene
Primers MLHl 5’(1) and MLHl 3’(1) were used with 20 ng of MITat 1.2 genomic DNA 
for PCR. Control reactions were performed with both primers in the absence of T. brucei 
DNA template (A), the MLHl 5’(1) primer only (B), and the MLHl 3’(1) primer only (C). 
Lane D shows the reaction containing both primers and template.
B D
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Figure 3.27 PCR of the putative T. brucei M LH l probe sequence
Primers M LH l\]\ and MLH1D6 were used with MITat 1.2 genomic DNA for PCR. 
Control reactions were performed with both primers in the absence of T. brucei DNA 
template (A), the MLH1\J\ primer only (B), and the MLH1D6 primer only (C). Lane D 
shows the reaction containing both primers and template.
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Figure 3.28 Genomic Southern blot probed for the putative T. brucei M LH l gene
A Southern blot of MITat 1.2 genomic DNA which was restriction-digested with the 
enzymes shown, separated on a 0.6% agarose gel, probed with a 472 bp PCR product 
amplified from the T. brucei MLHl gene and washed to 0.2 x SSC, 0.1% SDS at 65°C.
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Figure 3.29 Genomic Southern blot probed for the putative T. brucei M LH l gene
A Southern blot of MITat 1.2 and ILTat 1.2 genomic DNA which was restriction-digested 
with the enzymes shown, separated on a 0.6% agarose gel, probed with a 472 bp PCR 
product amplified from the T. brucei MLHl gene and washed to 0.2 x SSC, 0.1% SDS at 
65°C.
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Figure 3.30 Analysis of the expression of the putative T. brucei M LH l gene
RT-PCR was performed on both bloodstream and procyclic form total RNA isolated from 
MITat 1.2. Internal primers complementary to the putative T. brucei MLHl gene were 
used and the integrity of the RNA was confirmed using primers directed against the large 
subunit of T. brucei RNA polymerase I (Rudenko et a i, 1996). For both genes RT positive 
(RT+), RT negative (RT-) and no template (NT) reactions were run.
RNA
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RNA
POLI MLHl
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Table 3.3 Pairwise comparison of the putative T. brucei M LHl polypeptide with a
range of MutL homologues
Pairwise alignments between the putative T. brucei MLHl polypeptide and a number of 
MutS homologues from other organisms were performed using the GCG gap program. In 
each case the full length polypeptide sequences were compared, and the percentage 
identity and similarity between the two sequences was calculated.
M utL hom ologue
T, brucei M L H l
% Identity % Sim ilarity
E. coli MutL 28.12 37.11
A. thaliana MLHl 34.07 42.67
D. melanogaster MLHl 32.19 41.84
H. sapiens MLH1 37.62 47.66
S. cerevisiae MLHl 36.38 47.25
A. thaliana PMSl 28.38 35.63
D. melanogaster PMS2 24.33 33.21
H. sapiens PMS2 25.19 33.68
S. cerevisiae PMSl 22.68 32.58
T. brucei PMSl 23.47 30.67
H. sapiens PMSl 21.68 33.01
S. cerevisiae MLH2 22.33 30.23
H. sapiens MLH3 21.83 30.33
S. cerevisiae MLH3 21.31 30.22
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F i g u r e  3 . 3 1  A  g r a p h i c a l  r e p r e s e n t a t i o n  o f  t h e  s i m i l a r i t y  b e t w e e n  t h e  p u t a t i v e  
T .  b r u c e i  M L H l  p o l y p e p t i d e  a n d  o t h e r  M u t L - r e l a t e d  p r o t e i n s
Pairwise alignments were performed as described in Table 3.3 to compare the putative 
T. brucei (Tbr) MLHl polypeptide sequence with other MutL-related polypeptide 
sequences from: A. thaliana (Ath), D. melanogaster (Dme), E. coli (Eco), H. sapiens (Hsa) 
and S. cerevisiae (See). Percentage identity is shown in blue and percentage similarity in 
red.
S ?
MutL
Eco Dme %  WLH1 See D^e PMSl pMs,
See Tbr
Hsa See MLH3See
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Figure 3.32 Global multiple alignment of the putative T. brucei M LHl polypeptide
with a range of M LHl orthologues
Multiple sequence alignment of the putative T. brucei MLHl (Tbr) polypeptide (shown in 
red) with homologues of MLHl from other eukaryotes: A. thaliana (Ath), D. melanogaster 
(Dme), H. sapiens (Hsa), and S. cerevisiae (See). Sequences were aligned using 
CLUSTAL X (Thompson et a l ,  1997), and shaded using the BOXSHADE server 
(http://www.ch.embnet.org/software/BOX_form.html): identical residues are shaded in 
black, and conserved residues in grey. The sequences identified as I, II, III and IV (shown 
in blue) are the four characteristic nucleotide binding motifs of the GHKL ATPase/kinase 
superfamily (Bergerat et a l ,  1997; Mushegian et a l , 1997; Ban and Yang, 1998; Dutta and 
Inouye, 2000); the carboxy-terminal homology region identified as CTH (shown in green) 
is also required for MMR activity (Pang et a l ,  1997), and the peptide labelled DIMER 
(shown in pink) contains the PMSl-interacting domain of & cerevisiae MLHl (Pang et a l ,  
1997; Kondo et a l ,  2001). The region identified beneath the T. brucei sequence 
corresponds to the region of the T. brucei MLHl gene that was amplified by PCR and used 
as a probe (shown in orange).
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HsaMLHl 4 1 5  DKTDISSGRARQQDEEMLELPA— PAEVAAKNQSLEGDTTKGTSEMSEKRGPjjS^PRKR
HsaMLHl 2 5 5
DmeMLHl 2 5 7
SceM LH l 2 5 4
AthM LHl 2 7 9
T b rM L H l 2 7 6
HsaMLHl 3 1 4
DmeMLHl 3 1 6
SceM LH l 3 1 4
AthM LHl 3 3 8
T b rM L H l 3 3 5
HsaMLHl 3 6 8
DmeMLHl 3 5 9
SceM LH l 3 7 4
AthM LHl 3 9 0
T b rM L H l 3 9 1
DmeMLHl 3 9 4
SceM LH l 4 3 1
AthM LHl 4 2 7
T b rM L H l 4 4 9
HsaMLHl 4 7 3
DmeMLHl 4 0 9
SceM LH l 4 9 1
AthM LHl 4 4 2
T b rM L H l 5 0 9
HsaMLHl 4 8 7
DmeMLHl 4 1 4
SceM LH l 4 9 6
AthM LHl 4 4 7
T b rM L H l 5 6 9
HsaMLHl 5 0 8
DmeMLHl 4 3 2
SceM LH l 5 1 6
AthM LHl 4 5 9
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3.4 Cloning and characterisation of a T, brucei gene encoding a putative 
orthologue of Post-Meiotic Segregation 1 (PMSl) from S* cerevisiae
3.4.1 Introduction
Post-meiotic segregation 1 (PMSl) in S. cerevisiae (and its mammalian homologue PMS2) 
interact with MLHl to form the primary MutL-related heterodimer involved in nuclear 
MMR (Prolla et a l , 1994b; Kolodner and Marsischky, 1999). The MLHl-PMSl 
heterodimer forms ternary complexes with both MSH2-MSH3 and MSH2-MSH6 thereby 
facilitating the repair of both base-base mismatches and insertion-deletion loops (IDLs) 
(Habraken et a l , 1997; Habraken et a l , 1998). PMSl orthologues are also highly 
conserved with the regions required for ATP-binding and dimérisation with MLHl 
showing the greatest levels of conservation. Examination of a multiple sequence 
alignment of eukaryotic MutL homologues performed by Schar et a l  (1997) reveals that 
the dimérisation domain of S, pombe PMSl exhibits higher levels of identity with the 
dimérisation domains of other orthologues of S. cerevisiae PMSl than with other MutL- 
homologues. The sequence PWNCPHGRPTMRH (residues 775-787 in S. pombe PMSl) 
was identified in this alignment as a highly conserved peptide motif which could be 
considered characteristic of PMSl, and thus is useful in the identification of possible 
PMSl orthologues (Schar et a l , 1997). Knowledge of characteristics of the dimérisation 
domain of PMSl allowed the isolation of a gene from T. brucei which putatively encodes 
an orthologue of PMSl from S. cerevisiae.
3.4.2 Identification of a second putative MutL homologue by searching of the 
r. brucei genome sequencing databases
Similarity searching of the TIGR and Sanger T. brucei genome sequencing databases using 
homologues of the S. cerevisiae PMSl protein from A. thaliana and H. sapiens revealed a 
number of clones showing high levels of sequence conservation with these proteins. These 
sequences were aligned into three contigs using the GCG fragment assembly programs: 
PMSl A  appeared to encode the C-terminus of the gene, PMSIB  spanned the N-terminal 
region of the gene, and PMSIC  seemed to encode the central region of the gene (Figure 
3.33). PMSIB and PMSIC obviously encoded regions of the same gene because they both 
contained sequence from the TIGR clone 42G23. In order to confirm the linkage of these 
contigs a PCR was performed (Figure 3.34) using MITat 1.2 genomic DNA and primers 
complementary to regions just upstream and downstream of the predicted stait and stop 
codons respectively {PMSl 5’(2) and PMSl 3’(2); see section 2.10.2).
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3.4.3 Cloning of the complete ORF of the putative T. brucei PM Sl gene from a 
genomic lambda library
Using primers complementary to the sequence encoding the C-terminal dimérisation 
domain of the putative PMSl (PMS1\J2 and PMSl 3’(2); see section 2.10.2), a 460 bp 
PCR product was generated from MITat 1.2 genomic DNA (Figure 3.35) This product 
was then used as a probe for an ILTat 1.2 genomic library from which several overlapping 
clones were retrieved and restriction mapped. A 5.5kb EcoPl fragment was cloned into 
pBluescript II KS (creating the plasmid pJB400). The library screening, restriction 
mapping and sub-cloning were generously performed by T. I. Harvey in a manner similar 
to that described in section 3.1.3. Sequencing of this clone revealed a putative ORF 788 
amino acids in length flanked by the 5’ and 3’ processing signals for the gene. A sequence 
map of the 5.5 kb insert is shown in Appendix 5.
3.4.4 Southern analysis of the putative J. brucei PM Sl locus
Both MITat 1,2 and ILTat 1.2 genomic DNA were restriction-digested with a panel of 
enzymes to analyse the genomic environment of the putative T. brucei PMSl ORF. The 
restriction digestions were separated by agarose gel electrophoresis. Southern blotted, and 
probed with the 460 bp PCR product described in section 3.4.3 revealing the gene to be 
present in single copy in the T. brucei genome (Figure 3.36). The genomic Southern blot 
reveals a 5.5 kb EcoPl fragment equivalent to the one sub-cloned in section 3.4.3, 
confirming that the lambda clone reflected the genomic context of the putative PMSl gene. 
Furthermore, it can be concluded that the genomic environment of this gene is the same in 
the MITat 1.2 and ILTat 1.2 strains since the restriction pattern in both sets of digestions 
were identical.
3.4.5 Analysis of the expression of the putative 71 brucei PM Sl gene
In order to investigate the expression of the putative PMSl gene RT-PCR was performed 
using gene-internal primers specific to the PMSl ORF {PMSIMI and PMS7D1; see section
2.4.2 and Appendix 5). The integrity of the cDNA used during this experiment was 
confirmed as described in section 3.1.5. The results show that PMSl is expressed in both 
procyclic and bloodstream form cells (Figure 3.37). However, since non-quantitative 
RT-PCR conditions were employed no conclusions can be drawn about the levels of 
expression in the different life cycle stages.
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3.4.6 Pairwise comparison of the putative 71 brucei PM Sl polypeptide with other 
MutL homologues
Using the GCG gap program, pairwise gap alignments were performed to compare a range 
of MutL homologues from E. coli, A. thaliana, H. sapiens, and S. cerevisiae with a 
conceptual translation of the putative T. brucei PMSl ORF. The data generated in these 
alignments is shown in Table 3.4 and as a graphical representation in Figure 3.38. The 
71 brucei PMSl polypeptide does indeed appear to be related to MutL, and shows between
6.5 and 11.5% greater sequence identity (or 5.0 and 12.0% greater similarity) with the 
eukaryotic PMSl homologues than it shows with homologues of MLH l. Although 
similarity does not necessarily equate to homology, these data suggest that the gene is an 
orthologue of PMSl from S. cerevisiae.
3.4.7 Multiple alignment of the putative 71 brucei PMSl polypeptide with 
orthologues of PMSl from S, cerevisiae
A global multiple alignment of the putative 71 brucei PMS1 polypeptide with a number of 
homologues of S. cerevisiae PMSl was performed using CLUSTAL X (Thompson et a l, 
1997) using the default settings (Figure 3.39). The alignment reveals two regions of high 
identity corresponding to the ATP-binding domain and the MLHl-interacting domain 
(Bergerat et a l, 1997; Mushegian et a l, 1997; Pang et a l , 1997; Schar et a l, 1997; Ban 
and Yang, 1998; Dutta and Inouye, 2000; Kondo et a l, 2001). 71 brucei PMSl shows 
conservation over these domains although the polypeptide is divergent compared with the 
other orthologues of S. cerevisiae PMSl shown. It is clear from this alignment that the 
putative 71 brucei PMS 1 polypeptide contains a sequence which differs at only one residue 
from the PWNCPHGRPTMRH sequence which is characteristic of homologues of PMSl 
from S. cerevisiae (residues 759-771 in 71 brucei PMSl; Schar et a l , 1997). A central 
region, approximately 300 amino acids in length, shows little or no sequence conservation, 
and the 71 brucei PMS 1 polypeptide appears to have two large deletions in this area in 
comparison with the other proteins in the alignment. Notably, 71 brucei PMSl appears to 
have three insertions within the region encompassing the ATP-binding motif: the first is 
13 amino acids in length and interrupts the consensus of the second nucleotide binding 
motif; the second and third are two and three amino acids in length respectively. The 
functional implications of these insertions, if any, are unknown and would require 3-D 
structure determination or experimental analysis to assess.
170
3.4.8 The genomic environment of the putative T. brucei P M Sl gene in TREU 927/4
Recent searching of the Sanger T, brucei genome sequencing database using the predicted 
PMSl polypeptide sequence retrieved a contig, TRYP9.0.000851 (10,249 bp), which 
encodes the putative PMSl gene. This contig is composed of sequence from 121 reads 
from chromosome IX. This suggests the putative PMSl gene is present on chromosome 
IX. Furthermore, comparison of the putative PMSl sequences from ILTat 1.2 and TREU 
927/4 shows the sequences to be identical at the polypeptide level, and 99.96% similar at 
the nucleotide level. Further analysis of this contig (see section 2.8.4) reveals that the 
putative PMSl gene lies upstream of three hypothetical ORFs (Figure 3.40), whose 
functions cannot be predicted by BLAST searches of the nucleotide and protein databases 
as no significant similarities to known sequences are found.
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Figure 3.34 PCR of a 2.7 kb région of the putative T. brucei PM Sl gene
Primers PMSl 5’(2) and PMSl 3%2) were used with 20 ng of MITat 1.2 genomic DNA for 
PCR. Control reactions were performed with both primers in the absence of T. brucei 
DNA template (A), the PMSl 5’(2) primer only (B), and the PMSl 3’(2) primer only (C). 
Lane D shows the reaction containing both primers and template.
A B C D
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Figure 3.35 PCR of T. brucei PM Sl probe sequence
Primers PMS1\J2 and PMSl 3’(2) were used with MITat 1.2 genomic DNA for PCR. 
Control reactions were performed with both primers in the absence of 71 brucei DNA 
template (A), the PMS1C2 primer only (B), and the PMSl 3’(2) primer only (C). Lane D 
shows the reaction containing both primers and template.
B D
174
Figure 3.36 Genomic Southern blot probed for the putative T. brucei PM Sl gene
A Southern blot of MITat 1.2 and ILTat 1.2 genomic DNA which was restriction-digested 
with the enzymes shown, separated on a 0.6% agarose gel, probed with a 460 bp PCR 
product amplified from the T. brucei PMSl gene and washed to 0.2 x SSC, 0.1% SDS at 
65°C.
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Figure 3.37 Analysis of the expression of the putative T. brucei PM Sl gene
RT-PCR was performed on both bloodstream and procyclic form total RNA isolated from 
MITat 1.2. Internal primers complementary to the putative 71 brucei PMSl gene were 
used and the integrity of the RNA was confirmed using primers directed against the large 
subunit of 71 brucei RNA polymerase I (Rudenko et a i, 1996). For both genes RT positive 
(RT+), RT negative (RT-) and no template (NT) reactions were run.
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Table 3.4 Pairwise comparison of the putative 71 brucei PM Sl polypeptide with a
range of MutL homologues
The percentage identity and similarity between the putative T. brucei PMSl polypeptide 
sequence and a number of MutS homologues was calculated by performing pairwise 
alignments using the GCG gap program. In each case the full length polypeptide 
sequences were compared.
M utL hom ologue
T. brucei PMSl
% Identity % Sim ilarity
E. coli MutL 28.03 36.16
A. thaliana MLHl 24.49 34.75
D. melanogaster MLHl 22.62 31.39
H. sapiens MLHl 24.55 33.05
S. cerevisiae MLHl 22.13 30.77
71 brucei MLHl 23.47 30.67
A. thaliana PMS 1 33.64 42.22
D. melanogaster PMS2 32.94 42.03
H. sapiens PMS2 31.66 42.91
S. cerevisiae PMSl 31.23 39.79
H. sapiens PMS 1 24.16 32.12
S. cerevisiae MLH2 24.02 32.78
H. sapiens MLH3 23.67 31.33
S. cerevisiae MLH3 25.26 36.63
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F i g u r e  3 . 3 8  A  g r a p h i c a l  r e p r e s e n t a t i o n  o f  t h e  s i m i l a r i t y  b e t w e e n  t h e  p u t a t i v e  
r .  b r u c e i  P M S l  p o l y p e p t i d e  a n d  o t h e r  M u t L - r e l a t e d  p r o t e i n s
Pairwise alignments were performed as described in Table 3.4 to compare the putative 
T. brucei (Tbr) PMSl polypeptide sequence with other MutL-related polypeptide 
sequences from: A. thaliana (Ath), D. melanogaster (Dme), E. coll (Eco), H. sapiens (Hsa) 
and S. cerevisiae (See). Percentage identity is shown in blue and percentage similarity in 
red.
% SimlintyA'h Dm. %  MLH1SC Tb,
P M S 2  PM S1 
S c
MLH3
See
178
Figure 3.39 Global multiple alignment of the putative T. brucei PM Sl polypeptide
with a range of PMSl orthologues
Multiple sequence alignment of the putative T. brucei PMSl (TbrPMSl) polypeptide 
(shown in red) with homologues of S. cerevisiae PMSl (ScePMSl) from other eukaryotes: 
A. thaliana (AthPMSl), D. melanogaster (DmePMS2), and H. sapiens (HsaPMS2). 
Sequences were aligned using CLUSTAL X (Thompson et a i,  1997), and shaded using the 
BOXSHADE server (http://www.ch.embnet.org/software/ BOX_form.html): identical 
residues are shaded in black, and conserved residues in grey. The sequences identified as 
I, II, III and IV (shown in blue) are the four characteristic nucleotide binding motifs of the 
GHKL ATPase/kinase superfamily (Bergerat et a l , 1997; Mushegian et a l, 1997; Ban and 
Yang, 1998; Dutta and Inouye, 2000), and the peptide labelled DIMER (shown in pink) 
contains the MLHl-interacting domain of S. cerevisiae PMSl (Pang et a l , 1997; Schâr et 
a l, 1997; Kondo et a l, 2001). The region identified beneath the T. brucei sequence 
corresponds to the region of the T. brucei PMSl gene that was amplified by PCR and used 
as a probe (shown in orange).
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Figure 3.40 Analysis of the genomic environment of the putative T, brucei PM Sl
gene
The nucleotide sequence of contig TRYP9.0.000851 was analysed using the Nucleotide 
Identification (NIX) server (http://www.hgmp.mrc.ac.uk/Registered/webapp/nix/) provided 
by the UK Human Genome Mapping Project Resource Centre. The output shows the 
results of selected programs which were used in the analysis. The sequence regions 
identified correspond to: (A) the putative T. brucei PMSl ORF; and (B) a number of 
hypothetical ORFs suggested by the HMMGene gene-prediction and Fex exon-prediction 
programs. The predicted direction of transcription is indicated by a black arrow.
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3.5 Discussion
A total of seven genes have been identified in T. brucei on the basis of their similarity to 
mutS- and mw/X-related genes from other organisms. Two putative mutS homologues, 
MSH2 and MSH8, have been cloned and characterised, while the sequence of a third, a 
putative orthologue of MSH3, has been analysed in this chapter. I propose that these three 
genes encode polypeptides active in MMR (see below). During BLAST searches of the 
T. brucei genome sequencing databases, two further putative MutS homologues were 
encountered (data not shown). These genes probably encode the MutS homologues MSH4 
and MSH5 which form a heterodimer active during meiotic crossing-over (Ross- 
Macdonald and Roeder, 1994; Hollingsworth et a l, 1995; Pochart et a l , 1997). Analysis 
of the sequence and functions of these genes is beyond the scope of this work.
Furthermore, two mw/L-related genes have been isolated from T. brucei, the first encoding 
a putative orthologue of MLHl, and the second encoding a putative orthologue of PMSl 
from S. cerevisiae. No genes bearing similarity to any of the other mutL homologues 
identified in eukaryotes (for instance MLH2 and MLH3 in S. cerevisiae) were encountered 
during this study. However, the T. brucei genome sequencing project is still in progress, 
and it is possible that more mutL- and mw/iS-related genes may come to light.
The three putative MutS homologues identified in T, brucei which are thought to be active 
in MMR, MSH2, MSH3 and MSH8, share sequence characteristics with all MSH family 
members. Towards the C-terminus, two highly conserved motifs comprising an ATP- 
binding domain and a helix-turn-helix motif are present in each polypeptide (Gorbalenya 
and Koonin, 1990; Adé et a l ,  1999; Biswas et a l, 2001). A middle-conserved domain, 
which is thought to be involved in protein-protein interactions and which is found in all 
MutS homologues is also present in the three polypeptides (Culligan et a l ,  2000). A 
further motif has only been observed in bacterial MutS and the eukaryotic MSH l, MSH2, 
MSH3, MSH6, and MSH7 proteins, and can therefore be considered characteristic of the 
MutS homologues involved in MMR. This motif is a conserved N-terminal domain which 
is involved in mismatch interaction (Maikov et a l, 1997; Culligan et a l, 2000; Schofield et 
a l , 2001), and it is present in the three T. brucei polypeptides under investigation, 
suggesting they are indeed involved in MMR.
The three T. brucei MutS-related polypeptides have been classified on the basis of 
sequence comparisons with MutS homologues from other eukaryotes. Sequence 
comparison of the first T. brucei MutS homologue identified that this gene encodes an 
orthologue of MSH2. Clear evidence for this is provided by the fact that T. brucei MSH2
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shows greater homology to its A. thaliana, H. sapiens and S. cerevisiae counterparts (47%, 
46% and 44% similarity respectively) than it does to either T. brucei MSH3 (35% 
similarity) or MSH8 (35% similarity). The predicted T. brucei MSH2 polypeptide is also 
similar in length to other MSH2 orthologues. Sequence comparisons using the second 
T. brucei MutS homologue to be identified indicated that this gene encodes a member of 
the MSH3/MSH6 subfamily. However, although it bore marginally greater similarity to 
MSH6 and MSH7 homologues (between 1.5 and 8.0%) than to MSH3 orthologues, it could 
not be classified beyond doubt. The third T. brucei MutS homologue was identified very 
recently, and sequence comparisons using this polypeptide suggested that this gene also 
encodes a member of the MSH3/MSH6 sub-family, although in this case the polypeptide 
showed a marginally greater similarity (between 1.0 and 6.0%) to the MSH3 orthologues 
used in the analysis. Global multiple alignment of these polypeptides with MSH3, MSH6 
and MSH7 homologues allowed the identification of short sequence motifs in the T. brucei 
sequences characteristic of either MSH3 or MSH6/MSH7 family members. On the basis 
of sequence similarity and the data gleaned from the global multiple alignment the third 
T. brucei MutS homologue was designated MSH3, but the second T. brucei MutS-related 
gene was assigned the name MSH8 because while it can be identified as a member of the 
MSH6/MSH7 sub-family it lacks the N-terminal extension characteristic of these proteins.
T. brucei MSH3 is similar in length to other MSH3 orthologues, a fact which strengthens 
its classification within this group. However, the putative MSH8 polypeptide is also 
similar in length to MSH3 orthologues. This observation was confirmed by RT-PCR 
which identified the 5’splice site of the gene, which lies 72 bp upstream of the proposed 
start codon, indicating that the predicted ORF is correct. This means that the MSH8 
polypeptide is N-terminally truncated in comparison with other members of the 
MSH6/MSH7 sub-family. There are a number of possible explanations for this. It may be 
that MSH8 simply encodes an orthologue of MSH6 but because of differences in the 
T, brucei MMR system in comparison with that of yeast and mammals, the N-terminal 
extension has been lost, although the function of the protein remains similar. Since the 
T. brucei genome sequencing project is not yet complete, an alternative possibility is that 
another member of the MSH6/MSH7 sub-family will come to light which encodes the true 
MSH6 orthologue in T. brucei, and that MSH8 recognises a different set of mismatches to 
either MSH3 or MSH6. This may suggest it performs a similar role to that of MSH7 in 
plants, or maybe a function unique to trypanosomes. The biochemical consequences of a 
third MutS-related binding partner for MSH2 in plants remains to be determined. From the 
global multiple alignment it is apparent that 7! brucei MSH8 is divergent in comparison 
with the MSH6 and MSH7 homologues, although this is also true of T. brucei MSH2 and
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MSH3 with respect to the MSH2 and MSH3 orthologues, making it difficult to ascertain if 
this reflects sequence differences due to trypanosomes being early-diverging eukaryotes 
(Sogin et a l , 1986; Sogin, 1989) or because of altered functional properties of the MSH8 
polypeptide. A final explanation may be that trypanosomes diverged from the main 
eukaryote line after the duplication of the progenitor of MSH3 and MSH6, but before 
MSH6 acquired its N-terminal extension. Without performing mutational analysis or other 
functional characterisations of T. brucei MSH8 it is impossible to determine the exact 
function of this gene.
Future analysis of the conserved N-terminal mismatch interacting domain would provide a 
definitive indication as to the function of the T. brucei MutS homologues. MutS-related 
polypeptides which possess this domain probably function in MMR, as the sequence is 
absent from the type II MutS homologues (for instance, MSH4 and MSH5) which do not 
interact with mismatches (Ross-Macdonald and Roeder, 1994; Rossolillo and Albertini, 
2001). Proteins which bind base-base mismatches, including E. coli MutS and Thermus 
aquaticus MutS possess a conserved Phe-X-Glu DNA binding motif, where the glutamic 
acid residue hydrogen bonds with either an unpaired thymidine or the thymidine of a G-T 
mismatch (Schofield et a l , 2001). This motif forms part of the conserved N-terminal 
mismatch interacting domain and is present in MSH6 and MSH7 homologues from 
A. thaliana, H  sapiens and S. cerevisiae, although MSH6 proteins are also required for the 
repair of small IDLs. Examination of the predicted T. brucei MSH8 polypeptide reveals 
the presence of this conserved DNA binding domain suggesting this protein may interact 
with base-base mismatches. The MSH3 proteins, which are involved in the repair of larger 
IDLs, do not have the conserved Phe-X-Glu motif but do show sequence conservation 
within this region. Across these residues the predicted T. brucei MSH3 polypeptide shows 
greater identity with the MSH3 orthologues studied than with the MSH6 and MSH7 
homologues from other eukaryotes. The mismatch interacting domain of MSH2 
orthologues also does not contain the Phe-X-Glu motif, probably because MSH2 is not 
responsible for mismatch specificity, although the equivalent residues in MSH2 
orthologues do show conservation. Surprisingly, the predicted T. brucei MSH2 polypeptide 
possesses dissimilar amino acid residues in this region and is divergent in comparison with 
the other MSH2 proteins shown over the length of the mismatch interacting domain. The 
functional implications of this, as well as the mismatch recognition predictions discussed 
above for the putative T. brucei MSH8 and MSH3 polypeptides, could be investigated by 
DNA binding studies in vitro combined with site-directed mutagenesis.
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Another conserved motif often present at the extreme N-terminus of members of the 
MSH3/MSH6 sub-family, but not in MSH2 orthologues, is the PCNA binding domain 
(Clark et a l , 2000; Flores-Rozas et a l , 2000). This motif is found in the MSH3, MSH6 
and MSH7 homologues from A. thaliana, H. sapiens and S. cerevisiae. Analyses of the 
putative T. brucei MSH3 and MSH8 amino acid sequences did not reveal convincing 
PCNA binding motifs anywhere along the length of these polypeptides, nor was a 
consensus motif apparent in T. brucei MSH2, MLHl or PMSl. Although partial PCNA 
binding sites could be identified in T. brucei MSH3 and MSH8, the location of the amino 
acids residues in question, in terms of domain organisation, would argue against their 
serious consideration. PCNA binding is required not only at an early stage in mismatch 
repair preceding mismatch excision (Umar et a l , 1996), but also during DNA resynthesis 
following the excision of the mismatch (Gu et a l , 1998). Lack of a PCNA binding motif is 
not unprecedented, however, as S. pombe SWI4 (an orthologue of MSH3) also lacks the 
consensus motif although it is present in S. pombe MSH6 (Kleczkowska et a l, 2001), and 
analyses of MSH6 from D, melanogaster and MSH7 from Zea mays retrieve only partial 
consensus motifs where both proteins lack the conserved glutamine residue. Moreover, 
interaction with PCNA is not limited to proteins possessing the conserved binding motif. 
For instance, Gadd45, which may be involved in regulating DNA repair, and CAFl, which 
links chromatin assembly to DNA replication, both interact with PCNA using different 
amino acid residues (Kearsey et a l , 1995; Shibahara and Stillman, 1999). Furthermore, 
two-hybrid experiments in yeast indicate that PCNA interacts with MLHl (Umar et a l, 
1996), suggesting mismatch repair proteins can bind at sites other than the interdomain 
connector loop of PCNA as MLHl does not contain the PCNA consensus binding motif. 
Whether the likely interactions of MSH8 or MSH3 and PCNA are mediated by a standard 
PCNA binding motif that is simply highly diverged in sequence, or whether they employ 
non-canonical binding interactions, would require further analysis.
The two putative T. brucei MutL-related genes were classified on the basis of sequence 
homology with MLH family members from other eukaryotes. The first MutL homologue 
identified in T. brucei has been designated MLHl because it is evident from sequence 
comparisons that this polypeptide bears greater similarity to MLHl orthologues from 
A. thaliana, D. melanogaster, H  sapiens, and S. cerevisiae (43%, 42%, 48% and 47% 
similarity respectively) than to any of the other MutL-related proteins used in the analysis. 
The T. brucei MLHl polypeptide is also within the expected size range for MLHl 
orthologues. The second T. brucei MLH family member has been designated PMSl since 
it shows greater homology to orthologues of PMSl fromzf. thaliana and S. cerevisiae 
(42% and 40% similarity respectively), and their closest homologues in animals, PMS2
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from D. melanogaster and H. sapiens (42% and 43% similarity respectively) than to the 
other MutL-related proteins analysed. The predicted T. brucei PMSl polypeptide is also 
similar in length to orthologues of PMSl from S. cerevisiae,
MLH family members are characterised by two sequence motifs: a highly conserved 
N-terminal ATP-binding domain, and a C-terminal dimérisation domain which shows 
more diffuse sequence conservation (Bergerat et a l, 1997; Mushegian et a l, 1997; Pang et 
a l ,  1997; Ban and Yang, 1998; Dutta and Inouye, 2000; Kondo et a l , 2001). The 
N-terminal ATP-binding domain of MutL homologues has been associated with a weak 
ATPase activity that is required for MMR (Ban and Yang, 1998; Spampinato and Modrich, 
2000; Hall et a l , 2002). Both the putative MutL homologues isolated from T. brucei, 
MLHl and PMSl, possess regions bearing high identity to this domain suggesting the 
ATPase activity is conserved in T. brucei. However, the predicted T. brucei PMS1 
polypeptide contains several insertions within this domain and without further study it is 
impossible to determine what the functional implications of these are. The conserved 
C-terminal dimérisation domain is required, as implied in its name, for interactions 
between two MutL homologues. The regions required for interaction between 
S, cerevisiae MLHl and PMSl have been well characterised and equivalent regions are 
present in the two putative T. brucei MutL homologues, indicating they are also likely to 
interact. A further motif, which has only been observed in orthologues of MLHl and 
which is therefore considered characteristic of these proteins, is the highly conserved 
C-terminal homology domain (CTH). The putative T. brucei MLHl orthologue shows a 
high level of identity with MLHl orthologues from other eukaryotes within this region. 
Deletion and mutation analyses of the CTH of yeast MLHl indicated that this sequence 
was essential for MMR activity, but was not required for interaction with PMSl (Pang et 
a l ,  1997). Given the high level of conservation of this region in the putative T, brucei 
MLHl polypeptide, this is probably also the case in trypanosomes.
At the genomic level, the T, brucei MSH2, MSH8, MLH l and PMSl genes are single copy, 
as evidenced by their detection in Southern analyses as single bands following restriction 
digestion of genomic DNA with enzymes which do not recognise any sites in the probe 
sequence. Furthermore, since the restriction pattern is identical in digestions of both 
MITat 1.2 and ILTat 1.2 genomic DNA it can be concluded that the genomic environment 
of each gene is the same in these two strains of T, brucei. This is important because the 
MSH2, MLH l and PMSl gene sequences were derived from ILTat 1.2 genomic DNA 
(cloned into the LambdaGEM-12 vector to form an ILTat 1.2 genomic library), whilst 
most of the dovmstream analyses of these genes, for instance analysis of the expression of
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the genes, were performed using DNA or RNA isolated from MITat 1.2 cells. Moreover, 
this rules out the possibility that the difference in VSG switching rates between the 
pleomorphic ILTat 1.2 strain and the monomorphic MITat 1.2 strain are due to loss, or 
other gross structural alterations, in any of these genes.
RT-PCR using total RNA isolated from both bloodstream and procyclic form MITat 1.2 
trypanosomes shows that MSH2, MSH8, MLH l and PMSl are all expressed in both life 
cycle stages. The expression of T. brucei MSH3 was not analysed. Since expression levels 
in T. brucei are predominantly regulated by post-translational mechanisms, it was deemed 
sufficient to demonstrate expression of the target ORFs by RT-PCR, as the technique is 
simpler and more sensitive than Northern analysis. In order to determine the expression 
levels of a protein in T. brucei it would be necessary to perform Western analysis using 
antibodies specific to that protein. At present such antibodies are not available for any of 
the mismatch repair proteins in T. brucei, although this would clearly be of interest in 
terms of understanding whether or not their levels of expression are modulated by any 
environmental or cellular signals.
Despite the obvious similarities between the T. brucei MMR genes and their counterparts 
in other eukaryotes, definite proof that their gene products are active in MMR in T. brucei 
can only be obtained through analysis of mutant cell lines. Since MSH2 is the primary 
MutS homologue involved in MMR, and MLH l is the most important mw/7-related gene, 
these two genes were chosen for mutant analysis in T. brucei. The gene knockout 
strategies and functional analyses of the putative MSH2 and MLH l genes are described in 
chapter 4.
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C h a p t e r  4
Generation and analysis of homozygous 
MSH2 and MLHl knockouts in T. brucei
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4.1 Introduction
In order to determine the roles of MMR in T. brucei it was decided that functional studies 
of both the putative MSH2 and MLH l genes were warranted as their gene products are 
believed to be required to form all complexes active in nuclear MMR (Harfe and Jinks- 
Robertson, 2000). Studies of MSH2 and MLH l null mutants in this organism will reveal 
whether T. brucei possesses a functional MMR system, and if this system acts in a manner 
similar to that described in other eukaryotes. Since the primary reason for studying MMR 
in T. brucei is its possible role in regulating DNA recombination, and thereby antigenic 
variation, it was deemed necessary to study both MSH2 and MLHl because, while they act 
in concert during MMR, MSH2 has been associated with activities independent of MLHl 
during a number of recombination processes. The MSH2-MSH3 complex in S. cerevisiae 
has been shown to impact upon SSA and gene conversion, where it is required to stabilise 
the recombination intermediates and allow the RADI-RAD 10 endonuclease to process 
non-homologous 3’ tails (Sugawara et a l, 1997; Studamire et a l ,  1999). Also, the 
MSH2-MSH6 heterodimer has been found to bind Holliday junctions and enhance their 
cleavage by phage resolution enzymes in vitro (Marsischky et a l , 1999). Furthermore, in 
S. cerevisiae loss of MSH2 resulted in the greatest increase in the rate of homeologous 
recombination relative to the wild-type (Nicholson et a l, 2000). Similar experiments 
using MLH l mutants revealed smaller increases in recombination between divergent 
sequences, suggesting that MSH2 acts to block recombination by a pathway independent 
of MLH l. If MSH2 can also act independently of MLHl during some processes in 
T. brucei, then these differences may be revealed by comparison between the phenotypes 
of null mutants of both these genes in this organism.
T. brucei is diploid in all life cycle stages that have been described, and for this reason any 
strategy to create null mutants must disrupt both alleles. Recently, strains enabling 
researchers to disrupt gene expression using RNA interference (RNAi) have been 
developed in T. brucei (Wirtz et a l, 1999; Bastin et a l ,  2000; LaCount et a l ,  2000; Shi et 
a l ,  2000; Wang et a l , 2000), but the use of this strategy was inappropriate for this work 
for two reasons. Firstly, given that neither MSH2 or MLH l are essential genes in either 
prokaryotes or unicellular eukaryotes, it is unlikely that stable knockouts would be lethal in 
T. brucei. Secondly, the main aim of this research was to determine whether MMR is 
involved in the regulation of VSG switching in this organism. In order to study the effect 
of MSH2 and MLH l gene disruption upon antigenic variation, the null mutants had to be 
created in the 3174 transgenic strain of T. brucei described in McCulloch et a l (1997).
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This strain underpins the only assay available which allows researchers to assay both the 
frequency of VSG switching and determine the relative contribution of the in situ and gene 
conversion switching mechanisms (see section 4.2.8). During this assay cells which have 
switched their VSG coat are selected in mice, and it is not known whether it is possible to 
sustain RNAi induction in trypanosomes grown in a host organism. This study has used 
the well-established method of gene disruption by performing two rounds of 
transformation with linear resistance cassettes possessing terminal sequence homology to 
the gene of interest (Ray and Hines, 1995; Li et a l, 1996; McCulloch and Barry, 1999). 
This strategy creates stable integrants in which the gene of interest has been inactivated, 
enabling long-term functional studies. The 3174 strain was derived from MITat 1.2a S427 
bloodstream forms, and contains antibiotic resistance markers for hygromycin B and G418 
within its active expression site. Since the 3174 strain is unaltered from its parent 
background at all other loci, other functional studies of the MSH2 and MLH l mutants 
reported in this chapter were also performed in this strain.
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4.2 Generation and analysis of homozygous MSH2 knockout trypanosomes
4.2.1 Introduction
MSH2 underpins the entire MMR system in eukaryotes. This protein is required for the 
formation of all the MutS-related mismatch-interacting complexes, MSH2-MSH3, 
MSH2-MSH6 and MSH2-MSH7, and so is necessary for the recognition of all mismatches 
repaired by MMR (Culligan and Hays, 2000; Harfe and Jinks-Robertson, 2000). Loss of 
MSH2 therefore leads to the complete elimination of nuclear MMR activity (Harfe and 
Jinks-Robertson, 2000). Several phenotypic changes are associated with the loss of MSH2, 
and a number of experimental approaches are available to characterise these in T. brucei. 
Primarily, cells develop a mutator phenotype, and although the frequency of point 
mutations is elevated, there is a greater effect on the stability of simple, repetitive 
sequences called microsatellites (Levinson and Gutman, 1987; Strand et a l ,  1993; de Wind 
et a l , 1995). For this reason, the effect of MSH2 mutation on a number of microsatellite 
loci in T. brucei will be determined in this study (see section 4.2.7). Furthermore, 
inactivation of MSH2 has been shown to lead to an increase in resistance to a number of 
cytotoxic chemicals, including alkylating agents and the anti-cancer drug cisplatin (Karran 
and Marinus, 1982; Aebi et a l , 1997; Marra and Schâr, 1999). The survival of MSH2 
mutant trypanosomes in the presence of the alkylating agent A-methy 1-Af -nitro-A- 
nitrosoguanidine (MNNG) will therefore be assessed during this work (see section 4.2.6). 
Loss of MSH2 has also been shown to lead to an increase in recombination between 
non-identical or homeologous DNA sequences, because mismatches formed during strand 
invasion are no longer recognised, and the recombination reaction, which would be 
prevented in MMR competent cells, is allowed to proceed (Alani et a l , 1994; de Wind et 
a l ,  1995; Selva et a l ,  1995; Datta et a l ,  1996). As the frequency of VSG switching is 
greatly decreased in trypanosomes lacking RAD51, a primary component of the 
homologous recombination machinery, it is hypothesised that other proteins involved in 
the catalysis or regulation of homologous recombination may also affect VSG switching 
(McCulloch and Barry, 1999). While a system to study the effect of MSH2 mutation on 
recombination between divergent sequences is described in Chapter 5, the possibility that 
MSH2 is involved in regulating recombination between DNA sequences during VSG 
switching was investigated by examining the role of MSH2 in trypanosome antigenic 
variation (see section 4.2.8).
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4.2.2 Design and generation of MSH2 knockout constructs
In order to examine the function of MSH2 in T. brucei, a strategy to create transgenic 
trypanosomes from which both copies of the MSH2 ORF were deleted was developed. 
Alignment of the protein sequence of T, brucei MSH2 (see section 3.1.7) with MSH2 
proteins from other eukaryotes revealed that the functional domains are spaced throughout 
the length of the polypeptide, and it has been reported that mutations in one domain do not 
necessarily inactivate all the activities of the MSH2 protein (Drotschmann et a l, 2001).
For this reason it was determined that both copies of the entire MSH2 ORF should be 
deleted from the genome, in order that no residual MSH2 activity could remain.
T. brucei MSH2 knockout constructs were designed to contain the sequences immediately 
5’ and 3’ of the MSH2 ORF to act as targeting sequences for replacement of the entire 
MSH2 ORF by homologous recombination (Figure 4.1). These targeting flanks were 
separated by one of two antibiotic resistance cassettes, containing either the puromycin-N- 
acetyltransferase ORF {PUR) or the blasticidin-S-deaminase ORF {BSD), flanked by 
5’ and 3’ processing signals from the tubulin locus. After integration, the resistance genes 
should be expressed by endogenous MSH2 transcription, since the knockout constructs 
contain no promoter elements.
PCR primers were designed to amplify 430 bp of 5’ flank {MSH2 5’(A) and MSH2 5’(B)) 
and 370 bp of 3’ flank {MSH2 3’(A) and MSH2 3’(B)) from the MSH2 locus. PCR from 
MITat 1.2 genomic DNA using these primers generated products of the expected sizes 
(Figure 4.2; see section 2.11.1). The MSH2 targeting flanks were then cloned 
simultaneously into pBluescript II KS, before the BSD- or PUR-containing resistance 
cassettes were cloned between the MSH2 flanks to generate the M4SH2::BSD and 
AMSH2::PUR constructs respectively (see section 2.11.1).
4.2.3 Design and generation of MSH2 re-expression construct
In order to determine whether any effects on MMR or antigenic variation were due to the 
loss of MSH2 and not incidental to changes which arose during electroporation, selection 
or cloning of the transformants, it was necessary to generate a construct capable of 
re-expressing the MSH2 gene in homozygous mutants (Figure 4.3). The 
AMSH2::MSH2-BLE construct was designed to contain the MSH2 ORF flanked by the 
same 5’ and 3’ MSH2 processing flanks used as targeting flanks in the knockout constructs 
(see section 4.2.2). This construct also incorporated a bleomycin resistance protein ORF
193
{BLE)', to allow the selection of transformants this was flanked by processing signals 
derived from the actin locus at the 5’ end, and the a - (3 tubulin intergenic region at the 
3’ end, positioned downstream of the 3’ end of the MSH2 3’ flank. This construct was 
designed to allow the re-expression of MSH2 from its original genomic location, and since 
it does not contain a promoter element both MSH2 and the resistance gene will be 
expressed by endogenous MSH2 transcription, circumventing the potential problem of 
altered MSH2 expression levels which could occur if an ectopic locus was used. The 
MSH2 5’ flank and the a-p tubulin intergenic region (also used as the 3’ processing flank 
for the BSD and PUR ORFs in the MSH2 knockout constructs) form the targeting flanks 
allowing integration of the construct into either the MSH2::BSD or MSH2: :PUR alleles in 
the MSH2''' mutants.
The AMSH2::MSH2-BLE construct was derived from the MSH2 lambda sub-clone which 
contains the MSH2 ORF and its processing flanks (pJBlOO) (see section 3.1.3). The BLE 
resistance cassette was cloned into the EcoBN site of the multiple cloning site downstream 
of the MSH2 3’ flank (see section 2.12).
4.2.4 Generation of MSH2 mutant cell lines in T. brucei
Three independent MSH2 bloodstream stage mutants were generated by direct 
transformation of 3174 bloodstream cells with the linearised knockout constructs (see 
section 2.11.1). Initially, the AMSH2::PUR construct was electroporated into a number of 
independent cell populations and transformants selected on semi-solid agarose plates 
containing 1.0 pg.ml'^ puromycin dihydrochloride to generate putative heterozygous 
{MSH2^^') mutants (see section 2.1.3). Three independent first round transformants were 
then electroporated with the AMSH2::BSD construct and transformants selected on 
semi-solid agarose plates containing 2.5 pg.ml'^ blasticidin S hydrochloride to generate 
putative homozygous {MSH2'^') mutants. Finally, a single second round transformant was 
electroporated with the linearised re-expression cassette AMSH2::MSH2-BLE and 
transformants selected in HMI-9 containing 2.5 pg.ml'^ phleomycin in 24-well plates to 
generate a putative re-expressor {MSH2'''^'^) mutant (see sections 2.1.3 and 2,12).
Correct integration of the constructs into the MSH2 locus was determined by Southern 
analysis. Genomic DNA from each transformant was digested with Sad, separated by 
agarose gel electrophoresis. Southern blotted, and probed with the MSH2 5’ flank 
described in section 4.2.2. Figure 4.4 shows the results of this analysis for untransformed
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3174 trypanosomes, the three independent heterozygous MSH2 knockouts, the three 
homozygous MSH2 knockouts derived from these heterozygotes, and the single MSH2 
re-expressor generated from one of the homozygotes. In the untransformed cells, a 5.8 kb 
restriction fragment was detected, corresponding to the intact wild-type MSH2 locus. This 
fragment was also detected in the three MSH2'^'' mutants, but was absent from the three 
MSH2'^' cell lines. The three first round transformants also possessed a 2.85 kb fragment 
corresponding to the MSH2 allele replaced by the AMSH2::PUR construct, and this allele 
was retained in the three second round knockout cell lines. The digestions of the three 
homozygous mutants also revealed a 2.65 kb fragment derived by replacement of the 
second MSH2 allele by the AMSH2::BSD construct. The two fragments present in the 
MSH2'^~ mutants designated 1.1 and 2.1 merged into one another in both digestions because 
the gel was overloaded with DNA resulting in an over-intense hybridisation signal.
Finally, two bands were detected in the digestion of the MSH2' '^ '^  ^cell line. The 2.85 kb 
fragment corresponded to the MSH2::PUR allele, while the MSH2::BSD allele was 
replaced by the AMSH2::MSH2-BLE construct, thus restoring a copy of the MSH2 gene to 
the genome and creating a 6.2 kb fragment. For each cell line. Southern analysis indicated 
that the knockout and re-expression constructs integrated into the MSH2 locus as expected 
to generate the desired MSH2 mutant trypanosomes.
PCR using primers internal to the MSH2 ORF {MSH2D5 and MSH2U2; Figure 4.1) was 
performed using genomic DNA isolated from the putative 3174 MSH2 mutants in order to 
show that no copies of the MSH2 ORF existed within the MSH2''' mutant cell lines (Figure 
4.5; see section 2.11.1). The integrity of the DNA template was confirmed using primers 
specific to the large subunit of T. brucei RNA polymerase I (Poll 5’ and Poll 3’; Rudenko 
et a l , 1996). PCR amplification using the MSH2 internal primers revealed that the 
untransformed cells, the three heterozygous mutants and the MSH2 re-expressor all gave a 
product of the expected size. No product was visible in the three homozygous mutants, 
however, indicating that no further copy of MSH2 had been created upon disruption of the 
two wild-type alleles.
Finally, in order to confirm that no wild-type MSH2 mRNA was transcribed in the 
homozygous mutants, total RNA was isolated from the transformants and cDNA generated 
by reverse-transcription (see section 2.4). The cDNA was used as a template for PCR 
amplification using the MSH2 internal primers used above (Figure 4.6), and the integrity of 
the cDNA was confirmed as above. Reverse transcription PCR was used in this analysis as 
antibodies against the T. brucei MSH2 polypeptide are not currently available. A PCR
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product of the expected size was amplified from the untransformed cells, the three MSH2^^' 
mutants and the cell line, but not from the MSH2'’' mutants. It can therefore be
concluded that it is possible to remove all intact transcripts of the MSH2 gene, and thus all 
expression of the MSH2 protein, and trypanosomes remain viable. These results again 
confirm that the knockout and re-expression constructs integrated into the cells as 
expected, and that the desired MSH2 mutant trypanosomes were generated.
4.2.5 Growth of MSH2 knockout trypanosomes in vitro
The in vitro growth rate of the MSH2 mutants was determined by diluting mid-log phase 
trypanosomes to a concentration of 1 x 10  ^cells.mf* in HMI-9 and measuring the 
trypanosome concentrations every 24 h thereafter (Figure 4.7). It is clear that MSH2'^' cells 
are not only viable but show no change in growth compared to the wild-type cells. The 
average population doubling time during exponential grov^h was 7.4 h for the MSH2 
wild-type cells, 6.5 (± 0.5) h for the MSH2'^^' cell lines, 6.5 (± 0.7) h for the MSH2'^' 
mutants and 6.69 h for the MSH2'^'''^ cell line. All the cultures reached similar maximal 
densities (data not shown).
4.2.6 Survival of MSH2 mutant trypanosomes in the presence of the alkylating 
agent, A-methyl-A^-nitro-A-nitrosoguanidine (MNNG)
Alkylating agents, including MNNG, are an important group of mutagenic and cytotoxic 
chemicals whose toxicity is affected by MMR. Primarily, these drugs act by generating 
O^-methylguanine (0^-meG) lesions by methylating the position of guanine. During 
replication, thymine is misincorporated opposite these lesions, forming mismatches that are 
recognised but not repaired by the MMR system (Griffin et a l , 1994; Duckett et a l , 1996). 
Inactivation of this repair pathway confers resistance to the cytotoxicity of alkylating 
agents, and results in cellular hypermutability, a phenomenon known as méthylation 
tolerance (reviewed in Karran and Bignami, 1994; Aquilina and Bignami, 2001). Given 
that O^-meG is a highly mutagenic and genotoxic modified base which can arise during 
normal cellular processes, a highly conserved protein has evolved, O^-methylguanine DNA 
methyltransferase (MGMT), which repairs these lesions in a single-step, error-free 
reaction. However, in many cell types this protein is expressed at low levels, and treatment 
with MNNG may overwhelm the normal repair pathway, leading to tumorigenesis or cell 
death in MMR-proficient cells (reviewed in Bignami et a l , 2000).
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Several models have been advanced to explain méthylation tolerance in MMR mutants.
The most widely accepted is termed the ‘futile cycle model’ (Goldmacher et a l ,  1986; 
Karran and Bignami, 1992; Vaisman et a l , 1998). It has been suggested that attempts by 
the MMR system to correct O^-meG-containing mispairs are abortive since correction will 
be directed to the newly synthesised strand while the methylated base is retained in the 
parental strand. Since resynthesis will again result in an 0^-meG-containing mismatch, 
this process leads to repetitive cycles of excision and resynthesis and thus single-stranded 
regions at the site of 0^-meG residues. Replication across these regions results in the 
formation of double-strand breaks, and hence chromosomal aberrations or cell death 
(D'Atri et a l , 1998; Toft et a l , 1999). An alternative model proposes that binding of the 
mispair by the MutS- and MutL-related heterodimers shields the lesion from other DNA 
repair proteins, allowing such adducts to persist in the genome (Mello et a l , 1996).
Further models suggest that assembly of the MMR machinery at 0^-meG-containing 
mismatches directly activates a damage-signalling cascade which leads to cell cycle arrest 
or cell death (Carethers et a l, 1996; Moreland et a l, 1999; Berardini et a l , 2000). These 
processes are avoided in MMR-defîcient cells, and loss of MSH2 has been shown to result 
in méthylation tolerance or resistance to alkylating agents in mammalian cells (de Wind et 
a l , 1995; Humbert et a l , 1999).
In order to determine if loss of MSH2 in T. brucei resulted in increased resistance to 
MNNG, the survival of MSH2 wild-type cells, MSH2'^ '^ mutants, MSH2''' mutants and 
MSH2~'~''^  cells was assayed in the presence of increasing concentrations of MNNG. Cells 
were plated in HMI-9 containing 0, 0.25, 0.5, 0.75 or 1.0 pg.mf^ MNNG at a density of 
2 cells per well in 96-well plates in triplicate, and after 14 days the number of wells 
containing growth were counted. The results of this assay are shown in tabular form in 
Table 4.1, and as a graph in Figure 4.8. It is clear from these data that loss of MSH2 results 
in increased resistance to MNNG in 71 brucei. Exposure to 0.25 pg.mf ^ MNNG results in 
a reduction in survival of 27% in MSH2 wild-type cells, but of only 6% and 12% in the 
MSH2^^' mutants. At this concentration the MSH2'^' mutants and MSH2'^'’^  cells were 
barely affected with reductions in survival of only 3% and 1% respectively. At 
0.5 pg.mf% the survival oiMSH2 wild-type cells was reduced by 85%, while in the 
MSH2^^' cell lines a reduction in survival of 37% and 33% was seen. The survival of 
MSH2'^' mutants at this concentration remained at 97%, but was reduced to 84% in 
MSH2'’'^  ^cells. At a concentration of 0.75 pg.mf \  the survival of MSH2 wild-type cells 
was severely affected with only 2% of wells showing any groAvth, and similarly reduced 
survival was seen in the MS772'*'^ “ cells at 19% and 12%, and the MSH2''''^ cells at 19%.
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The increased resistance of the MSH2''' mutants became obvious at this concentration as 
91% and 87% of wells showed growth, equating to a 4.5-fold increase in survival over 
cells expressing MSH2, At the final concentration, 1.0 pg.mf % no growth was observed 
for the MSH2 wild-type cells, or one of the MSH2 heterozygous cell lines. The second 
MSH2^^' cell line showed only 3% survival and survival in the MSH2'^ ~^ '  ^cell line was 
reduced to 10%. At this concentration, the survival of the MSH2''' mutants was also 
affected but 52% and 43% of wells still showed growth, which represents a minimum 
increase in survival of 33% over cells expressing MSH2. These results are consistent with 
the loss of MMR activity in the MSH2'^' cells as a result of the deletion of MSH2 from 
these cell lines.
4.2.7 Microsatellite instability in MSH2 knockout cell lines
Microsatellites are an extremely abundant class of repetitive elements which are composed 
of tandem arrays of short repetitive sequences, generally 1 to 6 bp in length (Beckmann 
and Weber, 1992). Many of these sequences show extensive variation in the number of 
repeat units per tract between alleles, and these polymorphisms have proved invaluable to 
studies of linkage analysis and population genetics in many organisms, including 
trypanosomes (Oliveira et a l , 1998; Hope et a l , 1999; Tait et a l ,  2002), Owing to their 
repetitive nature, microsatellites are especially prone to slippage of DNA polymerase 
during replication which leads to the formation of insertion-deletion loops (Figure 4.9; 
reviewed in Sia et a l ,  1997a; Strauss, 1999; Ellegren, 2000b). If  uncorrected, these loops 
result in base additions or deletions which are collectively termed frameshift mutations. 
The MMR system is responsible for correcting these misalignments, and inactivation of 
this repair pathway induces high levels of mutation at such repetitive loci (termed 
microsatellite instability or MSI; Buermeyer et a l ,  1999). In bacteria, inactivation of 
either the mutS or mutL genes leads to greater than 13-fold increases in the rate of tract 
instability (Levinson and Gutman, 1987). Destabilisation of microsatellites has also been 
reported for MMR mutants in S. cerevisiae (Strand et a l, 1993; Strand et a l , 1995; 
Johnson et a l , 1996b; Sia et a l , 1997b; Sia et a l , 2001 ). Mutations in the yeast MSH2 
and MSH3 genes decrease the stability of repetitive tracts composed of repeat units 1 to 13 
bp in length (Strand et a l , 1993; Sia et a l, 1997b), while inactivation of MSH6 decreases 
the stability of microsatellites with repeat units of 1 or 2 bp (Sia et a l , 1997b). Given the 
requirement for the MLHl-PMSl heterodimer in both MSH2-MSH3 and MSH2-MSH6 
mediated mismatch repair it is expected that these proteins are also required to correct 
replication slippage events in microsatellites of all sizes (Kolodner and Marsischky, 1999; 
Harfe and Jinks-Robertson, 2000). In support of this argument is the finding that
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inactivation of MLH l or PMSl led to similar increases in tract instability as MSH2 
mutation for a poly(GT) microsatellite (Strand et a l, 1993). Also, mutations in MLH3 
have been reported to increase the rate of 1 bp insertions and deletions in naturally 
occurring homopolymeric sequences (Flores-Rozas and Kolodner, 1998). MSI is also an 
important consequence of MMR deficiency in mammalian cells (de Wind et a l , 1995), and 
is known to occur in tumours from patients with HNPCC (Aaltonen et al., 1993).
Currently, mutations in five human MMR genes have been described in patients suffering 
from HNPCC; the majority of mutations occur within MSH2 and M LH l, while mutations 
in MSH6, PMSl and PMS2 are relatively rare (Liu et a l ,  1996; Viel et a l , 1998). 
Furthermore, the stability of a repetitive tract is also dependant upon the number of repeat 
units within the tract in that the frequency of mutation increases with the number of repeat 
units (Wierdl et a l , 1997). Tract stability is also affected by whether the tract contains 
perfect or imperfect repeats (Petes et a l, 1997). Perfect repeats are uninterrupted by base 
insertions or deletions, while imperfect repeats are punctuated by bases which are different 
to those comprising the repeat units. The rate of replication slippage in imperfect repeats is 
likely to be reduced because misalignments will be disrupted by the formation of 
mismatches between the imperfect repeat units.
To investigate whether MSH2 is involved the repair of slipped replication intermediates in 
T. brucei, the stability of five naturally occurring microsatellite loci was compared in 
MSH2 wild-type cells, MSH2'^^' cells, MSH2''' mutants and MSH2''~‘'^  cells. To this end, 
each cell line was cloned (see section 2.1.3), ten clones from each were grown for 
approximately 25 generations (data not shown), and genomic DNA isolated from the 
cultures (see section 2.16). The five microsatellite loci used in this analysis were chosen to 
reflect different types of repeat unit and different genomic locations (see below).
The first microsatellite chosen for this analysis has been mapped to Chromosome IV, and 
is composed of GT-dinucleotide repeats (JS-2; Figure 4.10; Hope et a l , 1999). Since 
polymorphisms at this microsatellite locus have been characterised by electrophoresis on 
high percentage agarose gels previously, it was decided that a similar approach might yield 
data about the MSH2 mutants. The JS-2 locus was amplified by PCR using the primers 
JS-2 A and JS-2B from all the clonal genomic DNA samples, and the resulting PCR 
products separated by electrophoresis on 3% agarose gels (Figure 4.11). It is evident that 
the JS-2 locus is stable in all ten MSH2 wild-type clones, yielding a PCR product 
approximately 320 to 340 bp in length. This is significantly longer than the larger JS-2 
allele in TREU 927/4, which is only 177 bp in length (containing 47 GT-dinucleotide 
repeat units: Sasse, 1998). Since JS-2 alleles vary greatly in length between different
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trypanosome stocks (Hope et a l , 1999) this is not surprising, and probably represents an 
increase in the number of repeat units contained within the microsatellite. This is also 
suggested by the fact that it proved impossible to clone the JS-2 PCR product amplified 
from 3174 genomic DNA, probably owing to the inability of bacterial DNA polymerase to 
replicate such long repetitive sequences. Analysis of the clones derived from the two
cell lines indicates that the JS-2 locus is stable in this background also. However, 
in the MSH2''~ background a number of clones show changes in the size of the PCR 
products amplified, suggesting that the JS-2 locus has mutated in these cells {MSH2'^' 1.1 
clones C, G and H; MSH2''' 1.1 clone A). Finally, the products generated from the 
MSH2'’'‘^  clones reveal that the JS-2 locus is different from that amplified from the MSH2 
wild-type strain, in that two PCR products, presumably representing the two JS-2 alleles, 
are apparent in the re-expressor but only one size is distinguished in the MSH2 wild-type 
cells. Since this difference is found in every MSH2'''^^ clone it probably arose prior to 
transformation with the AMSH2::MSH2-BLE construct when the cells were MSH2'^~ 
mutants. For this reason the JS-2 locus was considered to be stable in the MSH2'^'^^ cell 
line. These results are summarised in Table 4.2 and shown as a graph in Figure 4.12.
These data indicate that MSH2 homozygous mutants display a mutator phenotype in 
T. brucei. Indeed, small changes may have occurred in clones derived from every cell line 
but it is probable that agarose gel electrophoresis cannot distinguish insertions or deletions 
under a threshold size. It is clear, however, that loss of MSH2 leads to greater changes 
than are observed in cells expressing MSH2. To determine the size of microsatellite alleles 
more accurately, and determine what types of mutation event occur to alter the lengths of 
repetitive tracts in MSH2 mutants in T. brucei, a more sensitive method of microsatellite 
analysis was required.
A more precise method for determining the sizes of microsatellites is fluorescence-based 
PCR (Figure 4.13; see section 2.16). In this system, often called GeneScan analysis after 
the softwEire required to analyse the data (GeneScan software; Applied Biosystems), a 
microsatellite locus is amplified using one unmodified primer and a primer labelled with a 
fluorescent dye. The resulting PCR products are separated by acrylamide-urea gel 
electrophoresis alongside GeneScan internal size standards which are included in the same 
well. The size standards are also fiuorescently labelled (with a different dye), and the 
automated DNA sequencer interprets the fluorescent bands as peaks. Since the sizes of the 
size standards are known, the length of the micro satellite PCR products can be determined 
automatically by comparison. This system is able to distinguish PCR products that differ 
in length by only 1 bp, and while a cluster of fragments is observed for each allele owing
200
to modifications caused by Taq polymerase during amplification, called ‘stutter’ or 
‘shadow’ bands, the highest peak is interpreted as the primary product, and can be 
compared with equivalent peaks from other samples (Oda et a l ,  1997; Paulson et a l,
1999). In this study, PCR product sizes are given in base-pairs to one decimal point, owing 
to slight differences in migration. In most cases, PCR products amplified from multiple 
clones derived from the 3174 wild-type cell line, and repetitions of the same clone, only 
vary in size by 0.5 bp by comparison with the internal GeneScan size markers (see below). 
However, large alleles (over 200 bp in length) showed greater variation of up to 1.5 bp 
between samples which probably share the same sequence.
Two microsatellite loci identified by searching the T. brucei sequencing databases are 
located on Chromosome I, and are termed ChrI-7 and ChrI-15 (A. MacLeod, A. Tweedie 
and A. Tait, personal communication). These were chosen for this analysis, because while 
they both consist of GT-dinucleotide repeats (Figure 4.14), they are located in distinct 
regions of the chromosome, approximately 290 kb apart (see The Wellcome Trust Sanger 
Institute T. brucei genome sequencing database; http://www.sanger.ac.uk/Projects/
T brucei/). Two loci identified on Chromosome II were also studied (Figure 4.15). The 
first contains a run of TA-dinucleotide repeats as well as a T-mononucleotide and an 
A-mononucleotide run (PLC; A. MacLeod, S. McLellan, C. M. R. Turner and A. Tait, 
personal communication). The second, ChrII-6, was again identified by searching the 
T. brucei databases and consisted of a CT-dinucleotide repeat (A. MacLeod, A. Tweedie 
and A. Tait, personal communication). These loci are separated by approximately 420 kb 
of sequence (see The Wellcome Trust Sanger Institute T. brucei genome sequencing 
database). Where possible, the PCR products generated from these loci were cloned and 
sequenced from wild-type cells in order to determine the composition of the microsatellite 
alleles in the 3174 trypanosome strain (see section 2.16).
The microsatellite locus ChrI-7 was amplified using the primers ChrI-7A and ChrI-7B (see 
section 2.16), and the resulting PCR products analysed using the GeneScan system. The 
results of this analysis are shown in Table 4.3, and the data summarised in Table 4.4. A 
graph of the data shown in Table 4.4 is depicted in Figure 4.16. At the ChrI-7 locus the 
two alleles differ considerably in size (Figure 4.13 and 4.14). In clones which appear not 
to have mutated at this locus, termed stable clones, GeneScan analysis gave sizes of 
between 102.2 and 102.6 bp for the smaller allele, and 218.2 to 218.9 bp for the larger 
allele. In all MSH2 wild-type clones, both sets of MSH2'^'' clones and the MSH2' '^ '^  ^clones 
both alleles appear to be stable. However, comparison of the sizes of the PCR products 
amplified from this locus in the MSH2''~ clones reveals a number of clones which appear to
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have mutated at one or both alleles (Figure 4.17). Out of the 19 clones analysed, 11 appear 
to contain mutated versions of the larger allele, while only one clone has a mutated smaller 
allele. This probably reflects the increased likelihood of replication slippage across longer 
tracts of repeats (Wierdl et a l , 1997). Most of the mutation events appear to be losses of a 
single repeat unit (-2 bp), including the only mutation in the smaller allele, although 
several larger deletions can be seen within the larger allele, probably of 2, 3 or 6 repeat 
units (-4, -6 and -12 bp). Only 3 of the events increase the length of the repeat tracts; two 
of these cases appear to have inserted a single repeat (+2 bp), and the other probably 
inserted 2 repeats (+4 bp). Without sequencing the mutated alleles, it is impossible to say 
whether these events truly represent changes in the number of repeats or whether other 
mutational events have led to these increases or decreases in microsatellite length. 
However, given that the mechanism of microsatellite instability, and its basis in replication 
slippage over repeat units, has been well characterised it seems highly probable that the 
mutations documented above arose in this way. These data provide further evidence that 
loss of MSH2 in T. brucei leads to the phenotype of microsatellite instability.
The second microsatellite locus analysed on Chromosome I was ChrI-15. This was 
amplified by PCR using the primers ChrI-15A and ChrI-15B, and analysed using the 
GeneScan system. The data generated in this analysis is shown in Table 4.5, and 
summarised in Table 4.6. A graph showing the summary of this data is shown in Figure 
4.18. Genescan analysis of this locus revealed that the two alleles present in 3174 
wild-type trypanosomes differed in size by only 8 bp (Figure 4.13), and in stable clones 
(defined as above) the size of the smaller allele ranged between 166.8 and 167.3 bp, while 
the size range of the larger allele was 174.9 to 175.4 bp. For all clones analysed from the 
MSH2 wild-type, MSH2^'' and MSH2'''''^ backgrounds, both alleles appear to be stable as 
no changes in length could be discerned. Once again, however, a number of MSH2''' 
clones appeared to contain mutated alleles (Figure 4.19). Out of 20 MSH2'^' clones 
analysed, 50% were mutated at one or both alleles. In this sample set, the smaller allele 
was mutated in 7 clones, while the larger allele was mutated in 4 cases. For both alleles, 
the most common change was either addition or deletion of 2 bp, equivalent to one repeat 
unit. These events appeared to occur with equal frequency in the smaller allele, as three 
2 bp additions and three 2 bp deletions were observed. Mutation of the larger allele 
appeared to favour a decrease in length, as three 2 bp deletions were apparent while only 
one 2 bp addition was observed. For both alleles, only one mutation event leading to a 
change in length greater than 2 bp was seen. In this case the smaller allele decreased in 
length by 4 bp, probably due to a loss of 2 repeat units. Again these data indicate that loss 
o f MSH2 in T. brucei leads to the phenotype of MSI.
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The first microsatellite locus analysed on Chromosome II was PLC, using amplification 
with the primers PLCG and PLCH3. Table 4.7 gives the results of this analysis, while 
Table 4.8 shows a summary of the data analysed. A graphical representation of these 
results is shown in Figure 4.20. GeneScan analysis shows that for all MSH2 wild-type, 
MSH2^^\ and clones the PCR products generated were 158 bp in length (a size
range of 157.8 to 158.2 bp after electrophoretic separation), indicating that the length of 
this microsatellite was stable in these backgrounds. Once again, alleles of a different 
length were observed in the MSH2 homozygous mutant clones (Figure 4.21). Since only 
one PCR product size was observed, PCR using the PLCG and PLCH3 primers appeared 
to have amplified only one allele, possibly due to variation in the primer sequences 
between the two alleles. During the initial work characterising this microsatellite locus 
numerous primers were tested before a primer pair which would amplify PLC alleles from 
several trypanosome stocks was identified (A. MacLeod, personal communication). The 
alternative explanation, that both alleles mutated to an identical size is highly unlikely.
This analysis revealed that out of 20 clones 3 contained mutated versions of the PLC allele, 
which was higher than the mutation frequency observed for the smaller allele of the ChrI-7 
micro satellite locus, even though the number of dinucleotide repeats in PLC is fewer than 
in the ChrI-7 smaller allele. This perhaps suggests that the mutation rate of 
TA-dinucleotide repeats is higher than for CA-repeats in this organism, although extensive 
analyses at a number of microsatellite loci would be required to confirm this. All of the 
mutation events in PLC resulted in deletions of sequence, 2 led to 2 bp deletions and the 
other to a 1 bp deletion. Sequencing of the wild-type PLC allele revealed that it contained 
a T9-mononucleotide run and an An-mononucleotide run in addition to the 
TA-dinucleotide repeat units. Therefore, the 1 bp deletion probably arose by a mutation 
within one of the mononucleotide runs as these are more likely to undergo to replication 
slippage and mutation than the intervening, non-repetitive sequence in the PLC allele.
Once again, these results indicated that inactivation of MSH2 in trypanosomes results in 
MSI and a mutator phenotype.
The final microsatellite locus studied was ChrII-6. It was amplified using the primers 
ChrII-6A and ChrII-6B, and the results of this analysis are documented in Table 4.9, and 
summarised in Table 4.10. Genescan analysis of the PCR products amplified from this 
locus gave sizes of between 96.2 and 96.7 bp. Every clone analysed from the MSH2 
wild-type, MSH2^‘\  MSH2''~ and MSH2'''^^ backgrounds fell within this size range, 
indicating that all clones were stable at this locus. This was surprising as this locus was 
chosen as it contained 32 perfect CT-dinucleotide repeats in the TREU 927/4 strain (Figure 
4.15). However, sequencing of the ChrII-6 locus in 3174 trypanosomes revealed that the
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microsatellite had degenerated in this strain and contained only 12 imperfect repeats. It is 
predicted that this microsatellite is unlikely to mutate owing to its small size and imperfect 
sequence. This locus therefore provided a control for the other microsatellite analyses 
performed above. Since no mutated alleles were observed it is impossible to say whether 
the ChrII-6A and ChrII-6B primers only amplified one allele from this locus as occurred 
for PLC, or if the ChrII-6 locus is homozygous in 3174 trypanosomes.
The mutational spectrum of all the microsatellite loci studied by GeneScan analysis using 
clones derived from MSH2 wild-type cells, MSH2 heterozygous mutants, MSH2 
homozygous mutants and MSH2 re-expressor cells is shown in Table 4.11. For each locus 
the number of alleles which increased or decreased in length by a given number of 
base-pairs was assessed and the total number of mutations of each type was calculated for 
all the loci. The most common events involved the loss or gain of 2 bp, equating to a 
single repeat unit in the dinucleotide micro satellites. These events accounted for 77% of 
the observed mutations, and approximately two thirds of these resulted in a decrease in 
microsatellite length. Larger insertions or deletions were less common, accounting for 
only 23% of mutations, and again deletions were more frequently observed than increases 
in length. Indeed, only one increase greater than 2 bp was seen, and this probably reflected 
an increase of only two repeat units. The larger deletions were found only in the larger 
allele of ChrI-7, which probably contained the greatest number of repeat units of any of the 
microsatellites studied. The sequence of this allele is unknown as it could not be cloned 
and sequenced, probably owing to the inability of our E. coli strain to maintain long 
microsatellite clones. Overall, this study revealed that 69% of the observed mutations 
resulted in a decrease in microsatellite length, indicating that loss of repeat units was more 
common than gain. The observation that inactivation of MSH2 in T. brucei results in a 
mutator phenotype and therefore MSI suggests that the protein is required for the repair of 
slipped replication intermediates, as is the case in both yeast and mammalian cells. This 
confirms that T. brucei MSH2 is required for nuclear MMR.
4.2.8 Antigenic variation in MSH2 knockout trypanosomes
In order to determine the effect of the MSH2'^~ mutation on antigenic variation in T. brucei, 
it was necessary to generate the mutant cell lines in the transgenic 3174 background 
(McCulloch et a l , 1997; McCulloch and Barry, 1999). The active expression site within 
this trypanosome strain has been modified to allow its use in experiments to determine the 
frequency of VSG switching, and to assess the relative contribution of the in situ 
transcriptional switching and gene conversion switching mechanisms. The exact
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conditions used during this assay are described in section 2,15, but a general description is 
given below. The modified expression site in the 3174 cell line contains antibiotic 
resistance markers for hygromycin and G418 (Figure 4,22). Growth of cells on both 
hygromycin and G418 allows the selection of cells expressing only the modified 
expression site and therefore the VSG coat encoded by the VSG221 gene. These cells were 
used to immunise mice against this VSG coat. Later, a measured number of trypanosomes 
which had been allowed to grow for a fixed number of generations without antibiotic 
selection, and which were therefore able to undergo VSG switching, were injected into 
these immunised mice. 24 h after injection, surviving trypanosomes, those which had 
switched their VSG coat and so were not killed by immune lysis, were recovered from the 
mice and plated over 96-well plates in HMI-9. After 10 days the number of wells which 
showed growth were counted, and the frequency of VSG switching was estimated. 
Furthermore, the drug sensitivities of the cells from the wells showing growth was 
assessed, and genomic DNA was isolated from the switched trypanosomes to allow PCR 
amplification of marker genes from the modified expression site. Using this system, three 
types of VSG switching event can be distinguished which result in the expression of a 
novel VSG gene. Cells which are sensitive to both hygromycin (Hy^) and G418 (G418^) 
may have undergone either an in situ transcriptional switch or a long-range expression site 
gene conversion. PCR amplification using primers directed against the hygromycin 
phosphotransferase (Hyg), neomycin phosphotransferase (Neo) and VSG221 (221) ORFs 
differentiates between these possibilities. During an in situ switch, the active expression 
site is transcriptionally silenced, while another expression site is activated, leaving all 
markers intact and allowing amplification of the Hyg, Neo and 221 PCR products (Hyg+, 
Neo+, 221+), Note that in principal these events could also be reciprocal exchanges 
upstream of the hygromycin marker, but in practise transcriptional switching is most 
common in these MITat 1.2a S427-derived cells (Rudenko et a l , 1996; McCulloch et a l, 
1997; McCulloch and Barry, 1999). In an expression site gene conversion, however, all 
the markers are replaced by sequence from another expression site so they cannot be 
amplified by PCR (Hyg-, Neo-, 221-). Cells which have undergone the third type of 
switching event, VSG gene conversion, are resistant to hygromycin (H y^), but are G418^. 
VSG gene conversion involves the replacement of the sequence from the 70-bp repeats to 
the 3’ end of VSG221 with sequence from another expression site, removing the Neo and 
221 markers but leaving the Hyg marker intact (Hyg+, Neo-, 221-).
The approach described above was used to isolate switched variants arising after immune 
selection for MSH2 wild-type cells, MSH2^^' mutants, MSH2'^' mutants and MSH2~''^  ^
trypanosomes. For each cell line a number of repetitions were performed from entirely
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independently grown populations, allowing an average VSG switching frequency to be 
calculated. The data retrieved during these experiments are shown in Table 4.12, and are 
represented graphically in Figure 4.23. For each cell line, the estimated VSG switching 
frequency varied greatly between repetitions. This is probably due to a founder effect. 
During growth of the trypanosome population in the absence of antibiotic prior to injection 
into an immunised mouse, switched variants can arise at any cell division. Thus, if a 
switching event occurred early in the growth of the population, a greater number of cells 
expressing that novel VSG will be present than if the event had occurred at a later division. 
On average, MSH2 wild-type cells switched their VSG coat at a frequency of 0.55 x 10'  ^
switches/cell/generation. Similai' average switching frequencies were observed for each 
cell line tested, including three independent MSH2 heterozygous mutants, three 
independent MSH2 homozygous mutants and a cell line re-expressing MSH2. These 
results indicate that inactivation of MSH2 has no substantial effect on the frequency of 
VSG switching in 3174 trypanosomes.
Where possible, ten switched variants were analysed from each repetition for MSH2 
wild-type cells, the three MSH2'^^' cell lines, the three MSH2'^~ mutants and the MSH2 
re-expressor cell line to determine the switching mechanisms used by each cell line. The 
results are shown in Table 4.13, and as a graph in Figure 4.24. Inactivation of MSH2 
appeared to make no substantial alteration to the relative use of the different switching 
mechanisms, although this is complicated by variation in their frequency from experiment 
to experiments, again because of founder effects. For most cell lines, except MSH2'^‘' 3.1, 
expression site gene conversion was the most commonly used switching mechanism, being 
used in 36% to 86% of the switched variants analysed. Switched variants that had arisen 
by in situ switching were also observed in every cell line, and this was the most common 
event seen in the MSH2'^^' 3.1 cell line. In situ transcriptional switching accounted for 
between 5% and 50% of the switched variants observed. Finally, VSG gene conversion 
was the least frequently observed switching mechanism, and was not used to generate any 
switched variants in the MSH2~ '^' 2.1, MSH2'^' 2.1 or MSH2'^~ 3.1 cell lines. However, it 
accounted for between 3% and 37% of the switched variants in the remaining cell lines, 
and could be detected in MSH2 wild-type cells, and MSH2 heterozygous and homozygous 
mutants. Taken together, these results indicate that loss of MSH2 has little or no effect on 
the frequency of antigenic variation in trypanosomes, or upon the types of VSG switching 
mechanisms used.
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Figure 4.1 A strategy for the generation of T. brucei MSH2 knockout mutants
The MSH2 locus is indicated as a red box, and the constructs used to disrupt its expression 
are shown below. MSH2 5 ’ and MSH2 3 ’ are sequences flanking the MSH2 ORF (ATG to 
TGA) which allow for integration of the knockout constructs, as indicated by crosses. Two 
constructs were used, one containing the 400 bp blasticidin S deaminase {BSD) gene and 
the other the 600 bp puromycin acetyltransferase gene {PUR); both are flanked by 
sequences derived from the tubulin locus (Pa and aP; grey boxes) that allow transcripts of 
the resistance markers to be trans-spliced and polyadenylated into mature mRNAs. In each 
construct, the 2860 bp MSH2 ORF is precisely replaced by the resistance cassettes. Arrows 
represent the direction of transcription of the genes, numbers in brackets denote lengths in 
base-pairs, and half-arrows indicate the approximate positions of primers used in the 
analysis. Sad  restriction sites are shown as vertical bars.
Sac Sad
MSH2
ATG MSH2X3i M S H 2 m TGA
X
MSH2 5 ' ( \ ) \  y M S H 2 y { B ] (A 2860) XMSH2 3 '(A )v  /  MSH2 3 (B)
MSH2 5 
(430)
5acl
MSH2 3 
(370)
Pa (270) BSD (400) / PUR (600) aP(350)
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Figure 4.2 PCR amplification of MSH2 knockout construct flanks
The MSH2 integration flanks were amplified from MITat 1.2 genomic DNA using the 
primers MSH2 5’(A) and MSH2 5’(B) (5’ flank), and MSH2 3’(A) and MSH2 3’(B)
(3’ flank). For each primer pair control reactions were performed with both primers in the 
absence of T. brucei DNA template ( 1 ) ,  the (A) primer only ( 2 )  and the (B) primer only 
( 3 ) .  Lane 4  shows the reaction containing both primers and template for each primer pair.
5 ’ flank 3 ’ flank
1  2  3  4  1  2  3  4
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Figure 4.3 MSH2 re-expression construct
The MSH2 locus, following inactivation by replacing the MSH2 ORF with either BSD or 
PUR resistance cassettes, is shown and (below) the construct AMSH2::MSH2-BLE for 
re-expression of MSH2 in the mutants is depicted. The construct integrates an intact MSH2 
ORF into the altered loci: MSH2 5 ' and ap  are the sequences that allow integration of the 
construct to replace either the MSH2::PUR or MSH2::BSD alleles (indicated by crosses). 
Correct integration of the re-expression construct will result in expression of MSH2 from 
its original genomic location and resistance to phleomycin. The MSH2 ORF is flanked by 
its original processing sequences (MSH2 5 ’ and MSH2 3 ’) while the bleomycin 
phosphotransferase ORF {BLE) is flanked at the 5’ end by sequence derived from the actin 
locus (actin IR) and at the 3’ end by sequence from the tubulin locus (aP) that allow the 
transcripts to be processed into mature mRNAs. ATG and TGA indicate the approximate 
positions of the start and stop codons of MSH2 respectively. Arrows represent the 
direction of transcription of the genes and numbers in brackets represent lengths in 
base-pairs. Sad  restriction sites are shown as vertical bars.
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MSH2::PUR/
MSH2::BSD
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MSH2 5 ' MSH2 MSH2 3 '  actin ALE (400) a p
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Figure 4.4 Southern analysis of the putative 3174 MSH2 mutant cell lines
Genomic DNA isolated from the putative 3174 MSH2 mutant cell lines was digested with 
S ad, separated on a 0.6% agarose gel. Southern blotted and probed with the MSH2 5’ 
flank used as the 5’ integration flank in the MSH2 knockout construct. The following 
samples were analysed: (WT) untransformed 3174 cells; (+/-) 3174 cells transformed with 
AMSH2::PUR; (-/-) 3174 cells transformed with AMSH2::PUR and AMSH2::BSD; (-/-/+) 
3174 cells transformed with AMSH2::PUR, AMSH2::BSD and AMSH2::MSH2-BLE.
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Figure 4.5 PCR analysis of the putative 3174 MSH2 mutant cell lines
PCR was performed using genomic DNA isolated from the 3174 cell lines transformed 
with the MSH2 knockout constructs. Internal primers complementary to the T. brucei 
MSH2 gene were used (MSH2) and the integrity of the DNA was confirmed using primers 
directed against the large subunit of T. brucei RNA polymerase 1 {RNA Pol 1; Rudenko et 
a i,  1996). For both sets of primers the following reactions were run: (NT) no template 
DNA; (WT) untransformed 3174 cells; (+/-) 3174 cells transformed with AMSH2::PUR; 
(-/-) 3174 cells transformed with both AMSH2::PUR and AMSH2::BSD\ (-/-/+) 3174 cells 
transformed with AMSH2::PUR, AMSH2::BSD and AMSH2::MSH2-BLE.
MSH2
RNA Pol I
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c e l l  l i n e s
RT-PCR was performed using total RNA isolated from the 3174 cell lines transformed 
with the MSH2 knockout constructs. Internal primers complementary to the T. brucei 
MSH2 gene were used (MSH2) and the integrity of the DNA was confirmed using primers 
directed against the large subunit of T. brucei RNA polymerase I {RNA Pol 7; Rudenko et 
a l,  1996). For both sets of primers RT positive (RT+), RT negative (RT-), and no 
template (NT) reactions were performed using total RNA isolated from the following cell 
lines: (WT) untransformed 3174 cells; (+/-) 3174 cells transformed with AMSH2::PUR\ 
(-/-) 3174 cells transformed with both AMSH2::PUR and AMSH2::BSD; (-/-/+) 3174 cells 
transformed with AMSH2::PUR, AMSH2::BSD and AMSH2::MSH2-BLE.
MSH2
WT +/-1.1 +/-2.I +/-3.I -/-I.I -/-2.I -/-3.1 -/-/+l.I
I T I T l  T l  T I T l  * r i  T »QCZûi û i Zûi Qi î Za î Qi ZQi Qi ZoCûi ZQe i Qi Za î c i i Z
kb
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—  1.6 
—  1.0
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RNA Pol I
WT +/-1.1 +/-2.1 +/-3.1 -/- 1.1 -/. 2.1 -/-3.1 -/-/+1.1
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Figure 4.7 Growth of MSH2 knockout trypanosomes
Bloodstream trypanosomes that had been unaltered at the MSH2 locus (WT); that had one 
MSH2 allele disrupted (+/-); that had both MSH2 alleles disrupted (-/-); or that had both 
alleles disrupted but the MSH2 gene restored to the genome (-/-/+) were grown in HMI-9. 
The concentration of trypanosomes in the medium was counted at given times.
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Table 4.1 Survival of MSH2 knockout trypanosomes in the presence of MNNG
Bloodstream trypanosomes that had been unaltered at the MSH2 locus (WT); that had one 
MSH2 allele disrupted (+/-); that had both MSH2 alleles disrupted (-/-); or that had both 
alleles disrupted but the MSH2 gene restored to the genome (-/-/+) were plated in HMl-9 
containing increasing concentrations of MNNG (as shown) at a density of 2 cells per well 
in 96-well plates. For each cell line, at each concentration, 3 plates were prepared, and the 
number of wells containing growth were counted after 14 days. Percentage survival is 
presented relative to the number of wells growing in the absence of MNNG, which is given 
as 100%.
No. of wells growing
Cell
Line
MNNG
Cone.
(pg.ml^)
Plate 1 Plate 2 Plate 3 Average Percentage
Survival
WT 0 72/96 70/96 75/96 72/96 100
0.25 49/96 53/96 57/96 53/96 73
0.50 13/96 12/96 7/96 11/96 15
0.75 0/96 1/96 3/96 1/96 2
1.00 0/96 0/96 0/96 0/96 0
+/- 1.1 0 89/96 91/96 86/96 89/96 100
0.25 86/96 78/96 86/96 83/96 94
0.50 58/96 58/96 51/96 56/96 63
0.75 11/96 17/96 22/96 17/96 19
1.00 0/96 1/96 0/96 0/96 0
+/“ 2.1 0 84/96 73/96 76/96 78/96 100
0.25 65/96 74/96 66/96 68/96 88
0.50 47/96 52/96 56/96 52/96 67
0.75 7/96 10/96 10/96 9/96 12
1.00 3/96 1/96 3/96 2/96 3
-/- 1.1 0 76/96 72/96 76/96 75/96 100
0.25 72/96 76/96 69/96 72/96 97
0.50 74/96 71/96 72/96 72/96 97
0.75 62/96 67/96 74/96 68/96 91
1.00 38/96 38/96 37/96 38/96 52
-/-2.1 0 73/96 81/96 81/96 78/96 100
0.25 78/96 80/96 69/96 76/96 97
0.50 81/96 68/96 80/96 76/96 97
0.75 71/96 65/96 68/96 68/96 87
1.00 30/96 37/96 30/96 32/96 43
-/-/+ 1.1 0 76/96 72/96 78/96 75/96 100
0.25 73/96 77/96 73/96 74/96 99
0.50 72/96 63/96 54/96 63/96 84
0.75 13/96 17/96 14/96 15/96 19
1.00 8/96 8/96 7/96 8/96 10
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Figure 4.8 Survival of MSH2 knockout trypanosomes in the presence of MNNG
The survival of bloodstream trypanosomes in increasing concentrations of MNNG (shown 
in pg.m f') that had been unaltered at the MSH2 locus (WT); that had one MSH2 allele 
disrupted (+/-); that had both MSH2 alleles disrupted (-/-); or that had both alleles 
disrupted but the MSH2 gene restored to the genome (-/-/+) was determined as described in 
Table 4.1.
□  0.25
+ / - 1.1 + / - 2.1 1.1 - / - 2.1 - / - / +  1.1
Cel l  L ine
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Figure 4.9 Model of microsatellite mutation by replication slippage
In this scheme arrows denote repeat units and numbers indicate the repeat unit number 
within each DNA strand. During replication the two strands dissociate, and can be 
misaligned upon reassociation, resulting in an out-of-register alignment of the two strands. 
(A) If the most 3’ repeat unit of the nascent strand rehybridises with a downstream repeat 
unit on the template strand, a loop is formed in the new strand. After elongation the new 
sequence will be correspondingly longer than the template. (B) Alternatively, if the most 
3’ repeat unit of the new strand reassociates with an upstream repeat unit on the template 
strand, after synthesis the new strand will be shorter than the template. (Adapted from 
Ellegren, 2000b)
A) Increase in microsateUite length B) Decrease in microsatellite length
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Figure 4.10 Sequence of microsatellite locus JS-2
The sequence of the 177 bp allele of the JS-2 microsatellite locus amplified from TREU 
927/4 genomic DNA using the primers JS-2A (shown in blue) and JS-2B (complementary 
sequence shown in green) is given (Sasse, 1998). This microsatellite locus contains 
GT-dinucleotide repeats (shown in red as CA), and this allele contains 47 perfect repeat 
units.
5 ' -GATTGGCGCAACAACTTTCACATACGCACACACACACACACACACACAC 
ACACACACACACACACACACACACACACACACACACACACACACACACACAC 
ACACACACACACACACACAAGCACTCACTAACACAAAACTACAACAATAGTA 
AAACAATGGCCAAGGAAGAAAGGG-3'
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Figure 4.11 PCR amplification of microsatellite JS-2 in 3174 MSH2 mutant cell 
lines
PCR amplification of the JS-2 locus, using the primers JS-2A and JS-2B (see section 2.16), 
was performed using genomic DNA isolated from 10 clones of each 3174 cell line 
(labelled A-J in each case): MSH2 wild-type cells (Wild-Type); MSH2 heterozygous 
mutants (+/-); MSH2 homozygous mutants (-/-); and MSH2 re-expressor cells (-/-/+). 
Control reactions with both primers but lacking template DNA were performed for each set 
of clones (NT). The PCR products were separated by electrophoresis on 3% agarose gels. 
In each case, the PCR products derived from five of the MSH2 wild-type clones were run 
along side the products amplified from the MSH2 mutant clones for ease of comparison.
Wild-Type
— 400
— 300
MSH2 Mutants
Wild-Type
+ / -  1.1
+ / - 2.1
- / - 2.1
—  200
bp
400
300
200
400
300
200
400
300
200
400
300
1— 2 0 0
— 400
— 300
— 200
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Table 4.2 Synopsis of results for microsatellite JS-2 in 3174 MSH2 knockout 
trypanosomes
The JS-2 microsatellite locus was analysed as shown in Figure 4.11. Ten clones each, 
derived from the 3174 MSH2 wild-type cell line (WT); two heterozygous MSH2 cell lines 
(+/-); two MSH2 homozygous mutants (-/-); and the MSH2 re-expressor cell line (-/-/+) 
were analysed. The amplified JS-2 alleles were compared between the 10 clones derived 
from the same MSH2 mutant cell line, and with alleles amplified from 5 MSH2 wild-type 
clones. Alleles which appeared identical between the majority of clones derived from the 
same cell line and with the products amplified from the MSH2 wild-type clones were 
considered stable. If all the alleles amplified firom all the clones derived from the same cell 
line appeared identical then they were also considered stable. Alleles which appeared 
different from the majority of alleles derived from the same cell line were considered 
mutant versions of the micro satellite. For each cell line, the number and percentage of 
clones in which the JS-2 locus was shown to be stable or mutated is given.
Cell line No. of clones 
analysed
Stable
clones
Percentage Mutated
clones
Percentage
WT 10 10 100 0 0
+/- 1.1 10 10 100 0 0
+/- 2.1 9 9 100 0 0
-/- 1.1 10 7 70 3 30
-/- 2.1 9 8 89 1 11
-/-/+ 1.1 10 10 100 0 0
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Figure 4.12 Analysis of microsateUite JS-2 in MSH2 knockout trypanosomes
The percentage number of clones which were stable (shown in blue) and mutated (shown 
in red) at the JS-2 microsatellite locus was determined as described in Table 4.2. (WT)
3174 MSH2 wild-type trypanosomes; (+/-) 3174 MSH2 heterozygous mutants; (-/-) 3174 
MSH2 homozygous mutants; (-/-/+) 3174 MSH2 re-expressor cells.
u
W T
+/-1.1
+/-2.1
- / -11
-/. 2 1
-/-/+ 1.1
I Stable 
I Mutated
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Percentage of Clones Analysed
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F i g u r e  4 . 1 3  G e n e s c a n  a n a l y s i s  o f  f l u o r e s c e n t l y - I a b e l l e d  P C R  p r o d u c t s  d e r i v e d  f r o m  
f o u r  i n d e p e n d e n t  m i c r o s a t e l l i t e  l o c i  f r o m  3 1 7 4  t r a n s g e n i c  
t r y p a n o s o m e s
PCR amplifications were performed with a 6-FAM-labelled primer, and the PCR products 
for each microsatellite locus were run in an acrylamide-urea gel (see section 2.16). Bands 
produced fluorescent peaks (alleles; shown in blue), and their molecular sizes were 
automatically determined by comparison to the TAMRA-labelled GeneScan-500 internal 
size standards loaded in each well (shown in red; the numbers refer to the sizes in 
base-pairs). Where a cluster of peaks are identified for each allele the size is determined 
by considering the fluorescent peak with the maximum height, as the other peaks arose as a 
consequence of modifications introduced by amplification with Tag polymerase (Oda et 
a i, 1997; Paulson et a l, 1999). The products shown in each panel below were amplified 
from genomic DNA isolated from 3174 trypanosomes. Panel A shows the two alleles 
amplified from the ChrI-7 microsatellite locus using the ChrI-7A and ChrI-7B primers. 
Panel B shows the two alleles amplified from the ChrI-15 microsatellite locus using the 
primers ChrI-15A and ChrI-15B. Panel C shows the single allele amplified from the PLC 
microsatellite locus using the primers PLCG and PLCH3. Panel D shows the allele(s) 
generated from the ChrII-6 locus using the ChrII-6A and ChrII-6B primers.
A )  C h r I - 7
----102 bp
^75 bp 1
A I
139^
A
150 bp1 ^160 bp
1 L .
200 bp \ A
218^ p
.A
250 bp \ 1
B )  C h r I - 1 5
167 bp160 bp 200 bp150 bp
175 bp
C )  P L C
150 bp 158 bp 160 bp139 bp
D )  C h r I I - 6
96 bp
75 bp 100 bp 139 bp
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Figure 4.14 Microsatellite loci on Chromosome I
Panel A depicts a scheme indicating the approximate positions of the ChrI-7 and ChrI-15 
microsatellite loci on Chromosome I in TREU 927/4 (The Wellcome Trust Sanger Institute 
T. brucei genome sequencing database; http://www.sanger.ac.uk/Projects/ T brucei/).
Panel B shows the sequences of the smaller (102 bp) and larger (218 bp) alleles of the 
ChrI-7 microsatellite locus amplified from transformant 3174 genomic DNA, using the 
primers ChrI-7A (shown in blue) and ChrI-7B (complementary sequence shown in green). 
This microsatellite locus contains GT-dinucleotide repeats (shown in red), and the smaller 
allele contains 18 perfect repeat units, while the larger allele contains 70 imperfect repeat 
units. Panel C shows the sequence of the smaller allele of the ChrI-15 microsatellite locus 
amplified from 3174 genomic DNA, using the primers ChrI-15A (shown in dark blue) and 
ChrI-15B (complementary sequence shown in purple). This locus also contains 
GT-dinucleotide repeats (shown in red) and the smaller allele contains 30 perfect repeat 
units. The larger ChrI-15 allele was not represented among the clones sequenced.
A)
Okb 415 kb 705 kb 941 kb
I #  #  If t
ChrI-7 ChrI-15
B)
Smaller allele -  102 bp
CCTGTTGGCCGCATTATTCGATGCGTGTGCATATGTGCATGTGTGTGTGTGTGTGTGTGTG
TGTGTGTGTGTGTGGTCTTCCGTCTCCCCTCACTTCCTCA
Larger allele -  218 bp
CCTGTTGGCCGCATTATTCGATGCGTGTGCATATGTGCATGTGTGCATGTGTGTGTGTGTG
TGTGTGTGTGCATGTGTGTGTGTGTGTGTGCATGTGTGTGCATGTGTGTGTGTGTGTGTGT
GTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG
TGTGGTCTTCCGTCTCCCCTCACTTCCTCA
C)
Smaller allele -  167 bp
TGGCTAGTTACACTGTAGTTCTCCGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG
TGTGTGTGTGTGTGTGTGTGTGTCAAAATTTAAACGGGGGCTGATAAGGCGGTTGAAAGAA
TCACTTTCGCAGAAAAATGTGTGAATATCAAGGAGTGGTTGTGG
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Figure 4.15 MicrosateUite loci on Chromosome II
Panel A depicts a scheme indicating the approximate positions of the ChrII-6 and PLC 
microsatellite loci on Chromosome II in TREU 927/4 (A. MacLeod, A. Tweedie and 
A. Tait, personal communication). Panel B shows the sequences of the PLC allele 
amplified from transformant 3174 genomic DNA, using the primers PLCG (shown in blue) 
and PLCH3 (complementary sequence shown in purple). This microsatellite locus 
contains 12 perfect TA-dinucleotide repeat units (shown in red), as well as a 
T-mononucleotide run (shown in turquoise) and an A-mononucleotide run (shown in pale 
green). Panel C shows the sequence of the ChrII-6 allele amplified from TREU 927/4 
genomic DNA and transformant 3174 genomic DNA, using the primers ChrII-6A (shown 
in dark blue) and ChrII-6B (complementary sequence shown in dark green). This locus 
contains CT-dinucleotide repeats (shown in pink) and the TREU 927/4 allele contains 32 
perfect repeat units, as well as a T-mononucleotide run (shown in turquoise). In contrast, 
however, the 3174 allele only contains 12 imperfect repeat units, interrupted by 3 separate 
insertions.
A)
Okb 427 kb -8 5 0 kb 1100kb
I •  ©  It t
ChrII-6 PLC
B)
3174 allele -  158 bp
CAACGACGTTGGAAGAGTGTGAACTATATATATATATATATATATATATGTATTCCTCCTG 
TTTTTTTTT GATTTGTTTGTTGCTTAAAAAAGAAAGAAGAAGAGGAGGAGGGGGAGAGA A A
AAAAAAAAGAAAGCGATCAAATGAAAGGTCAGTGG
C)
TREU 927/4 allele -  144 bp
GTTGTGTGAGCAACGCAGGGCGGAACAAATTCACATTTTTCTCCTCTCTCTCTCTCTCTCT
CTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTTTTTTTTTTTTTTCCCC
CTCTCCTTCACCTGTTGTTATA
3174 allele -  96 bp
GTTGTGTGAGCAACGCAAGGGCGGAACAAATTCACATTTTTCTCCTCCTCTCTCTATCTCT
CTCTTTTTTTCCCCCTCTCCTTCACCTGTTGTTATA
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Table 4.3 Genescan analysis of microsateUite ChrI-7 in 3174 MSH2 mutant cell 
lines
PCR amplification of the ChrI-7 locus was performed using the primers ChrI-7A (labelled 
with 6-F AM) and ChrI-7B (see section 2.16) on genomic DNA isolated from 10 clones of 
each 3174 cell line (designated A-J in each case): (WT) MSH2 wild-type trypanosomes; 
(+/-) MSH2 heterozygous mutants; (-/-) MSH2 homozygous mutants; (-/-/+) MSH2 
re-expressor cells. The PCR products were separated by acrylamide-urea gel 
electrophoresis and the fluorescent bands detected by an automated sequencer. The sizes 
(shown in bp) of the PCR products were determined using the GeneScan software as 
described in Figure 4.13. The size of stable alleles, taking migration error into account to 
give a size range, was determined by comparing the size of alleles in every clone analysed, 
and assessing which sizes occurred most frequently. The most frequently observed size 
was considered the stable, or wild-type, allele length. Where a PCR product differed from 
this size by 1 bp or more it was considered to have mutated, and the change in length from 
the stable allele length was determined.
Cell Clone Size of Stable/ Size of Stable/
Line Smaller Mutated Larger Mutated
Allele (change in bp) Allele (change in bp)
WT A 120.5 Stable 218.8 Stable
B 102.5 Stable 218.8 Stable
C 102.4 Stable 218.8 Stable
D 102.6 Stable 218.7 Stable
E 102.4 Stable 218.7 Stable
F 102.4 Stable 218.7 Stable
G 102.3 Stable 218.6 Stable
H 102.3 Stable 218.7 Stable
I 102.4 Stable 218.6 Stable
J 102.3 Stable 218.6 Stable
+/- 1.1 A 102.5 Stable 218.8 Stable
B 102.5 Stable 218.8 Stable
C 102.4 Stable 218.7 Stable
D 102.4 Stable 218.7 Stable
E 102.4 Stable 218.8 Stable
F 102.3 Stable 218.6 Stable
G 102.3 Stable 218.7 Stable
H 102,3 Stable 218.6 Stable
I 102.3 Stable 218.7 Stable
J 102.4 Stable 218.6 Stable
+/-2.1 A 102.5 Stable 218.8 Stable
B 102.5 Stable 218.8 Stable
C 102.4 Stable 218.8 Stable
D 102.4 Stable 218.7 Stable
E 102.4 Stable 218.7 Stable
F 102.3 Stable 218.7 Stable
G 102.3 Stable 218.6 Stable
H 102.3 Stable 218.6 Stable
I 102.4 Stable 218.6 Stable
J 102.4 Stable 218.6 Stable
Table 4.3 continued
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C e l l C l o n e S i z e  o f S t a b l e / S i z e  o f S t a b l e /
L i n e S m a l l e r M u t a t e d L a r g e r M u t a t e d
A l l e l e ( c h a n g e  i n  b p ) A l l e l e ( c h a n g e  i n  b p )
-/- 1.1 A 102.5 Stable 218.7 Stable
B 102.5 Stable 2 1 6 . 7 M u t a t e d  ( - 2 )
C 102.6 Stable 2 1 6 . 6 M u t a t e d  ( - 2 )
D 102.4 Stable 2 2 1 . 0 M u t a t e d  ( + 2 )
E ND ND ND ND
F 102.3 Stable 218.6 Stable
G 102.3 Stable 2 1 2 . 3 M u t a t e d  ( - 6 )
H 102.4 Stable 2 1 6 . 6 M u t a t e d  ( - 2 )
I 102.4 Stable 2 0 6 . 0 M u t a t e d  ( - 1 2 )
J 102.3 Stable 218.7 Stable
-/-2.1 A 102.5 Stable 2 1 6 . 6 M u t a t e d  ( - 2 )
B 1 0 0 . 6 M u t a t e d  ( - 2 ) 2 2 0 . 9 M u t a t e d  ( + 2 )
C 102.4 Stable 218.9 Stable
D 102.5 Stable 218.9 Stable
E 102.2 Stable 2 2 3 . 1 M u t a t e d  ( + 4 )
F 102.4 Stable 2 1 4 . 4 M u t a t e d  ( - 4 )
G 102.3 Stable 2 1 6 . 5 M u t a t e d  ( - 2 )
H 102.3 Stable 218.7 Stable
I 102.4 Stable 218.7 Stable
J 102.4 Stable 218.7 Stable
-/-/+ 1.1 A 102.6 Stable 218.8 Stable
B 102.6 Stable 218.8 Stable
C 102.6 Stable 218.2 Stable
D 102.5 Stable 218.4 Stable
E 102.4 Stable 218.8 Stable
F 102.3 Stable 218.6 Stable
G 102.3 Stable 218.6 Stable
H 102.3 Stable 218.6 Stable
I 102.5 Stable 218.4 Stable
J ND ND ND ND
Size range of allele in 102.2- 102.6 218.2-218.9
stable clones (bp)
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Figure 4.16 Analysis of microsatellite ChrI-7 in MSH2 knockout trypanosomes
The percentage number of clones (A) and alleles (B) which were stable (shown and blue) 
and mutated (shown in red) at the ChrI-7 locus was determined as described in Table 4.4. 
(WT) 3174 MSH2 wild-type trypanosomes; (+/-) 3174 MSH2 heterozygous mutants; (-/-) 
3174 MSH2 homozygous mutants; (-/-/+) 3174 MSH2 re-expressor cells.
A)
+/- 1.1
+/- 2 .1
- / - I I
- / -  2.1
- / - / +  1.1
I Stable 
I Mutated
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Percentage of Clones Analysed
B)
+ /-  1.1
+ /-  2 .1
-/- 1.1
- / -  2  .1
- / - / +  1.1
I Stable 
I Mutated
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Percentage of Alleles Analysed
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Figure 4.17 Spectrum of mutations observed at microsatellite ChrI-7 in MSH2 
homozygous mutants
The ChrI-7 microsatellite locus was analysed as described in Table 4.3. The change in 
allele length from the stable allele length, indicated as either no change (shown in purple), 
addition (+; shown in red) or deletion (-; shown in blue), was calculated for each allele
from 9 clones derived from the MSH2''' 1.1 cell line, and 10 clones derived from the 
M SH I''2A  cell line.
CO 2 0
-12 -10 -8 - 6 - 4 - 2  0 +2 +4
Change in allele length (bp)
228
Table 4.5 Genescan analysis of microsatellite ChrI-15 in 3174 MSH2 mutant cell 
lines
PCR amplification of the ChrI-15 locus was performed using the primers ChrI-15A 
(labelled with 6-FAM) and ChrI-15B (see section 2.16) on genomic DNA isolated from 10 
clones of each 3174 cell line (designated A-J in each case): (WT) MSH2 wild-type 
trypanosomes; (+/-) MSH2 heterozygous mutants; (-/-) MSH2 homozygous mutants; (-/-/+) 
MSH2 re-expressor cells. The PCR products were separated by acrylamide-urea gel 
electrophoresis and the fluorescent bands detected by an automated sequencer. The sizes 
(shown in bp) of the PCR products were determined using the Gene Scan software as 
described in Figure 4.13. The size of stable alleles, taking migration error into account to 
give a size range, was determined by comparing the size of alleles in every clone analysed, 
and assessing which sizes occurred most frequently. The most frequently observed size 
was considered the stable, or wild-type, allele length. Where a PCR product differed from 
this size by 1 bp or more it was considered to have mutated, and the change in length from 
the stable allele length was determined.
Cell Clone Size of Stable/ Size of Stable/
Line Smaller
Allele
Mutated Larger
Allele
Mutated
WT A 167.3 Stable 175.4 Stable
B 167.2 Stable 175.3 Stable
C 167.2 Stable 175.3 Stable
D 167.2 Stable 175.3 Stable
E 167.3 Stable 175.4 Stable
F 166.9 Stable 175.0 Stable
G 166.9 Stable 175.1 Stable
H 166.9 Stable 175.1 Stable
I 166.8 Stable 175.0 Stable
J 166.9 Stable 175.1 Stable
+/- 1.1 A 167.2 Stable 175.3 Stable
B 167.2 Stable 175.3 Stable
C 167.2 Stable 175.3 Stable
D 167.2 Stable 175.3 Stable
E 167.3 Stable 175.4 Stable
F 166.8 Stable 175.0 Stable
G 166.9 Stable 175.2 Stable
H 166.9 Stable 175.2 Stable
I 166.8 Stable 175.0 Stable
J 166.8 Stable 175.0 Stable
+/- 2.1 A 167.1 Stable 175.2 Stable
B 167.1 Stable 175.4 Stable
C 167.1 Stable 175.4 Stable
D 167.1 Stable 175.4 Stable
E 167.3 Stable 175.4 Stable
F 166.8 Stable 175.1 Stable
G 166.8 Stable 175.1 Stable
H 166.8 Stable 174.9 Stable
I 166.8 Stable 175.1 Stable
J 166.8 Stable 175.1 Stable
Table 4.5 continued
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Cell
Line
Clone Size of 
Smaller 
Allele
Stable/
Mutated
Size of 
Larger 
Allele
Stable/
Mutated
-/- 1.1 A 167.2 Stable 175.4 Stable
B 167.1 Stable 175.4 Stable
C 167.2 Stable 175.4 Stable
D 165.1 Mutated (-2) 175.2 Stable
E 169.3 Mutated (+2) 175.3 Stable
F 164.8 Mutated (-2) 173.0 Mutated (-2)
G 162.7 Mutated (-4) 175.0 Stable
H 164.9 Mutated (-2) 175.1 Stable
I 166.9 Stable 175.0 Stable
J 166.9 Stable 175.0 Stable
-/- 2.1 A 167.2 Stable 175.3 Stable
B 169.2 Mutated (+2) 175.3 Stable
C 167.1 Stable 173.2 Mutated (-2)
D 169.3 Mutated (+2) 175.3 Stable
E 167.1 Stable 175.3 Stable
F 166.9 Stable 173.0 Mutated (-2)
G 166.9 Stable 175.0 Stable
H 167.1 Stable 175.4 Stable
I 166.9 Stable 177.2 Mutated (+2)
J 167.2 Stable 175.4 Stable
-/-/+ 1.1 A 167.2 Stable 175.3 Stable
B 167.2 Stable 175.3 Stable
C 167.1 Stable 175.3 Stable
D 167.2 Stable 175.3 Stable
E 167.2 Stable 175.4 Stable
F 167.3 Stable 175.4 Stable
G 166.9 Stable 175.1 Stable
H 166.8 Stable 175.0 Stable
I 166.9 Stable 175.1 Stable
J 166.9 Stable 175.1 Stable
Size Range of Allele 
in Stable Clones (bp)
166.8 -  167.3 174.9 -  175.4
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Figure 4.18 Analysis of microsatellite ChrI-15 in MSH2 knockout trypanosomes
The percentage number of clones (A) and alleles (B) which were stable (shown and blue) 
and mutated (shown in red) at the ChrII-15 locus was determined as described in Table 4.6. 
(WT) 3174 MSH2 wild-type trypanosomes; (+/-) 3174 MSH2 heterozygous mutants; (-/-)
3174 MSH2 homozygous mutants; (-/-/+) 3174 MSH2 re-expressor cells.
A)
+ / - 1.1
+ / - 2.1
- / - 1.1
- / - 2.1
- / - / + 1.1
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Percentage of Clones Analysed
I Stable 
I Mutated
B)
W T
+ / - 1.1
«  + / - 2.1
U - / - 1.1
- / - 2.1
- /- /+  1.1
X  /  X y /  y 7^^
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Percentage of Alleles Analysed
I Stable 
I Mutated
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Figure 4.19 Spectrum of mutations observed at microsatellite ChrI-15 in MSH2 
homozygous mutants
The ChrI-15 microsatellite locus was analysed as described in Table 4.5. The change in 
allele length from the stable allele length, indicated as either no change (shown in purple), 
addition (+; shown in red) or deletion (-; shown in blue), was calculated for each allele 
from 10 clones each derived from the MSH2''' 1.1 and 2.1 cell lines.
30
25
8 20 
0)
5  15 o
6z  10 
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0
%
-2 0 +2 
Change in allele length (bp)
+4
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Table 4.7 Genescan analysis of microsatellite PLC in 3174 M SH2 m u tant cell 
lines
PCR amplification of the PLC locus was performed using the primers PLCG (labelled with 
6-FAM) and PLCH3 (see section 2.16) on genomic DNA isolated from 10 clones of each 
3174 cell line (designated A-J in each case): (WT) MSH2 wild-type trypanosomes; (+/-) 
MSH2 heterozygous mutants; (-/-) MSH2 homozygous mutants; (-/-/+) MSH2 re-expressor 
cells. The PCR products were separated by acrylamide-urea gel electrophoresis and the 
fluorescent bands detected by an automated sequencer. The sizes (shown in bp) of the 
PCR products were determined using the GeneScan software as described in Figure 4.13. 
The size of stable alleles, taking migration error into account to give a size range, was 
determined by comparing the size of alleles in every clone analysed, and assessing which 
sizes occurred most frequently. The most frequently observed size was considered the 
stable, or wild-type, allele length. Where a PCR product differed from this size by 1 bp or 
more it was considered to have mutated, and the change in length from the stable allele 
length was determined.
Cell Line Clone Size Stable/Mutated
WT A 158.1 Stable
B 157.9 Stable
C 157.9 Stable
D 157.9 Stable
E 158.1 Stable
F 158.1 Stable
G 158.1 Stable
H 157.9 Stable
I 157.9 Stable
J 157.9 Stable
+/-1.1 A 158.1 Stable
B 158.2 Stable
C 158.2 Stable
D 157.9 Stable
E 157.9 Stable
F 158.1 Stable
G 157.9 Stable
H 157.9 Stable
I 157.9 Stable
J 157.9 Stable
+/-2.1 A 158.1 Stable
B 158.2 Stable
C 157.9 Stable
D 158.1 Stable
E 157.9 Stable
F 158.1 Stable
G 157.9 Stable
H ND ND
I 157.9 Stable
J 157.9 Stable
Table 4.7 continued
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Cell Line Clone Size Stable/Mutated
-/- 1.1 A 157.9 Stable
B 158.1 Stable
C 157.9 Stable
D 156.2 Mutated (-2)
E 157.9 Stable
F 157.9 Stable
G 158.1 Stable
H 158.1 Stable
I 157.9 Stable
J 155.9 Mutated (-2)
-/- 2.1 A 157.9 Stable
B 157.9 Stable
C 158.0 Stable
D 157.8 Stable
E 157.3 Mutated (-1)
F 158.0 Stable
G 157.8 Stable
H 157.9 Stable
I 158.1 Stable
J 157.9 Stable
-/-/+ 1.1 A 158.1 Stable
B 157.8 Stable
C 158.1 Stable
D 158.0 Stable
E 157.9 Stable
F 157.8 Stable
G 157.8 Stable
H 157.9 Stable
I 157.8 Stable
J 157.9 Stable
Size Range of Allele in 
Stable Clones (bp)
157.8- 158.2
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Table 4.8 Synopsis of results for microsatellite PLC in 3174 MSH2 knockout
trypanosomes
The PLC microsatellite locus was analysed as described in Table 4.7. Ten clones (where 
possible) were analysed from each of the following 3174-derived cell lines: MSH2 
wild-type (WT); two heterozygous MSH2 mutants (+/-); two MSH2 homozygous mutants 
(-/-); and the MSH2 re-expressor cell line (-/-/+). For each cell line, the number and 
percentage of clones which were stable or mutated at this locus is given.
Cell line No of clones 
analysed
Stable
clones
Percentage Mutated
clones
Percentage
WT 10 10 100 0 0
+/- 1.1 10 10 100 0 0
+/-2.1 9 9 100 0 0
-/- 1.1 10 8 80 2 20
-/- 2.1 10 9 90 1 10
-/-/+ 1.1 10 10 100 0 0
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Figure 4.20 Analysis of microsatellite PLC in MSH2 knockout trypanosomes
The percentage number of clones which were stable (shown and blue) and mutated (shown 
in red) at the PLC locus was determined as described in Table 4.8. (WT) 3174 MSH2 
wild-type trypanosomes; (+/-) 3174 MSH2 heterozygous mutants; (-/-) 3174 MSH2 
homozygous mutants; (-/-/+) 3174 MSH2 re-expressor cells.
WT
+ /-  1.1
■*■/- 2.1
• / *  1.1
- / -  2 .1
- / - /♦  1.1
I stable 
I Mutated
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Percentage of Clones Analysed
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The PLC microsatellite locus was analysed as described in Table 4.7. The change in allele 
length from the stable allele length, indicated as either no change (shown in purple), 
addition (+; shown in red) or deletion (-; shown in blue), was calculated for each allele 
from 10 clones each derived from the MSH2''' 1.1 and 2.1 cell lines.
o>o
o
6
18 /
16 /
14 X
12 X
10 X
8 X
6 X
4 X
2 X
0
-1 0 +1 
Change in allele length (bp)
+2
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Table 4.9 Genescan analysis of microsatellite ChrII-6 in 3174 MSH2 mutant cell
lines
PCR amplification of the ChrII-6 locus was performed using the primers ChrII-6A 
(labelled with 6-FAM) and ChrII-6B (see section 2.16) on genomic DNA isolated from 10 
clones of each 3174 cell line (designated A-J in each case): (WT) MSH2 wild-type 
trypanosomes; (+/-) MSH2 heterozygous mutants; (-/-) MSH2 homozygous mutants; (-/-/+) 
MSH2 re-expressor cells. The PCR products were separated by acrylamide-urea gel 
electrophoresis and the fluorescent bands detected by an automated sequencer. The sizes 
(shown in bp) of the PCR products were determined using the GeneScan software as 
described in Figure 4.13. The size of stable alleles, taking migration error into account to 
give a size range, was determined by comparing the size of alleles in every clone analysed, 
and assessing which sizes occurred most frequently. The most frequently observed size 
was considered the stable, or wild-type, allele length. Where a PCR product differed from 
this size by 1 bp or more it was considered to have mutated, and the change in length from 
the stable allele length was determined.
Cell Line Clone Size Stable/Mutated
WT A 96.5 Stable
B 96.6 Stable
C 96.7 Stable
D 96.4 Stable
E 96.4 Stable
F 96.4 Stable
G 96.6 Stable
H 96.7 Stable
I 96.4 Stable
J 96.2 Stable
+/- 1.1 A 96.4 Stable
B 96.4 Stable
C 96.4 Stable
D 96.4 Stable
E 96.4 Stable
F 96.4 Stable
G 96.4 Stable
H 96.2 Stable
I 96.4 Stable
J 96.2 Stable
+/- 2.1 A 96.4 Stable
B 96.4 Stable
C 96.4 Stable
D 96.7 Stable
E 96.4 Stable
F 96.4 Stable
G 96.3 Stable
H 96.2 Stable
I 96.2 Stable
J 96.4 Stable
Table 4.9 continued
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Cell Line Clone Size Stable/Mutated
-/- 1.1 A 96.4 Stable
B 96.4 Stable
C 96.4 Stable
D 96.4 Stable
E 96.4 Stable
F 96.7 Stable
G 96.3 Stable
H 96.2 Stable
I 96.2 Stable
J 96.2 Stable
-/-2.1 A 96.4 Stable
B 96.4 Stable
C 96.4 Stable
D 96.4 Stable
E 96.4 Stable
F 96.4 Stable
G 96.3 Stable
H 96.2 Stable
I 96.4 Stable
J 96.2 Stable
-/-/+ 1.1 A 96.4 Stable
B 96.4 Stable
C 96.4 Stable
D 96.4 Stable
E 96.4 Stable
F 96.4 Stable
G 96.2 Stable
H 96.5 Stable
I 96.2 Stable
J 96.4 Stable
Size Range of Allele in 
Stable Clones (bp)
96.2 -  96.7
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Table 4,10 Synopsis of results for microsatellite ChrII-6 in 3174 MSH2 knockout
trypanosomes
The ChrII-6 microsatellite locus was analysed as described in Table 4.9. Ten clones were 
analysed from each of the following 3174-derived cell lines: MSH2 wild-type (WT); two 
heterozygous MSH2 mutants (+/-); two MSH2 homozygous mutants (-/-); and the MSH2 
re-expressor cell line (-/-/+). For each cell line, the number and percentage of clones 
which were stable or mutated at this locus is given.
Cell line No of clones 
analysed
Stable
clones
Percentage Mutated
clones
Percentage
WT 10 10 100 0 0
+/- 1.1 10 10 100 0 0
+/-2.1 10 10 100 0 0
-/- 1.1 10 10 100 0 0
-/- 2.1 10 10 100 0 0
-/-/+ 1.1 10 10 100 0 0
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The microsatellite loci were amplified by PCR, using one fiuorescently-labelled primer and 
an unmodified primer, and the PCR products separated by acrylamide-urea gel 
electrophoresis. The resulting fluorescent bands were detected using an automated 
sequencer and analysed using the GeneScan system. After comparing the size of alleles at 
a given locus in every sample, the most frequently observed size was determined to be the 
size of the wild-type or stable allele. Where a PCR product differed from this size by 1 bp 
or more it was considered to have mutated, and the change in length from the size of the 
stable allele was calculated. For each microsatellite locus the number of clones and alleles 
analysed is given, and the number of alleles which increased (+) or decreased (-) in length 
is shown. The total number of mutations of a given size at all loci has been calculated and 
expressed as a percentage of all the mutations observed. For the ChrII-6 locus the number 
of alleles analysed could not be determined (ND).
N u m b e r  o f  t r a c t s  w i t h  a d d i t i o n s  ( + )  o r  d e l e t i o n s  ( - )  
o f  b a s e - p a i r s
L o c u s T y p e
o f
R e p e a t
N o .  o f  
c l o n e s  
( a l l e l e s )  
a n a l y s e d
- 1 2 - 6 - 4 - 2 - 1 + 2 + 4
Chrl-7 GT 19(38) 1 1 1 6 0 2 1
ChrI-15 GT 20 (40) 0 0 1 6 0 4 0
PLC TA + T 
+ A
20 (20) 0 0 0 1 1 1 0
ChrII-6 None 20 (ND) 0 0 0 0 0 0 0
N u m b e r  o f  M u t a t i o n s  
( t o t a l  n u m b e r  a n a l y s e d )
1/26 1/26 2/26 13/26 1/26 7/26 1/26
P e r c e n t a g e  o f  M u t a t i o n s 4 4 8 50 4 27 4
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This scheme depicts the telomeric region of the actively transcribed expression site in 3174 
bloodstream form cells. This expression site was modified to include the resistance 
markers for hygromycin (Hyg; shown in green), between the most proximal ESAG 
(ESAG 1; shown in purple) and the 70-bp repeats (70-bp rep; shown as a vertically striped 
box), and G418 (Neo; shown in red), between the 70-bp repeats and the VSG221 gene 
(VSG 221; shown as a black box). A dashed arrow indicates transcription of the site while 
X depicts cessation of transcription. Small arrows represent the positions of primers used 
to assay for the presence of genes within the expression site. Three different switching 
events can be distinguished in this trypanosome strain. During an in situ transcriptional 
switch, an inactive expression site containing the unknown VSGX (VSG X; shown as a 
white box) is transcriptionally activated and the VSG221 site is inactivated. Cells which 
have undergone this type of switching event are sensitive to hygromycin (Hyg ) and G418 
(G418^), and each marker gene can be amplified by PCR (Hyg+, Neo+, 221+). Cells 
which are Hyg^ and G418  ^from which the markers cannot be amplified by PCR (Hyg-, 
Neo-, 221-), have undergone a long range expression site gene conversion event in which 
all the marker genes have been replaced by sequence from another expression site which 
introduces the VSGX gene. In a VSG gene conversion event the sequence from the 70-bp 
repeats to the 3’ end of VSG221 is replaced by sequence containing VSGX, deleting the 
Neo and VSG221 markers; cells which are resistant to hygromycin (Hyg!^) but G418^, and 
from which only the Hyg marker can be amplified by PCR (Hyg+, Neo-, 221-) have 
undergone this type of switching event. The integrity of the genomic DNA template was 
confirmed using primers directed against the large subunit of RNA polymerase I (Rudenko 
et a l , 1996). (After McCulloch and Barry, 1999)
in situ  transcriptional switch
transformant 3174
VSGX
expression site gene conversion
PCR p i im tn  ► '4
VSG gene conversion
Hygs G418S 
Hyg+ Neo+ 221 +
ESAG 1 Hyg 70-bp r ip  Nk  VSG 221 VSGX HygS G418S 
Hyg- Neo- 221-
VSGX HygR G418S 
Hyg+ Neo- 221-
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Table 4.12 Effect of MSH2 mutation on the frequency of VSG switching in the 
3174 trypanosome strain
The frequency of VSG switching was determined as described in Materials and Methods 
(see section 2.15) using 3174 bloodstream trypanosomes that had been unaltered at the 
MSH2 locus (WT); that had one MSH2 allele disrupted (+/-); that had both MSH2 alleles 
disrupted (-/-); or that had both alleles disrupted but the MSH2 gene restored to the genome 
(-/-/+). In each independent experiment, switched trypanosomes were plated over 96-well 
plates in HMI-9 and the number of wells containing grovW:h were counted after 10 days. 
The number of VSG switching events/cell/generation (estimated VSG switching frequency 
(x 10'^)) was determined as described in McCulloch et a l (1997).
Estimated VSG
No. of wells switching frequency
Cell Line growing (X  10'*)
WT 64/96 1 . 0 0
9/96 0.14
3/96 0.05
65/96 1.02
Average 35/96 0.55
+/- 1.1 49/96 0.77
33/96 0.52
Average 41/96 0.65
+/-2.1 57/96 0.89
18/96 0.28
48/96 0.75
Average 41/96 0.64
+/-3.1 61/96 0.95
24/96 0.38
20/96 0.31
Average 35/96 0.55
- / -  1 .1 5/96 0.08
49/96 0.77
16/96 0.25
Average 23/96 0.37
-/- 2.1 53/96 0.83
46/96 0.72
4/96 0.06
Average 34/96 0.54
-/-3.1 26/96 0.41
58/96 0.91
18/96 0.28
Average 34/96 0.53
- 1- 1+  1.1 37/96 0.58
28/96 0.44
29/96 0.45
Average 31/96 0.49
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The average frequency of VSG switching was determined as described in Table 4.12 using 
3174 bloodstream trypanosomes that had been unaltered at the MSH2 locus (WT; shown in 
green); that had one MSH2 allele disrupted (+/-; shown in blue); that had both MSH2 
alleles disrupted (-/-; shown in red); or that had both alleles disrupted but the MSH2 gene 
restored to the genome (-/-/+; shown in purple). Error bars depict standard deviation.
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0.8
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0.2
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+ /-
2.1
+ /-
3 . 1
- / -
1.1
- / -
2.1
- / -
3 . 1
-/-/+
1.1
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Table 4.13 VSG switching mechanisms used by MSH2 wild-type and MSH2 
mutant trypanosomes
The types of switching event used by untransformed 3174 bloodstream forms (WT); 3174 
cells transformed with AMSH2::PUR (+/-); 3174 cells transformed with both 
AMSH2::PUR and AMSH2::BSD (-/-); and 3174 cell transformed with AMSH2::PUR, 
AMSH2::BSD and AMSH2: :MSH2-BLE (-/-/+) was determined as described in Figure
4.22, Materials and Methods (see section 2.15) and McCulloch et al, (1997).
Strain
(no. of switched variants 
analysed)
In  situ switch Expression site 
gene conversion
VSG gene 
conversion
MSH2 wild-type (30) 3/30 16/30 11/30
10% 53% 37%
MSH2+/- 1.1 (19) 1/19 15/19 3/19
5% 79% 16%
MSH2 +/- 2.1 (27) 8/27 19/27 0/27
30% 70% 0%
MSH2 +/-3.1 (28) 14/28 10/28 4/28
50% 36% 14%
MSH2-/-1.1 (25) 7/25 13/25 5/25
28% 52% 20%
MSH2-1- 2.1 (21) 3/21 18/21 0/21
14% 86% 0%
MSH2 -/- 3.1 (30) 13/30 17/30 0/30
43% 57% 0%
MSH2-/-/+ 1.1 (29) 9/29 19/29 1/29
31% 66% 3%
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Figure 4.24 VSG switching mechanisms used by MSH2 knockout trypanosomes
The types of switching event used were determined as described in Table 4.13 for 
untransformed 3174 bloodstream forms (WT); 3174 cells transformed with AMSH2::PUR 
(+/-); 3174 cells transformed with both AMSH2::PUR and AMSH2::BSD (-/-); and 3174 
cells transformed with AMSH2::PUR, AMSH2::BSD and AMSH2::MSH2-BLE (-/-/+). For 
each cell line the percentage of switched variants generated by in situ transcriptional 
switching (shown in blue), expression site gene conversion (shown in red), and VSG gene 
conversion (shown in yellow) are presented.
100
IS>a
In situ 
ES 
□  VSG
WT + / -  1.1 + / - 2.1 +/-3.1 -/. 1.1
Cell Line
- / - 2.1 -/- 3.1 - / - / +  1.1
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4.3 Generation and analysis of homozygous MLHl knockout trypanosomes
4.3.1 Introduction
MLHl is the primary MutL-related protein in eukaryotes (Harfe and Jinks-Robertson, 
2000). It is a component of every MutL-related heterodimer described in eukaryotes so 
far, and is believed to be required for all nuclear MMR reactions to proceed (Harfe and 
Jinks-Robertson, 2000). Inactivation of MLH l therefore leads to the complete elimination 
of MMR activity (Harfe and Jinks-Robertson, 2000). The roles of MLH l in T. brucei can 
be investigated using the same assays applied to study the functions of T. brucei MSH2, as 
loss of MLH l has also been associated with méthylation tolerance in mammals (Koi et a l , 
1994; Hawn et a l, 1995), and has been shown to result in the mutator phenotype, MSI 
(Strand et a l , 1993; Baker et a l , 1996). For these reasons the survival of ML//7-deficient 
trypanosomes in the presence of the alkylating agent, MNNG, will be assessed during this 
study (see section 4.3.5), and a number of microsatellite loci will be studied in 
ML//7-proficient and MX7T7-deficient trypanosomes to determine the effect of MLHl 
mutation on microsatellite stability in T. brucei (see section 4.3.6). It is hypothesised that 
homeologous recombination reactions are inhibited in MMR competent cells due to their 
ability to recognise mismatches which form in heteroduplex intermediates (Datta et a l , 
1996; Datta et a l, 1997), and it is hypothesised that since trypanosome antigenic variation 
involves recombination (McCulloch and Barry, 1999), MMR may also regulate VSG 
switching. As for MSH2, inactivation of MLH l has been reported to cause an increase in 
the frequency of recombination between non-identical sequences in yeast and mammals, 
although the elevation in recombination frequency seen in MLH l mutants is consistently 
less than that seen in MSH2 mutants (Nicholson et a l, 2000). It is therefore believed that 
MSH2 possesses some anti-recombination activity that is independent of MLHl (Evans 
and Alani, 2000). MSH2 has also been associated with activities which facilitate the 
resolution of recombination intermediates, including non-homologous tail removal 
(Sugawara et a l , 1997) and Holliday junction cleavage (Marsischky et a l, 1999), and may 
therefore function both to promote recombination as well as suppress it. MLHl is not 
required to process non-homologous tails (Sugawara et a l , 1997), and its role in Holliday 
junction resolution has not been investigated. Deletion of MSH2 did not result in a 
detectable alteration in VSG switching (section 4.2.8), but it is possible that MSH2 acts 
both to promote and inhibit recombination in T. brucei, and these conflicting activities 
cancel each other out at the phenotypic level. Since MLHl has not been associated with 
activities which promote recombination, the same VSG switching assay used to study the
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role of MSH2 will be employed to determine if inactivation of MLH l affects antigenic 
variation in this organism.
4.3.2 Design and generation of M LHl knockout constructs
The same strategy used to generate MSH2'‘' trypanosomes was adopted to delete both 
copies of the MLH l ORF in order to investigate the function of MLH l in T, brucei. It is 
clear from an alignment of the T. brucei MLHl polypeptide with MLHl protein sequences 
from other eukaryotes (see section 3.3.7) that the primary functional domains are located in 
the N- and C-terminal regions. Since mutations in one domain do not necessarily 
inactivate all the activities of the MLHl protein (Pang et a l , 1997), it was again deemed 
necessary to delete both copies of the entire MLH l ORF from the genome, in order that no 
residual MLHl activity could remain.
The design of the T. brucei MLHl knockout constructs mirrored the MSH2 constructs: 
sequences immediately 5’ and 3’ of the MLH l ORF were used as targeting sequences for 
the replacement of the entire MLH l ORF by homologous recombination (Figure 4.25) and 
were separated by either the BSD or PUR antibiotic resistance cassettes (see section 4.2.2). 
The resistance genes should be expressed by endogenous MLH l transcription after 
integration, as there are no promoter elements within the knockout constructs.
PCR primers were designed to amplify 413 bp of 5’ flank (MLHl 5’(A) and MLH l 5’(B)) 
and 520 bp of 3’ flank (MLHl 3’(A) and MLH l 3’(B)) from the MLH l locus. PCR using 
these primers with MITat 1.2 genomic DNA generated products of the expected sizes 
(Figure 4.26; see section 2.11.2). The MLH l targeting flanks were then cloned 
simultaneously into pBluescript II KS. Finally, the BSD- or PUR-containing resistance 
cassettes were cloned between the MLH l flanks to generate the AMLH1::BSD and 
AMLH1::PUR constructs respectively (see section 2.11.2).
4.3.3 Generation of M LHl mutant cell lines in T. brucei
Direct transformation of 3174 bloodstream cells with the linearised knockout constructs 
allowed the generation of two independent MLH l mutants (see section 2.11.2). In order to 
generate putative heterozygous (MLHl^^') mutants, a number of independent cell 
populations were electroporated with the AMLH1::PUR construct, and transformants 
selected in HMI-9 containing 1.0 pg.ml'^ puromycin dihydrochloride in 24-well plates (see 
section 2.1.3). Two independent first round transformants were then electroporated with
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the AMLHlr.BSD  construct, and transformants selected in HMI-9 containing 2.5 pg.ml'^ 
blasticidin S hydrochloride in 24-well plates to generate putative homozygous 
mutants.
Southern analysis was performed to determine whether or not the constructs had integrated 
in to the MLH l locus correctly. Genomic DNA was isolated from each transformant, 
digested with Kpnl, separated by agarose gel electrophoresis. Southern blotted, and probed 
with the MLH l 5’ flank described in section 4.3.2. The results of this analysis for MLH l 
wild-type trypanosomes, the two independent MLHl'^^' cell lines and the two independent 
MLHL'' mutants are shown in Figure 4.27. A 4.0 kb fragment, corresponding to the intact 
MLH l locus, was detected in both the MLH l wild-type cells and the two MLH1^'~ mutants. 
This fragment was absent from the two MLHL^' mutants. A second fragment which was 
1.3 kb in length, was detected in the two first round transformants and the two second 
round transformants. This fragment was generated by replacement of one of the MLH l 
alleles by the AMLH1::PUR construct. Finally, the digestions of the two MLHf^' mutants 
revealed a 1.1 kb fragment, corresponding to the MLHl::BSD allele, derived by 
replacement of the second MLH l allele by the AMLH1::BSD construct. Taken together, 
these results indicate that the knockout constructs integrated into the MLH l locus as 
expected to generate the desired MLH l mutant trypanosomes.
In order to show that no copies of the MLH l ORF existed within genomic DNA isolated 
from the putative MLHl'^' mutant cell lines, PCR using primers internal to the MLH l ORF 
{MLH1\]\ and MLH1D6) was performed (Figure 4.28; see section 2.11.2). The integrity 
of the DNA template was confirmed using primers specific to the large subunit of RNA 
polymerase I in T. brucei (Poll 5’ and Poll 3’; Rudenko et a l ,  1996). PCR amplification 
using the MLH l internal primers showed that MLH l wild-type cells and the two MLH l^'' 
mutants gave products of the expected size. No product was visible in the two 
homozygous mutants, however, indicating that no further copy of MLH l had been created 
upon disruption of the two wild-type alleles.
Finally, as antibodies against the T. brucei MLHl polypeptide are not currently available, 
reverse transcription PCR was used to confirm that no wild-type MLH l mRNA was being 
transcribed in the homozygous mutants. Total RNA was isolated from the transformants, 
and cDNA was generated by reverse-transcription (see section 2.4) for use as a template 
for PCR amplification using the MLH l internal primers as above (Figure 4.29). The 
integrity of the cDNA was confirmed as described above. A PCR product of the expected 
size was amplified from the MLH l wild-type cells and the two MLHl^^' mutants, but not
250
from the two MLHV^' mutants. This indicates that it is possible to remove all intact 
transcripts of the MLH l gene, and therefore all expression of the MLHl protein, and 
trypanosomes remain viable. These results also confirm that the knockout constructs 
integrated into the cells as expected to generate the desired MLH l mutant trypanosomes.
4.3.4 Growth of MLHl knockout trypanosomes in vitro
The in vitro growth rate of the MLH l mutant trypanosomes was assessed by diluting 
mid-log phase cultures to a concentration of 1 x 10  ^cells.mf ^ in HMI-9 and measuring the 
trypanosome concentrations every 24 h thereafter. Figure 4.30 shows that the MLH l''' 
cells are not only viable but show no alteration in growth compared with the wild-type 
cells. The average population doubling time during exponential growth was 7.88 h for the 
MLH l wild-type cells, 7.96 (±0.9) h for the MLHl^'' mutants, and 8.73 (± 1.4) h for the 
MLH l''' cell lines. All the cultures reached similar maximal densities (data not shown). 
Surprisingly, the 3174 wild-type trypanosomes grew more slowly during this experiment 
than they did during the same experiment for the MSH2 mutants (see section 4.2.5). Since 
all the cell lines used were re-cloned prior to each experiment to ensure vigorous growth, it 
is unlikely that the wild-type cells used during the MLH l experiment were unhealthy. It is 
more probable that the differences in growth rate were due to differences between the 
batches of HMI-9 used as the culture medium, or result from the use of a different 
incubator.
4.3.5 Survival of MLHl mutant trypanosomes in the presence of the alkylating 
agent, MNNG
As described in section 4.2.6, loss of mismatch repair activity in bacteria and mammalian 
cells results in increased resistance to the cytotoxic effects of alkylating agents, such as 
MNNG (Karran and Marinus, 1982; de Wind et a l, 1995; Humbert et a l , 1999). In order 
to determine if inactivation of MLH l resulted in méthylation tolerance in T. brucei, the 
survival of MLH l wild-type, MLHÜ'' and MLH l''' mutant cell lines was assessed by a 
clonal growth assay in the presence of increasing concentrations of MNNG, as described 
for MSH2 mutants (section 4.2.6). The results of this assay are shown in tabular form in 
Table 4.14, and as a graph in Figure 4.31. It is evident from these data that inactivation of 
MLH l resulted in increased tolerance to the cytotoxic effects of MNNG in T. brucei. The 
survival of MLH l wild-type cells was severely reduced after exposure to 0.25 pg.mf* 
MNNG as only 2% of wells showed growth. Similarly, the survival of MLHl 
heterozygous mutants was reduced by 99% and 91% under the same conditions. At this
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concentration, however, the survival of the MLH l homozygous mutants was only reduced 
to 73% and 87%, equating to a 8.1-fold increase in survival over cells expressing MLHL 
At 0.5 pg.ml'^ MNNG, no growth was observed for either the MLH l wild-type cells or the 
MLH1^'~ mutants, but 16% and 29% of wells showed grovri;h for the MLHV'' mutants. 
Again, at a concentration of 0.75 pg.m l'\ no growth was observed for MLH l wild-type 
cells, either of the MLH1^'~ mutants, or the MLHL'' mutant 1.1. For the second MLH l''' 
mutant, 2.1, 2% of wells showed growth at this concentration. At the final concentration,
1.0 pg.ml"\ no growth was observed for any cell line. These results indicate that 
inactivation of MLH l results in MMR deficiency in T. brucei. Comparison of the data 
generated during the survival assays performed using the MSH2 and MLH l mutants 
indicates that the wild-type cells used during the assay using the MLH l mutants were 
inherently more sensitive to MNNG than those used during the assay using the MSH2 
mutants (see section 4.2.6). For instance. Table 4.1 shows that for MSH2 wild-type cells, 
73% of wells showed groAvth at a concentration of 0.25 |xg.mf^ MNNG. In contrast. Table 
4.14 shows that for MLH l wild-type cells at the same drug concentration only 2% of wells 
showed growth. Since the MSH2 and MLH l wild-type cell lines used during these assays 
were, in fact, the same 3174 transgenic trypanosome cell line it seems unlikely that this 
dramatic difference in drug sensitivity is genuine. A mundane explanation for this 
discrepancy could be that the stock solution of MNNG used for the assay performed on the 
MLH l mutants was more concentrated than that used for the assay using the MSH2 
mutants, owing to changes in the sensitivity of the balance used to weigh the drug. 
Alternatively, the discrepancy could have arisen as a consequence of the difference in 
grov^h rate between the two sets of mutants (discussed above).
4.3.6 Microsatellite instability in MLHl knockout cell lines
An overview of the role of the bacterial and eukaryotic MMR systems in microsatellite 
instability (MSI) is given in section 4.2.7, along with a description of the experimental 
approaches used to assay for this phenotype during this study. To investigate whether 
MLHl is required to facilitate the repair of misaligned replication intermediates in 
T. brucei, the stability of the three naturally occurring microsatellite loci examined 
previously was compared in MLH l wild-type cells, MLH1~ '^' cells and MLHV'' mutants. 
These microsatellite loci were chosen because they had the highest mutation frequencies of 
the five loci studied in MSH2''' cells, and so were expected to give the most easily 
observable phenotypes in MLH l mutant trypanosomes. Each of these cell lines was cloned 
(see section 2.1.3), ten clones from each were grown for approximately 25 generations
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(data not shown), and genomic DNA was isolated from each of the cultures (see section
2.16).
The first microsatellite locus analysed in the MLH l mutants was JS-2 (Figure 4.10; Hope 
et al, 1999). The primers JS-2A and JS-2B were used to amplify the locus from all the 
clonal genomic DNA samples, and the resulting PCR products were separated by 
electrophoresis on 3% agarose gels (Figure 4.32). It is clear that the JS-2 locus is stable in 
each of the ten MLH l wild-type clones, and that the PCR products are approximately 320 
to 340 bp in length. Analysis of the M LH t^' clones also indicates that this locus is stable 
in these cell lines. In contrast, two of the clones derived from the MLH l''’ 1.1 cell line (A 
and E) appear to show changes in the sizes of the PCR products amplified, suggesting that 
the JS-2 locus has mutated in these cells. The PCR products amplified from the clones 
derived from the second MLHV'' mutant do not show any obvious size changes at this 
locus. These results are summarised in Table 4.15 and are shown as a graph in Figure 
4.33. In Figure 4.32, the PCR products are resolved into two bands in some of the agarose 
gels, while in others only a single band is observed. These differences are probably due to 
the quality of the agarose gels used to separate the samples, as the five wild-type samples 
shown in the MLH1^'~ 2.1 panel were taken from exactly the same PCR reactions as 
samples F-J shown in the wild-type panel, and the same electrophoresis conditions were 
used in each case. These observations suggest that agarose gel electrophoresis is limited as 
a technique for the analysis of changes in microsatellite length and that it cannot be used to 
distinguish insertions or deletions under a threshold size. While it appears that MLH l- 
deficient trypanosomes display greater changes in microsatellite length than cells 
expressing the gene, it is possible that small changes have occurred in clones derived from 
every cell line. The more sensitive technique of GeneScan analysis was therefore 
employed (see section 4.2.7 and Figure 4.13), for the two remaining microsatellite loci, 
ChrI-7 and ChrI-15 (Figure 4.14; see section 2.16).
The first of these loci, ChrI-7, was amplified from each of the clonal genomic DNA 
samples using the primers ChrI-7A and ChrI-7B, and the resulting PCR products were 
analysed using the GeneScan system (see section 2.16). The results of this analysis are 
shown in Table 4.16, and the data summarised in Table 4.17. A graph of the data shown in 
Table 4.17 is shown in Figure 4.34. Two alleles, which differed greatly in size, were 
amplified in each case. In stable clones, clones which did not appear to have mutated at 
this locus, GeneScan analysis gave sizes of between 102.4 and 102.8 bp for the smaller 
allele, and 217.1 to 218.5 bp for the larger allele. For all clones analysed from the MLHl 
wild-type and MLHl^'' backgrounds, both alleles appear to be stable as no changes in
253
length could be discerned. In contrast, a number of MLHV'' clones appeared to contain 
mutated alleles (Figure 4.35). Out of the 20 MLH l''' clones analysed, 50% had mutated at 
one allele. The larger allele mutated more frequently, as 8 out of the 20 clones showed 
mutations in this allele, accounting for 80% of the mutation events observed at this locus. 
The smaller allele was only mutated in two clones. This is probably a reflection of the 
greater number of repeat units present in the larger allele, which increases the likelihood of 
slippage during replication of this sequence (Figure 4.14). The most frequent mutation 
events decreased the length of the microsatellite, in most cases probably reflecting the loss 
of a single repeat unit, as 6 out of the 10 mutations observed resulted in a loss of 2 bp. A 
single event decreased the size of the larger allele by 6 bp, probably equating to the loss of 
3 repeat units. Increases in allele length were also seen, albeit less frequently. Two 
mutations of the larger allele probably led to the gain of a single repeat unit (+2 bp), while 
in one case, a single base-pair was introduced into the smaller allele. Since there is no 
mononucleotide-run in this allele (Figure 4.14), this 1 bp insertion may have occurred by a 
mechanism other than replication slippage. These data confirm that inactivation of MLH l 
in T. brucei leads to the mutator phenotype MSI.
The second locus analysed using the GeneScan system, ChrI-15, was amplified from all of 
the clonal genomic DNA samples using the primers ChrI-15A and ChrI-15B (see section
2.16). Table 4.18 gives the results of this analysis, while Table 4.19 shows a summary of 
the data analysed. A graphical representation of these results is shovm in Figure 4.36. The 
length of the two alleles amplified from the ChrI-15 locus differed by only 8 bp in stable 
clones (defined as above). GeneScan analysis revealed the smaller allele to be between
167.0 and 167.3 bp in length, while the larger allele was 175,3 to 175.7 bp in length. In 
every MLH l wild-type clone, and both sets of the MLHl^'' clones, both alleles were shown 
to be stable. However, comparison of the sizes of the PCR products amplified from this 
locus in the MLH l''' clones revealed a number of clones which appear to have mutated at 
one or both alleles (Figure 4.37). Again, the larger allele appears to have mutated more 
frequently, accounting for 7 out of the 10 mutation events observed, while only 3 out of the 
19 smaller alleles analysed showed evidence of mutation. For both alleles, the most 
frequent change resulted in the loss or addition of 2 bp, probably equating to a single 
repeat unit. Such changes accounted for 80% of the observed mutations, with 5 out of the 
8 events leading to a decrease in microsatellite length. Two events which changed the 
length of the alleles by 4 bp were also seen, one probably resulting in the loss of 2 repeat 
units and the other in an equivalent gain. Again these data indicate that inactivation of 
MLH l in T. brucei leads to a mutator phenotype.
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The mutational spectra of the two microsatellite loci analysed using the GeneScan system 
are shown in Table 4.20. Since mutations were only observed in MT7T7-deficient clones, 
only the data from the two sets of clones derived from the M LH l''' mutant cell lines is 
shown. For both loci, the number of alleles which increased or decreased in length by a 
given number of base-pairs was recorded, and the total number of mutations of each type 
was calculated. It is clear that mutations most frequently involved the loss of sequence, as 
decreases in length accounted for 65% of the observed events. The most common decrease 
in length was 2 bp, which probably resulted from the loss of a single repeat unit in the 
dinucleotide microsatellites, as this occurred in 55% of the mutations analysed. Losses of 
4 and 6 bp were also observed, and probably represent the deletion of 2 and 3 repeat units 
respectively. 25% of the mutation events seen involved an increase in length of 2 bp, again 
probably representing the addition of a single repeat unit. One allele was also seen to 
increase in length by 4 bp, which probably involved the addition of 2 repeat units. Finally, 
a single event in which an allele increased by 1 bp may not have involved replication 
slippage. Overall, this study revealed that inactivation of MLH l in T. brucei results in the 
mutator phenotype, MSI, indicating that the protein is involved in the repair of slipped 
replication intermediates, as is the case in yeast and higher eukaryotes. These data confirm 
that T. brucei MLH l is required for nuclear MMR.
4.2.7 Antigenic variation in M LHl knockout trypanosomes
In order to assay for potential changes in the frequency and mechanisms used in antigenic 
variation in MLH l''' mutant trypanosomes, the MLH l knockout mutants were generated in 
the transgenic 3174 background (McCulloch et a l, 1997; McCulloch and Barry, 1999).
The experimental approach used was essentially the same as that described in section 4.2.8 
and Figure 4.22, and the exact experimental conditions used during this study are given in 
section 2.15. This approach was used to isolate switched variant trypanosomes, arising 
after immune selection, in two independent MLHl^'', and two independent MLH l''' cell 
lines. A number of repetitions were performed using entirely independently grown 
populations for each cell line. The data from each repetition was combined to allow the 
calculation of an average VSG switching frequency for each cell line, as shown in Table 
4.21 and Figure 4.38, where it is compared with the switching frequency data for wild-type 
cells determined previously (section 4.2.8). As described previously, the estimated VSG 
switching frequency varied greatly between repetitions within the same cell line, due to a 
founder effect. MLH l wild-type cells switched their VSG coat at an average frequency of 
0.55 X 10’^  switches/cell/generation. The average switching frequency of the two 
independent MLHl^'' mutants was about half that of the MLH l wild-type cells. In
255
contrast, the average switching frequency of the two independent MLH l''' mutants was
similar to the frequency observed for the MLH l wild-type cells. The differences observed 
between the cell lines probably reflects the influence of founder effects rather than real 
changes in the frequency of antigenic variation. These results suggest that inactivation of 
the MLH l gene, like inactivation of MSH2, has no substantial effect on the frequency of 
VSG switching in 3174 trypanosomes.
To determine the switching mechanisms used by each cell line, ten switched variants were 
analysed (where possible) from each repetition for MLH l wild-type cells, the two MLHl^'' 
cell lines and the two MLHV'' mutants. The results of this analysis are shown in Table
4.22, and as a graph in Figure 4.39. Inactivation of MLH l appeared to have no substantial 
effect on the relative use of the different switching mechanisms, although this is again 
complicated by the influence of founder effects which caused variation in their frequency 
from experiment to experiment. Expression site gene conversion was the most commonly 
observed switching mechanism, except in the MLHl'^'' 2.1 cell line, being used in 14% to 
76% of the switched variants analysed. Every cell line also used the in situ transcriptional 
switching mechanism, which occurred in between 10% and 48% of the switched variants 
analysed. This mechanism was the most common mechanism used in the MLHl'^'' 2.1 cell 
line. The final switching mechanism, VSG gene conversion, was the least frequently 
observed, and was not used to generate any switched variants in the MLH l''' 2.1 cell line. 
However, it could be detected in 12% to 37% of the switched variants analysed in the 
remaining cell lines, including MLH l wild-type trypanosomes, MLH l heterozygous cells 
and MLH l homozygous mutants. The lack of a detectable alteration in the use of VSG 
switching mechanisms, allied to the lack of change in switching frequency, due to MLHl 
deletion is highly comparable to the result detailed for MSH2 mutation. Taken together, 
they suggest that MMR plays little or no role in regulating VSG switching in T, brucei.
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Figure 4.25 A strategy for the generation of T, brucei M LH l knockout mutants
The MLH l locus is indicated as a blue box, and the constructs used to disrupt its 
expression are shown below. MLH l 5 ’ and MLHl 3 ’ are sequences flanking the MLHl 
ORF (ATG to TGA) which allow for integration of the knockout constructs, as indicated 
by crosses. Two constructs were used, one containing the 400 bp blasticidin S deaminase 
{BSD) gene and the other the 600 bp puromycin acetyltransferase gene {PUR)\ both are 
flanked by sequences derived from the tubulin locus (pa and aP; grey boxes) that allow 
transcripts of the resistance markers to be trans-spliced and polyadenylated into mature 
mRNAs. In each construct, the 2851 bp MLHl ORF is precisely replaced by the resistance 
cassettes. Arrows represent the direction of transcription of the genes, numbers in brackets 
denote lengths in base-pairs, and half-arrows indicate the approximate positions of primers 
used in the analysis. Kpn\ restriction sites are shown as vertical bars.
Kpn\
_L_
Kpn\
_ l _
MLHl
ATG TGA
X
M LH l 5’(A )\ . M LH l 5 (B) (A 2851) XM U !I  3’(A )\ /  M IJH  3 (B)
M L H l 5 ' 
(413) Kpnl
M L H l 3 ' 
(520)
Pa (270) BSD (400) / PUR (600) aP (350)
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Figure 4.26 PCR amplification of M LH l knockout construct flanks
The MLHl integration flanks were amplified from MITat 1.2 genomic DNA using the 
primers MLHl 5’(A) and MLHl 5’(B) (5’ flank), and MLHl 3’(A) and MLH l 3’(B) (3’ 
flank). For each primer pair control reactions were performed with both primers in the 
absence of T. brucei DNA template (1), the (A) primer only (2) and the (B) primer only 
(3). Lane 4 shows the reaction containing both primers and template for each primer pair.
5 ’ flank 3 ’ flank
A B C D  A B C D
Figure 4.27 Southern analysis of 3174 M LHl knockout cell lines
Genomic DNA isolated from the 3174 MLHl knockout cells lines was digested with Kpn\, 
separated on a 0.6% agarose gel. Southern blotted and probed with the MLHl 5’ flank used 
as the 5’ integration flank in the MLHl knockout construct. The following samples were 
analysed: (WT) untransformed 3174 cells; (+/-) 3174 cells transformed with 
AMLH1::PUR; (-/-) 3174 cells transformed with AMLHl::PUR and AMLH1::BSD.
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Figure 4.28 PCR analysis of the 3174 M LH l knockout cell lines
PCR was performed using genomic DNA isolated from the 3174 cell lines transformed 
with the MLHl knockout constructs. Internal primers complementary to the T. brucei 
MLHl gene were used {MLHl) and the integrity of the DNA was confirmed using primers 
directed against the large subunit of T. brucei RNA polymerase I {RNA Pol 7; Rudenko et 
a i ,  1996). For both sets of primers the following reactions were run: (NT) no template 
DNA; (WT) untransformed 3174 cells; (+/-) 3174 cells transformed with AMLHl::PUR\ 
(-/-) 3174 cells transformed with both AMLHl::PUR and AMLHl::BSD.
MLHl — <N (N
I
RNA Pol I
zou
Figure 4.29 Analysis of the expression of M LHl in the putative 3174 M LHl mutant
cell lines
RT-PCR was performed using total RNA isolated from the 3174 cell lines transformed 
with the MLHl knockout constructs. Internal primers complementary to the T. brucei 
MLHl gene were used {MLHl)  and the integrity of the DNA was confirmed using primers 
directed against the large subunit of T. brucei RNA polymerase I {RNA Pol /; Rudenko et 
a i ,  1996). For both sets of primers RT positive (RT+), RT negative (RT-), and no 
template (NT) reactions were performed using total RNA isolated from the following cell 
lines: (WT) untransformed 3174 cells; (+/-) 3174 cells transformed with AMLHl::PUR; 
(-/-) 3174 cells transformed with both AMLHl::PUR and AMLHl::BSD.
MLHl
WT + /-  1.1 + /-  2.1
+ 1 + 1  H H H H H0^  oi: ^  oc Qi
RNA Pol 1
WT + /-  1.1 + /-  2.1
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Figure 4.30 Growth of M LH l knockout trypanosomes
Bloodstream trypanosomes that had been unaltered at the MLH l locus (WT); that had one 
MLHl allele disrupted (+/-); or that had both MLHl alleles disrupted (-/-) were grown in 
HMI-9. The concentration of trypanosomes in the medium was counted at given times.
Time (h)
10000000
1000000
100000
10000
+ / - 1.1
+ / - 2.1
262
Table 4.14 Survival of M LH l knockout trypanosomes in the presence of MNNG
Bloodstream trypanosomes that had been unaltered at the MLH l locus (WT); that had one 
MLHl allele disrupted (+/-); or that had both MLHl alleles disrupted (-/-) were plated in 
HMI-9 containing increasing concentrations of MNNG (as shown) at a density of 2 cells 
per well in 96-well plates. For each cell line, at each concentration, 3 plates were prepared, 
and the number of wells containing growth were counted after 14 days. Percentage 
survival is presented relative to the number of wells growing in the absence of MNNG, 
which is given as 100%.
No. of wells growing
Cell Line MNNG
Cone.
(pg.mr‘)
Plate 1 Plate 2 Plate 3 Average Percentage
Survival
WT 0 61/96 60/96 57/96 59/96 100
0.25 2/96 2/96 0/96 1/96 2
0.50 0/96 0/96 0/96 0/96 0
0.75 0/96 0/96 0/96 0/96 0
1.00 0/96 0/96 0/96 0/96 0
+/- 1.1 0 64/96 50/96 60/96 58/96 100
0.25 1/96 0/96 1/96 1/96 1
0.50 0/96 0/96 0/96 0/96 0
0.75 0/96 0/96 0/96 0/96 0
1.00 0/96 0/96 0/96 0/96 0
+/- 2.1 0 80/96 76/96 75/96 77/96 100
0.25 6/96 7/96 8/96 7/96 9
0.50 0/96 0/96 0/96 0/96 0
0.75 0/96 0/96 0/96 0/96 0
1.00 0/96 0/96 0/96 0/96 0
-/- 1.1 0 50/96 47/96 55/96 51/96 100
0.25 32/96 35/96 44/96 37/96 73
0.50 4/96 9/96 11/96 8/96 16
0.75 0/96 0/96 0/96 0/96 0
1.00 0/96 0/96 0/96 0/96 0
-/- 2.1 0 56/96 66/96 62/96 61/96 100
0.25 54/96 50/96 56/96 53/96 87
0.50 16/96 16/96 22/96 18/96 29
0.75 1/96 2/96 0/96 1/96 2
1.00 0/96 0/96 0/96 0/96 0
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Figure 4.31 Survival of MLHl knockout trypanosomes in the presence of MNNG
The survival of bloodstream trypanosomes in increasing concentrations of MNNG (shown 
in pg.m f') that had been unaltered at the MLHl locus (WT); that had one MLHl allele 
disrupted (+/-); or that had both MLHl alleles disrupted (-/-) was determined as described 
in Table 4.14.
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Figure 4.32 PCR amplification of microsatellite JS-2 in 3174 MLHl mutant cell
lines
PCR amplification of the JS-2 locus, using the primers JS-2A and JS-2B (see section 2.16), 
was performed using genomic DNA isolated from 10 clones of each 3174 cell line 
(labelled A-J in each case): MLHl wild-type cells (Wild-Types); MLHl heterozygous 
mutants (+/-); and MLHl homozygous mutants (-/-). Control reactions with both primers 
but lacking template DNA were performed for each set of clones (NT). The PCR products 
were separated by electrophoresis on 3% agarose gels. In each case, the PCR products 
derived from five of the MLHl wild-type clones were run along side the products 
amplified from the MLHl mutant clones for ease of comparison.
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M L H l  M u t a n t s
W i l d - T y p e
+ / -  1.1
+ / - 2.1
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Table 4.15 Synopsis of results for microsatellite JS-2 in 3174 MLHl knockout
trypanosomes
The JS-2 microsatellite locus was analysed as shown in Figure 4.32. Ten clones each, 
derived from the 3174 MLHl wild-type cell line (WT); two heterozygous MLHl cell lines 
(+/-); and two MLHl homozygous mutants (-/-) were analysed. The amplified JS-2 alleles 
were compared between the 10 clones derived from the same MLH l mutant cell line, and 
with alleles amplified from 5 MLHl wild-type clones. Alleles which appeared identical 
between the majority of clones derived from the same cell line and with the products 
amplified from the MLHl wild-type clones were considered stable. If all the alleles 
amplified from all the clones derived from the same cell line appeared identical then they 
were also considered stable. Alleles which appeared different from the majority of alleles 
derived from the same cell line were considered mutant versions of the microsatellite. For 
each cell line, the number and percentage of clones in which the JS-2 locus was shown to 
be stable or mutated is given.
C e l l  l i n e N o  o f  c l o n e s  
a n a l y s e d
S t a b l e
c l o n e s
P e r c e n t a g e M u t a t e d
c l o n e s
P e r c e n t a g e
WT 10 10 1 0 0 0 0
+/- 1.1 10 10 1 0 0 0 0
+/- 2.1 10 10 1 0 0 0 0
-/- 1.1 10 8 8 0 2 2 0
-/-2.1 10 10 1 0 0 0 0
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Figure 4.33 Analysis of microsatellite JS-2 in MLHl knockout trypanosomes
The percentage number of clones which were stable (shown in blue) and mutated (shown 
in red) at the JS-2 microsatellite locus was determined as described in Table 4.2. (WT) 
3174 MLH l wild-type trypanosomes; (+/-) 3174 MLHl heterozygous mutants; (-/-) 3174 
MLHl homozygous mutants.
-< ♦/- 2 1 I Stable 
I Mutated
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Percentage of Clones Analysed
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Table 4.16 Genescan analysis of microsatellite ChrI-7 in 3174 MLHl mutant cell
lines
PCR amplification of the ChrI-7 locus was performed using the primers ChrI-7A (labelled 
with 6-FAM) and ChrI-7B (see section 2.16) on genomic DNA isolated from 10 clones of 
each 3174 cell line (designated A-J in each case): (WT) MLHl wild-type trypanosomes; 
(+/-) MLHl heterozygous mutants; (-/-) MLHl homozygous mutants. The PCR products 
were separated by acrylamide-urea gel electrophoresis and the fluorescent bands detected 
by an automated sequencer. The sizes (shown in bp) of the PCR products were determined 
using the GeneScan software as described in Figure 4.13. The size of stable alleles, taking 
migration error into account to give a size range, was determined by comparing the size of 
alleles in every clone analysed, and assessing which sizes occurred most frequently. The 
most frequently observed size was considered the stable, or wild-type, allele length.
Where a PCR product differed from this size by 1 bp or more it was considered to have 
mutated, and the change in length from the stable allele length was determined.
C e l l C l o n e S i z e  o f S t a b l e / S i z e  o f S t a b l e /
L i n e S m a l l e r
A l l e l e
M u t a t e d L a r g e r
A l l e l e
M u t a t e d
WT A 102.7 Stable 217.2 Stable
B 102.7 Stable 217.2 Stable
C 102.7 Stable 217.2 Stable
D 102.7 Stable 217.3 Stable
E 102.7 Stable 217.3 Stable
F 102.7 Stable 217.3 Stable
G 102.4 Stable 218.4 Stable
H 102.5 Stable 2 1 8 . 3 Stable
1 102.5 Stable 218.4 Stable
J 102.5 Stable 218.5 Stable
+/- 1.1 A 102.6 Stable 217.2 Stable
B 102.7 Stable 217.2 Stable
C 102.6 Stable 217.7 Stable
D 102.8 Stable 217.2 Stable
E 102.7 Stable 217.2 Stable
F 102.7 Stable 217.3 Stable
G 102.4 Stable 218.4 Stable
H 102.4 Stable 218.3 Stable
I 102.4 Stable 218.3 Stable
J 102.5 Stable 218.4 Stable
+/- 2.1 A 102.7 Stable 217.2 Stable
B 102.6 Stable 217.2 Stable
C 102.7 Stable 217.3 Stable
D 102.7 Stable 217.1 Stable
E 102.8 Stable 217.2 Stable
F 102.8 Stable 217.2 Stable
G 102.5 Stable 218.3 Stable
H 102.4 Stable 218.3 Stable
I 102.5 Stable 218.4 Stable
J 102.5 Stable 218.4 Stable
Table 4.16 continued
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C e l l C l o n e S i z e  o f S t a b l e / S i z e  o f S t a b l e /
L i n e S m a l l e r M u t a t e d L a r g e r M u t a t e d
A l l e l e A l l e l e
-/- 1.1 A 102.6 Stable 217.3 Stable
B 102.7 Stable 217.2 Stable
C 102.7 Stable 217.2 Stable
D 102.6 Stable 2 1 5 . 7 M u t a t e d  ( - 2 )
E 102.8 Stable 217.3 Stable
F 102.8 Stable 217.3 Stable
G 102.4 Stable 218.3 Stable
H 102.7 Stable 2 1 5 . 7 M u t a t e d  ( - 2 )
1 102.6 Stable 2 1 5 . 8 M u t a t e d  ( - 2 )
J 102.5 Stable 218.4 Stable
-/-2.1 A 102.6 Stable 217.2 Stable
B 1 0 0 . 7 M u t a t e d  ( - 2 ) 217.5 Stable
C 102.6 Stable 2 1 2 . 0 M u t a t e d  ( - 6 )
D 102.8 Stable 217.3 Stable
E 102.8 Stable 217.3 Stable
F 102.6 Stable 2 1 5 . 9 M u t a t e d  ( - 2 )
G 102.6 Stable 2 2 0 . 3 M u t a t e d  ( + 2 )
H 1 0 3 . 4 M u t a t e d  ( + 1  ) 218.5 Stable
I 102.6 Stable 2 1 6 . 1 M u t a t e d  ( - 2 )
J 102.6 Stable 2 2 0 . 4 M u t a t e d  ( + 2 )
Size Range of Allele 102.4 -  102.8 217.1 -218.5
in Stable Clones (bp)
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Figure 4.34 Analysis of microsatellite ChrI-7 in MLHl knockout trypanosomes
The percentage number of clones (A) and alleles (B) which were stable (shown and blue) 
and mutated (shown in red) at the ChrI-7 locus was determined as described in Table 4.17. 
(WT) 3174 MLHl wild-type trypanosomes; (+/-) 3174 MLHl heterozygous mutants; (-/-) 
3174 MLHl homozygous mutants.
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F i g u r e  4 . 3 5  S p e c t r u m  o f  m u t a t i o n s  o b s e r v e d  a t  m i c r o s a t e l l i t e  C h r l - 7  i n  M L H l  
h o m o z y g o u s  m u t a n t s
The ChrI-7 microsatellite locus was analysed as described in Table 4.16. The change in 
allele length from the stable allele length, indicated as either no change (shown in purple), 
addition (+; shown in red) or deletion (-; shown in blue), was calculated for each allele 
from 10 clones each derived from the MLHT'' 1.1 and 2.1 cell lines.
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Table 4.18 Genescan analysis of microsatellite ChrI-15 in 3174 M LHl mutant cell
lines
PCR amplification of the ChrI-15 locus was performed using the primers ChrI-15A 
(labelled with 6-FAM) and ChrI-15B (see section 2.16) on genomic DNA isolated from 10 
clones of each 3174 cell line (designated A-J in each case): (WT) MLH l wild-type 
trypanosomes; (+/-) MLH l heterozygous mutants; (-/-) MLH l homozygous mutants. The 
PCR products were separated by acrylamide-urea gel electrophoresis and the fluorescent 
bands detected by an automated sequencer. The sizes (shown in bp) of the PCR products 
were determined using the GeneScan software as described in Figure 4.13. The size of 
stable alleles, taking migration error into account to give a size range, was determined by 
comparing the size of alleles in every clone analysed, and assessing which sizes occurred 
most frequently. The most frequently observed size was considered the stable, or 
wild-type, allele length. Where a PCR product differed from this size by 1 bp or more it 
was considered to have mutated, and the change in length from the stable allele length was 
determined.
C e l l C l o n e S i z e  o f S t a b l e / S i z e  o f S t a b l e /
L i n e S m a l l e r
A l l e l e
M u t a t e d L a r g e r
A l l e l e
M u t a t e d
WT A 167.2 Stable 175.6 Stable
B 167.2 Stable 175.5 Stable
C 167.2 Stable 175.7 Stable
D 167.2 Stable 175.5 Stable
E 167.2 Stable 175.5 Stable
F 167.2 Stable 175.5 Stable
G 167.2 Stable 175.4 Stable
H 167.0 Stable 175.3 Stable
I 167.0 Stable 175.4 Stable
J 167.2 Stable 175.4 Stable
+/- 1.1 A 167.2 Stable 175.5 Stable
B 167.1 Stable 175.4 Stable
C 167.2 Stable 175.5 Stable
D 167.3 Stable 175.4 Stable
E 167.3 Stable 175.6 Stable
F ND ND ND ND
G 167.2 Stable 175.4 Stable
H 167.2 Stable 175.5 Stable
I 167.2 Stable 175.4 Stable
J 167.2 Stable 175.4 Stable
+/- 2.1 A 167.2 Stable 175.5 Stable
B 167.1 Stable 175.5 Stable
C 167.1 Stable 175.4 Stable
D 167.1 Stable 175.4 Stable
E 167.2 Stable 175.4 Stable
F 167.3 Stable 175.6 Stable
G 167.1 Stable 175.4 Stable
H 167.2 Stable 175.4 Stable
I 167.1 Stable 175.4 Stable
J 167.2 Stable 175.5 Stable
Table 4.18 continued
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C e l l C l o n e S i z e  o f S t a b l e / S i z e  o f S t a b l e /
L i n e S m a l l e r M u t a t e d L a r g e r M u t a t e d
A l l e l e A l l e l e
-/- 1.1 A 167.3 Stable 1 7 7 . 6 Mutated (+2)
B 1 6 9 . 2 Mutated (+2) 1 7 3 . 4 Mutated (-2)
C 167.3 Stable 175.6 Stable
D 167.1 Stable 175.4 Stable
E 167.3 Stable 1 7 3 . 5 Mutated (-2)
F 1 6 5 . 3 Mutated (-2) 1 7 7 . 6 Mutated (+2)
G 167.2 Stable 175.4 Stable
H 167.2 Stable 1 7 3 . 4 Mutated (-2)
I 167.1 Stable 175.4 Stable
J 167.1 Stable 175.4 Stable
- / - 2 . 1 A ND ND ND ND
B 167.3 Stable 175.6 Stable
C 167.3 Stable 175.6 Stable
D 167.3 Stable 1 7 9 . 7 Mutated (+4)
E 167.3 Stable 175.4 Stable
F 167.3 Stable 175.4 Stable
G 167.1 Stable 1 7 3 . 3 Mutated (-2)
H 1 6 2 . 9 Mutated (-4) 175.3 Stable
I 167.2 Stable 175.4 Stable
J 167.2 Stable 175.4 Stable
Size Range of Allele 167.0 -  167.3 175.3 -  175.7
in Stable Clones (bp)
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Figure 4.36 Analysis of microsatellite ChrI-15 in MLHl knockout trypanosomes
The percentage number of clones (A) and alleles (B) which were stable (shown and blue) 
and mutated (shown in red) at the ChrII-15 locus was determined as described in Table 
4.19. (WT) 3174 MLHl wild-type trypanosomes; (+/-) 3174 MLH l heterozygous mutants; 
(-/-) 3174 MLHl homozygous mutants.
A)
+ / - 1.1
-  + / - 2.1 I Stable 
IkAjtated
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Percentage of Clones Analysed
B)
WT
♦/-11
+/-2 1
- / - 1.1
-/-2 1
I Stable 
I Mutated
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Percentage of Alleles Analysed
276
F i g u r e  4 . 3 7  S p e c t r u m  o f  m u t a t i o n s  o b s e r v e d  a t  m i c r o s a t e l l i t e  C h r I - 1 5  i n  M L H l  
h o m o z y g o u s  m u t a n t s
The ChrI-15 microsatellite locus was analysed as described in Table 4.18. The change in 
allele length from the stable allele length, indicated as either no change (shown in purple), 
addition (+; shown in red) or deletion (-; shown in blue), was calculated for each allele 
from 10 clones derived from the MLHl '' 1.1 cell line, and 9 clones derived from the 
MLHV'- 2.1 cell line.
(g 20
- 4 - 2  0 + 2
Change in allele length (bp)
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T a b l e  4 . 2 0  M u t a t i o n a l  s p e c t r u m  o f  M L H V ^ '  m u t a n t s  a n a l y s e d  b y  G e n e S c a n  i n  
T .  b m c e i
The microsatellite loci were amplified by PCR, using one fiuorescently-labelled primer and 
an unmodified primer, and the PCR products separated by acrylamide-urea gel 
electrophoresis. The resulting fluorescent bands were detected using an automated 
sequencer and analysed using the GeneScan system. After comparing the size of alleles at 
a given locus in every sample, the most frequently observed size was determined to be the 
size of the wild-type or stable allele. Where a PCR product differed from this size by 1 bp 
or more it was considered to have mutated, and the change in length fi-om the size of the 
stable allele was calculated. For each microsatellite locus the number of clones and alleles 
analysed is given, and the number of alleles which increased (+) or decreased (-) in length 
is shovm. The total number of mutations of a given size at both loci has been calculated 
and expressed as a percentage of all the mutations observed.
N u m b e r  o f  t r a c t s  w i t h  a d d i t i o n s  ( + )  o r  d e l e t i o n s  ( - )  
o f  b a s e - p a i r s
L o c u s T y p e
o f
R e p e a t
N o .  o f  
c l o n e s  
( a l l e l e s )  
a n a l y s e d
- 6 - 4 - 2 + 1 + 2 + 4
ChrI-7 GT 20 (40) 1 0 6 1 2 0
ChrI-15 GT 19(38) 0 1 5 0 3 1
N u m b e r  o f  M u t a t i o n s  
( t o t a l  n u m b e r  a n a l y s e d )
1/20 1/20 11/20 1/20 5/20 1/20
P e r c e n t a g e  o f  M u t a t i o n s 5 5 55 5 25 5
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T a b l e  4 . 2 1  E f f e c t  o f  M L H l  m u t a t i o n  o n  t h e  f r e q u e n c y  o f  V S G  s w i t c h i n g  i n  t h e
3 1 7 4  t r y p a n o s o m e  s t r a i n
The frequency of VSG switching was determined as described in Materials and Methods 
(see section 2.15) using 3174 bloodstream trypanosomes that had been unaltered at the 
MLH l locus (WT); that had one MLH l allele disrupted (+/-); or that had both MLHl 
alleles disrupted (-/-). In each independent experiment, switched trypanosomes were 
plated over 96-well plates in HMI-9 and the number of wells containing growth were 
counted after 10 days. The number of VSG switching events/cell/generation (estimated 
VSG switching frequency (x 10'^)) was determined as described in McCulloch et a l 
(1997).
S t r a i n
N o  o f  w e l l s  
g r o w i n g
E s t i m a t e d  V S G  
s w i t c h i n g  f r e q u e n c y
(X 10*)
WT 64/96 1.00
9/96 0.14
3/96 0.05
65/96 1.02
A v e r a g e 35/96 0.55
+/“ 1.1 13/96 0.20
7/96 0.11
16/96 0.25
A v e r a g e 12/96 0.19
+/- 2.1 23/96 0.36
14/96 0.22
15/96 0.23
A v e r a g e 17/96 0.27
-/- 1.1 62/96 0.97
28/96 0.44
A v e r a g e 45/96 0.71
V-2T 3/96 0.05
27/96 0.42
16/96 0.25
A v e r a g e 15/96 0.24
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F i g u r e  4 . 3 8  E f f e c t  o f  M L H l  m u t a t i o n  o n  t h e  f r e q u e n c y  o f  V S G  s w i t c h i n g  i n  t h e  
3 1 7 4  t r y p a n o s o m e  s t r a i n
The average frequency of VSG switching was determined as described in Table 4.21 using 
3174 bloodstream trypanosomes that had been unaltered at the MLH l locus (WT; shown in 
green); that had one MLHl allele disrupted (+/-; shown in blue); or that had both MLHl 
alleles disrupted (-/-; shown in red). Error bars depict standard deviation.
I  k  0 . 4
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Table 4.22 VSG switching mechanisms used by M LHl wild-type and MLHl
mutant trypanosomes
The types of switching event used by untransformed 3174 bloodstream forms (WT); 3174 
cells transformed with AMLHlr.PUR (+/-); and 3174 cells transformed with both 
AMLH1::PUR and AMLHlr.BSD (-/-) was determined as described in Figure 4.22, 
Materials and Methods (see section 2.15) and McCulloch et al. (1997).
S t r a i n
( n o .  o f  s w i t c h e d  v a r i a n t s  
a n a l y s e d )
I n  s i t u  s w i t c h E x p r e s s i o n  s i t e  
g e n e  c o n v e r s i o n
V S G  g e n e  
c o n v e r s i o n
MLH l wild-type (30) 3/30 16/30 11/30
10% 53% 37%
MLH l +/- 1.1 (25) 6/25 16/25 3/25
24% 64% 12%
MLH l +/- 2.1 (29) 14/29 4/29 11/29
48% 14% 38%
MLH l -/- 1.1 (20) 6/20 8/20 6/20
30% 40% 30%
M L H l-l-l.X  (21) 5/21 16/21 0/21
24% 76% 0%
281
Figure 4.39 VSG switching mechanisms used by MLHl knockout trypanosomes
The types of switching event used were determined as described in Table 4.22 for 
untransformed 3174 bloodstream forms (WT); 3174 cells transformed with AMLHlr.PUR 
(+/-); and 3174 cells transformed with both AMLHlr.PUR and AMLHlr.BSD  (-/-). For 
each cell line the percentage of switched variants generated by in situ transcriptional 
switching (shown in blue), expression site gene conversion (shown in red), and VSG gene 
conversion (shown in yellow) are presented.
80
70
c0) 60  O)
.2 50
2  40
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4.4 Discussion
In order to confirm that the putative MSH2 and MLH l genes encoded active components of 
a nuclear MMR system in T, brucei, a strategy to generate homozygous knockout mutants 
of each of these genes was developed. Since this study involved long-term functional 
assays, a well-established method of gene dismption was adopted, involving homology- 
directed gene targeting and stable integration of antibiotic resistance markers into the 
trypanosome genome (Ray and Hines, 1995; Lief a/., 1996; McCulloch and Barry, 1999). 
Homozygous knockout mutants were generated for each of the genes, indicating that it is 
possible to remove all intact transcripts of either MSH2 or MLH l, and thus all expression 
of either the MSH2 or MLHl proteins, and trypanosomes remain viable. However, to 
confirm that any phenotypes observed were due to the loss of MMR, and not to changes 
which arose during cloning and selection of the transformants, a copy of the MSH2 ORF 
was re-integrated into one of the MSH2 homozygous mutants. The equivalent re-expressor 
cell line was not generated for MLH l since the properties of MLH l mutant cell lines were 
investigated primarily to confirm the results obtained in MS/L2-deficient trypanosomes. As 
predicted by studies of MMR in other eukaryotes, the phenotypes observed for MLHl 
mutants were essentially the same as those observed in MSH2 knockout cell lines. As it 
seems highly unlikely that such similar phenotypes could arise in MLH l knockout 
trypanosomes as a consequence of the cloning and selection process used to generate the 
cell lines, it was deemed unnecessary to generate an MLH l re-expressor cell line.
Since neither gene is essential in other eukaryotes it was expected that both MSH2 and 
MLH l knockout trypanosomes would be viable (Strand et a l ,  1993; Durant et a l, 1999; 
Flores and Engels, 1999; Degtyareva et a l , 2002). Analysis of the MSH2 mutant 
trypanosomes revealed no differences in growth compared with MSH2 wild-type cells 
(Figure 4.7). This is similar to the results of MSH2 insertion mutations in S. cerevisiae, 
where no obvious effects on cell growth were identified in diploid cells (Reenan and 
Kolodner, 1992a). Similarly, MSH2'^' mouse ES cells were indistinguishable from MSH2 
wild-type cells with respect to growth and plating efficiency, and MSH2'^' mice were 
healthy at birth and fertile, although they were predisposed to tumorigenesis (de Wind et 
a l , 1995). This study also revealed that ML/77-deficient trypanosomes showed no 
difference in growth in comparison with MLH l wild-type cells (Figure 4.30). Again, this 
bears comparison to other eukaryotes, since disruption of S. cerevisiae MLH l does not lead 
to growth rate changes in diploid cells (Prolla et a l , 1994a), and MLHl'^' mice are healthy 
at birth, but develop tumours at the same time of onset as MSH2'^' mutants (Baker et a l , 
1996). M LH r‘~ mutants reveal some differences compared to MSH2''~, however.
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Disruption of S. cerevisiae MLH l causes an increase in spore lethality and increased post- 
meiotic segregation (Prolla et a l , 1994a), and both female and male MLHF'' mice are 
infertile (Baker et a l , 1996). Studies indicate that MLHl'^' spermatocytes arrest in meiosis 
I with prematurely separated chromosomes (Baker et a l, 1996; Edelmann and 
Kucherlapati, 1996). While T. brucei possesses a non-obligatory sexual cycle which 
occurs between life cycle stages in the tsetse fly vector, it is unknown whether this process 
of genetic exchange involves meiosis, although segregation is Mendelian (Jenni et a l , 
1986; Gibson and Stevens, 1999). Currently it would be technically challenging to 
determine whether MLHl is involved in genetic exchange in this organism, given the 
difficulties of generating knockout mutants in the pleomorphic cell lines used during 
mating experiments, and the low rates of T. brucei transmission through the tsetse fly 
vector. However, it is interesting to note that putative homologues of MSH4 and MSH5, 
the components of the MutS-related heterodimer involved in meiosis, are also present in 
the T. brucei genome (data not shown), perhaps suggesting that meiosis is involved in the 
trypanosome sexual cycle, and that the roles of the MutS and MutL homologues associated 
with this process in other eukaryotes are conserved in this organism.
Loss of MMR in bacteria and some eukaryotes (see below) is associated with increased 
resistance to a number of cytotoxic drugs, including the alkylating agent, MNNG (Karran 
and Marinus, 1982; Branch et a l ,  1993; Koi et a l, 1994; Hawn et a l , 1995). This study 
has revealed that inactivation of either MSH2 or MLH l in T. brucei results in increased 
resistance to MNNG, and therefore the phenotype of méthylation tolerance (Tables 4.1 and 
4.14 and Figures 4.8 and 4.31). The results of these assays appear to suggest that 
inactivation of MLH l results in a greater increase in resistance to méthylation than does 
inactivation of MSH2. As discussed in section 4.3.5, it seems likely that this is simply a 
consequence of the cells growing more poorly during the MLH l analysis that was 
performed later, probably due to altered growth conditions. Nevertheless, it maybe 
interesting to repeat the MNNG survival assays for both the MSH2 and MLH l mutants to 
determine if a difference in méthylation tolerance does exist. In contrast to bacteria and 
mammalian cells, MMR-deficient yeast cells and fruit flies do not exhibit increased 
resistance to MNNG (Xiao et a l, 1995; Flores and Engels, 1999). It is not clear why the 
MMR systems of S. cerevisiae and D. melanogaster should differ in this respect, primarily 
due to a lack of complete understanding of the mechanism of méthylation tolerance. 
However, this study reveals that the phenotype of méthylation tolerance in eukaryotes is 
not limited solely to mammalian cells. Under normal cellular conditions in most 
eukaryotes, 0*-meG lesions would be repaired by the highly conserved MGMT protein 
(described in section 4.2.6). This is also likely to be the case in trypanosomes, as BLAST
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searching of the T. brucei sequencing databases revealed that a putative MGMT 
homologue is present in the genome (data not shown). Nothing is known about the 
expression levels of this gene in T. brucei, nor has it been functionally characterised, but it 
may be that insufficient levels of MGMT are available to repair the lesions formed after 
treatment with the concentrations of MNNG used here and thereby prevent cell death.
Another phenotype associated with the loss of MMR is micro satellite instability (described 
in section 4.2.7). In other organisms, MMR-deficient cells exhibit a mutator phenotype 
since mismatches arising in DNA during replication, or due to the actions of chemical 
mutagens, are not recognised and repaired (Levinson and Gutman, 1987; Strand et a l,
1993; de Wind et a l, 1995; Baker et al., 1996). The mutation rate is elevated in such cells, 
and while mutations occur more frequently throughout the genome, the rate of mutation at 
microsatellite loci is more greatly increased, due to slippage of the DNA polymerases over 
repetitive sequences during replication (Strand et a l ,  1993; Prolla et a l ,  1994a; Strauss, 
1999; Ellegren, 2000b). Since a number of microsatellite loci have been well characterised 
in T. brucei (Hope et a l , 1999; A. MacLeod, A. Tweedie, S. McLellan, C.M.R. Turner, 
and A. Tait, personal communication), an assay to investigate whether the frequency of 
mutation at such loci was elevated in MMR-deficient trypanosomes was utilised. Five 
microsatellite loci were investigated in the MSH2''" mutants, and mutant alleles were 
detected at four of these loci (Figure 4.11 and Tables 4.3, 4.5, 4.7 and 4.9). Of these four 
loci, the three which showed the greatest frequency of mutation in MSH2''~ mutants were 
also analysed in the mutants, and mutant alleles were observed in all three
microsatellites (Figure 4.32 and Tables 4.16 and 4.18). The results of these assays clearly 
demonstrate that inactivation of either MSH2 or MLH l results in the mutator phenotype, 
MSI. Since MSI results from a failure to repair replication errors (Claij and te Riele,
1999), this indicates that the MMR system is involved in the correction of replication 
slippage events in T. brucei.
In general, slightly fewer mutations were observed in the M LH l''' mutants than in the 
MSH2’'~ clones, but it is possible that these differences arose because the MLH l''' mutant 
cell lines were cultured for a shorter period of time before cloning than the MSH2''' 
mutants, allowing fewer generations to accumulate mutations. No rates of microsatellite 
instability can be inferred from these data as the number of generations the mutant cells 
were cultured for after their generation and prior to re-cloning was unknown, as was the 
sequence of the microsatellite loci in the parental clones. The assay was designed simply 
to demonstrate whether or not inactivation of MMR resulted in an MSI phenotype in 
T. brucei. However, the assay could be adapted to allow determination of the frequency of
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microsatellite mutation in MMR-deficient trypanosomes. This would involve cloning of 
the cell lines prior to growth in culture for a given length of time. A sample of cells would 
be removed from an early passage and the genomic DNA isolated so that the microsatellite 
loci could be sequenced to determine the length of the parental or wild-type microsatellites. 
It would also be important to assay the growth rate of the cells so that the number of 
generations the eells had undergone since cloning could be estimated for the final genomic 
DNA samples. After the period in culture, the cells would be re-cloned to separate cells 
containing mutated microsatellite alleles from cells containing wild-type alleles, and 
genomic DNA would then be isolated from these cultures. GeneScan analysis of the 
microsatellite loci in the genomic DNA samples would reveal the number of clones 
containing mutated microsatellites. In conjunction with the estimate of the number of 
generations the cells had undergone since cloning, these data could be used to estimate the 
frequency of microsatellite mutation in MMR mutants. Moreover, if a large enough 
number of wild-type clones were analysed, it might also be possible to infer a mutational 
frequency for microsatellites in MMR-proficient T. brucei cells.
The first of the microsatellite loci investigated in both the MSH2''~ and MLHV'' mutant cell 
lines, JS-2, was analysed by agarose gel electrophoresis. This revealed that greater 
changes in microsatellite length were apparent in MSH2''' and MLHV'' mutants than in 
cells expressing both these genes (Table 4.2 and Table 4.15). However, while this method 
is quick and simple, and can be used to differentiate relatively large changes in allele size 
only, it cannot be used to determine the length of alleles precisely. For this reason, a 
fluorescence-based PCR method, GeneScan analysis, was adopted.
GeneScan analysis allows the determination of the precise length of microsatellite alleles, 
and therefore mutations altering the length of these alleles can be accurately characterised. 
This study has revealed that in MMR-deficient cells, for all the microsatellites analysed, 
except ChrII-6 where no mutations were observed, there was a bias towards mutations 
which resulted in a decrease in microsatellite length. These events accounted for 
approximately two thirds of the 46 mutations analysed in the MSH2'^' and mutant
backgrounds (Tables 4.11 and 4.20). This is in contrast to the findings in other eukaryotes 
(see below; Wierdl et a l ,  1997; Yamada et a l, 2002). Further analysis of the data gathered 
during this study shows that the majority of the mutational events appear to involve the 
addition or deletion of one repeat unit. Conversely, this is in agreement with the findings in 
yeast and mammals (Henderson and Petes, 1992; Weber and Wong, 1993; Wierdl et a l, 
1997; Twerdi et a l ,  1999). In yeast and mammalian cells there is a tendency for mutations 
to increase the length of a microsatellite, until the allele reaches a threshold size, after
286
which deletions become more common, thereby preventing infinite growth of the 
microsatellite sequence (Wierdl et a l , 1997). Similarly, a slight bias towards increasing 
microsatellite length has been reported for D. melanogaster (Flores and Engels, 1999). A 
probable explanation for this discrepancy lies in the size of the microsatellite alleles 
analysed in this study. In yeast it has been shown that GT-dinucleotide repeat tracts 51 bp 
(25 repeat units) or longer in length exhibit significantly more large deletions than similar 
tracts 33 bp (16 repeat units) or less in length (Wierdl et a l , 1997). Similar results have 
also been observed in human cells (Yamada et a l , 2002). Since the smallest allele 
containing GT-dinucleotide repeats analysed in this study contained 18 repeat units (the 
ChrI-7 smaller allele), it is probable that the mutational bias observed towards decreasing 
microsatellite length in this study of MSH2''' and MLHl''" mutant trypanosomes has arisen 
due to the large size of the microsatellite alleles analysed. If a mutational bias towards 
decreasing microsatellite length is really active in T. brucei, it would be difficult to explain 
how this organism could maintain its large array of microsatellite loci. In addition, as no 
mutations were observed in any of the microsatellites in MMR-proficient trypanosomes, it 
is impossible to determine if the mutations observed in the MSH2''" and MLHl"'" mutants 
reflect the mutational dynamics of these loci in wild-type T. brucei.
Comparison of the GeneScan analysis results from both the MSH2''" and MLHV'' mutants, 
indicates that the frequency of replication slippage increases with the number of repeat 
units encoded within the micro satellite allele. This phenomenon is also observed in yeast 
and human microsatellites, where the number of mutations observed increases as the length 
of the allele increases (Wierdl et a l , 1997; Ellegren, 2000a; Yamada et a l ,  2002).
Although the ChrI-7 and ChrI-15 microsatellite loci are not directly comparable as they are 
found in distinct genomic locations, they both contain GT-dinucleotide repeats, and so the 
mutational pressures on these loci may be similar. Sequencing has shown that in stable 
clones the smaller allele of ChrI-7 contains 18 perfect repeats, while the larger allele 
comprises 70 imperfect repeat units (Figure 4.14). At least 50% of MSH2''" and MLHl"'' 
clones were mutated at this locus: 8% of the clones analysed were mutated at the smaller 
allele, but the larger allele was mutated in 49% of the clones analysed (see Tables 4.4 and 
4.17). For ChrI-15, the stable allele sizes differ by only 8 bp, and the smaller allele 
contains 30 perfect repeats, which is intermediate between the two alleles of ChrI-7 (Figure 
4.14). (The larger allele of ChrI-15 was omitted from this analysis because its sequence is 
unknown, although it probably contains 34 GT-dinucleotide repeats.) Again, at least 50% 
o f MSH2''" and MLHl"'" clones were mutated at this locus, and overall, the smaller ChrI-15 
allele was mutated in 26% of the clones analysed (see Tables 4.6 and 4.19). It should also 
be noted that studies in yeast have revealed that interruption of the microsatellite by variant
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repeats, such as the imperfections seen in the ChrI-7 larger allele, have a strong stabilising 
effect on the microsatellite (Petes et a l, 1997). It is therefore possible that the mutation 
rate observed for the Chrl-7 larger allele may not be as high as it would have been if the 
microsatellite sequence was not interrupted.
In E. coli, artificial GC- and AT-dinucleotide repeats have been shown to mutate at a 
higher frequency than other, non-self-complementary dinucleotide repeats (Bichara et a l ,
2000). It is also possible that different repeat sequences exhibit different mutation rates in 
T. brucei. Unfortunately, although microsatellites composed of repeat units with different 
sequences were included in the analysis performed using the MSH2''' mutants, very little 
can be inferred about the effect of repeat unit sequence on microsatellite stability, because 
the data set generated during this study is very small. Both the ChrI-7 and ChrI-15 loci are 
composed of GT-dinucleotide repeats, while PLC contains TA-dinucleotide repeats, and 
ChrII-6 consists of CT-dinucleotide repeats (Figures 4.14 and 4.15). On average, the PLC 
locus contained mutations in 15% of the MSH2''~ clones (Table 4.8). By comparison, an 
average of only 5% of the same clones contained mutations in the smaller allele of the 
ChrI-7 locus (Table 4.4). Although these alleles are not directly comparable, since the 
smaller allele of ChrI-7 contains 18 perfect repeat units, while the PLC allele only contains 
12 perfect repeat units, the greater frequency of mutation of the PLC allele may indicate 
that TA-dinucleotide repeats are more unstable in T. brucei than GT-dinucleotide repeats. 
No mutations were observed for the ChrII-6 microsatellite locus in any of the clones 
analysed, suggesting that the mutation rate at this locus is very low. This is not surprising 
given the small size and imperfect sequence of this microsatellite in 3174 trypanosomes.
In order to assess the effect of repeat unit sequence on the frequency of micro satellite 
mutation in T. brucei, it would probably be necessary to develop a range of size-matched 
artificial microsatellite alleles which could be integrated into the genome. By targeting the 
alleles to different regions of the genome it would be possible not only to assess the effect 
of base composition on microsatellite stability but also the influence of genomic context.
Finally, an assay to determine the frequency of, and mechanisms used during, antigenic 
variation was employed to determine whether MMR was involved in the regulation of VSG 
switching in T. brucei. The frequency of VSG switching was similar in wild-type 
trypanosomes, MSH2'^'' cells, MSH2~''‘ mutants and MSH2'^'^^ cells (Table 4.12 and Figure 
4.23), and there was no clearly detectable change in the relative levels of transcriptional 
versus recombinational VSG switching mechanisms between the cell lines (Table 4.13 and 
Figure 4.24), indicating that the product of the MSH2 gene has little or no effect on 
antigenic variation. Extrapolation from data generated in other eukaryotes suggested that
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MSH2 may be involved in the inhibition of recombination between divergent sequences in 
T. brucei (de Wind et a l ,  1995; Datta et a l , 1996; Nicholson et a l ,  2000), and thus might 
be expected to down-regulate recombinational VSG switching. It was therefore 
hypothesised that inactivation of MSH2 might increase the frequency of recombinational 
VSG switching. In contrast, other studies in eukaryotes have revealed that MSH2 may also 
be required to facilitate resolution of recombination intermediates (Sugawara et a l, 1997; 
Marsischky et a l , 1999), and thus loss of MSH2 might also be expected to decrease the 
frequency of recombination because the protein would not be available to perform these 
functions. If this were the case in T. brucei, loss of MSH2 might not result in a detectable 
change in VSG switching, as the protein would perform both an active and suppressive 
role. However, this possibility was excluded by the data derived by performing the assay 
using MLHl^^' cells and MLHV'' mutants. Again, all these cell lines underwent VSG 
switching at a similar frequency to the wild-type (Table 4.21 and Figure 4.38) and there 
was no detectable change in the mechanisms used during antigenic variation (Table 4.22 
and Figure 4.39). MLHl has not been implicated in the resolution of recombination 
intermediates, but is known to be involved in the inhibition of homeologous recombination 
in other eukaryotes (Nicholson et al., 2000). In T. brucei, MLHl would be predicted to 
suppress recombinational VSG switching, and so the frequency of expression site gene 
conversion and VSG gene conversion would be expected to increase in ML/77-deficient 
trypanosomes. Since this is not the case, and the results of the VSG switching assay 
indicate that neither MSH2 or MLH l affect either the frequency of, or mechanisms used 
during, VSG switching in trypanosomes, it is probable that MMR exerts little or no 
influence over antigenic variation in T. brucei.
It has been hypothesised that the monomorphic cell line MITat 1.2a S427 used during this 
analysis is deficient in an active mechanism which promotes recombinational VSG 
switching in pleomorphic cell lines (Barry, 1997b; Robinson et a l , 1999). An enzymatic 
activity that promotes homologous recombination has been invoked to explain the 
discrepancy in VSG switching rates between monomorphic and pleomorphic trypanosomes 
strains, which differ by several orders of magnitude (Lamont et a l ,  1986; Turner and 
Barry, 1989; Turner, 1997). However, in bacteria, loss of MMR can lead to a 1000-fold 
increase in recombination between divergent DNA sequences, allowing inter-species 
recombination to occur (Rayssiguier et a l, 1989). Therefore, it was possible, if highly 
unlikely, that pleomorphic trypanosomes achieved their high rates of VSG switching via 
down-regulation or inactivation of MMR. Since inactivation of MSH2 or MLH l caused no 
substantial alterations to either the frequency of, or mechanisms used during, antigenic
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variation in the monomorphic line used in this study, MMR cannot account for the huge 
differences in VSG switching rates between monomorphic and pleomorphic trypanosomes.
The VSG switching assay used in this study relies upon in vivo selection of switched 
trypanosomes, and it is necessary to make a number of assumptions about the data in order 
to calculate VSG switching frequencies. This reduces the sensitivity and reproducibility of 
the assay, perhaps to the point where subtle changes induced by inactivation of genes such 
as MSH2 and MLH l cannot be detected. It is possible, therefore, that MMR may play a 
small regulatory role in antigenic variation, but that the changes caused by inactivation of 
MSH2 or MLH l are beneath the threshold which can be detected by the approach adopted. 
Furthermore, this assay is not able to detect changes in the order of VSG gene expression, 
since it looks only at one relapse peak, rather than a long-term infection. It has been 
demonstrated that different VSGs are activated at different points during the course of an 
infection (Gray, 1965; Capbern et a l, 1977; Barry, 1986a). Some VSGs are activated 
early in infection, some are expressed later during infection, and others are expressed 
towards the end of infection. It is possible that the probability of a given VSG being 
activated by recombinational switching is dependent on the level of homology between its 
flanking sequences, and the sequence flanking the active VSG. Given that MMR is known 
to regulate recombination between non-identical DNA sequences (Shen and Huang, 1989; 
de Wind et a l ,  1995; Datta et a l ,  1996), it is possible that MMR might regulate 
recombinational switching, and thus the hierarchy of VSG expression in T. brucei.
The functions of a number of other genes in trypanosome antigenic variation have now 
been assessed using the same VSG switching assay. The first knockout mutants analysed 
in this way were inactivated for the RAD51 gene, which encodes a primary component of 
the homologous recombination machinery in trypanosomes (McCulloch and Barry, 1999). 
RADSr^' mutant cell lines displayed a reduced frequency of antigenic variation and were 
impaired in their ability to undergo both transcriptional and recombinational VSG 
switching, indicating that the gene was either involved in the regulation or catalysis of 
these processes. However, VSG switching was not completely ablated in RAD51'^' cell 
lines and switched variants were isolated which had arisen by both the transcriptional and 
recombinational VSG switching mechanisms in these cells. More recently, the roles of the 
KU70 and M R E ll genes have been investigated using the VSG switching assay. 
Extrapolation from other eukaryotes suggests that KU70 encodes a component of the 
NHEJ machinery, catalysing a double-strand break repair pathway that competes with 
homologous recombination in other eukaryotes (Pâques and Haber, 1999; Cromie et a l ,
2001). While any potential contribution of KU70 to DNA recombination has not been
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directly investigated in T. brucei, Conway et a l (2002a) have shovm that inactivation of 
this gene has no effect on antigenic variation. This is in keeping with the supposition that 
antigenic variation occurs by homologous recombination. Surprisingly, however, 
inactivation of T. brucei M RE ll also had no discernible effect on VSG switching 
(Robinson et a l, 2002). In other eukaryotes, MREl 1 forms a complex with RAD50, and 
either XRS2 in yeast, or NBSl in mammals. This complex is thought to be involved in the 
nucleolytic processing of DSBs, and DNA damage checkpoint signalling, and is also 
believed to play a structural role in the alignment of DNA ends in both homologous 
recombination and NHEJ (D'Amours and Jackson, 2002; Hopfner et a l , 2002). The fact 
that M R E ll mutation does not affect antigenic variation may suggest that it occurs via a 
pathway of homologous recombination that is different to general DNA damage repair 
pathways. Recently, analysis of general recombination in RAD5r^' cells has revealed that 
trypanosomes possess at least two, and perhaps three, pathways of homologous 
recombination (Conway et a l ,  2002b). It is also known that at least two of these pathways 
can promote VSG switching, in either a RAD51-dependent or -independent manner 
(McCulloch and Barry, 1999). It is clear that we are far from fully understanding the 
controls and mechanisms that underlie VSG switching, and it remains possible that the 
process involves a distinct RAD 51 -dependent pathway which does not require M REll, 
and which is not influenced by MMR. This hypothesis may be supported by the recent 
finding that VSG switching events, in which the upstream limit of gene conversion maps to 
the 70-bp repeats, can utilise as little as 40 bp of homology between the donor repeat 
sequence and the 70-bp repeats within the recipient expression site (P. Burton and J. D. 
Barry, personal communication). It is possible that most, if not all, VSG switching events 
utilise small regions of homology, thereby avoiding MMR surveillance and inhibition. It 
would be valuable, therefore, to determine the role of MMR and sequence divergence in 
the regulation of recombination in T. brucei. To this end, an assay has been developed to 
investigate both homologous and homeologous recombination in wild-type and MMR- 
deficient trypanosomes, and is described in Chapter 5 of this work. Studies to date have 
suggested that transcriptional switching is at least as frequently used as recombinational 
switching during antigenic variation in monomorphic trypanosomes (Liu e/ a l , 1985; 
McCulloch and Barry, 1999), while recombinational VSG switching appears to 
predominate in the fast-switching pleomorphic cell lines (Robinson et a l , 1999). It is 
likely, therefore, that a full understanding of the role of MMR in VSG switching will not be 
elucidated until techniques for investigating antigenic variation in pleomorphic cell lines 
are readily available.
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C h a p t e r  5
An assay to determine the influence of 
mismatch repair on trypanosome 
homeologous recombination
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5.1 Introduction
Recombination between homeologous (divergent) DNA sequences occurs much less 
efficiently than recombination between homologous (identical) sequences in such diverse 
organisms as bacteria, yeast and mammals (reviewed in Evans and Alani, 2000). During 
heteroduplex formation between two independent but complementary single-stranded 
DNA molecules, mismatched base-pairs form where the single-strands differ in sequence. 
These mispairs seem to be subject to recognition by components of the MMR system since 
the frequency of recombination between divergent sequences is often greatly elevated in 
MMR-deficient cell lines (Shen and Huang, 1989; Alani et a l ,  1994; de Wind et a l,  1995; 
Selva et a l ,  1995; Datta et a l ,  1996; Datta et a l , 1997). This evidence suggests that MMR 
forms the basis of an active anti-recombination activity within the cell. Indeed, it has been 
reported that even a single mismatch is sufficient to inhibit recombination in S. cerevisiae 
(Datta et a l , 1997). Studies in yeast have shown that MSH2 mutants exhibit the greatest 
elevation in homeologous recombination frequencies, compared with wild-type strains, 
suggesting that this protein possesses the most potent anti-recombination activity 
(Nicholson et a l , 2000). Similar elevations in homeologous recombination frequency 
were observed with MSH3 MSH6 double mutants suggesting that these proteins act in 
concert with MSH2, forming heterodimers with similar roles to those performed in MMR. 
However, analysis of MLHl and PMSl single mutants and MLHl PMSl double mutants 
indicated that although these proteins appear to act as a heterodimer, as in MMR, they are 
involved in repressing only a portion of the homeologous recombination events inhibited 
by MSH2, since none of these mutants show the same elevation in recombination as MSH2 
mutants (Datta et a l , 1996; Nicholson et a l,  2000). This suggests that the MutS-related 
proteins can block some homeologous recombination events without the assistance of the 
MLHl-PMSl heterodimer, indicating that the mechanism underlying this anti­
recombination activity has distinct characteristics compared with the mechanism of MMR.
It is clear that the combined results from MSH2- and ML/77-deficient trypanosomes 
confirm the existence of an active MMR system in T. brucei, and indicate that MSH2 and 
MLHl represent genuine homologues of mutS and mutL respectively. As in other 
eukaryotes, inactivation of MSH2 or MLHl results in both méthylation tolerance and 
microsatellite instability, two phenotypes which are commonly detected in MMR-deficient 
cells, and can be considered diagnostic when investigating potential components of the 
MMR system. Furthermore, the observation that MMR exerts little or no influence on 
antigenic variation in this organism indicates that VSG switching may rely on a distinct 
recombination mechanism, which perhaps relies on only short stretches of sequence
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homology, or which can successfully bypass sequence heterology. In this chapter, an assay 
will be described whose use will help elucidate the effect of sequence divergence on the 
frequency of recombination in both MMR-proficient and MMR-deficient trypanosomes.
5.2 Design of an assay to determine the frequency of integration of homologous 
and homeologous constructs into MMR-deficient trypanosomes
In order to assess the impact of MMR on homologous and homeologous recombination in 
r. brucei, an assay was developed to determine the frequency of integration of increasingly 
divergent targeting constructs into the trypanosome genome. For explanatory purposes the 
assay system can be considered as three separate components: a T. brucei cell line 
containing an unique target integration site; a set of MMR mutant trypanosomes containing 
this integration site; and a set of targeting constructs that possess integration flanks for 
homologous recombination based on the sequence of this integration site, but which 
contain increasing numbers of heterologies compared with this sequence. Figure 5.1 
shows an overview of this experimental approach.
It was necessary that the sequence chosen as the integration site fulfilled a number of 
criteria. Firstly, it was important that the exact sequence of the locus chosen as the 
integration site was known so that the level of divergence of the targeting constructs could 
be accurately calculated. It was also necessary that this sequence be unique in the genome, 
otherwise the targeting constructs might be able to integrate into related sequences. 
Furthermore, it would be interesting to determine the relative frequencies of integration, 
and therefore recombination, into different genomic locations, including chromosome- 
internal and telomeric sites, using the same targeting constructs so that the results would be 
directly comparable. Given these requirements, no native T. brucei sequence seemed 
adequate. Instead, the one type of targeting sequence which fulfilled all these requirements 
was a bacterial antibiotic resistance gene integrated into the T. brucei genome. Such an 
antibiotic resistance gene should not only have no natural T. brucei related sequences, but 
could be integrated anywhere within the genome by modification of associated targeting 
and processing flanks, and could be targeted by a single set of increasingly divergent 
homeologous constructs. For this reason, the hygromycin phosphotransferase {HYG) ORF 
was chosen as the integration site.
For this assay, the tubulin array was chosen as the chromosome-internal location into 
which the HYG ORF would be inserted, since a construct targeting the HYG gene to this 
locus was already available (Figure 5.1 A and Figure 5.2). The plasmid pHygro-Tub
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contains the HYG ORF flanked at the 5’ end by 230 bp of a-(3 tubulin intergenic sequence 
and at the 3’ end by 300 bp of (3-a tubulin intergenic sequence. These intergenic 
sequences act as targeting flanks for the replacement of an a  tubulin gene, and also provide 
splicing signals for the HYG ORF allowing transcripts of the gene to be processed into 
mature mRNAs. The HYG gene is expressed by endogenous tubulin transcription since the 
targeting construct contains no promoter elements. Transformation of MITat 1.2a S427 
bloodstream form trypanosomes with the linearised pHygro-Tub construct would generate 
the HTUB cell line (see section 5.3).
Having generated a unique targeting site, the assay required that MMR mutants be 
generated in this HTUB background. Since extrapolation from other eukaryotes suggested 
that loss of MSH2 should result in greater increases in the frequency of homologous and 
homeologous recombination than loss of MLH l (Nicholson et a l, 2000), it was decided 
that inactivation of MSH2 would afford the best opportunity to assess the usefulness of this 
assay (Figure 5.IB). As described in section 4.2, Imockout constructs have been developed 
for the deletion of both copies of the MSH2 ORF in T. brucei. The HTUB cell line was 
therefore transformed with the AMSH2::PUR and AMSH2::BSD constructs to generate two 
independent MSH2 knockout cell lines (see section 5.4).
The HYG ORF was used as parental sequence to generate targeting flanks for a number of 
antibiotic resistance constructs aimed at the HYG integration site in the trypanosome 
genome (Figure 5.1C and Figure 5.3). The flanks differed in each construct in that they 
were either perfectly homologous to the HYG ORF in the genome, or contained increasing 
numbers of base changes compared with the wild-type HYG gene sequence. In each 
construct, the antibiotic resistance cassette used contained the bleomycin resistance protein 
ORF (JBLE) flanlced at the 5 ’ end by intergenic sequence derived from the actin locus and 
at the 3 ’ end by intergenic sequence from the calmodulin locus. These sequences provided 
splicing and polyadenylation signals for the BLE ORF allowing transcripts of the gene to 
be processed into mature mRNAs, and since the constmcts do not contain promoter 
elements the BLE gene is expressed by endogenous tubulin transcription. The actin and 
calmodulin loci are unlinked in the T. brucei genome (see The Wellcome Trust Sanger 
Institute T. brucei genome sequencing database; http://www.sanger.ac.ulc/Projects/
T brucei/), so homologous integration can only occur via the HYG targeting flanks. To 
allow this construction, the HYG targeting sequences were amplified by PCR around an 
Ndel restriction site within the HYG ORF. Ascl restriction sites were introduced at the 5 ’ 
and 3’ termini of each amplified PCR product to allow linearisation of the final constructs
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and to ensure the termini of all the constructs were equivalent. After cloning the HYG 
products into the pCR2.1-TOPO vector, the BLE cassette was introduced into the Ndel site. 
The generation of these targeting constructs is described fully in section 5.5.
5.3 Generation of the transgenic HTUB strain of T, brucei
The HTUB transgenic cell line was generated by direct transformation of MITat 1.2a S427 
bloodstream form trypanosomes with the linearised pHygro-Tub construct, and the 
transformants were selected in HMI-9 containing 5 pg.ml"^ hygromycin B in 24-well plates 
(Figure 5.2; see section 2.17.2). Correct integration of the construct into the tubulin locus 
was deteimined by Southern analysis using the 914 bp PCR product shown in Figure 5.4 as 
a probe. This PCR product was amplified using Herculase polymerase with the primers 
HYGYox and LTTGRev and the pHygro-Tub plasmid as a template (see section 2.17.1). 
Genomic DNA isolated fi'om each transformant was digested with Kpnl or EcoBl, 
separated by agarose gel electrophoresis, Southern blotted and probed with the 914 bp 
probe. Figure 5.5 shows the results of this analysis for the MITat 1.2a S427 cell line and a 
putative HTUB transformant. As predicted, no fragments were detected by the probe in 
the digestions of MITat 1.2a S427 genomic DNA as this cell line does not contain a copy 
of the HYG ORF. For the HTUB transformant, the probe hybridised to fragments which 
appeared smaller than the expected sizes for both restriction digestions: a Kpnl fragment 
approximately 2.5 kb in length was detected, while two EcoBl fragments, the larger of 
which was approximately 1.7 kb in length, and the smaller approximately 0.6 kb in length, 
were revealed. The restriction map of the tubulin locus and the pHygro-Tub sequence 
suggests that the Kpnl fragment should be 2.9 kb in length, and the EcoBl fragments 2.1 kb 
and 1.0 kb in length. However, these differences in size are probably a consequence of the 
agarose gel electrophoresis conditions used, as the gel shown in Figure 5.5 was run rapidly 
at 100 kV for 3 h, rather than at 20 kV for 18 h which would normally be used for a gel 
intended for Southern analysis. Since the fragments show the correct pattern of 
hybridisation, it is probable that the size differences are simply the result of a poor quality 
gel, and that the linearised pHygro-Tub construct has integrated into the genome correctly 
to generate the desired HTUB transfonnant. From this analysis it was impossible to 
determine whether only a single copy of the HYG ORF had integrated into the tubulin 
locus of the HTUB cell line, as more than one copy would give the same restriction 
pattern. However, given that all the cell lines used in this analysis were derived from these 
transgenic HTUB tiypanosomes, the results of this assay were comparable.
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5.4 Generation of MSH2 mutants in the HTUB trypanosome strain
Two independent MSH2 mutants were generated by transformation of the HTUB 
transgenic cell line with the MSH2 knockout constructs AMSH2::PUR and AMSH2::BSD 
described in section 4.2.2, Initially, the linearised AMSH2::PUR construct was 
electroporated into two independent cell populations and the transformants selected in 
HMI-9 containing 1 pg.ml'^ puromycin dihydrochloride in 24-well plates to generate 
putative MSH2 heterozygous {MSH2^'') knockout cell lines (see section 2.1.3). Two 
independent first round transformants were then electroporated with the linearised 
AMSH2::BSD construct and selected in HMI-9 containing 2.5 pg.mT^ blasticidin S 
hydrochloride in 24-well plates to generate putative MSH2 homozygous {MSH2''') mutants. 
Since the results described in Chapter 4 (section 4.2) illustrate that the phenotypes 
demonstrated by trypanosomes transformed with the AMSH2::PUR and AMSH2::BSD 
constructs arise due to loss of MSH2 and not as a consequence of incidental changes 
associated with the generation of such transformants, it was considered unnecessary to 
generate an MSH2 re-expressing (MS772'^ '^ )^ mutant in the HTUB background.
Furthermore, integration of the AMSH2::MSH2-BLE construct results in resistance to 
phleomycin, and selection of transformants which have integrated the divergent targeting 
constructs generated for this assay also relies on phleomycin resistance (see section 5.6), 
making it impossible to determine the frequency of integration of the targeting constructs 
in cells.
Correct integration of the constructs into the MSH2 locus of the HTUB cell line was 
determined by Southern analysis (see section 2.11.1). Genomic DNA from untransformed 
HTUB trypanosomes, two independent putative MSH2~^ '' mutants and two independent 
putative MSH2''~ mutants was digested with either S ad  or Kpnl, separated by agarose gel 
electrophoresis and Southern blotted. The Southern blot of the S a d  genomic digestions 
was probed with the MSH2 5’ flank described in section 4.2.2, and for each transformant 
the probe hybridised to fragments of the expected size (Figure 5.6). A 5.8 kb fragment 
corresponding to the intact MSH2 locus was detected in the MSH2 wild-type cell line and 
the two putative MSH2 heterozygous mutants, but was absent from the two putative MSH2 
homozygous mutants. Integration of the AMSH2::PUR construct was indicated by the 
detection of a 2.85 kb fragment, which was present in all the MSH2' '^' and MSH2''~ mutant 
cell lines. Finally, the probe hybridised to a 2.65 kb fragment corresponding to the 
MSH2::BSD allele in the MSH2 homozygous mutants. For each cell line. Southern 
analysis indicated that the MSH2 knockout constructs had integrated into the HTUB cell
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line as expected to generate the desired MSH2 mutant trypanosomes. In order to verify 
that the HYG ORF was present in all the putative MSH2 mutants generated in the HTUB 
background, the Southern blot of the Kpnl digestions was probed with the 914 bp HYG 
probe described in section 5.3 (Figure 5.4). Figure 5.7 shows that the probe hybridises to a 
2.9 kb fragment in each cell line, indicating that the HYG ORF is present in each 
transformant. Furthermore, this 2.9 kb fragment corresponds to the 2.5kb fragment 
detected in the HTUB transformant shovm in Figure 5.5, confirming that the HYG ORF did 
indeed integrate as expected into the tubulin locus in this cell line.
In order to show that no copies of the MSH2 ORF existed within the putative MSH2 
homozygous mutants, PCR using primers internal to the MSH2 ORF (MS772D5 and 
MSH21J2; Figure 4.1) was performed using genomic DNA isolated from the putative 
HTUB MSH2 mutant cell lines (Figure 5.8; see section 2.11.1). The integrity of the DNA 
template was confirmed using primers specific to the large subunit of T. brucei RNA 
polymerase I (Poll 5’ and Poll 3’; Rudenko et a l ,  1996). PCR amplification using the 
MSH2 internal primers indicated that the MSH2 ORF was present in the MSH2 wild-type 
cell line, and the two putative MSH2' '^' mutants. However, no PCR product could be 
identified for the two putative MSH2''' mutants confirming the results of the Southern 
analysis and indicating that both copies of the MSH2 ORF had been removed during the 
integration of the AMSH2::PUR and AMSH2::BSD constructs into these cell lines.
In order to confirm that no MSH2 mRNA was being transcribed in the putative HTUB 
MSH2 homozygous mutants, total RNA was isolated from HTUB MSH2 wild-type cells, 
the two putative MSH2 '^~ cell lines and the two putative MSH2''' mutants (see section 2.4). 
cDNA was generated from these samples by reverse transcription, and used as a template 
for PCR amplification using the MSH2 internal primers described above (Figure 5.9; see 
section 2.11.1). As predicted, a PCR product of the expected size was generated from the 
untransformed HTUB trypanosomes and the MSH2 heterozygous mutants since these cells 
all possess intact copies of the MSH2 locus. However, no PCR product could be discerned 
for the putative MSH2 homozygous mutants, confirming that no copies of the MSH2 ORF 
were present in these cells. Amplification using primers specific to the large subunit of 
RNA polymerase I (Poll 5’ and Poll 3’; Rudenko et a l ,  1996) confirmed that the cDNA 
was intact for each transformant. Amplification with these primers using the samples 
generated from the putative MSH2''~ 2.1 cell line gave a product in both the RT positive 
and RT negative reactions. The product in the RT negative reaction probably arose 
because of incomplete DNase I treatment leaving some intact genomic DNA present in the 
sample. Since the PCR product seen in the RT positive reaction is much more abundant it
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can be assumed that it was generated from cDNA derived from MSH2 mRNA present in 
the total RNA sample. These results confirm that the putative MSH2 knockout cell lines 
developed in the transgenic HTUB strain of trypanosomes are genuine MSH2 mutants and 
that the MSH2 knockout constructs integrated into the transformants as expected.
5.5 Generation of homologous and homeologous HYG targeting constructs
As outlined in section 5.2, the HYG ORF was used as the parental sequence to generate a 
set of targeting constructs possessing increasingly divergent integration flanks aimed at the 
HYG gene integrated into the HTUB cell line (Figure 5.3). HYG sequence for use as 
targeting flanks was amplified from the HYG ORF present in the plasmid pHygro-Tub, 
using a variety of PCR conditions (see 2.17.1). In every case, the primers HYGFor and 
HYGKqv were used, both of which contain an Ascl restriction site to allow linearisation of 
the final constructs prior to transformation into trypanosomes. To generate the perfectly 
homologous wild-type HYG flanks, PCR amplification was performed using high-fidelity 
Herculase polymerase (Figure 5.4). The resulting PCR product was cloned to give the 
plasmid pHYGWT, and sequencing revealed it to be 914 bp in length. Apart from the 
terminal 10 bp regions which include the Ascl sites introduced by the primers, the 
sequence of pHYGWT was identical to the sequence of the HYG ORF in pHygro-Tub (see 
Appendix 6). This sequence was therefore used as the 0% divergent targeting flanks. 
Furthermore, the Herculase polymerase PCR product shown in Figure 5.4 was also used a 
probe for the HYG ORF during Southern analysis (see sections 5.3 and 5.4).
To generate HYG flanks containing base changes compared to the wild-type HYG 
sequence, a random mutagenesis approach was used (see section 2.17.1). This required 
two rounds of PCR amplification with Taq polymerase and the HYGFox and HYGFsw 
primers using the pHygro-Tub plasmid as a template (Figure 5.10). The first round PCR 
reaction was supplemented with two nucleotide analogues: dPTP, which is incorporated in 
place of dTTP and to a lesser extent dCTP; and 8-oxo-dGTP which is incorporated in place 
of dTTP (Zaccolo et a l ,  1996). At the end of cycles 5, 10, 15, 20, 25 and 30, a 1 pi sample 
of the reaction mix was removed and used as the template for a second, standard Taq PCR 
amplification reaction. The second reaction was required to remove the mismatches 
generated by incorporation of the nucleotide analogues, thereby completing the 
mutagenesis. The PCR products generated from the six second round amplifications were 
cloned, and a number of clones from each PCR were sequenced. The levels of divergence, 
or number of base-pair changes, compared with the pHYGWT sequence were calculated, 
and for this study clones showing 1% and 3% divergence were chosen, although many
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other clones showing up to 11% divergence were observed (see Appendix 6; all 
percentages rounded to the nearest integer). The two clones chosen were named pHYGOl 
and pHYG03 respectively, and were both 914 bp in length. It is apparent in Figure 5.10 
that a number of larger, non-specific PCR products were generated during the second 
round amplification reactions. Since these were approximately twice the size of the 
expected PCR products it is possible that these arose by annealing the Ascl sites at opposite 
ends of the denatured PCR products, while at the other ends the correct primers annealed, 
thereby priming the next round of amplification to generate a double length PCR product.
A multiple alignment of the pHYGWT, pHYGOl and pHYG03 is shown in Figure 5.11.
This highlights the positions of the heterologies compared to the sequence of the pHYGWT 
plasmid which is perfectly homologous to the wild-type HYG ORF (except for 10 bp at 
each terminus; see Appendix 6). The pHYGOl sequence contains 7 base changes. 
Unfortunately, these are not divided equally between the flanks, as the 5’ flank contains 6 
base changes while the 3’ flank only contains 1 mutation. Ideally the changes would be 
dispersed throughout the flanks, but this was the only clone sequenced which contained so 
few mutations. The pHYG03 sequence contains 30 base changes from the wild-type HYG 
sequence, and these are distributed equally, with 15 changes each in the 5’ and 3’ flanks.
At both the 5’ and 3’ termini of the flanks contained within the pHYGWT, pHYGOl and 
pHYG03 plasmids there are 10 bp of sequence, incorporating the^^cl sites, which are not 
present in the wild-type HYG ORF. While these bases can be considered as heterologous 
from the wild-type HYG sequence, they are present in all the HYG flanks generated for this 
assay. Therefore, any influence these bases have on the frequency of integration will be 
equivalent between the constructs and so their effect can be disregarded.
The RLL-containing resistance cassette was cloned between the HYG flanks within the 
pHYGWT, pHYGOl and pHYG03 plasmids to generate the HYGWTrBLE, HYGOlrBLE, 
and HYG03::BLE targeting constructs respectively (see section 2,17.1), Prior to 
transformation into transgenic HTUB trypanosomes, the constructs were linearised by 
restriction digestion with^^cl, and resuspended to approximately 3 pg.pf^ each (Figure 
5.12), thereby ensuring that any differences in the frequency of integration of the three 
constructs were due to the mutations in the HYG flanks and not to differences in DNA 
concentration.
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5.6 Assay to determine the effect of MSH2 mutation on the frequency of
integration of homologous and homeologous HYG targeting constructs into the 
HTUB cell line
The transgenic HTUB cell line, which contains a HYG ORF integrated into the tubulin 
array, was used to generate both heterozygous and homozygous HTUB MSH2 mutant 
trypanosomes. Also, three constructs were developed which contained either perfectly 
homologous or increasingly divergent targeting flanks derived from the HYG ORF. These 
targeting constructs and the HTUB cell line were developed to assay for the effect of 
sequence divergence on the frequency of integration into both MMR-proficient and MMR- 
deficient cell lines. To this end, HTUB MSH2 wild-type trypanosomes, two HTUB 
MSH2' '^' cell lines and two HTUB MSH2''' mutants were electroporated with either the 
linearised HYGWT::BLE, HYGOlrBLE or HYGOSr.BLE constructs (see section 2.17.3).
To ascertain the effect of mismatch repair on both homologous and homeologous 
recombination, the HTUB MSH2 wild-type cell line, and each of the HTUB MSH2 
heterozygous and HTUB MSH2 homozygous cell lines were electroporated with 6 pg of 
v4.9cl-digested HYGWTrBLE, HYGOlrBLE and HYG03::BLE. Three independent 
transformations were performed using each construct with each cell line. Transformants 
were selected in HMI-9 containing 2.5 pg.ml'^ phleomycin in 24-well tissue culture plates, 
and the number of wells showing growth was determined after 7 days.
Table 5.1 shows the estimated frequency of integration, expressed as numbers of 
transformants per 10* cells put on selection, and these data are represented in graphical 
form in Figure 5.13. In almost all the HYGWTrBLE transformations for every cell line, all 
24 wells showed growth. If it is assumed that the growth in each well arose from a single 
transformant, this represents an estimated 3.20 x 10"* integration events/cell. However, 
where every well, or indeed a large proportion of the wells, shows growth in a 24-well 
plate it is probable that some of the wells contained more than one transformant, making it 
impossible to derive an accurate estimate of the integration frequency from these 
transformations. For the purposes of this study, where all 24 wells showed growth the 
frequency has been shown as equal to or more than 3.20 x 10 * integration events/cell, 
although in reality the frequencies could be significantly higher. For transformations 
where up to 23 wells showed growth after selection, the frequency of construct integration 
has been calculated on the assumption that there was only one transformant in each well 
showing growth, even though here also this could be an underestimation. These problems 
arose because too many cells were placed on selection after electroporation with the 
targeting constructs, and would be avoided by selecting fewer transformants in future
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experiments. Transformation with the HYGOl ::BLE construct resulted in similar 
integration frequencies in every cell line. These were slightly lower than the frequencies 
seen using the HYGWT::BLE construct, perhaps suggesting that the introduction of 
mutations into the targeting flanks reduced the ability of the construct to integrate into the 
HYG ORF. From these data loss of MSH2 does not appear to affect the frequency of 
integration of this construct. However, the effect of MSH2 deletion may have been masked 
owing to the fact that too many cells were placed on selection during these 
transformations, and the resulting problems in estimating integration frequencies. These 
experiments would have to be repeated and refined to address this issue. Finally, 
transformation with the HYG03::BLE construct gave similar integration frequencies in the 
HTUB MSH2 wild-type cell line and the two MSH2 heterozygous mutants. These were 
greatly reduced (by at least 1.5-fold) in comparison to the results observed for the 
HYGWTrBLE and HYGOl::BLE constructs, suggesting that the probability of successful 
integration into the trypanosome genome decreases as the level of sequence divergence 
between the donor and recipient molecules increases. In the MSH2 homozygous mutants, 
however, the frequency of integration of the HYG03::BLE construct was at least 1.3-fold 
higher than in cells expressing MSH2. Furthermore, in the MSH2''' 1.1 cell line the 
frequency of integration of this construct was barely reduced in comparison with the 
HYGWT::BLE construct. These results suggest that the probability of recombination 
between homeologous sequences in T. brucei is elevated in MSH2 null mutants, at least 
where the sequences have diverged by 3%. While this conclusion is perhaps at odds with 
the results of the transformations using the HYGOl:: BLE construct, and would need to be 
repeated to confirm these data, it appears that loss of MSH2 does elevate the frequency of 
integration of the HYG03::BLE construct.
5.7 Discussion
In both bacteria and eukaryotes, MMR had been found to regulate recombination between 
homeologous DNA sequences. The aim of this present study was to determine if this was 
also the case in T. brucei. At present, very little is known about the sequence requirements 
of recombination in this organism. No illegitimate recombination event has ever been 
observed in wild-type trypanosomes during many transformations in several laboratories 
(Lee and Van der Ploeg, 1990; Ten Asbroek et a l,  1990; Bid and Sollner-Webb, 1991; Ten 
Asbroek et a l ,  1993), although altered forms of homologous recombination are seen in 
RAD51 null mutants (McCulloch and Barry, 1999; Conway et a l ,  2002b). Also, it has 
been shown that targeting of an antibiotic resistance marker into a region conserved 
between the VSG expression sites resulted in integration into the expression site where the
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sequence was identical to the targeting flanks rather than into a site where the sequence 
differed by 8% (Blundell et a l,  1996). Although the targeting construct did appear to 
integrate into a number of other expression sites the sequenee of these sites was never 
determined. This chapter describes an assay which should yield quantifiable data about the 
effect of sequence divergence on the frequency of integration into the trypanosome 
genome in both MMR-proficient and MMR-deficient cells.
Wlrile the assay has greater potential than has been exploited in this pilot study (see 
below), it has nonetheless yielded several important observations about the mechanism of 
recombination in trypanosomes. Firstly, the frequency of integration of constructs 
decreases as the number of heterologies between the targeting flanks and the target 
sequence increases. Where the targeting flanlts were diverged by 1%, the frequency of 
integration appeared to be slightly reduced, although the actual level could not be 
accurately calculated because too many transformants had been put on selection during 
these experiments, resulting in an underestimation of the integration frequencies. To 
determine the frequencies more accurately these experiments would need to be repeated 
placing fewer transfonuants on selection. It can be concluded, however, that where the 
targeting flanks have diverged by 3% from the target sequence, the integration frequency is 
reduced by at least 1.5-fold in MSH2 wild-type cells. Secondly, although there was no 
discernible difference between the frequency of integration of the constructs bearing 
perfeetly homologous or 1% divergent targeting flanles between the MSH2 null mutants or 
cells expressing MSH2, there was a clear elevation in the integration frequency of the 
construct containing 3% divergent targeting flanks in the MSH2 homozygous mutants.
This supports the conclusion that a functional MMR system inhibits recombination 
between divergent sequences in T. brucei. The anti-recombination activity of MMR has 
been characterised most fully in S. cerevisiae. While is seems clear that mismatch 
recognition underlies the process, the mechanism by which MMR down-regulates 
homeologous recombination remains unknown. Furthermore, it has been observed that the 
overall frequency of recombination between identical DNA sequences is also elevated in 
MMR-deficient yeast cells, again without a clear understanding of the mechanistic basis 
(Datta et a l ,  1997). This may also be the case in T. brucei, but too many transformants 
were placed on selection in these experiments to get an accurate measure of integration 
frequency, and any elevation in the frequency of integration in the MSH2 homozygous 
mutants may have been masked. Again, these questions can only be addressed by 
repeating these experiments and placing fewer transformants on selection to collect more 
accurate data.
One problem evident from this pilot study is that there is no way to determine the number 
of copies of the HYG ORF that have integrated into the trypanosome genome using 
Southern analysis. Unfortunately, pulsed-field gel electrophoresis of whole chromosomes 
could not be used to resolve this issue either, since two copies of the HYG ORF could 
integrate into the tubulin array of a single chromosome again resulting in hybridisation to a 
single fragment. Given the generally low frequency of integration of constructs into 
bloodstream stage trypanosomes it seems unlikely that two copies of the HYG ORF would 
integrate into the same cell. Nevertheless, it would be still be useful to be able to 
determine the copy number of the HYG ORF within the cell lines used in the assay. It is 
possible to do this after transformation of the HTUB-derived cell lines with the HYGr.BLE 
constructs. Genomic DNA could be isolated from the bleomycin resistant clones, and PCR 
amplification using primers specific to the HYG locus performed. In cells possessing only 
one copy of the locus a single allele would be amplified corresponding to the HYG ORF 
interrupted by the BLE resistance cassette {HYG::BLE allele). PCR amplification from any 
clones containing two or more copies of the HYG locus would give two products, the allele 
described above and a smaller product corresponding to the intact HYG ORF. It would be 
possible to determine the HYG alleles present in a number of BLE resistant transformants 
from all the HTUB-derived cell lines in order to confirm that only a single copy of the 
HYG ORF was present in the genomes of the HTUB cell line and its descendants. 
Furthermore, sequencing of the PCR products corresponding to the HYG::BLE allele 
generated in MMR-proficient cell lines might reveal details about the mechanisms of the 
recombination reactions used to create them. In MMR-proficient yeast cells it has been 
reported that during gene conversion reactions between homeologous substrates, more than 
85% of the mismatches present in the heteroduplex intermediate are repaired in favour of 
the recipient (unbroken) strand (Leung et a l ,  1997), This same study suggested that 
recombination reactions between linear and chromosomal DNA proceeded by complete 
assimilation of one of the two strands of linear DNA, rather than by two crossovers each 
close to the end of the linear fragment. Comparison of the sequences of the HYG: :BLE 
allele from MMR-proficient transformants with both the wild-type HYG ORF and relevant 
HYG::BLE construct sequences would show whether the mismatches formed in the 
heteroduplex recombination intermediate were repaired in favour of the donor or recipient 
strand. Where base changes from the wild-type HYG ORF were observed this would 
suggest that the mismatch was repaired in favour of the donor {HYG::BLE construct) 
sequence. Furthermore, if such changes were observed in the sequences corresponding to 
the extreme termini of the HYG::BLE construct this would indicate that the gene 
conversion reaction involved the assimilation of the entire sequence of the linear
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transfomiation construct as in yeast. The sequence of the HYG::BLE alleles generated in 
MMR-deficient transfonuants could not be used in this way as the mismatches present in 
the heteroduplex intermediate would not be repaired, and would segregate at mitosis. 
Therefore some clones would contain sequence derived from the wild-type HYG ORF and 
others the sequence derived from the HYG::BLE construct.
In the future, this assay could be extended to further investigate the sequence requirements 
of recombination in T. brucei. A  broader range of constructs with divergent targeting 
flanks could be generated; as stated earlier, flanks which show up to 11 % sequence 
divergence are already available (see Appendix 6). These span the 8% sequence 
divergence of the only previous study (Blundell et al., 1996), and could be used to 
investigate the effect of increasing numbers of heterologies on recombination in T. brucei 
in detail. In an MMR-competent yeast strain a construct containing a single mismatch 
(0.3% divergence) showed a 4.1-fold reduction in the frequency of recombination 
compared to identical substrates (Datta et a l, 1997). Increasing the levels of divergence in 
the substrates led to a cumulative negative effect on recombination, with the integration 
fi'equencies decreasing further as the number of heterologies between the substrates 
increased. In MMR-deficient yeast cells, however, sequence divergence showed little 
effect on the frequency of integration until the sequences differed by about 10% (Datta et 
a l, 1996). This indicates that where substrates are greater than 90% identical the MMR 
machinery is responsible for all the inhibitory effects of sequence divergence upon 
recombination. Above this level of sequence divergence another factor strongly inhibits 
homeologous recombination, and it has been hypothesised that this repression may be due 
to an inability to fonn sufficiently stable base-paired strand exchange intermediates where 
high levels of mismatches are present (Selva et a l, 1995; Datta et a l, 1996; Datta et a l, 
1997; Chen and Jinks-Robertson, 1998). It has been speculated that the inhibitory effect of 
MMR on homeologous recombination in T. brucei may be suppressed to allow gene 
conversion reactions between divergent VSG sequences (Blundell et a l, 1996). While this 
assay cannot be directly used to investigate recombination between the flanking sequences 
of VSG genes, it will reveal whether the sequence requirements for general recombination 
are less stringent in this organism.
The influence of MMR on the frequency of integration could be determined more fully 
using a range of divergent targeting constructs in both MSH2 and MLH l null mutants (and 
perhaps eventually MSH3, MSH8 and PMSl mutants). As discussed in section 5.1, 
experiments in S. cerevisiae have revealed that the frequency of homeologous 
recombination shows the greatest elevation in MSH2 mutants, while MLHl is required in
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the repression of only a portion of these events (Datta et a l ,  1996; Nicholson et a l ,  2000). 
Similar results in T. brucei would suggest that the mechanism of inhibition was conserved 
between these organisms, and that the models of heteroduplex rejection which have been 
expounded to explain the anti-recombination activities of MMR could be applied to 
trypanosomes as well.
It is possible that different genomic locations exhibit different intrinsic recombinogenic 
potentials. For instance, the tubulin array in T. brucei is composed of tandem repeats of 
a  and p tubulin genes, so this locus may be more prone to intra- and inter- chromosomal 
recombination events between the numerous alleles. Also, regions of the genome which 
are being actively transcribed, and so are more accessible to the recombination machinery, 
appear to participate in recombination events more frequently than silent loci (Saxe et a l , 
2000). It should also be noted that in a number of organisms which undergo antigenic 
variation, for instance T. brucei, Pneumocystis carinii, Plasmodium spp and Borrelia spp, 
the expressed surface antigen gene is positioned in a sub-telomeric location, where it 
frequently recombines, often with sequences from other telomeric regions, resulting in the 
expression of a novel surface antigen (Zhang et a l ,  1997; Newbold, 1999; Barry and 
McCulloch, 2001; Stringer and Keely, 2001). This perhaps suggests that these regions of 
the genome are predisposed to recombination. This assay system could be used with 
transgenic cell lines containing the HYG ORF integrated into sites other than the tubulin 
array; for instance, the active expression site close to the VSG, or the telomeric region of a 
minichromosome. Assaying for the frequency of integration simply using the perfectly 
homologous HYGWT::BLE construct would indicate whether there were any differences in 
the recombinogenic potential of these loci. Moreover, assaying the effects of MSH2 and 
MLHl mutants on integration into HYG within the active ES would address whether this 
site is some form of ‘privileged domain’ not scoured by the MMR system, perhaps 
explaining the lack of detectable effect these mutations had on VSG switching (see chapter 
4). As the same sequences, all derived from the HYG ORF, would be used in each case, 
any differences seen would be due to the properties of the locus under investigation and 
not to sequence specific effects. Moreover, this system could be used to investigate the 
influence of other genes, such as RAD51 ov M R E ll, on recombination in T. brucei, and 
since the data gathered would be comparable it would be possible to generate a 
‘league-table’ suggesting the relative importance of numerous genes to recombination in 
T. brucei.
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Figure 5.1 Overview of experimental approach
(A) A hygromycin phosphotransferase {HYG) gene ORF (derived from pHygro-Tub; see 
section 2.17.2; green boxes) was integrated into the tubulin array (only a  tubulin is shown) 
using integration and processing flanks derived from the tubulin locus (pa and ap; grey 
boxes) and replaced an a  tubulin gene (purple box) to generate the HTUB cell line. (B) 
Transformation of the HTUB cell line with the AMSH2::PUR and AMSH2: :BSD 
constructs generated MSH2 heterozygous (+/-) and homozygous (-/-) knockout mutant cell 
lines (see section 2.11.1). (C) The HYG ORF was the parental sequence of the HYG 5’ and 
HYG 3’ integration flanks (green boxes)which were separated by a resistance cassette that 
contained the bleomycin resistance protein {BLE) ORF (white boxes) flanked by sequences 
encoding splicing and polyadenylation signals (actin IR and calmodulin IR; grey boxes).
A number of constructs incorporating integration flanks which contained increasing 
numbers of base changes compared to the wild-type HYG sequence (shown as vertical 
yellow lines) were generated. The HYG 5’ and HYG 3’ flanks allowed the integration of 
the targeting constructs into the HYG ORF in the HTUB transgenic cell line (indicated by 
crosses). Transformants were selected on phleomycin in 96-well plates, the number of 
wells showing growth was recorded and the frequency of integration calculated. Arrows 
indicate the direction of transcription of the genes.
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Figure 5.2 Targeting a hygromycin phosphotransferase ORF into the tubulin 
array
A resistance cassette (derived from pHygro-Tub; see section 2.17.2) containing a 
hygromycin phosphotransferase ORF {HYG) will be integrated into the tubulin array 
(indicated by crosses) and replace an a  tubulin gene (shown in purple), p tubulin genes are 
shown in turquoise. The targeting flanks for this replacement reaction consist of the 5’
P-a intergenic sequence (Pa) and the 3’ a-p intergenic sequence (ap) which flank the 
a  tubulin genes. These flanks will also provide signals allowing the transcripts of the 
resistance gene to be processed into mature mRNAs. Arrows denote the direction of 
transcription of the genes and numbers in brackets indicate lengths in base-pairs.
Restriction sites are shown as black vertical bars.
Kpn £coRI
__1_
Kpn EcoKl
__L_
hul l (X t ub u l i n(X t ub u l i n
EcoRi
Pa (230) //KG (1000) aP (300)
309
Figure 5.3 Design of constructs with homeologous integration flanks to target the 
HYG ORF present in the HTUB transgenic cell line
HYG 5’ and HYG 3’ are the sequences derived from the hygromycin phosphotransferase 
gene (shown in green) that allow integration of the constructs into the HYG ORF in the 
HTUB transgenic cell line (indicated by crosses). A number of constructs incorporating 
integration flanks which contain increasing numbers of base changes compared to the wild- 
type HYG sequence (shown as vertical yellow lines) were generated. Between these flanks 
is an expression cassette that gives phleomycin resistance to select for integration; this 
contains the bleomycin resistance protein ORF {BLE) flanked at the 5’ end by sequence 
derived from the actin locus (actin IR) and at the 3’ end by sequence from the calmodulin 
locus (calmodulin IR). Arrows indicate the direction of transcription of the genes, 
numbers in brackets denote lengths in base-pairs and restriction sites are shown as vertical 
black lines.
HYG ORF
bJde\
Asc\
HYG 5’ (450) HYG 3' (450)
Asc\
actin IR 
(400)
BLE {400) calmodulin IR 
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Figure 5.4 PCR amplification of homologous HYG targeting flanks and HYG 
probe sequence
PCR was performed using Herculase polymerase and the pHygro-Tub plasmid as a 
template. Primers complementary to the HYG ORF were used {HYGYox and //FGRev; see 
section 2.17.1) and the following reactions were run: (A) both primers with no template 
DNA; (B) HYGYor primer only with plasmid template DNA; (C) //FGRev primer only 
with plasmid template DNA; (D) both primers with plasmid template DNA.
A B C D D
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Figure 5.5 Southern analysis of the HTUB transgenic cell line
(A) Genomic DNA isolated from the MITat 1.2a S427 cell line (427 wt) and the HTUB 
transgenic cell line (HTUB wt) was digested with Kpn\ and EcoYA and separated on a 0.6% 
agarose gel. (B) Southern blot of the gel shown in panel (A) probed with the 914 bp HYG 
probe described in Figure 5.4.
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Figure 5.6 Southern analysis of HTUB MSH2 knockout cell lines
Genomic DNA isolated from the HTUB MSH2 knockout cells lines was digested with 
Sac\, separated on a 0.6% agarose gel. Southern blotted and probed with the MSH2 5’ 
flank used as the 5’ integration flank in the MSH2 knockout construct (see section 2.11.1). 
The following samples were analysed: (WT) untransformed HTUB cells; (+/-) HTUB cells 
transformed with AMSH2::PUR; (-/-) HTUB cells transformed with AMSH2::PUR and 
AMSH2::BSD.
kb
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Figure 5.7 Southern analysis of HTUB MSH2 knockout cell lines
Genomic DNA isolated from the HTUB MSH2 knockout cells lines was digested with 
Kpn\, separated on a 0.6% agarose gel, Southern blotted and probed with the 914 bp HYG 
probe described in Figure 5.4. The following samples were analysed: (WT) untransformed 
HTUB cells; (+/-) HTUB cells transformed with AMSH2::PUR\ (-/-) HTUB cells 
transformed with AMSH2::PUR and AMSH2::BSD.
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Figure 5.8 PCR analysis of the HTUB MSH2 knockout cell lines
PCR was performed using genomic DNA isolated from the HTUB cell lines transformed 
with the MSH2 knockout constructs. Internal primers complementary to the T. brucei 
MSH2 gene were used {MSH2) and the integrity of the DNA was confirmed using primers 
directed against the large subunit of T. brucei RNA polymerase I {RNA Pol /; Rudenko et 
a i,  1996). For both sets of primers the following reactions were run: (NT) no template 
DNA; (WT) untransformed HTUB cells; (+/-) HTUB cells transformed with 
AMSH2::PUR\ (-/-) HTUB cells transformed with both AMSH2::PUR and AMSH2::BSD.
MSH2
RNA Pol I ë —' fN  ^ (N
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Figure 5.9 Analysis of the expression of MSH2 in the putative HTUB MSH2
mutant cell lines
RT-PCR was performed using total RNA isolated from the HTUB cell lines transformed 
with the MSH2 knockout constructs. Internal primers complementary to the T. brucei 
MSH2 gene were used (MSH2) and the integrity of the DNA was confirmed using primers 
directed against the large subunit of T. brucei RNA polymerase I {RNA Pol /; Rudenko el 
a i ,  1996). For both sets of primers RT positive (RT+), RT negative (RT-), and no 
template (NT) reactions were performed using total RNA isolated from the following cell 
lines: (WT) untransformed HTUB cells; (+/-) HTUB cells transformed with 
AMSH2::PUR\ (-/-) HTUB cells transformed with both AMSH2::PUR and AMSH2::BSD.
MSH2
WT + / - 1.1 + / - 2.1
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WT + / - 1.1 + / - 2.1 / -  1.1 - / -  2.1
J I D
Figure 5.10 PCR amplification of homeologous HYG targeting flanks
Two rounds of PCR amplification were performed using Taq polymerase and the primers 
HYGYov and //TGRev (see section 2.17.1). In the first round of amplification, the 
pHygro-Tub plasmid was used as a template and the reaction was supplemented with two 
nucleotide analogues: dPTP, which Taq polymerase incorporates in place of dTTP and to a 
lesser extent dCTP; and 8-oxo-dGTP which is incorporated in place of dTTP (Zaccolo et 
a i, 1996). During amplification, at the end of cycles 5, 10, 15, 20, 25 and 30, a 1 pi 
sample was removed and used as a template for a second round of PCR amplification using 
standard reaction conditions. (A) A sample of the first round PCR product taken after 30 
cycles. (B) Samples of the second round PCR products taken after 30 cycles. Numbers 
refer to the cycle number of the first round of PCR from which the template was derived.
B
10 15 20 25  30
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Figure 5.11 Multiple alignment of the pHYGWT, pHYGOl and pHYGOS sequences
Multiple alignment of the pHYGWT, pHYGOl and pHYGOS DNA sequences. Sequences 
were aligned using Multalin (http://prodes.toulouse.inra.fr/multalin/multalin.html; Corpet, 
1988) and shaded using the BOXSHADE server (http://www.ch.embnet.org/ 
software/BOX_form.html): identical residues are shown in black; residues that differ from 
the pHYGWT sequence are shown in turquoise for the pHYGOl sequence and in red for the 
pHYGOS sequence. The sequence of the HYGYor primer is indicated in blue, and the 
sequence complementary to the //TGRev primer is indicated in green. The sequence 
corresponding to the Nde\ restriction site is shown in purple.
pHYGWT 1 AAGGCGCGCCAGCCTGAACTCACCGCGACGTCTGTCGAGAAGTTTCTGATCGAAAAGTTC
pHYGOl 1 AAGGCGCGCCAGCCTGAACTCACCGCGACGTCTGTCGAGAAGTTTCTGATCGAAAAGTTC
pHYG03 1 AAGGCGCGCCAGCCTGAACTCACCGCGACGTCTGTCGAGAAGCTTCTGATCGAAAAGTTC
pHYGWT 61 GACAGCGTCTCCGACCTGATGCAGCTCTCGGAGGGCGAAGAATCTCGTGCTTTCAGCTTC
pHYGOl 61 GACAGCGTCTCCGACCTGATGCAGCTCTCGGAGGGCGAAGAATCTCGTGCTTTCAGCTTC
pHYG03 61 GACAGCGTCTCCGACCTGATGCAGCTCTCGGAGGGCGAAGAATCTCGTGCTTTCAGCTCC
pHYGWT 121  CATGTAGGAGGGCGTGGATATGTCCTGCGGGTAAATAGCTGCGCCGATGGTTTCTACAAA 
pHYGOl 121  ATG AGGAGGGCGTGGATA-GTCCTGCGGGTAAATAGCTGCGCCGATGGTTTCTACAAA 
pHYG03 121  GATGTAGGAGGGCGTGGATATGTCCTGCGGGTAAATAGCTGTGCCGATGGTTTCTACAAA
pHYGWT 181  GATCGTTATGTTTATCGGCACTTTGCATCGGCCGCGCTCCCGATTCCGGAAGTGCTTGAC 
pHYGOl 181  GATCGTTATGT TATCGGCACTTTGCATCGGCCGCGCTCCCGATTCCGGAAGTGCTTG'~C 
pHYG03 181  GATCGCTATGTTTATCGGCACTCTGCATCGGCCGCGCTCCCGATTCCGGAAGTGCTTGAC
pHYGWT 2 4 1  ATTGGGGAATTCAGCGAGAGCCTGACCTATTGCATCTCCCGCCGTGCACAGGGTGTCACG 
pHYGOl 2 41  ATTGGGGAATTCAGCGAGAGCCTGACCTATTGCATCTCCCGCCGTGCACAGGGTGTCACG 
pHYG03 2 4 1  ATCGGGGAATTCAGCGAGAGCCTGGCCTATTGCACCTCCCGCCGCGCACAGGGTGTCACG
pHYGWT 301  TTGCAAGACCTGCCTGAAACCGAACTGCCCGCTGTTCTGCAGCCGGTCGCGGAGGCCATG 
pHYGOl 301  TTGCAAGACCTGCCTGAAACCGAACTGCCCGCTGTTCTGCAGCCGGTCGCGGAGGCCATG 
pHYG03 301  TTGCAAGACCTGCCTGAAACCGAACTGCCCGCTGTTCTGCAGCCGGTCGCGGAGGCCATG
pHYGWT 36 1  GATGCGATCGCTGCGGCCGATCTTAGCCAGACGAGCGGGTTCGGCCCATTCGGACCGCAA 
pHYGOl 36 1  GATGCGATCGCTGCGGCCGATCTTAGCCAGACGAGCGGGTTCGGCCCATTCGGACCGCAA 
pHYG03 361  GATGCGACCGCTGCGGCCGATCTTAGCCAGACGAGCGGGTTTGGCCCATTCGGACCGCAA
pHYGWT 421  GGAATCGGTCAATACACTACATGGCGTGATTTCATATGCGCGATTGCTGATCCCCATGTG 
pHYGOl 42 1  GGAATCGGTCAATACACTACATGGCGTGATT CATATGCGCGATTGCTGATCCCCATGTG 
pHYG03 42 1  GGAATCGGTCAATACACCACACGGCGTGATCTCATATGCGCGATTGCTGATCCCCATGTG
pHYGWT 481  TATCACTGGCAAACTGTGATGGACGACACCGTCAGTGCGTCCGTCGCGCAGGCTCTCGAT 
pHYGOl 48 1  TATCACTGGCAAACTGTGATGGACGACACCGTCAGTGCGTCCGTCGCGCAGGCTCTCGAT 
pHYG03 48 1  TATCACTGGCGAACTGTGACGGACGACACCGCCAGTACGTCCGTCGCGCAGGCTCTCGGT
pHYGWT 541  GAGCTGATGCTTTGGGCCGAGGACTGCCCCGAAGTCCGGCACCTCGTGCACGCGGATTTC 
pHYGOl 5 41  GAGCTGATGCTTTGGGCCGAGGACTGCCCCGAAGTCCGGCACCTCGTGCACGCGGATTTC 
pHYG03 5 41  GAGTTGATGCTTTGGGCCGAGGACTGCCCCGAAGTCCGGCACCTCGTGCACGCGGATTTC
J I8
Figure 5.11 continued
pHYGWT 601  GGCTCCAACAATGTCCTGACGGACAATGGCCGCATAACAGCGGTCATTGACTGGAGCGAG 
pHYGOl 601  GGCTCCAACAATGTCCTGACGGACAATGGCCGCATAACAGCGGTCATTGACTGGAGCGAG 
pHYG03 601  GGCTCCAACAATGCCCTGACGGACAATGGCCGCATAACAGCGGTCATCGGCTGGAGCGAG
pHYGWT 661  GCGATGTTCGGGGATTCCCAATACGAGGTCGCCAACATCTTCTTCTGGAGGCCGTGGTTG
pHYGOl 661  GCGATGTTCGGGGATTCCCAATACGAGGTCGCCAACATCTTCTTCTGGAGGCCGTGGTTG
pHYG03 661  GCGATGTTCGGGGATTCCCAATACGAGGTCGCCAACATCTTCTTCTGGAGGCCGTGGCTG
pHYGWT 721  GCTTGTATGGAGCAGCAGACGCGCTACTTCGAGCGGAGGCATCCGGAGCTTGCAGGATCG 
pHYGOl 72 1  GCTTGTATGGAGCAGCAGACGCGCTACTTCGAGCGGAGGCATCCGGAGCTTGCAGGATCG 
pHYG03 72 1  GCTTGTATGGAGCAGCAGGCGCGCTACTTCGGGCGGAGGCATCCGGAGCTTGCAGGATCG
pHYGWT 78 1  CCGCGGCTCCGGGCGTATATGCTCCGCATTGGTCTTGACCAACTCTATCAGAGCTTGGTT 
pHYGOl 78 1  CCGCGGCTCCGGGCGTATATGCTCCGCATTGGTCTTGACCAACTCTATCAGAGCTTGGTT 
pHYG03 7 8 1  CCGCGGCTCCGGGCGTATATGCCCCGTATTGGTCTTGACCAACTCTATCAGAGCTTGGTT
pHYGWT 841  GACGGCAATTTCAATGATGCAGCTTGGGCGCAGGGTCGATGCGACGCAATCGTCCGATCC 
pHYGOl 841  GACGGCAATTTCi^ATGATGCAGCTTGGGCGCAGGGTCGATGCGACGCAATCGTCCGATCC 
pHYG03 841  GACGGCAATTTCGATGATGCAGCTTGGGCGCAGGGTCGATGCGACGCAATCGTCCGATCC
pHYGWT 901  GGAGGGCGCGCCAT
pHYGOl 901 GGAGGGCGCGCCAT
pHYG03 901 GGAGGGCGCGCCAT
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Figure 5.12 Estimation of the concentration of the linearised HYGWT::BLE, 
HYG01::BLE, and HYG03::BLE constructs
The HYGWT::BLE (HWT), HYG01::BLE (HOI), and HYG03::BLE (H03) constructs were 
linearised by restriction digestion with Ascl (see section 2.17.1). The purified restriction 
fragments were diluted 1 in 10(1:10), 1 in 25 (1:25) and 1 in 50 (1:50) in distilled H2O and 
separated by electrophoresis on a 1.0% agarose gel to estimate their concentrations. By 
comparison with the 1.6 kb marker band (which contained 50 ng of DNA) the 
concentration of the undiluted linearised constructs was estimated to be approximately 
3 p g .p f’ each.
1:10 1:25 1:50
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Table 5.1 Effect of MSH2 mutation on the frequency of integration of constructs 
containing increasing numbers of mismatches into the HTUB 
trypanosome strain
Bloodstream HTUB trypanosomes that had been unaltered at the MSH2 locus (WT); that 
had one MSH2 allele disrupted (+/-); or that both MSH2 alleles disrupted (-/-) were 
transformed with either the HYGWTr.BLE, HYGOl::BLE or HYG03::BLE constructs (see 
section 2.17.3). For each transformation 7.5 x 10  ^cells were plated over a 24-well plate on 
selection with 2.5 pg.ml ' phleomycin, and three independent transformations were 
performed using each construct for each cell line. After 7 days the number of wells which 
showed growth were counted, and it was assumed that in each well growth arose from a 
single transformant. The estimated frequency of construct integration (x 10'^) was 
calculated.
Estimated Frequency of Construct Integration (x 10'^ )
Cell Line HYGWT::BLE HYG01::BLE HYG03::BLE
WT >3.20 3.00 0.80
>3.20 2.60 0.60
>3.20 2.07 0.47
Average > 3.20 2.56 0.62
MSH2+/- 1.1 >3.20 2.93 1.27
>3.20 3.13 1.33
>3.20 3.13 1.40
Average > 3.20 3.06 1.33
MSH2+/- 2.1 >3.20 3.13 1.67
>3.20 2.87 0.53
>3.20 3.00 0.87
Average > 3.20 3.00 1.02
MSH2-I- 1.1 >3.20 >3.20 >3.20
>3.20 >3.20 >3.20
>3.20 >3.20 3.07
Average > 3.20 > 3.20 >3.16
MSH2-/-2A 3.07 2.87 2.27
>3.20 3.00 2.13
>3.20 3.00 2.27
Average >3.16 2.96 2.22
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F i g u r e  5 . 1 3  T h e  f r e q u e n c y  o f  i n t e g r a t i o n  o f  c o n s t r u c t s  c o n t a i n i n g  i n c r e a s i n g  
n u m b e r s  o f  m i s m a t c h e s  i n t o  H T U B  M S H 2  k n o c k o u t  c e l l  l i n e s
The average frequency of integration of the HYGWT::BLE (HWT), HYGOl r.BLE (HOI), 
and HYG03::BLE (H03) constructs was determined as described in Table 5.1 for HTUB 
MSH2 wild-type trypanosomes (WT), HTUB MSH2 heterozygous mutants (+/-) and 
HTUB MSH2 homozygous mutants (-/-).
□  H W T
1
+ / - 1.1 + / - 2.1 1.1
Cell Line
-1-2 A
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C h a pter  6
Final Discussion
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6.1 Final discussion
The aim of this study was to investigate the MMR system in T. brucei, and assess the role 
of this highly conserved DNA repair pathway in antigenic variation. Initially, it was 
important to identify as many putative MutS and MutL homologues as possible, so that an 
overview of the MMR system in this organism could be attained. During the course of this 
work, five putative MutS homologues were identified along with two putative MutL- 
related proteins. The mutS family members included putative homologues of the MSH2, 
MSH3 and MSH6/7 genes (designated MSH2, MSH3 and MSH8 respectively) which 
probably encode components of the nuclear post-replicative MMR system (see chapter 3), 
and also putative homologues of the meiotic mw/5'-related genes MSH4 and MSH5. The 
/ww^L-related genes in T. brucei appear to encode homologues of the MLHl and PMSl 
proteins from S. cerevisiae (see chapter 3).
In order to confirm the presence of an active MMR system in T. brucei, functional analyses 
were performed on the putative T, brucei MSH2 and MLH l genes (see chapter 4). These 
genes were chosen because the MSH2 and MLHl proteins are central to the MMR process 
in that they are required to form all known MutS- and MutL-related heterodimers active in 
MMR respectively, and thus were likely to give the most easily observable phenotypes 
upon deletion analysis. Homologous integration constructs, containing a selectable 
marker, were used to generate stable transformants from which both copies of either the 
MSH2 or MLH l ORFs were deleted. A cell line re-expressing the MSH2 gene from its 
original genomic location was then generated from an MSH2 homozygous mutant in order 
to confirm that any phenotypes observed were due to the loss of MMR in these 
trypanosomes, and not to incidental changes which arose during the generation of the 
knockout mutants. Two assays were performed to confirm that MSH2 and MLH l encoded 
genuine components of the T. brucei MMR system. Firstly, in bacteria and mammals, loss 
of MMR leads to an increase in resistance to alkylating agents such as MNNG. Using 
increasing concentrations of MNNG, the relative survival of the MSH2 and MLH l mutants 
compared with cells expressing these genes was assayed. It was clear from the data 
generated that the MMR-deficient mutants showed increased resistance to the cytotoxic 
effects of MNNG compared with wild-type cells, indicating that deletion of MSH2 or 
MLH l resulted in the loss of MMR activity. In both bacteria and eukaryotes MMR is 
involved in the correction of replication slippage events at microsatellite loci. Loss of 
MMR results in the second phenotype characteristic of MMR mutants, termed 
microsatellite instability, because slippage of DNA polymerase at these loci is not 
corrected. In T. brucei, analysis of PCR products amplified from several micro satellite loci
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revealed that clones derived from both MSH2 and MLH l homozygous mutants showed a 
higher frequency of microsatellite mutation than clones derived from cells expressing both 
of these genes. Observation of alkylation tolerance and microsatellite instability in 
T. brucei MSH2 or MLH l homozygous mutants indicates that these genes encode genuine 
and active components of the MMR pathway in this organism.
In order to elucidate whether MMR regulates antigenic variation in trypanosomes, an assay 
to determine the frequency of, and mechanisms used during, VSG switching in the MSH2 
and MLH l mutant cell lines was performed (see chapter 4). These data indicated that there 
was no alteration in either the frequency or profile of the VSG switching mechanisms used 
in the MMR mutants compared with cells expressing both MSH2 and MLH l, revealing that 
MMR has little or no influence over antigenic variation. This clearly shows that MMR 
activity does not underlie the difference in switch rates between monomorphic and 
pleomorphic cell lines. However, this assay is not sensitive enough to detect any subtle 
influence that MMR might exert on VSG switching, nor can it be used to detect changes in 
the hierarchy of VSG expression. In order to detect a subtle regulatory effect imposed by 
MMR it would be advantageous to develop an in vitro VSG switching assay, which would 
be more reproducible than the current in vivo assay. Here the switched variants would be 
isolated by clearing cells expressing VSG221 using a specific-antiserum followed by 
complement-mediated lysis.
Recent advances have made it possible to generate knockout mutants in pleomorphic cells, 
allowing investigation into the roles of MMR in antigenic variation in non-adapted, high- 
switching trypanosome strains. Currently, an assay is under development which will allow 
investigation of the hierarchy of VSG switching in pleomorphic cells (L. Morrison and 
J. D. Barry, personal communication). Ten single copy VSG genes representing telomeric, 
minichromosomal, and internal (basic-copy) loci have been characterised from T. brucei 
strain ILTat 1.2, and antibodies against these VSG coats raised. The appearance of these 
VSG coats during chronic infections in mice is being monitored by in vitro immune lysis, 
and the position of each VSG in the VSG switching hierarchy assessed. Comparison of the 
results of this assay for wild-type and MMR mutant trypanosomes could therefore reveal 
whether MMR had any influence on the timing of activation, or hierarchy, of these VSG 
genes.
In both bacteria and eukaryotes, MMR has been shown to constrain recombination so that 
it occurs only between highly related DNA sequences. An assay to investigate whether 
MMR regulates homologous recombination in trypanosomes was therefore developed (see
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chapter 5). A unique sequence was integrated into the T. brucei genome, and used as the 
integration site for a set of antibiotic resistance constructs that possess integration flanks 
for homologous recombination based on the sequence of this unique site, but which contain 
increasing numbers of heterologies compared with this sequence. A pilot study using this 
system was performed to determine the frequency of integration of these increasingly 
divergent targeting constructs into wild-type and MSH2 mutant trypanosomes. In 
wild-type cells, a construct containing 3% divergent flanks integrated at a greatly reduced 
frequency compared to a construct containing identical flanks, indicating that the 
probability of integration into the trypanosome genome decreases upon the introduction of 
sequence heterologies. However, the integration frequency of the 3% divergent construct 
was greater in MSH2 mutant cells than wild-type trypanosomes, suggesting that the 
probability of recombination between homeologous sequences is elevated in MMR- 
deficient cells, and revealing that MMR does indeed regulate homologous and 
homeologous recombination in this organism. In the future this assay can be used to 
further investigate the effect of sequence divergence on the frequency of recombination in 
T. brucei, as well as the anti-recombination activities of the MMR components. 
Furthermore, this assay could be extended to include constructs containing a greater 
variety of mismatches, as well as investigating the influence of other DNA repair and 
recombination factors on trypanosome homologous recombination. To attempt to tie this 
with the process of VSG switching by recombination, it would be interesting to develop an 
assay to examine rates of recombination between homologous or homeologous markers 
already integrated in the T. brucei genome. This would provide a more realistic measure 
of the contribution MMR makes to VSG translocation reactions.
During this study the functions of only the T. brucei MSH2 and MLH l genes have been 
investigated. However, as stated above, a number of other mutS- and /MW/L-related genes 
are present in the genome. At present, nothing is known about the roles of the 
polypeptides encoded by these loci. Functional analyses, similar to those described above, 
would reveal whether the putative T. brucei MSH3, MSH8 and PMSl genes encode active 
MMR components. Further to this, the assay to assess the frequency of homeologous 
recombination could be used to investigate the types of mismatches recognised by the 
MSH3 and MSH8 gene products. Further constructs containing insertions or deletions 
which would form IDLs upon heteroduplex formation could be generated for this purpose. 
If the putative T. brucei MSH3 gene encodes a genuine orthologue of MSH3 from yeast or 
mammals, inactivation of this gene would be expected to increase the frequency of 
integration of constructs containing large insertions or deletions. In contrast, deletion of 
the putative MSH8 gene should result in an increase in the frequency of integration of
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constructs containing simple base changes, but not large insertions or deletions, if this gene 
encodes an orthologue of MSH6. This assay could also be used to investigate the role of 
MLH l and PMSl in homeologous recombination in T. brucei.
In eukaryotes, the MutS and MutL homologues function as heterodimers which interact to 
form ternary complexes. It would therefore be interesting to look for interactions between 
the putative T. brucei polypeptides using yeast two-hybrid analysis. Using this system, it 
would be possible to test for heterodimer formation between T. brucei MSH2 and the 
putative MSH3 or MSH8 polypeptides, as well as between MLHl and the putative PMSl 
polypeptide. In addition it would be possible to examine the interactions between the 
putative T. brucei MutS and MutL homologues and thereby the potential for ternary 
complex formation. Furthermore, a putative PCNA gene has recently been identified in 
T. brucei (J. Bell and R. McCulloch, unpublished), and in other eukaryotes this protein also 
interacts with components of the MMR machinery (Umar et a l , 1996; Gu et a l , 1998; 
Kleczkowska et a l , 2001). It would therefore it would be possible to test for interactions 
between the T. brucei MMR polypeptides and PCNA.
Currently, antibodies specific to the T. brucei MSH2 and MLHl proteins are unavailable. 
The generation of such antibodies would allow further investigation of the functions of 
MMR in this organism. Initially, it would be possible to determine the expression levels of 
the MMR proteins in both bloodstream form and procyclic trypanosomes by Western 
blotting. It would also be interesting to determine whether the MMR proteins are 
expressed only at certain stages of the cell cycle using fluorescent in situ hybridisation 
(FISH). In trypanosomes, the kinetoplast and nuclear genomes each have a distinct S 
phase, followed by segregation, prior to cell division (Matthews and Gull, 1994), and 
fluorescent staining of these genomes can be used to determine the approximate cell cycle 
stage. Furthermore, it would be possible to investigate whether the MMR proteins localise 
to newly replicated DNA labelled with 5-bromodeoxyuridine (BrdU).
Far-Western analysis using purified recombinant MMR proteins could be used to confirm 
the protein-protein interactions seen using yeast two-hybrid analysis. Increasing amounts 
of each recombinant protein could be spotted on to a nitrocellulose membrane and allowed 
to hybridise to a second recombinant protein which could be detected using the antibody 
specific to that protein. Alternatively, recombinant proteins could be used in band-shift 
assays. Two recombinant MMR components could be mixed and the sizes of the products 
present in the mixture determined by polyacrylamide gel electrophoresis followed by 
Western blotting. Identification of a band of increased size, compared to either of the
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recombinant proteins, indicates that these proteins form a complex. This approach could 
also be used to determine the mismatch specificities of the complexes identified, by mixing 
the protein complexes with radiolabelled DNA duplexes containing a mismatch or IDL, 
and assaying for an increase in the size of the radiolabelled band. Addition of a MutS- 
related heterodimer to a mismatch-containing DNA duplex, followed by addition of a 
MutL-heterodimer might allow the definition of ternary complexes in T. brucei. 
Theoretically, such approaches could be carried out without recombinant protein, using 
simply T. brucei cell extracts.
Several phylogenetic analyses have been performed on the known MutS homologues 
(Kolodner, 1996; Eisen, 1998; Culligan et a l, 2000). These studies suggest that the 
progenitor of the eukaryotic MutS homologues was transferred from the genome of an 
endosymbiont into the host cell nucleus early in eukaryote evolution (Figure 6.1; Culligan 
et a l ,  2000). Duplication events then led to the evolution of both the MMR- and meiosis- 
specific MutS homologues. Although the phylogenetic relationships between the MutL 
homologues have yet to be fully investigated, it is speculated that similar transfer and 
duplication events occurred during their evolution (Kolodner, 1996; Culligan et a l, 2000). 
In both cases, these events are believed to have occurred prior to the radiation of animals, 
plants and fungi (Culligan et a l , 2000). This knowledge raises several questions about the 
putative T. brucei MSH3 and MSH8 genes. Sequence analysis suggests that the MSH8 
gene encodes a member of the MSH6/MSH7 subfamily of MutS homologues. However, 
in comparison with MSH6 and MSH7 proteins from other eukaryotes, the predicted MSH8 
polypeptide appears to exhibit a large N-terminal truncation (Figure 3.21). Furthermore, 
neither the T. brucei MSH3 or MSH8 polypeptides appear to possess the conserved PCNA 
binding site characteristic of members of the MSH3/MSH6 subfamily (Figure 3.22; Flores- 
Rozas et a l , 2000). Without functional analysis it is impossible to determine the effect 
these features have on the MMR system in T. brucei, but, it would nevertheless be 
interesting to determine when these sequence differences arose in trypanosome evolution. 
There are two possibilities: trypanosomes diverged prior to the acquisition of the conserved 
PCNA binding sites and N-terminal extension; or the trypanosome MSH3 and MSH8 
polypeptides once possessed these features but have subsequently lost them.
Investigation of the MutS and MutL homologues present in early-diverging eukaryotes 
(Baldauf et a l , 1996; Philippe and Adoutte, 1998), which include many unicellular 
parasites, may shed light on the evolution of these features, and indeed the timing of the 
duplication events which occurred to generate the variety of MutS- and MutL-related 
proteins found in eukaryotes. To this end, we searched the genome sequencing databases
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of a number of unicellular eukaryotic parasites in an attempt to determine which MutS and 
MutL family members are present in these organisms (Table 6.1). These database searches 
could not be exhaustive, as not all of the sequencing databases available for each organism 
were searched, and none of the genome sequencing projects are complete, except that of 
Encephalitozoon cuniculi (Katinka et ah, 2001). Furthermore, the identities assigned to the 
sequences retrieved during these database searches are putative and based solely on their 
similarity to sequences present in the NCBI protein database. Every species examined 
contains at least one gene encoding a putative MMR component, suggesting that all these 
organisms possess the MMR pathway. All three kinetoplastids, including T. brucei, 
Leishmania major and Trypanosoma cruzi, contain putative homologues of both MSHS 
and MSH6. Unfortunately, the ORFs of the L. major and T cruzi genes are incomplete, 
making it impossible to determine if these genes encode polypeptides which also lack the 
PCNA binding motifs. Neither is it possible to determine whether the MSH6 homologues 
from these species possess a similar N-terminal truncation to T. brucei MSH8. These three 
species also encode orthologues of MSH2, and a comparison of the predicted T. brucei and 
T. cruzi polypeptides reveals that they share 65% sequence identity (72% similarity). This 
suggests that a high degree of sequence conservation will also be found between the other 
MMR components of these species when their full sequences become available.
E. cuniculi has recently been shown to be an atypical member of the fungal kingdom, 
rather then an early-diverging eukaryote as was previously believed (Katinka et a l , 2001). 
As the genome sequence of this organism is complete, it is evident that this species 
possesses a highly streamlined MMR system, probably consisting of one MutS-related 
heterodimer and one MutL-related heterodimer. It is possible that a similar streamlining 
has taken place among the apicomplexan parasites, as putative homologues of only MSH2, 
MSH6, MLHl and PMSl were identified in any of the databases searches of Babesia 
bovis, Plasmodium falciparum, Theileria annulata and Toxoplasma gondii. Searches of 
the genome sequencing databases compiled for P. chabaudi, P. knowlesi and P. yoelii also 
failed to identify any other MutS or MutL homologues (data not shovm). While these 
databases are all incomplete, it seems unlikely that these genes have simply been missed 
by the sequencing so far performed on these seven related genomes. The earliest-diverging 
eukaryote examined here, Giardia lamblia (Baldauf et a l, 1996), also appears to possess 
only putative homologues of the MSH2, MSH6, MLHl and PMSl proteins. However, no 
conclusion can be drawn about the evolution of the MMR system in this organism until the 
genome sequencing project is complete, because this was the only diplomonad species 
examined and more MMR components may yet come to light.
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Entamoeba histolytica is also thought to have diverged from the main eukaryote lineage 
prior to the Kinetoplastida (Baldauf et a l, 1996). While still incomplete, the genome 
sequence of this organism contains putative homologues of the same MMR components as 
T. brucei, with the exception that, as yet, no gene encoding MSH3 can be identified. Once 
the genome sequence is complete it will be interesting to determine whether MSH3 is truly 
absent from this organism, and whether the gene which looks most similar to MSH6 
encodes the N-terminal extension found in MSH6 orthologues from higher eukaryotes. If 
the E. histolytica and G. lamblia MSH6 homologues also lack the N-terminal extension 
and PCNA binding motif, this might indicate that these features evolved after the 
divergence of the Kinetoplastida from the main eukaryote lineage. Furthermore, the 
absence of genes encoding an MSH3 homologue from the complete G. lamblia and 
E. histolytica genome sequences might indicate that MSH3 arose from an event which 
duplicated the MSH6 gene after the divergence of E. histolytica but prior to the divergence 
of the Kinetoplastida. Alternatively, if the genomes of both G. lamblia and E. histolytica 
encode homologues of MSH3 and MSH6 which possess PCNA binding motifs, and the 
MSH6 orthologues have the N-terminal extension found in fungi, animals and plants, then 
this would indicate that the T. brucei MSH3 and MSH8 genes had lost these features after 
the divergence of this organism from the main eukaryote line.
T. brucei possesses a non-obligatory sexual cycle which occurs in the tsetse fly (Jenni et 
a l, 1986). Stocks undergo genetic exchange during co-transmission through the vector 
and crossing over events have been detected in the hybrid progeny. However, very little is 
known about the molecular events underlying this sexual cycle. The genes putatively 
encoding the meiosis-specific MutS homologues MSH4 and MSH5 in T. brucei might 
represent the first components of the genetic exchange machinery identified in 
trypanosomes. Unfortunately, it would be impossible to determine the roles of these 
proteins in knockout mutants as the frequency of genetic exchange in the tsetse fly is not 
quantifiable. However, cloning of these genes from a number of stocks, including both 
pleomorphic and monomorphic trypanosomes lines, might reveal differences between the 
loci, as mutations may have disrupted the ORFs in monomorphic stocks which cannot 
complete the life cycle and therefore no longer require the meiotic recombination 
machinery. In stocks able to undergo genetic exchange, for instance TREU 927/4, the 
MSH4 and MSH5 loci should still be intact, providing circumstantial evidence of the role 
of MSH4 and MSH5 in the sexual cycle of T. brucei. It is interesting to note that during 
searches of the genome sequencing databases of other unicellular eukaryotic parasites, 
putative homologues of MSH4 and MSH5 were identified only in E. histolytica. This 
organism is believed to undergo genetic exchange (Sargeaunt et a l , 1988). Not
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surprisingly, the meiosis-specific MutS-homologues are absent from E. cuniculi reflecting 
the asexual life cycle of this organism (Vivarès and Méténier, 2001). Unexpectedly, 
however, these genes also appear to be absent from P. falciparum, which has an obligate 
sexual cycle (Walliker et a l, 1987). Searches of the genome sequencing databases 
compiled for P. chabaudi, P. Imowlesi and P. yoelii also failed to identify the meiosis- 
specific MutS homologues (data not shown). The absence of the MSH4 and MSH5 
proteins is not unprecedented in sexual organisms, however, as D. melanogaster also lacks 
these conserved elements (Sekelsky et a l, 2000).
Given the complexity of the kinetoplast DNA, it might be expected that this organellar 
genome would possess its own dedicated DNA repair mechanisms. In yeast, the MSHl 
protein appears to recognise and con'ect premutagenic mismatches in the mitochondrial 
genome. MSH l has also been identified in A. thaliana, and may perfonn a similar function 
in this organism, but no MSH l homologues have been identified in the C. elegans,
D, melanogaster or H. sapiens genomes, suggesting that this protein is absent from the 
animal kingdom. During searches of the T. brucei, L. major and T. cruzi genome 
sequencing databases, no MSHl homologues were identified (Table 6.1). However, the 
complete genome sequences are not yet available for these organisms and it is possible that 
further MutS and MutL homologues remain to be discovered in these species. Given the 
high levels of divergence of the putative T. brucei MSH3 and MSH8 genes, it is also 
possible that any MSH l homologue encoded in this organism is sufficiently different to 
other MutS-related proteins that it is not recognised during BLAST searches.
Alternatively, it may be encoded in the kinetoplast DNA rather than the nuclear genome, 
and so has yet to be recognised. This is not unprecedented as the mitochondrial DNA of 
the coral Sarcophyton glaucum encodes a MutS homologue which is thought to have been 
transferred to this organelle from the nucleus (Pont-Kingdon et a l, 1998).
Until the genome sequences of these organisms are complete it will be impossible to draw 
any fiim conclusions about the evolution of the MMR system in early-diverging 
eukaryotes. Even so, the available data reveals a complex picture of acquisition and loss of 
MMR components during eukaryote evolution. On a final note, it is interesting that MutL 
homologues other than MLHl and PMSl have yet to be identified in any organisms other 
than yeast and mammals. This perhaps suggests that the MLH2, MLH3 and human PMSl 
proteins evolved after the divergence of the primitive eukaryotes.
The findings of this investigation into the MMR system in 71 brucei have not only 
advanced our Icnowledge of DNA repair in this organism, but have also shed light on the
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development of the MMR system during eukaryote evolution. This work has revealed that 
many of the components involved in MMR in higher eukaryotes had already evolved prior 
to the divergence of the Kinetoplastids. 71 brucei contains an active MMR system which 
functions to repair mismatches formed during replication, and also provides an anti­
recombination activity, which constrains homologous recombination to occur between 
highly-related DNA sequences. However, although antigenic variation in this organism is 
thought to involve homologous recombination, MMR does not appear to regulate these 
reactions. Further investigation into the roles of the MMR components, as well as other 
DNA repair and recombination proteins, may begin to unravel to the complex inter­
relationships between the DNA repair and recombination systems present in this organism.
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Figure 6.1 Scheme of MutS/MSH evolution
It is thought that mutS genes arose and evolved in the eubacteria. The progenitor of the 
MSH l gene was introduced into the eukaryotes by a mitochondrial endosymbiont. This 
gene was later transferred into the host cell nucleus where it gave rise to all eukaryotic 
MSH genes. (After Culligan et al., 2000)
MSHl
Mots
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T a b l e  6 . 1  M u t S  a n d  M u t L  h o m o l o g u e s  i n  u n i c e l l u l a r  e u k a r y o t i c  p a r a s i t e s
BLAST searching of the genome sequencing databases for the organisms shown was 
performed using MutS- and MutL-related protein sequences from A. thaliana, S. cerevisiae 
and 71 brucei (see section 2.8.5). Putative protein identities was assigned solely on the 
basis of similarity of the sequences retrieved as above to knovm proteins as assessed by 
BLAST searching of the NCBI protein database (http://Avww.ncbi.nlm.nih.gov/). Where 
published sequences homologous to MutS and MutL were identified in the organisms, the 
accession numbers are shown in brackets. Since the genome sequencing projects are on­
going (except that of Encephalitozoon cuniculi, which is complete), further putative 
components of the MMR system may be identified in these organisms, and the assignment 
of homologues listed here may need revision.
O r g a n i s m M u t S  H o m o l o g u e s M u t L  H o m o l o g u e s
Babesia bovis MSH2
Encephalitozoon cuniculi MSH2 (CAD26200) 
MSH6 (CAD25790)
MLHl (CAD26547) 
PMSl (CAD26036)
Entamoeba histolytica MSH2
MSH6
MSH4
MSH5
MLHl
PMSl
Giardia lamblia MSH2 MLHl
MSH6 PMSl
Leishmania major MSH2 MLHl
MSH3 PMSl
MSH6
Plasmodium falciparum MSH2
MSH6
MLHl
PMSl
Theileria annulata MSH2
MSH6
MLHl
Toxoplasma gondii MSH2
MSH6
Trypanosoma brucei MSH2 (AAK08648)
MSH8 (AAK51796)
MSH3
MSH4
MSH5
MLHl (AAK29067) 
PMSl (AAK08649)
Trypanosoma cruzi MSH2 (AAG00261 )
MSH3
MSH6
334
A p pe n d ic e s
335
Appendix 1 Sequence map showing the T, brucei MSH2 ORF
A map showing the DNA sequence of the 4.5 kb EcoKl fragment sub-cloned from the 
ILTat 1.2 genomic lambda clone ‘Plaque 1’ into pBluescript II KS to form the plasmid 
pJB 100, which contains the entire 71 brucei MSH2 ORF along with its processing flanks 
(see sections 2.9.1 and 3.1.3). The conceptual translation of the MSH2 ORF is shown in 
red beneath the DNA sequence and restriction sites are shown above the sequence in black. 
Half arrows denote primer sequences: those used to amplify the MSH2 5’ targeting flank 
{MSH2 5’(A) and MSH2 5’(B)) are shown in blue; those used to amplify the MSH2 3’ 
flank {MSH2 3’(A) and MSH2 3’(B)) are shown in green; those used to amplify the MSH2 
internal fragment (MSH2D5 and MSH2V2) are indicated in turquoise; and the degenerate 
primers used to amplify the conserved ATP-binding site (MSH2 5’(1) and MSH2 3’(1)) are 
shown as dashed purple half arrows.
EcoRI
IGAATTCTAGAGCCGTTTGTCGTAGGGCTTGGCGGCGTAGAAAAAGTGAACGTCGGTTAAC
CTTAAGATCTCGGCAAACAGCATCCCGAACCGCCGCATCTTTTTCACTTGCAGCCAATTG
ATGCAACTGAGAAGGCGGACGATTTGGCAACGCAAGAAGGTAAGAAAACATTTCGTATCT
TACGTTGACTCTTCCGCCTGCTAAACCGTTGCGTTCTTCCATTCTTTTGTAAAGCATAGA
CAGCATGTCTAACGGAGCAAGATGCAAAGCTAAGTGGGGAAATGGTGAATGAACGACTGT
GTCGTACAGATTGCCTCGTTCTACGTTTCGATTCACCCCTTTACCACTTACTTGCTGACA
AATTGCCTCTGAGGACTCAGGAGCCTTTACGCATGCTTGTCACGCCTGTTGTTATTGTTG
TTAACGGAGACTCCTGAGTCCTCGGAAATGCGTACGAACAGTGCGGACAACAATAACAAC
GATTTTTTCTGTTTTGGTCCCAACAGGAGCGCTTTTTGCCCTGATCCATTATAGCTTCTT
2 4 1   + --------------------+ ------------------- + ------------------- + --------------------+ -------------------- + 3 0 0
CTAAAAAAGACAAAACCAGGGTTGTCCTCGCGAAAAACGGGACTAGGTAATATCGAAGAA
CTCATAAACGAGCCCGTTGTAGGCAAGTTGTGTCAGTTATGTGGAGGGTGTAACCCATTT
3 0 1   + --------------------+ ------------------- + ------------------- + --------------------+ -------------------- + 3 6 0
GAGTATTTGCTCGGGCAACATCCGTTCAACACAGTCAATACACCTCCCACATTGGGTAAA
TCTGAGCGTAAGGTTCAACTAACTTTAAAAGACTTAACGAAAAGGGGAGGGAAGCTTCTA
3 6 1   + --------------------+ --------------------+ ------------------- + --------------------+ -------------------- + 4 2 0
AGACTCGCATTCCAAGTTGATTGAAATTTTCTGAATTGCTTTTCCCCTCCCTTCGAAGAT
TGCGTGCGTATATGTAACATATATACGAACATGCACAAAAACTGGTCACCCTGTTAAAAG
4 2 1   + ------------------- + --------------------+ ------------------- + --------------------+ -------------------- + 4 8 0
ACGCACGCATATACATTGTATATATGCTTGTACGTGTTTTTGACCAGTGGGACAATTTTC
CAATATGAGAGCTTTGTCGCTATTCAAATGCTTCTACCCTTTTTTTTCCACCCTTCAGTT481  +------------ +------------ +------------ +------------ +-------------+ 540
GTTATACTCTCGAAACAGCGATAAGTTTACGAAGATGGGAAAAAAAAGGTGGGAAGTCAA
GTGTTTTCATGGGCTAAAGGTAAATATTGACGAACATCACGGGGACACATGATACTTTAA
5 4 1   + ------------------- + --------------------+ ------------------- + --------------------+ -------------------- + 6 0 0
CACAAAAGTACCCGATTTCCATTTATAACTGCTTGTAGTGCCCCTGTGTACTATGAAATT
336
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MSH2 5 ' (A)
ATAGCAGCGAGTCCAGGAGAAAATAGCGCCTCCTCTGATGACGCTGCACAGATGTGGAAT
601  + + + + + + 660TATCGTCGCTCAGGTCCTCTTTTATCGCGGAGGAGACTACTGCGACGTGTCTACACCTTA
 ^
GAGGGAATCTTCGATGTTCTTGTTGCCACCTCCACTGTCCGCACCAGGGCGCCGTGGAGT
661  +-------- +---------  +---------*■  ^ 720CTCCCTTAGAAGCTACAAGAACAACGGTGGAGGTGACAGGCGTGGTCCCGCGGCACCTCA
TCTTAACGTTTTGCTCGCAATTTGGTGGATATTTAGGAGGCCTGCCATGAGGGAAATAGT
721  +---------+-------- +-------- +--------+---------+ 780AGAATTGCAAAACGAGCGTTAAACCACCTATAAATCCTCCGGACGGTACTCCCTTTATCA
S a i l
IGCATCGTGGAGGTCATCAGATAACGGCACTGTTTATCAGTGTTGAACTACCGTCGACACG
781  +---------+-------- +-------- +--------+---------+ 840
CGTAGCACCTCCAGTAGTCTATTGCCGTGACAAATAGTCACAACTTGATGGCAGCTGTGC
ATGTCGGTCTGATGCATGCGATGCCGAACAGCGGGAAGGCAGCTACAGGCAAAGGTAGTG
TACAGCCAGACTACGTACGCTACGGCTTGTCGCCCTTCCGTCGATGTCCGTTTCCATCAC
GATGAAACGCTTCTCTGCCGAGTCCTTTCTTCTGTGCCGAAGTGCTTGAGCGAGGCTAGG
CTACTTTGCGAAGAGACGGCTCAGGAAAGAAGACACGGCTTCACGAACTCGCTCCGATCC
TCAACACTGTGCTCTTCTCCGCGTCTACCTCAACGTTAGGCGTTACTGTTTCCCTTCCTT
AGTTGTGACACGAGAAGAGGCGCAGATGGAGTTGCAATCCGCAATGACAAAGGGAAGGAA
TCAAACCCTTTTCACTGGTTCTATCTCTTTATCCCAACGGGTGTGTAGTCAGCAACAACT
AGTTTGGGAAAAGTGACCAAGATAGAGAAATAGGGTTGCCCACACATCAGTCGTTGTTGA
MSH2 5'(B)
GTAAAAAGTATTATGAGTGACGACCGCGACCCGGCGGTGGTGCAGGCCTTTAATGGTGCC
CATTTTTCATAATACTCACTGCTGGCGCTGGGCCGCCACCACGTCCGGAAATTACCACGGM S D D R D P A V V Q A F N G A
GGTGGCGATGATACTTCCTGCTTGCGGTTGTTCTCGCGTGCATCGGCTGGCTGTTTTATT
CCACCGCTACTATGAAGGACGAACGCCAACAAGAGCGCACGTAGCCGACCGACAAAATAA
G G D D T S C L R L F S R A S A G C F I
CTAGGCAGCTGGGCTTCACTCGTGGCGCGTGAATATGTCAAGTCCACTGCCGTTCTGAAG
GATCCGTCGACCCGAAGTGAGCACCGCGCACTTATACAGTTCAGGTGACGGCAAGACTTCL G S W A S L V A R E Y V K S T A V L K
AACTGGAGCGGAGTGGATGCCGTCGCCGTTAATGACAGCATCACCCGCGAAGTCATACGT
TTGACCTCGCCTCACCTACGGCAGCGGCAATTACTGTCGTAGTGGGCGCTTCAGTATGCAN W S G V D A V A V N D S I T R E V I R
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GACTGCCTGCTTCGACGCGGTGTTTCTGTTGAACAATACGACCGACAGACGAGCGGCGGC
1321  +-------- +-------- +-------- +-------- +-------- + 1380CTGACGGACGAAGCTGCGCCACAAAGACAACTTGTTATGCTGGCTGTCTGCTCGCCGCCGD C L L R R G V S V E Q Y D R Q T S G G
AGATATGTTTGCATGCGGCGCGGCTCCCCTGGGCACATTGCAGACTTCGAAGCAATGCTC
1381  +-------- +-------- +-------- +-------- +-------- + 1440
TCTATACAAACGTACGCCGCGCCGAGGGGACCCGTGTAACGTCTGAAGCTTCGTTACGAGR Y V C M R R G S P G H I A D F E A M L
TTTGCCTTCGAAGACGCAGAGATACAACTCATGGCAATTGGGAGTGTGGTTATTGACGAT
1441  +-------- +-------- +-------- +-------- +-------- + 1500
AAACGGAAGCTTCTGCGTCTCTATGTTGAGTACCGTTAACCCTCACACCAATAACTGCTA F A F E D A E  I Q L M A I G S V V I D D
AAAGCAAATAGGGTTAATGGCCCAGGTGGACAGCACGTCCGGGTGGGTTACGCAGCGCTC
TTTCGTTTATCCCAATTACCGGGTCCACCTGTCGTGCAGGCCCACCCAATGCGTCGCGAGK A N R V N G P G G Q H V R V G Y A A L
AATACAACACTACGGACACTTACGTACGCGGAATATCATGACACACCACAGTTAACAAAC
TTATGTTGTGATGCCTGTGAATGCATGCGCCTTATAGTACTGTGTGGTGTCAATTGTTTGN T T L R T L T Y A E Y H D T P Q L T N
CTTGATGTGCTTATGGCGCAGTGTAACCTGAAGCAGCTGCTGTACTCTAACACTGACTTT
GAACTACACGAATACCGCGTCACATTGGACTTCGTCGACGACATGAGATTGTGACTGAAAL D V L M A Q C N L K Q L L Y S N T D F
TCGATGAATAATACGGGTGAGAAGGCTGCAGACTCTGACGAAAGTAGGGAACAGAGTGAT
AGCTACTTATTATGCCCACTCTTCCGACGTCTGAGACTGCTTTCATCCCTTGTCTCACTAS M N N T G E K A A D S D E S R E Q S D
TTGTTACGAGCACTCAAGCAGCTCTGTGAACGAGCGAACATTACGCTCCAAGAGCGTGGA
AACAATGCTCGTGAGTTCGTCGAGACACTTGCTCGCTTGTAATGCGAGGTTCTCGCACCTL L R A L K Q L C E R A N I T L Q E R G
CAAAGTAATCTACCTCATGGAAAGCAGAAGTCCAGGGCCACGAAGCGTAACAGCACTGGC
GTTTCATTAGATGGAGTACCTTTCGTCTTCAGGTCCCGGTGCTTCGCATTGTCGTGACCGQ S N L P H G K Q K S R A T K R N S T G
CCGAATGGAGAGCTACTTAGCACGCTCGAAGGGATTCTTCGCGTGCCGGAAGATAGACAT
GGCTTACCTCTCGATGAATCGTGCGAGCTTCCCTAAGAAGCGCACGGCCTTCTATCTGTAP N G E L L S T L E G I L R V P E D R H
GGTTTAAATAGCTTCCCTCTTGCTTCCAGGGCTTTGGAAAGCCTTCTAGAATCCGCCATA
CCAAATTTATCGAAGGGAGAACGAAGGTCCCGAAACCTTTCGGAAGATCTTAGGCGGTATG L N S F P L A S R A L E S L L E S A I
GATCCATTCGATTCCACTAATCAACATACATTTTACCTTAAGCATGTTATCCCTTCTACG
CTAGGTAAGCTAAGGTGATTAGTTGTATGTAAAATGGAATTCGTACAATAGGGAAGATGC D P F D S T N Q H T F Y L K H V I  P S T
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TTCATGAAGATGGATGCGGCAGCCATCGAGGCGCTGCATATAATCCACCGAAAGCCAGAG
AAGTACTTCTACCTACGCCGTCGGTAGCTCCGCGACGTATATTAGGTGGCTTTCGGTCTCF M K M D A A A I E A L H I I H R K P E
GCACGAGGATCGATGCCAACGTCTATTTACTCGTGGTTGAACCGCTGTACTACGGGTATG
CGTGCTCCTAGCTACGGTTGCAGATAAATGAGCACCAACTTGGCGACATGATGCCCATACA R G S M P T S I Y S W L N R C T T G M
GGGTCGCGACTGATGCAGCAGTGGCTACTCCAACCGTTGCGGAGCATCGAAGATATAAAT
CCCAGCGCTGACTACGTCGTCACCGATGAGGTTGGCAACGCCTCGTAGCTTCTATATTTAG S R L M Q Q W L L Q P L R S I E D I N
CAACGGCTCTCGCTTGTACAGATAATGGTGGAGAGTCCAATCCTAAGGGATGCGCTGATC
2221  + + + + + + 2280
GTTGCCGAGAGCGAACATGTCTATTACCACCTCTCAGGTTAGGATTCCCTACGCGACTAGQ R L S L V Q I M V E S P I L R D A L I
M.CTHPn.S
ACGCAGGTACTGCGGCGCTGCACTGACATGGACAGGTTGAACCGAAAGTTGCAACGCCGC2281  +-------- +-------- +-------- +-------- +-------- + 2340
TGCGTCCATGACGCCGCGACGTGACTGTACCTGTCCAACTTGGCTTTCAACGTTGCGGCGT Q V L R R C T D M D R L N R K L Q R R
ACAGTGGCTCTCAAGGACCTGCAATCTATTCTTGTCTTCGCTAATACTGTACCCCTAGCG
2341  +-------- +-------- +-------- +-------- +-------- + 2400
TGTCACCGAGAGTTCCTGGACGTTAGATAAGAACAGAAGCGATTATGACATGGGGATCGCT V A L K D L Q S I L V F A N T V P L A
GTCGATGTGCTGCGAACATATCATGGCGGGCACGACAGCAGCTTACTTTTGAAGGGATAC2401  +-------- +-------- +-------- +-------- +-------- + 2460
CAGCTACACGACGCTTGTATAGTACCGCCCGTGCTGTCGTCGAATGAAAACTTCCCTATGV D V L R T Y H G G H D S S L L L K G Y
GTGACACCTCTGGAAGACATTAGCGAGCATCTTTCAAATCTGCGCACGTTGATAAATGCA
2461  +-------- +-------- +-------- +-------- +-------- + 2520
CACTGTGGAGACCTTCTGTAATCGCTCGTAGAAAGTTTAGACGCGTGCAACTATTTACGTV T P L E D I S E H L S N L R T L I N A
ACCGTTGACTTGTCAGATGAGAATACCGTGCGTATTAACCCTGAATTTGACGATGACCTC
TGGCAACTGAACAGTCTACTCTTATGGCACGCATAATTGGGACTTAAACTGCTACTGGAG T V D L S D E N T V R I N P E  F D D D L
AGCTTCCTGGAGCGGCAGCGTCAGAATCTTGTGAAGGCGATTGAAAAAGAAAACCACCGT
2581  +-------- +-------- +-------- +-------- +-------- + 2640
TCGAAGGACCTCGCCGTCGCAGTCTTAGAACACTTCCGCTAACTTTTTCTTTTGGTGGCA
S F L E R Q R Q N L V K A I E K E N H R
GTGCTGAAACAGTGCGGATGGACTGAAAAACAAATGAAGTGTGAATATCACGCTAGTTAC
2641  +-------- +-------- +-------- +-------- +-------- + 2700
CACGACTTTGTCACGCCTACCTGACTTTTTGTTTACTTCACACTTATAGTGCGATCAATGV L K Q C G W T E K Q M K C E Y H A S Y
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GGTTATGTGTTTCGCGTTCCTCGGAAAGATGACCACCAGGTGCGCACGAGCAAAGAGTTC
CCAATACACAAAGCGCAAGGAGCCTTTCTACTGGTGGTCCACGCGTGCTCGTTTCTCAAGG Y V F R V P R K D D H Q V R T S K E F
ATAACGGTAAGCACGGCAAAGGATGGCGTACGGTTCGTATCCGGGCAATTATCATCGCTG
TATTGCCATTCGTGCCGTTTCCTACCGCATGCCAAGCATAGGCCCGTTAATAGTAGCGACI T V S T A K D G V R F V S G Q L S S L
^ -------------
AGCGAGCAGTATAAGGGCATTACTGAGGACTACAAGACACGTCAGCAGGTCCTCAAAAAA
TCGCTCGTCATATTCCCGTAATGACTCCTGATGTTCTGTGCAGTCGTCCAGGAGTTTTTT
S E Q Y K G I T E D Y K T R Q Q V L K K
M S H  PIT?
AAGCTCGTTGATACTGTAGCTACATACCTCCCGGTCCTTGATGATGCGAAAGAGCTACTT
TTCGAGCAACTATGACATCGATGTATGGAGGGCCAGGAACTACTACGCTTTCTCGATGAA
K L V D T V A T Y L P V L D D A K E L L
GCAGCATTGGATGTGTTCGCGGCGTGGGCACTCGTAGTGAAGGATTCGTCGCGGCCGATG
CGTCGTAACCTACACAAGCGCCGCACCCGTGAGCATCACTTCCTAAGCAGCGCCGGCTAC
A A L D V F A A W A L V V K D S S R P M
GTGCGTCCCACCGTGAGGGCAACACAGAGTGAGGAGGTGAAAGGAAACGTTGACAACAAC
CACGCAGGGTGGCACTCCCGTTGTGTCTCACTCCTCCACTTTCCTTTGCAACTGTTGTTGV R P T V R A T Q S E E V K G N V D N N
AGCGATGGTGCTATTTTGACCATTGTGAACGCCCGACACCCCCTTGTTGAACTGCGGCAG
TCGCTACCACGATAAAACTGGTAACACTTGCGGGCTGTGGGGGAACAACTTGACGCCGTCS D G A I L T I V N A R H P L V E L R Q
CCCGCCTTCACACCGAATACTGTACAACTTACCAACGAGGCCAATGCCCTTATAATAACT
GGGCGGAAGTGTGGCTTATGACATGTTGAATGGTTGCTCCGGTTACGGGAATATTATTGA 
P A F T P N T V Q L T N E A N A L I  I T
MSH2 5'(1)
GGGCCAAATATGGGAGGTAAGTCAACTTTCATGAGGAGCATTGGTGTTTGTGTCGCACTC
CCCGGTTTATACCCTCCATTCAGTTGAAAGTACTCCTCGTAACCACAAACACAGCGTGAG
G P N M G G K S T F M R S I G V C V A L
Sad I
IGCCCAAGCTGGGTGCTTTGTTCCCGCGGATTCAGCGGATATTGTTGTCCGTGACGCGATC
CGGGTTCGACCCACGAAACAAGGGCGCCTAAGTCGCCTATAACAACAGGCACTGCGCTAGA Q A G C F V P A D S A D I V V R D A I
34U
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ATGTGCCGTGTTGGCGCGACAGACCACCTTGCGCAAGGAGTTTCTACCTTCATGGTGGAA
TACACGGCACAACCGCGCTGTCTGGTGGAACGCGTTCCTCAAAGATGGAAGTACCACCTTM C R V G A T D H L A Q G V S T F M V E
S a c l l
IATGCTCGAGTCCGCGGCTATGCTCAACTCCGCCACCCAACAGACTCTGGCCATTGTAGAT
TACGAGCTCAGGCGCCGATACGAGTTGAGGCGGTGGGTTGTCTGAGACCGGTAACATCTAM L E S A A M L N S A T Q Q T L A I V D
GAACTGGGCCGGGGGACGTCAACGTACGATGGATTCGGTCTTGCCTGGGCCATTGCACAG
CTTGACCCGGCCCCCTGCAGTTGCATGCTACCTAAGCCAGAACGGACCCGGTAACGTGTCE L G R G T S T Y D G F G L A W A I A Q
^  MSH2 3' (1)
GAGGTGGCAGTCAACGCAAAGTCTGCACTTCTCTTTTCAACTCATTTCCACGAAATGACA
CTCCACCGTCAGTTGCGTTTCAGACGTGAAGAGAAAAGTTGAGTAAAGGTGCTTTACTGT
E V A V N A K S A L L F S T H F H E M T
CAACTTGCGGCCCGACATACAAACGTGCGGAACGTTCATTTCGGCGCTGATGTGGATACT
GTTGAACGCCGGGCTGTATGTTTGCACGCCTTGCAAGTAAAGCCGCGACTACACCTATGA
Q L A A R H T N V R N V H F G A D V D T
GCCGCTCGGACCTTACGTTTCTCTTACCAACTTCAACCAGGGCCATGCGGGCGCAGCTAC3601  +-------- 4.-------- +-------- +-------- + + 3660
CGGCGAGCCTGGAATGCAAAGAGAATGGTTGAAGTTGGTCCCGGTACGCCCGCGTCGATGA A R T L R F S Y Q L Q P G P C G R S Y
GGATTGTACGTGGCGCAACTCGCGCACATTCCCGACGACGTGCTCGATTTCGCGCGGCAG
CCTAACATGCACCGCGTTGAGCGCGTGTAAGGGCTGCTGCACGAGCTAAAGCGCGCCGTC G L Y V A Q L A H I  P D D V L D F A R Q
AAGGCTGTGGAGTTGGAGGATTTCGGGGGAGACGAAACCAAGAACCGCGCTCAGGTGCTC3721  +-------- +-------- +-------- +-------- +-------- + 3780
TTCCGACACCTCAACCTCCTAAAGCCCCCTCTGCTTTGGTTCTTGGCGCGAGTCCACGAG
K A V E L E D F G G D E T K N R A Q V L
TTTTCCACCGCCACGCCGGAGGTTGTGCAACGGGTGACGGAGTATGCAAAGCGCATCCGC
3781  +-------- +-------- +-------- +-------- +-------- + 3840
AAAAGGTGGCGGTGCGGCCTCCAACACGTTGCCCACTGCCTCATACGTTTCGCGTAGGCGF S T A T P E V V Q R V T E Y A K R I R
GAGTTGGAAAGTGGGGAGGGCGACGGTGACTCGAGGGAGGCTGCCCGTCGCCGGCTGTGC3841  +-------- +-------- +-------- +-------- +-------- + 3900
CTCAACCTTTCACCCCTCCCGCTGCCACTGAGCTCCCTCCGACGGGCAGCGGCCGACACG
E L E S G E G D G D S R E A A R R R L C
MSH2 3'(A)
AGCGAGATTAAGGAAGATGCATTGTTGTCGTCATTGGTGGAGGTGTGAGAAGGTAGAAGG3901  +-------- +-------- +-------- +-------- +-------- + 3960
TCGCTCTAATTCCTTCTACGTAACAACAGCAGTAACCACCTCCACACTCTTCCATCTTCC S E  I K E D A L L S S L V E V
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ACTTAAAGCGGGAGTCAGAGAAATTTGTTGTTGGGTTTTTCTTTAAAAGCTGCTTTATCA
TGAATTTCGCCCTCAGTCTCTTTAAACAACAACCCAAAAAGAAATTTTCGACGAAATAGT
TTATTTTTCTATTTTTTCTTTTTTTTTCTGTTGTCGTTGTTTTGGGCTTTCCCGCCCCCC
AATAAAAAGATAAAAAAGAAAAAAAAAGACAACAGCAACAAAACCCGAAAGGGCGGGGGG
CCCCAGTCCCTTTCTCTCTTGATATACCCCTCATCGCATTTGACTTCACCAGCCTTTCGC
GGGGTCAGGGAAAGAGAGAACTATATGGGGAGTAGCGTAAACTGAAGTGGTCGGAAAGCG
ATTGGATTGGCACGTTAATTTCCTTTCGCACCCGCGTACGACTCACATGATTTGGTGTGC
4141  +-------- +-------- +-------- +-------- + + 4200
TAACCTAACCGTGCAATTAAAGGAAAGCGTGGGCGCATGCTGAGTGTACTAAACCACACG
CAGTGTGCTGAAAGAAATGTCACGGCTGAGTCCGAAGGGGGCCGATTGGTCGTTAGTAAT
4201  +-------- +-------- +-------- +-------- +-------- + 4260
GTCACACGACTTTCTTTACAGTGCCGACTCAGGCTTCCCCCGGCTAACCAGCAATCATTA
AGTTCCTTTTTATTATTCTTTTGCTATCCTTACTTCAGTACCTCGTAGAATCTAAGGGGG4261  +-------- +-------- +-------- +-------- +-------- + 4320
TCAAGGAAAAATAATAAGAAAACGATAGGAATGAAGTCATGGAGCATCTTAGATTCCCCC
T :-------------------------MSH2 3' (B)
AATGAGGAGGGGGGATGAAAATAACTGAAGAACCAAAGGGGGAGCTACAAACGCAAACGG
4321  +-------- +-------- +-------- +-------- +-------- + 4380
TTACTCCTCCCCCCTACTTTTATTGACTTCTTGGTTTCCCCCTCGATGTTTGCGTTTGCC
GAAGTTTCTAAAAAGGATGTAGAGAGACCAGGGTGCCAAATAACATGGATACTCAGCTGG4381  +-------- +-------- +-------- +-------- +-------- + 4440
CTTCAAAGATTTTTCCTACATCTCTCTGGTCCCACGGTTTATTGTACCTATGAGTCGACC
CGGCTGAGGACCTGTACAGGGACAACAGTGGGGGAAATTTTTTTTTGAAAAAAAAATTGT4441  +-------- +-------- +-------- +-------- +-------- + 4500
GCCGACTCCTGGACATGTCCCTGTTGTCACCCCCTTTAAAAAAAAACTTTTTTTTTAACA
EcoRI
IGGCTATGAAGAATTC
4501-- 1----- 4515
CCGATACTTCTTAAG
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Appendix 2 Sequence map showing the putative T, brucei MSH8 ORF
A map showing the DNA sequence of the entire putative 71 brucei MSH8 ORF (see 
sections 2.9.2 and 3.2.3). The conceptual translation of the MSH8 ORF is shown in red 
beneath the DNA sequence. The putative 5’ trans-splicing signals for the MSH8 gene are 
shown: a polypyrimidine tract (PPT) is highlighted in blue and the splice acceptor (SA) site 
in green. Half arrows denote primer sequences: those used to amplify a control fragment 
to check the integrity of the cDNA used to investigate the 5’ splicing of MSH8 {MSH8D6 
and MSH8\J6) are shown in pink; those used in conjunction with the splice-leader specific 
primer {MSH8\J1 and MSH8\JK) are indicated in dark red; those used to amplify the MSH8 
internal fragment and 540 bp MSH8 probe {MSH8D3 and MSH8\J\) are indicated in 
turquoise; and those used to generate the insert of the plasmid pJB301 and confirm the 
linkage of the initial putative MSH8 contigs (MSH8 5’ and MSH8 3’) are shown in purple.
PPT SA
GTATTGCCTTTCGCTCTTTGTTTACTTGCCTAAGTGCTGGAGGGAGATCTAACCCTTGGT
1  + + + + + + 60
CATAACGGAAAGCGAGAAACAAATGAACGGATTCACGACCTCCCTCTAGATTGGGAACCA
^ -------------MSH8U8
ATCCTGAATTATTTAGTTGAGGAGATCTCTAGTTCCGCTTTCCAATGCCTGAGGTTTCGC61  + + + + + + 120
TAGGACTTAATAAATCAACTCCTCTAGAGATCAAGGCGAAAGGTTACGGACTCCAAAGCGM P E V S L
TTGAATGTGAGGACATTTGCCCTGAAAACGTTTCTTACCCGTTTTTAAGGGGTATTGATC121  + + + + + + 180
AACTTACACTCCTGTAAACGGGACTTTTGCAAAGAATGGGCAAAAATTCCCCATAACTAGE C E D I C P E N V S Y P F L R G I D P
CGAAACGACCGCCCTCTTCTATTACTATCCCTCCTAGGGACTTGGAGGCAATGGCTGCCA
181  +-------- +-------- +-------- +-------- + + 240
GCTTTGCTGGCGGGAGAAGATAATGATAGGGAGGATCCCTGAACCTCCGTTACCGACGGT K R P P S S I T I  P P R D L E A M A A M
TGGAACGACAGTACTGGGAAGTGAAGTCAAAGCACTACGATGTGGTAATTTTTTTCAAAA
ACCTTGCTGTCATGACCCTTCACTTCAGTTTCGTGATGCTACACCATTAAAAAAAGTTTT E R Q Y W E V K S K H Y D V V I  F F K K
MSHSDS
AGGGCAAATTTTATGAGCTTTACGACCAAGATGCCGCTATGGCTCACCGTGAGTTTGGGT301  +-------- +-------- +-------- +-------- +-------- + 360
TCCCGTTTAAAATACTCGAAATGCTGGTTCTACGGCGATACCGAGTGGCACTCAAACCCAG K F Y E L Y D Q D A A M A H R E F G L
TGAAGCTAGTTGTTGACACCACTAACCGAGGGAAAATGCGGCTCGCAGGCGTCCCTGAAC361  +-------- +-------- +-------- +-------- +-------- + 420
ACTTCGATCAACAACTGTGGTGATTGGCTCCCTTTTACGCCGAGCGTCCGCAGGGACTTGK L V V D T T N R G K M R L A G V P E Q
AAACATTTAGTGAATGGGCCCGTCTCTTCGTTTTTCGGGGCTACAAGGTGGGTCGAGTAG421  +-------- +-------- +-------- +-------- +-------- + 480
TTTGTAAATCACTTACCCGGGCAGAGAAGCAAAAAGCCCCGATGTTCCACCCAGCTCATCT F S E W A R L F V F R G Y K V G R V E
343
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AGCAAATGAAGGAGGAAGGGGAGTCATCAAAAAATGCTCGTCCGAAAGTCGTGCCACGAG
TCGTTTACTTCCTCCTTCCCCTCAGTAGTTTTTTACGAGCAGGCTTTCAGCACGGTGCTCQ M K E E G E S S K N A R P K V V P R E
AGCTAGTTGAGATACTTACCCCTGGCACCATAACCGATCCCATGATGATCAGCGGCTATG
TCGATCAACTCTATGAATGGGGACCGTGGTATTGGCTAGGGTACTACTAGTCGCCGATACL V E I L T P G T I T D P M M I S G Y G
T:-----------------------
MSH8 0 1
GTGCAGTGTTCGTACTTGCACTGTATCCAATGGGGAGCGGTAGTGTGGATGGAATGGCCG
601  ►---------1---------H---------4-------- + + 660
CACGTCACAAGCATGAACGTGACATAGGTTACCCCTCGCCATCACACCTACCTTACCGGC A V F V L A L Y  P M G S G S V D G M A V
TCGATCTTTCCCGTCGCGTTGTTTTCCACTGTCCCTGCGGTACGAATGGCAAGGAGAGCG
AGCTAGAAAGGGCAGCGCAACAAAAGGTGACAGGGACGCCATGCTTACCGTTCCTCTCGCD L S R R V V F H C P C G T N G K E S A
CCGCAGGCTTTGTTGAAGAGGTGCTTAATGAAGTTTCTGCGCTCCTTCAACAAATCCGTC721  +-------- +-------- +-------- +-------- +-------- + 780
GGCGTCCGAAACAACTTCTCCACGAATTACTTCAAAGACGCGAGGAAGTTGTTTAGGCAGA G F V E E V L N E V S A L L Q Q I R P
CCCGTGAAATAATAATTCCGCGTGGGGCTGTTGATGCGCCTGGTGAGGAGCCCAAGGGAT7 81-- 1--------- 1--------- 1--------- 1--------- 1--------- 1- 840
GGGCACTTTATTATTAAGGCGCACCCCGACAACTACGCGGACCACTCCTCGGGTTCCCTA R E  I I I P R G A V D A P G E  E P K G S
CATTTGGGAGACGTCTATTTGAATGGGTAGAAGGGGAGGGTTTCCAGGTTGAACTGGTTG841  +-------- +-------- +-------- +-------- +-------- + 900
GTAAACCCTCTGCAGATAAACTTACCCATCTTCCCCTCCCAAAGGTCCAACTTGACCAAC
F G R R L F E W V E G E G F Q V E L V E
AAGAGGTTGGTACCTCACTTCGCAAACTCCCCCTTGAGGAGAGGAGCTTAAAGGAGGCGG901  +-------- +-------- +-------- +-------- +-------- + 960
TTCTCCAACCATGGAGTGAAGCGTTTGAGGGGGAACTCCTCTCCTCGAATTTCCTCCGCCE V G T S L R K L P L E E R S L K E A G
"S MSHgU6
GTCGTTTCTTAGCTCAGTATTTTAGATCGTTAAAGTTGAGTAATGTTGACTCTATACTTT961  +-------- +-------- +-------- +-------- +-------- + 1020
CAGCAAAGAATCGAGTCATAAAATCTAGCAATTTCAACTCATTACAACTGAGATATGAAAR F L A Q Y F R S L K L S N V D S I L L
TGGAGGCTCGACCATACAACTTTCACCTTTTAAAGCAGCAGGTAACCAGCGGTGTGCCGT1021  + + + + + + 1080
ACCTCCGAGCTGGTATGTTGAAAGTGGAAAATTTCGTCGTCCATTGGTCGCCACACGGCAE A R P Y N F H L L K Q Q V T S G V P S
MSH8 5'
CGAATGATCGAAGTCGTTGCTCCGATTCAACTCTTCTGTGGTACGAACGTCGCGAAGACC1081  +-------- +-------- +-------- +-------- +-------- + 1140
GCTTACTAGCTTCAGCAACGAGGCTAAGTTGAGAAGACACCATGCTTGCAGCGCTTCTGGN D R S R C S D S T L L W Y E R R E D P
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CCGGGTTGGTTCTTGATGCCGCGACAGTAAGTAATCTTGAACTCGTGGGTAACCTGCGGG
GGCCCAACCAAGAACTACGGCGCTGTCATTCATTAGAACTTGAGCACCCATTGGACGCCCG L V L D A A T V S N L E L V G N L R D
ACGATAGTGAACGCGGATCTCTTTTTAATCTGATCAACCGTTGTTGCACCAACGGTGGAA
TGCTATCACTTGCGCCTAGAGAAAAATTAGACTAGTTGGCAACAACGTGGTTGCCACCTTD S E R G S L F N L I N R C C T N G G K
AGCGTCTTTTCCGTTCTTGGATTTTGCGACCTTCCGCGTCCCCGCGTGTTATCAATGCGA
TCGCAGAAAAGGCAAGAACCTAAAACGCTGGAAGGCGCAGGGGCGCACAATAGTTACGCTR L F R S W I L R P S A S P R V I N A R
GGCAGGAAGCGGTACGCTTTATCATCGAAAATAATTTGAATGATCTCTGGGCCAAAACGG1321  +-------- +-------- +-------- +-------- +-------- + 1380
CCGTCCTTCGCCATGCGAAATAGTAGCTTTTATTAAACTTACTAGAGACCCGGTTTTGCC Q E A V R F I  l E N N L N D L W A K T E
AGGAGTCTGCCGATGTTACGACACCAATATGCACCCCTAATTCGAGCACTCGTACTTCCG
1381  +-------- +-------- +-------- +-------- +-------- + 1440
TCCTCAGACGGCTACAATGCTGTGGTTATACGTGGGGATTAAGCTCGTGAGCATGAAGGCE S A D V T T P I C T P N S S T R T S E
AGGGCCCTACCCAAGAATTCACTCAGGCGAGTGGTACGCAGTGTGGATCGAAGCGGGGGA
1441  +-------- +-------- +-------- +-------- +-------- + 1500
TCCCGGGATGGGTTCTTAAGTGAGTCCGCTCACCATGCGTCACACCTAGCTTCGCCCCCT
G P T Q E F T Q A S G T Q C G S K R G R
GGACAACAAACACATTTGAATCTCGATTTACAAACCTTTTCGCCACAGATTTCGAGCGCA
1501  +-------- +-------- +-------- +-------- +-------- + 1560
CCTGTTGTTTGTGTAAACTTAGAGCTAAATGTTTGGAAAAGCGGTGTCTAAAGCTCGCGTT T N T F E S R F T N L F A T D F E R N
ATCTTTCACGGTTGGCCGATTTGAAGGGTGACTCGCAACAAATAGCCTTCGTAGATCCTC
1561  +-------- +-------- +-------- +-------- +-------- + 1620
TAGAAAGTGCCAACCGGCTAAACTTCCCACTGAGCGTTGTTTATCGGAAGCATCTAGGAG
L S R L A D L K G D S Q Q I A F V D P L
TCGTGCAGTACAAGAAGCATCTTCAACTTATTATTTCAACCGTTGTTGCATTCGAGGAGA1621  + + + + + + 1680
AGCACGTCATGTTCTTCGTAGAAGTTGAATAATAAAGTTGGCAACAACGTAAGCTCCTCTV Q Y K K H L Q L I I S T V V A F E E M
TGCTGGATTGGTCTAACAACGTCCAAAAGGAGTGTGCCCCCCCTCTTTTGCAGGAACTGT
1681  +-------- +-------- +-------- +-------- +-------- + 1740
ACGACCTAACCAGATTGTTGCAGGTTTTCCTCACACGGGGGGGAGAAAACGTCCTTGACAL D W S N N V Q K E C A P P L L Q E L W
GGGGAACCATGGGCGCAGTGGCTCCTGCTGTCGCCTCAATCAAGGCCTGTTTCGATCGAA1741  +-------- +-------- +-------- +-------- +-------- + 1800
CCCCTTGGTACCCGCGTCACCGAGGACGACAGCGGAGTTAGTTCCGGACAAAGCTAGCTTG T M G A V A P A V A S I K A C F D R K
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AAGCTGCTGAGGTGTCAGGGGTGATTGTACCATCGCAGGGAGCATGTCCCGCGTACGACG
1801  + + + + + + 1860
TTCGACGACTCCACAGTCCCCACTAACATGGTAGCGTCCCTCGTACAGGGCGCATGCTGCA A E V S G V I V P S Q G A C P A Y D E
AAGCTACGGAGTGCTTAGATATCATAGAGAAAAAATTGGATGAAGTTTTAAGGGAGCTGC
TTCGATGCCTCACGAATCTATAGTATCTCTTTTTTAACCTACTTCAAAATTCCCTCGACG A T E C L D I  l E K K L D E V L R E L R
GCGACAACATTTTCAACGGTGCTGCAATCACCTACTCTCATATCGGTCGTGAAAATTTTC
CGCTGTTGTAAAAGTTGCCACGACGTTAGTGGATGAGAGTATAGCCAGCACTTTTAAAAGD N I F N G A A I T Y S H I G R E N F L
TGGTTGAGGTTCCATTGATGGAGGCACCTAAGAGATGTCCCCCTGGGTTCATCGAGCGAT
ACCAACTCCAAGGTAACTACCTCCGTGGATTCTCTACAGGGGGACCCAAGTAGCTCGCTA
V E V P L M E A P K R C P P G F I E R S
CCCGTACTTCAGCGTGTGTCAGATATACAGTCGCAGGTTTGGAACCTCTGGTAGAGGAGC
GGGCATGAAGTCGCACACAGTCTATATGTCAGCGTCCAAACCTTGGAGACCATCTCCTCGR T S A C V R Y T V A G L E P L V E E H
ATAAGCGTGCCAAAACGAAGAAAGCAGATGCCCTCTTACTTGTTGTTCGAAACATTGCCT
TATTCGCACGGTTTTGCTTCTTTCGTCTACGGGAGAATGAACAACAAGCTTTGTAACGGA
K R A K T K K A D A L L L V V R N I A S
CGCATATATTTAATTACTTCCCCGTCCTTTATGAAGCCACAGCGGCTCTTTGCTATTTTG
GCGTATATAAATTAATGAAGGGGCAGGAAATACTTCGGTGTCGCCGAGAAACGATAAAAC
H I F N Y F P V L Y E A T A A L C Y F D
. .  ■
ATTGTTTGCTCAGTCTGGCGTCGCTACATACCAGTGCTGTCGCTACTTGCTACCCCGTTG
TAACAAACGAGTCAGACCGCAGCGATGTATGGTCACGACAGCGATGAACGATGGGGCAACC L L S L A S L H T S A V A T C Y P V V
TACAAGAATGTGACGCCGGTGCGTACCTGCTTGCGGAAGAACTACGACATCCATTTCTCA
2281  +-------- +-------- +-------- +-------- +-------- + 2340
ATGTTCTTACACTGCGGCCACGCATGGACGAACGCCTTCTTGATGCTGTAGGTAAAGAGTQ E C D A G A Y L L A E E L R H P F L K
AAAGCGATTCTGTCCCAAACACTGTCAATCTTGACGCTACACATGGACGCATTTTGGTGC2341  +-------- +-------- +-------- +-------- +-------- + 2400
TTTCGCTAAGACAGGGTTTGTGACAGTTAGAACTGCGATGTGTACCTGCGTAAAACCACGS D S V P N T V N L D A T H G R I L V L
TGACCGGACCGAATATGGCTGGAAAGAGTACGCTGATGCGCACAGTTGCCGTGAATGTTA2401  +-------- +-------- +-------- +-------- +-------- + 2460
ACTGGCCTGGCTTATACCGACCTTTCTCATGCGACTACGCGTGTCAACGGCACTTACAATT G P N M A G K S T L M R T V A V N V I
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TAATAGCCCAAATGGGTGGACCAGTGTTTGCTACGTCTATGCGCTTGGCGCCCGTTACCC
2461  +-------- +-------- +-------- +-------- +-------- + 2520
ATTATCGGGTTTACCCACCTGGTCACAAACGATGCAGATACGCGAACCGCGGGCAATGGGl A Q M G G P V F A T S M R L A P V T R
GTGTTTTCACAAGGATTGGCGCTCGCGATGCAACGCACAAAGGACAGAGTACCCTTTATG
2521  +-------- +-------- +-------- +-------- +-------- + 2580
CACAAAAGTGTTCCTAACCGCGAGCGCTACGTTGCGTGTTTCCTGTCTCATGGGAAATACV F T R I G A R D A T H K G Q S T L Y V
TCGAGTTAAGTGAGACAGCCGAGATTGTGCGGTTTGCCGGTCCATGGAGTCTTTGTTTAG
AGCTCAATTCACTCTGTCGGCTCTAACACGCCAAACGGCCAGGTACCTCAGAAACAAATCE L S E T A E I V R F A G P W S L C L V
TGGATGAACTCGGCAGGGGGACATCTACGCACGACGGCTACACAATAGCGCACGCAATGC
ACCTACTTGAGCCGTCCCCCTGTAGATGCGTGCTGCCGATGTGTTATCGCGTGCGTTACGD E L G R G T S T H D G Y T I A H A M L
TCGCCGCCATGAAGAAAAGGCACCCAGTGCCGCCCCTTCTACTCTTCTCTACCCACTACC
AGCGGCGGTACTTCTTTTCCGTGGGTCACGGCGGGGAAGATGAGAAGAGATGGGTGATGGA A M K K R H P V P P L L L F S T H Y H
-----------------------------MSHf^ 71
ACGCGCTCGCGCAGGAGGAGCACAAGTCCATGCAGAAATCCACTTCCTCAGCAGCATCTG
TGCGCGAGCGCGTCCTCCTCGTGTTCAGGTACGTCTTTAGGTGAAGGAGTCGTCGTAGAC
A L A Q E E H K S M Q K S T S S A A S E
AAACTGGGGGGGTTCAGCTCGGTTACATGGACTTTGCCGTTTCTGCTGCAAGTGACAGCA
TTTGACCCCCCCAAGTCGAGCCAATGTACCTGAAACGGCAAAGACGACGTTCACTGTCGTT G G V Q L G Y M D F A V S A A S D S N
ATATACCGACCATTACTTTTCTTTATCGCCTTGTGCCCGGAATCTGCGCGAGAAGCTATG
TATATGGCTGGTAATGAAAAGAAATAGCGGAACACGGGCCTTAGACGCGCTCTTCGATAC I P T I T F L Y R L V P G I C A R S Y G
GCGTTGAGGTGGCGCTGCTTGCCGGTATTTCCCCCGGGGTTGTAAACACAGCACGGGTTA
CGCAACTCCACCGCGACGAACGGCCATAAAGGGGGCCCCAACATTTGTGTCGTGCCCAATV E V A L L A G I S P G V V N T A R V K
AGTCTCTGGAGCTCGCCAAGTGGTACGAACGACAAAGGGACCTGGGTACGGTTCGGGGGT
TCAGAGACCTCGAGCGGTTCACCATGCTTGCTGTTTCCCTGGACCCATGCCAAGCCCCCAS L E L A K W Y E R Q R D L G T V R G F
MSH6 3'
TCATCACGCCCAGCGGGACACAGTTCTCGCATCGGTAGAAACCCAGGTGACGCCTTTACC
AGTAGTGCGGGTCGCCCTGTGTCAAGAGCGTAGCCATCTTTGGGTCCACTGCGGAAATGGI T P S G T Q F S H R
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A p p e n d i x  2  c o n t i n u e d
AATGAGTCCGAGGACTTGGCGGAGAGGAACATAGATCAAATTTCACCCCTGTTCTGATGC
TTACTCAGGCTCCTGAACCGCCTCTCCTTGTATCTAGTTTAAAGTGGGGACAAGACTACG
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Appendix 3 Sequence map showing the putative T, brucei MSH3 ORF
A map showing the DNA sequence of the putative T. brucei MSH3 ORF, derived from The 
Wellcome Trust Sanger Institute T. brucei genome sequencing database contig 
TRYP9.0.000864 (http://www.sanger.ac.uk/Projects/T_brucei/; see sections 2.8.4 and 
2.9.3). The conceptual translation of the MSH3 ORF is shown in red beneath the DNA 
sequence.
ATGAGCAAACGCCGCCGTGGTGACGATGAAAGCGATATTTTCCGGAAGGCTATCGAGCTG
 +  +  +  +  +  + 60
TACTCGTTTGCGGCGGCACCACTGCTACTTTCGCTATAAAAGGCCTTCCGATAGCTCGAC
M S K R R R G D D E S D I F R K A I E L
CTGTGTCACCGCCGGGCCACAACTGAAGAACTGTCAGTTGCAACTAAGCTCACGCCTTTG
61   +  +  +  +  +  + 120
GACACAGTGGCGGCCCGGTGTTGACTTCTTGACAGTCAACGTTGATTCGAGTGCGGAAAC
L C H R R A T T E E L S V A T K L T P L
GAAAGGCAGGTGGTGTGCCTCAAGGAGTCCCTTCCGCCCGATGTTATTCTGATGGTAGCG
CTTTCCGTCCACCACACGGAGTTCCTCAGGGAAGGCGGGCTACAATAAGACTACCATCGCE R Q V V C L K E S L P P D V I L M V A
TGTGGTTACCGTGTGAAGTTTTACGGTCGTGACAGTCGCGTCGTCAGCCGCCGTTTTGGG
ACACCAATGGCACACTTCAAAATGCCAGCACTGTCAGCGCAGCAGTCGGCGGCAAAACCC
C G Y R V K F Y G R D S R V V S R R F G
ATAATGTGCATTCAAGCAACTCCATTCGAGTATAGCAGTGTTCCTTACACAGGGGTCAAT
TATTACACGTAAGTTCGTTGAGGTAAGCTCATATCGTCACAAGGAATGTGTCCCCAGTTAI M C I Q A T P F E Y S S V P Y T G V N
ATTTATGTGCGCCGCCTGGTAGCGATGGGTTATCGTGTTGCTTTTGCGGATCAAGAGAGC
TAAATACACGCGGCGGACCATCGCTACCCAATAGCACAACGAAAACGCCTAGTTCTCTCG 
I Y V R R L V A M G Y R V A F A D Q E S
GCTTCTATTCGGTCGACCAGTGGTAACTCGAAGGGGTTGTTTTCCCGAGAGATTGGGCGA
CGAAGATAAGCCAGCTGGTCACCATTGAGCTTCCCCAACAAAAGGGCTCTCTAACCCGCT
A S I R S T S G N S K G L F S R E I G R
GTGTACAGCCGAGGAACGATGTTGCCTGATGAGGTGGTTGTCACCGCTGGAACCCCTCAA
CACATGTCGGCTCCTTGCTACAACGGACTACTCCACCAACAGTGGCGACCTTGGGGAGTT
V Y S R G T M L P D E V V V T A G T P Q
GAAGGAAGCGCTACCGGTCAGGGGGATGAAGGGGCACCGGAAGGAGGAGATCCCGTTGGT
CTTCCTTCGCGATGGCCAGTCCCCCTACTTCCCCGTGGCCTTCCTCCTCTAGGGCAACCA
E G S A T G Q G D E G A P E G G D P V G
GTGGAGGAACTTCTCCCCTTGAAGGAGGGATCTTCGGAATTGTTTATTTGCTTCTTGTGG
CACCTCCTTGAAGAGGGGAACTTCCTCCCTAGAAGCCTTAACAAATAAACGAAGAACACCV E E L L P L K E G S S E L F I C F L W
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CCCTCAACTGGGTCGGCGGGTGTGAGCCTGGTCGAAGTGACGCTTCTCAGTTTCGTCACG
601  + + + + + + 660GGGAGTTGACCCAGCCGCCCACACTCGGACCAGCTTCACTGCGAAGAGTCAAAGCAGTGC
P S T G S A G V S L V E V T L L S F V T
TACTCTCTTTCTCGTCATCACCTGTCTTCAGGGGGAGAGCTTTTGGACATACTCAATCGC
661  +-------- 1- ------- 4---------H----------------------- 4---------4- 720
ATGAGAGAAAGAGCAGTAGTGGACAGAAGTCCCCCTCTCGAAAACCTGTATGAGTTAGCG
Y S L S R H H L S S G G E L L D I L N R
TACAATATTGTTGAGGTGGTTCTGTTTTATGATGAAGACGGAGCGCGGGAGCTCGACCGG
ATGTTATAACAACTCCACCAAGACAAAATACTACTTCTGCCTCGCGCCCTCGAGCTGGCC
Y N I V E V V L F Y D E D G A R E L D R
CATCAGAACGCAGCAGCTACCGACGGCACTTTGCCTCCTTTTCGCTTGTGCGGTTTACCG
GTAGTCTTGCGTCGTCGATGGCTGCCGTGAAACGGAGGAAAAGCGAACACGCCAAATGGC
H Q N A A A T D G T L P P F R L C G L P
GAGGCGTTTTACACACCCTTAAACACAATTCTATCGCTTCATCATGGACCGACGGTTAAC
CTCCGCAAAATGTGTGGGAATTTGTGTTAAGATAGCGAAGTAGTACCTGGCTGCCAATTG
E A F Y T P L N T I L S L H H G P T V N
GGTGAAGAGGATAATAATTCTGTAACTGTCTGCACCTCGCCATTCATCGGTTCTATCGAT
CCACTTCTCCTATTATTAAGACATTGACAGACGTGGAGCGGTAAGTAGCCAAGATAGCTA
G E E D N N S V T V C T S P F I G S I D
GACTCAATTGCAGAGTATTTAAAGCCTAGTCGATTTGATACGACCTTCAGGAAAATGTGC
CTGAGTTAACGTCTCATAAATTTCGGATCAGCTAAACTATGCTGGAAGTCCTTTTACACG
D S I A E Y L K P S R F D T T F R K M C
TCTAAATCTCCGCCGTTACTTGCGCGGAGCACGGCCGGTGGGGTGGCTGAGTTGGTAATG
AGATTTAGAGGCGGCAATGAACGCGCCTCGTGCCGGCCACCCCACCGACTCAACCATTAC
S K S P P L L A R S T A G G V A E L V M
GAGATGCCCGGCACCACGATGAGCGCGTTGGACATATTTCACAGCAGCATTGGGCTAAAA
CTCTACGGGCCGTGGTGCTACTCGCGCAACCTGTATAAAGTGTCGTCGTAACCCGATTTT
E M P G T T M S A L D I F H S S I G L K
GGTTCTCTGCTGGCTCTATTGGACCACAGCCTTACGGTGCCTGGTCTGCGGCGGTTGCGT
CCAAGAGACGACCGAGATAACCTGGTGTCGGAATGCCACGGACCAGACGCCGCCAACGCA
G S L L A L L D H S L T V P G L R R L R
TCGTGGCTGGCGGCCCCGCTCTGCGACTTACGGGCCATTAATTCTCGGCGTGAGGCGGTG
AGCACCGACCGCCGGGGCGAGACGCTGAATGCCCGGTAATTAAGAGCCGCACTCCGCCAC
S W L A A P L C D L R A I N S R R E A V
GCGTTTTTACTTCGCGGCGAAGGGGGTGACTCAGTGGTGGGCCTGCTGCGAGAGTTTGCC
CGCAAAAATGAAGCGCCGCTTCCCCCACTGAGTCACCACCCGGACGACGCTCTCAAACGG
A F L L R G E G G D S V V G L L R E F A
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AAGTTTGGTGATCTCGAGGCAACACTGGGGAAGCTGCGGGCGCAGCGGTGCACTGTAACC
1321  +--------- +---------+---------+---------+--------- + 1380TTCAAACCACTAGAGCTCCGTTGTGACCCCTTCGACGCCCGCGTCGCCACGTGACATTGGK F G D L E A T L G K L R A Q R C T V T
GATTATCTTCGTTTGTTGCGTGCGGTGAAAGTGACGCATAAACTCGCTCTTGACATTTTA
1381  +--------- +---------+---------+---------+--------- + 1440CTAATAGAAGCAAACAACGCACGCCACTTTCACTGCGTATTTGAGCGAGAACTGTAAAATD Y L R L L R A V K V T H K L A L D I L
TCACTTTGTGGCGAAGGCATGTGCGATCAGATTCGTGATGCTCTTGTTGCCGTCACGTCT
1441  +---------+---------+---------+---------+ + 1500
AGTGAAACACCGCTTCCGTACACGCTAGTCTAAGCACTACGAGAACAACGGCAGTGCAGA
S L C G E G M C D Q I R D A L V A V T S
GAGAATGTCGAGTTGTTCCTTCAATCGTGTAAGTGTGAGTTAAACTTGGATGCGGATTCC
1501  +---------+---------+---------+---------+ + 1560
CTCTTACAGCTCAACAAGGAAGTTAGCACATTCACACTCAATTTGAACCTACGCCTAAGGE N V E L F L Q S C K C E L N L D A D S
CCTCAGGAGTACTACGCAGCACTTGGTTCCCCCCTACCCGACCTTTTGCAGACTCATGCT
1561  +---------+---------+---------+---------+ + 1620
GGAGTCCTCATGATGCGTCGTGAACCAAGGGGGGATGGGCTGGAAAACGTCTGAGTACGA
P Q E Y Y A A L G S P L P D L L Q T H A
AAGGAGCGCGACGAAGTGCTACGTGCGTTGGACGTGGAGCTGGAATGCATTCGAAAGACA
TTCCTCGCGCTGCTTCACGATGCACGCAACCTGCACCTCGACCTTACGTAAGCTTTCTGTK E R D E V L R A L D V E L E C I R K T
CTCAAGTTACCTGCGTTGGAGTACCGTACAATCGCTGGCACCACATTCATTGTGGACGTG
GAGTTCAATGGACGCAACCTCATGGCATGTTAGCGACCGTGGTGTAAGTAACACCTGCACL K L P A L E Y R T I A G T T F I V D V
CCCAACGTAAGGGCCAATGATGCACCGAAAGAGTGGATTGTGCTGACAAGAACAAAGACT
1741  +---------+---------+---------+---------+ + 1800GGGTTGCATTCCCGGTTACTACGTGGCTTTCTCACCTAACACGACTGTTCTTGTTTCTGA
P N V R A N D A P K E W I V L T R T K T
CATGTGCGATTTCACACTCCAAGAATTGTCAATCTTACCGTGGAGCTCTGCTCCGCCAAG
GTACACGCTAAAGTGTGAGGTTCTTAACAGTTAGAATGGCACCTCGAGACGAGGCGGTTCH V R F H T P R I V N L T V E L C S A K
GAACGCCTTGCCATTGCAGCAAATGAGGCATGGTTAGCGAAGCAAGCCGAGTTGGAAGGT
CTTGCGGAACGGTAACGTCGTTTACTCCGTACCAATCGCTTCGTTCGGCTCAACCTTCCA
E R L A I A A N E A W L A K Q A E L E G
TCTGTCGACACGATGGAGATATTTAAGAGTGTCATTAACTCTGTTGCTGTGCTTGACGCA
AGACAGCTGTGCTACCTCTATAAATTCTCACAGTAATTGAGACAACGACACGAACTGCGT 
S V D T M E  I F K S V I N S V A V L D A
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CTTCACTGTCTTGCTGTCGCATCTTCGGCCCCTGGATACACTGCTCCATCCATCTCAGAC
GAAGTGACAGAACGACAGCGTAGAAGCCGGGGACCTATGTGACGAGGTAGGTAGAGTCTGL H C L A V A S S A P G Y T A P S I S D
GATGAGCAGTCGATTGTGATCCGCGACGGACGCCACCCGATGCTTGAGTCGCTCATGCGT
CTACTCGTCAGCTAACACTAGGCGCTGCCTGCGGTGGGCTACGAACTCAGCGAGTACGCA
D E Q S I V I R D G R H P M L E S L M R
GGGGGCTACGTGGGGTGTGACGTTTCCCTTGTCAAGCACGGCGCGTGGATTCTCACAGGG
CCCCCGATGCACCCCACACTGCAAAGGGAACAGTTCGTGCCGCGCACCTAAGAGTGTCCC G G Y V G C D V S L V K H G A W I  L T G
CCCAACATGGGAGGTAAATCAGCTCTGATGCGTATGGTAGGTACGTTTGTGGTATTGGCA
2161  + + + + + + 2220
GGGTTGTACCCTCCATTTAGTCGAGACTACGCATACCATCCATGCAAACACCATAACCGT
P N M G G K S A L M R M V G T F V V L A
CAACTGGGTTGCTACGTGCCTGCCAAGTCTGCGCAACTGCCCTTGTTTGGGGCTGTATAC
2221  + + + + + + 2280
GTTGACCCAACGATGCACGGACGGTTCAGACGCGTTGACGGGAACAAACCCCGACATATGQ L G C Y V P A K S A Q L P L F G A V Y
TGTCGAATGGGGTCGAGCGATTCTCTGCTGGAGGGAAGTTCCACCTTTTTGAAAGAGATG
2281  +---------+---------+---------+---------+--------- + 2340
ACAGCTTACCCCAGCTCGCTAAGAGACGACCTCCCTTCAAGGTGGAAAAACTTTCTCTACC R M G S S D S L L E G S S T F L K E M
GAGGAAACAAGTCGGATCCTCCGCTCTGAGATTGTGTCCTCTTCGCTTGTACTACTGGAT
2341  +---------+---------+---------+---------+--------- + 2400
CTCCTTTGTTCAGCCTAGGAGGCGAGACTCTAACACAGGAGAAGCGAACATGATGACCTA
E E T S R I L R S E I V S S S L V L L D
GAACTCGGCAGGGGAACGAGCAGTTATGATGGTATTGCTATTGCCGCTGCGACACTGGAG
2401  +---------+---------+---------+---------+--------- + 2460
CTTGAGCCGTCCCCTTGCTCGTCAATACTACCATAACGATAACGGCGACGCTGTGACCTCE L G R G T S S Y D G I A I A A A T L E
TATCTGCTTCGGAAGGGTGCAACAACATTCTTCGTGACGCACTATTCGCAACTCTGTGAG
2461  +---------+---------+---------+---------+--------- + 2520
ATAGACGAAGCCTTCCCACGTTGTTGTAAGAAGCACTGCGTGATAAGCGTTGAGACACTC
Y L L R K G A T T F F V T H Y S Q L C E
CCCTATGTCAATTCCAGCAACAACGGACTGGTGTCATGCTATTATATGGGATTTCATGAG
2521  +---------+---------+---------+---------+--------- + 2580
GGGATACAGTTAAGGTCGTTGTTGCCTGACCACAGTACGATAATATACCCTAAAGTACTC
P Y V N S S N N G L V S C Y Y M G F H E
GAAAAGATTGTGTCTAGAGAGGGCGAGGGGGAGGTAAAAATTGTATTTACTTACAAACCA
2581  +---------+---------+---------+---------+--------- + 2640
CTTTTCTAACACAGATCTCTCCCGCTCCCCCTCCATTTTTAACATAAATGAATGTTTGGT
E K I V S R E G E G E V K I V F T Y K P
ACACTTGGGGTCACGCCTTCTAGCTTTGGTGCGCGCGTGGCCCGCATGGCTGGGTTGCCC
2641  +---------+---------+---------+---------+--------- + 2700
TGTGAACCCCAGTGCGGAAGATCGAAACCACGCGCGCACCGGGCGTACCGACCCAACGGGT L G V T P S S F G A R V A R M A G L P
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TCTGCAGTTGTAACTGAAGCGCAGCTGATCAGCGAGGAGGCGGAACGCACTCACGACTGG
2701  +---------+---------+---------+---------+---------+ 2760AGACGTCAACATTGACTTCGCGTCGACTAGTCGCTCCTCCGCCTTGCGTGAGTGCTGACC S A V V T E A Q L I  S E E A E R T H D W
TGCTTGTCTCTTCTTGAATTGCGGCGCTTCGTCAAAAACAATTCTT
ACGAACAGAGAAGAACTTAACGCCGCGAAGCAGTTTTTGTTAAGAA
C L S L L E L R R F V K N N S
353
Appendix 4 Sequence map showing the T, brucei MLHl ORF
A map showing the DNA sequence of the 4.0 kb Kpn\ fragment sub-cloned from the ILTat 
1.2 genomic lambda clone ‘Plaque 6’ into pBluescript II KS to form the plasmid pJB200, 
which contains the entire T. brucei MLHl ORF along with its processing flanks (see 
section 2.10.1 and 3.3.2). The conceptual translation of the MLH l ORF is shown in red 
beneath the DNA sequence and restriction sites are shown above the sequence in black. 
Half arrows denote primer sequences: those used to amplify the MLH l 5’ targeting flank 
{MLHl 5’(A) and MLHl 5’(B)) are shown in blue; those used to amplify the MLHl 3’ 
flank {MLHl 3’(A) and MLHl 3’(B)) are shown in green; those used to amplify the 472 bp 
MLHl probe or MLHl internal fragment {MLH1\J\ and MLH1T>6) are shown in 
turquoise; and those used to confirm the linkage of the two putative MLH l contigs {MLHl 
5’(1) and MLHl 3’(I)) are indicated in purple.
K p n l  M LH l 5' (A) ^I - - - - - - - - - ^GGTACCTTCTTAGATATGGGTATGCATTTTGTCCTACCTGCAGAATGTTACGCAACGAGA
CCATGGAAGAATCTATACCCATACGTAAAACAGGATGGACGTCTTACAATGCGTTGCTCT
GAGACCGTGCTCTTCATTTTACTGTTGGTTACTACTCGCTTCCTGATACATGTCTCACTG
CTCTGGCACGAGAAGTAAAATGACAACCAATGATGAGCGAAGGACTATGTACAGAGTGAC
GAATGGAGCGCGGCCGTGCATGGTTTCCGACATACAGCTAGTGAAGGCTTTTTAACTGAG
CTTACCTCGCGCCGGCACGTACCAAAGGCTGTATGTCGATCACTTCCGAAAAATTGACTC
M LH l 5'(1)
GATGGCAAACGGCACACGGTGGCAGGATAATTCGGACATAATGTTCGCGCTCGTAAGTGT
CTACCGTTTGCCGTGTGCCACCGTCCTATTAAGCCTGTATTACAAGCGCGAGCATTCACA
TGCCGTTCAGTTGGTGTGCGTATTTCAATGTAGCACGATGCGGCGCAATTTGTGTCCTTC
ACGGCAAGTCAACCACACGCATAAAGTTACATCGTGCTACGCCGCGTTAAACACAGGAAG
CGACCTCTATTTGTTCCATTATACACTTTAAAAACTGCGCATTGACGTTATTGTTACATT
GCTGGAGATAAACAAGGTAATATGTGAAATTTTTGACGCGTAACTGCAATAACAATGTAA
CACCACCGTGTTTGTCTTCGTTCGAACCGCTCTTTCACACATTTACATCTATCTACATAT
GTGGTGGCACAAACAGAAGCAAGCTTGGCGAGAAAGTGTGTAAATGTAGATAGATGTATA
M LH l 5'(B)
ATATATATTTCCGGTATTCTCCCCCTACTTTTCGTTTTAAGGGAAATAAAAAATTTTTGA
TATATATAAAGGCCATAAGAGGGGGATGAAAAGCAAAATTCCCTTTATTTTTTAAAAACTM
TGAGGGGTATTGAGCGGCTACCAGAAGATGTTATCAACCGTATTGCCGCTGGCGAAGTGG
ACTCCCCATAACTCGCCGATGGTCTTCTACAATAGTTGGCATAACGGCGACCGCTTCACCR G I E R L P E D V I N R I A A G E V V
354
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TTCAGCGTCCAAGTGCTGCACTGAAGGAGTTATTGGAAAACTCCCTGGATGCGGGTAGTA
AAGTCGCAGGTTCACGACGTGACTTCCTCAATAACCTTTTGAGGGACCTACGCCCATCATQ R P S A A L K E L L E N S L D A G S T
CGTGCATTCAGGTGGTTGTTCAGGATGGTGGCTTAGAATTGCTGCAGGTTACAGACGATG
601  + +  +  + +  + 660
GCACGTAAGTCCACCAACAAGTCCTACCACCGAATCTTAACGACGTCCAATGTCTGCTAC
C I Q V V V Q D G G L E L L Q V T D D G
GTCATGGTATACGTTTTGGTGATCTCCCATTGCTGTGCGAACGTTACGCCACAAGCAAGT
CAGTACCATATGCAAAACCACTAGAGGGTAACGACACGCTTGCAATGCGGTGTTCGTTCA
H G I R F G D L P L L C E R Y A T S K L
TACGCGCTTTTGATGAACTGAATAACATTCGTTCTTTTGGGTTCCGTGGTGAGGCACTGT
ATGCGCGAAAACTACTTGACTTATTGTAAGCAAGAAAACCCAAGGCACCACTCCGTGACA
R A F D E L N N I R S F G F R G E A L C
GCTCGATTTCATACGTGGCACGAGTAACTGTGACCACGATGCGCCACAATGACACCGTCG
CGAGCTAAAGTATGCACCGTGCTCATTGACACTGGTGCTACGCGGTGTTACTGTGGCAGCS I S Y V A R V T V T T M R H N D T V A
SailICGTGGCGCTGCCACTATGTCGACGGGCGGATGCAGGAGGAACCGAAGCCATGTGCCGGAA
GCACCGCGACGGTGATACAGCTGCCCGCCTACGTCCTCCTTGGCTTCGGTACACGGCCTTW R C H Y V D G R M Q E E P K P C A G N
ATCCGGGGACATGTATACGAGCGGAGAAGATGTTTTACAATGCTGCTGTCCGCCGGCGGG
TAGGCCCCTGTACATATGCTCGCCTCTTCTACAAAATGTTACGACGACAGGCGGCCGCCCP G T C I R A E K M F Y N A A V R R R A
CGTTCAGTCGGCCTTCTGAGGAGTGTAGCCGTGTTGAAGACGTGGTTTCTCGCTATGCAC
GCAAGTCAGCCGGAAGACTCCTCACATCGGCACAACTTCTGCACCAAAGAGCGATACGTGF S R P S E E C S R V E D V V S R Y A L
TAGCCTTCCCGAGCGTCGCGTTCTCGTGCCGTCGCTCCGATGGTAGTGTTGCTGGTGTTA
1021  + +  +  +  + + 1080
ATCGGAAGGGCTCGCAGCGCAAGAGCACGGCAGCGAGGCTACCATCACAACGACCACAAT
A F P S V A F S C R R S D G S V A G V T
MI.
CAAAGAATTGTGTGTGTTTCCCCAAGGATTCCAACACATTGGCGAACATCCGTCAGCACT
GTTTCTTAACACACACAAAGGGGTTCCTAAGGTTGTGTAACCGCTTGTAGGCAGTCGTGAK N C V C F P K D S N T L A N I R Q H W
GGGGTGGGGAGGTCGCTTCCCGCCTGTGTGAGGTTCGTTGCACCGGTGAATCACCTAGCG
CCCCACCCCTCCAGCGAAGGGCGGACACACTCCAAGCAACGTGGCCACTTAGTGGATCGCG G E V A S R L C E V R C T G E S P S E
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AAGATAACTGCACGCCAGAGAGTGTGCTGGCAACGTCTGGACCATCGGGTGAAGGGCGTT
1201  + + + + + + 1260TTCTATTGACGTGCGGTCTCTCACACGACCGTTGCAGACCTGGTAGCCCACTTCCCGCAAD N C T P E S V L A T S G P S G E G R F
TCCTTATCACAGGTTACACCAGCGATATAACACTCGCTAGCCGTAAATCGTATCTTTGCG
1261  +---------+---------+---------+---------+---------+ 1320AGGAATAGTGTCCAATGTGGTCGCTATATTGTGAGCGATCGGCATTTAGCATAGAAACGCL I T G Y T S D I T L A S R K S Y L C V
TATTCGTCAACAATCGGCTGGTGGACAGTACGGCCATTCGCCGGGCTCTTGACGCAGTGT
1321  +---------+---------+---------+---------+--------- + 1380ATAAGCAGTTGTTAGCCGACCACCTGTCATGCCGGTAAGCGGCCCGAGAACTGCGTCACA
F V N N R L V D S T A I R R A L D A V Y
ACAGTGGTGTGTTGGTGCGCGGGAACCGCCCGTTTACCGTCCTCTTCGTCACGGTGCCAC
1381  +---------+---------+---------+---------+---------+ 1440
TGTCACCACACAACCACGCGCCCTTGGCGGGCAAATGGCAGGAGAAGCAGTGCCACGGTGS G V L V R G N R P F T V L F V T V P P
CTGACAGGGTGGACGTGAATATTCACCCAACAAAACATGAGGTCTGTCTTCTTGATGAAG
GACTGTCCCACCTGCACTTATAAGTGGGTTGTTTTGTACTCCAGACAGAAGAACTACTTCD R V D V N I H P T K H E V C L L D E E
AAATAATTGTATCGCAACTGTCCGAATGCGTTCAGGGTGCTCTTCAGGCGTCTGCGGCTC
TTTATTAACATAGCGTTGACAGGCTTACGCAAGTCCCACGAGAAGTCCGCAGACGCCGAG I I V S Q L S E C V Q G A L Q A S A A R
GCAGGCAGATGGATATTCGGCAGATTCACTCCAAGGCGGTTATGCTAGGCGATAGGGAGA
CGTCCGTCTACCTATAAGCCGTCTAAGTGAGGTTCCGCCAATACGATCCGCTATCCCTCT
R Q M D I R Q I H S K A V M L G D R E S
GTCAACGGTCCAACCAGCCGATGCAGCCTCATTCCTCAACCTCGCCGTTTAACCCATTAC
CAGTTGCCAGGTTGGTCGGCTACGTCGGAGTAAGGAGTTGGAGCGGCAAATTGGGTAATG
Q R S N Q P M Q P H S S T S P F N P L P
CCACTGGTGCCCGTGGTGGTGTGGCTGCTGTGGCACCTTGTTCACTTGTGCGGGTGGAGC
GGTGACCACGGGCACCACCACACCGACGACACCGTGGAACAAGTGAACACGCCCACCTCG T G A R G G V A A V A P C S L V R V E  P
CACAGCGAGGCGCGCTCGACGCCTTCGTGCGCCGGCCGAAGCCGACCGCTGAGGGCAATG
GTGTCGCTCCGCGCGAGCTGCGGAAGCACGCGGCCGGCTTCGGCTGGCGACTCCCGTTACQ R G A L D A F V R R P K P T A E G N G
GAGATGCTCCGCTGCGTAGTGAGTCCATTGAGGAGCGCGCAGGTGGAGGCGTTGACGCAC
CTCTACGAGGCGACGCATCACTCAGGTAACTCCTCGCGCGTCCACCTCCGCAACTGCGTGD A P L R S E S I E E R A G G G V D A Q
356
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AGGTCCGCAGTGCGGGTACTGGGTCGTCCATCAAATCTCAAGATACAGCTACTGGGGGAA.
TCCAGGCGTCACGCCCATGACCCAGCAGGTAGTTTAGAGTTCTATGTCGATGACCCCCTT
V R S A G T G S S I K S Q D T A T G G N
ATTTTCAGGTTGCGAGAACCGCCGATGATGGTAAGGCTCCCTCGGGTTTGACGTGTGCTG
TAAAAGTCCAACGCTCTTGGCGGCTACTACCATTCCGAGGGAGCCCAAACTGCACACGACF Q V A R T A D D G K A P S G L T C A A
CATCATCCAGCCCTGCAGTAACCACCGTGACTGATGCCGAAGCCAGCAGCGGGAGTGGGG
GTAGTAGGTCGGGACGTCATTGGTGGCACTGACTACGGCTTCGGTCGTCGCCCTCACCCC
S S S P A V T T V T D A E A S S G S G A
CCAGAGGCTGGTCGGAAAACCAAAGCACTGGGACTCTTTCCATGACCCCAGTTTTGCTGT
GGTCTCCGACCAGCCTTTTGGTTTCGTGACCCTGAGAAAGGTACTGGGGTCAAAACGACAR G W S E N Q S T G T L S M T P V L L L
TAGATACCACCGATGAGGATGGTGAAGAAGTGGAGTACACAATGGAGCATTTCAAGAAAC
ATCTATGGTGGCTACTCCTACCACTTCTTCACCTCATGTGTTACCTCGTAAAGTTCTTTGD T T D E D G E E V E Y T M E H F K K H
ATAGAAAGGAGGTTCAGGATGTGGTGAGTTCTGTAATAGATACCGCAGGGGTGGGTGTGG
TATCTTTCCTCCAAGTCCTACACCACTCAAGACATTATCTATGGCGTCCCCACCCACACCR K E V Q D V V S S V I D T A G V G V G
GGCGCGGCGCGTCGGATTATATCGCCGCTGAAGATAACAAGGCGGCTGCATCGACGGGGG
CCGCGCCGCGCAGCCTAATATAGCGGCGACTTCTATTGTTCCGCCGACGTAGCTGCCCCCR G A S D Y I A A E D N K A A A S T G D
ATGCCGCTGTGCGCATGGTGGAGGGCGCTGATTCGGCTGGGAGCCAGGAGGAGGCGGGAT
TACGGCGACACGCGTACCACCTCCCGCGACTAAGCCGACCCTCGGTCCTCCTCCGCCCTAA A V R M V E G A D S A G S Q E E A G F
SailITTCTTTTGCTCACTAGTGTGTCGACCATTGTATCGAACATTCGCGCGGGTACATCACAAA
AAGAAAACGAGTGATCACACAGCTGGTAACATAGCTTGTAAGCGCGCCCATGTAGTGTTTL L L T S V S T I V S N I R A G T S Q T
CTGCTCAATCCCTTTTTCAGAATTTGGCCTACGTTGGTGTTCTTAAGGGGCACCTCTTCT
GACGAGTTAGGGAAAAAGTCTTAAACCGGATGCAACCACAAGAATTCCCCGTGGAGAAGAA Q S L F Q N L A Y V G V L K G H L F F
TCGCCCAATCGGGTACGACACTTTACGTTGTTGATTCCCTACGGCTCGTCCGGCACGTCG
AGCGGGTTAGCCCATGCTGTGAAATGCAACAACTAAGGGATGCCGAGCAGGCCGTGCAGCA Q S G T T L Y V V D S L R L V R H V V
357
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TGTATCAGCGAATTTTCCTTCGGTGGGCCACCCCCTCTCTCTCCACTGTGCCTCAGTTGT
2521  +---------+---------+---------+---------+---------+ 2580
ACATAGTCGCTTAAAAGGAAGCCACCCGGTGGGGGAGAGAGAGGTGACACGGAGTCAACA Y Q R I  F L R W A T P S L S T V P Q L S
CGTTTGAGGAGCCTATACACTTGTCAGATTTGCTTTCCTTTGCACTACAGAATGACGTTC
GCAAACTCCTCGGATATGTGAACAGTCTAAACGAAAGGAAACGTGATGTCTTACTGCAAGF E E P I H L S D L L S F A L Q N D V Q
AGCTTCCACCTTCACAAAAGCGCGCTGACGGAGGACCGGGTTCTCTTCTGTCTCGCTTGG
TCGAAGGTGGAAGTGTTTTCGCGCGACTGCCTCCTGGCCCAAGAGAAGACAGAGCGAACCL P P S Q K R A D G G P G S L L S R L G
GGCGCCGCCTCTGCAACTGGCGTTACATGTTGCAGGATTACTTTGCCGTGGAAATCAGTG
CCGCGGCGGAGACGTTGACCGCAATGTACAACGTCCTAATGAAACGGCACCTTTAGTCACR R L C N W R Y M L Q D Y F A V E I S A
CTGATGGCCACCTGATCGCGCTTCCACTTTCTATGGGCACTTCGTGGCCACCCCCGCTTC
2761  +---------+---------+---------+---------+--------- + 2820
GACTACCGGTGGACTAGCGCGAAGGTGAAAGATACCCGTGAAGCACCGGTGGGGGCGAAGD G H L I A L P L S M G T S W P P P L R
GGGCTGTGCCTCTTTTTATATGGCGGCTTGCAGCAGAAGTTCCGTATAATGCCGGGGAGA
2821  + + + + + + 2880
CCCGACACGGAGAAAAATATACCGCCGAACGTCGTCTTCAAGGCATATTACGGCCCCTCTA V P L F I W R L A A E V P Y N A G E I
TTGAGTGTTTCACTGCCATAGCTCGGCACATTGCAGAGACATTGTATGGTGTGCAGCTGC
2881  +---------+---------+---------+---------+--------- + 2940
AACTCACAAAGTGACGGTATCGAGCCGTGTAACGTCTCTGTAACATACCACACGTCGACGE C F T A I A R H I A E T L Y G V Q L H
ACAGCTCGTGGCTGCCGAATGTAATAAAGGATGGTATTCGGCAAGATGATGTTCCTCCAT
2941  +---------+---------+---------+---------+--------- + 3000
TGTCGAGCACCGACGGCTTACATTATTTCCTACCATAAGCCGTTCTACTACAAGGAGGTAS S W L P N V I K D G I R Q D D V P P F
TTTGTGATGCCATTCGCTTTGGCCTTTTGCCGTGCGCGACGAACTCAACCTTCTTTGTGC
3001  +----------t----------+---------+---------+ + 3060
AAACACTACGGTAAGCGAAACCGGAAAACGGCACGCGCTGCTTGAGTTGGAAGAAACACGC D A I R F G L L P C A T N S T F F V P
SailICTCCGTGTGACGCGCTGGTCGACGGAACCGTGCAGGCGGTAGTTTCTGTGGATGAGCTGT
3061  +---------+---------+---------+---------+---------+ 3120
GAGGCACACTGCGCGACCAGCTGCCTTGGCACGTCCGCCATCAAAGACACCTACTCGACAP C D A L V D G T V Q A V V S V D E L Y
ACAAGGTCTTCGAGCGTTGCTGAGCTTTTCGTTTTCCCTCTTTTCTTTTTCTTAGTTTTC
3121  +---------+---------+---------+---------+---------+ 3180
TGTTCCAGAAGCTCGCAACGACTCGAAAAGCAAAAGGGAGAAAAGAAAAAGAATCAAAAG K V F E R C
M LH l 3'(1)
358
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TTTTTTTGACTTTCACTTGTTGGTTCATTTTACTTTTCTGTCGTTGAAAAGCGCTTAATT
3181  +-------- +-------- +-------- +-------- +-------- +AAAAAAACTGAAAGTGAACAACCAAGTAAAATGAAAAGACAGCAACTTTTCGCGAATTAA
3240
MLHl 3'(A)
GCGGTGCATTTTGGGCTTATATATCCTCTTCTTTCTGTCGTGGTTAACATTGAACTCTTC
CGCCACGTAAAACCCGAATATATAGGAGAAGAAAGACAGCACCAATTGTAACTTGAGAAG
3300
AAGACCTCGTTACCCGGGTTGGTGTGGAAAGTTACTATGCTCAAGAGAAGGGCGGGATGC
TTCTGGAGCAATGGGCCCAACCACACCTTTCAATGATACGAGTTCTCTTCCCGCCCTACG
3360
GCGTCTTCAGAAGAAAGGGATAGTGGAACCGAAGGTTACCAAGGGGCGGGAAATGAATAA
CGCAGAAGTCTTCTTTCCCTATCACCTTGGCTTCCAATGGTTCCCCGCCCTTTACTTATT
3420
TTGTGCTCAATGCACACCAACAGACCGAGTAAACCTCGTGTGCTTTCTTCCCCCACTCCT
AACACGAGTTACGTGTGGTTGTCTGGCTCATTTGGAGCACACGAAAGAAGGGGGTGAGGA
3480
GCTTTCGGGTTCTCTTTTTTACACGTTTTCCCTCCTGTCATACCTTTATTCTATGCTGAG
CGAAAGCCCAAGAGAAAAAATGTGCAAAAGGGAGGACAGTATGGAAATAAGATACGACTC
3540
TTTCTTTTACTATTTTTTCTTGTCATCACGCGTATTTTCTTTCTTTTGCAGCGCACCTTC
AAAGAAAATGATAAAAAAGAACAGTAGTGCGCATAAAAGAAAGAAAACGTCGCGTGGAAG
3600
GTAATGCAGCATTAAGTTTAGTGTATTGCTTTCACTATTAAGTGGCAGCAATTTCCCCAC
CATTACGTCGTAATTCAAATCACATAACGAAAGTGATAATTCACCGTCGTTAAAGGGGTG
3660
CACCCCGCTGTATACATATATATATATATATTCCCTCGTTTTTTTGTTTCTGGTTAAGCT
GTGGGGCGACATATGTATATATATATATATAAGGGAGCAAAAAAACAAAGACCAATTCGA
3720
TCTGGTTTCATCCTCACACCGGCGTGTTTGTGGCTTGTTTCCTCCCCACTTGAAATTTGA
AGACCAAAGTAGGAGTGTGGCCGCACAAACACCGAACAAAGGAGGGGTGAACTTTAAACT
MLHl 3'(B)
3780
TACAAATTTCCCCCCTTTCAACAGGAGACAGCGACTCCATTTACATGCTCACACACCCAC
ATGTTTAAAGGGGGGAAAGTTGTCCTCTGTCGCTGAGGTAAATGTACGAGTGTGTGGGTG
3840
AACTGTCGCGAAAATTATACACCGCTTCCCCCTTTTCATTGTGTTGGTTTCAGCAAATAT
TTGACAGCGCTTTTAATATGTGGCGAAGGGGGAAAAGTAACACAACCAAAGTCGTTTATA
3900
ATGTATATGCATATATTACACATTTCTGTGACATGTGACCGTTTGAGGGGATGTAAGGGG
TACATATACGTATATAATGTGTAAAGACACTGTACACTGGCAAACTCCCCTACATTCCCC
3960
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ATCTTTTTTTTTTTTTGGCATTTGGGAACTCGAAGCCGTTGGAGACAAAGGTTTTGTACT
TAGAAAAAAAAAAAAACCGTAAACCCTTGAGCTTCGGCAACCTCTGTTTCCAAAACATGA
CGTTTTTTGTAAGTTAGTGGGGCGAGCAATTTTTGCACCTTCCTCGTCACTATTGCTGCT
GCAAAAAACATTCAATCACCCCGCTCGTTAAAAACGTGGAAGGAGCAGTGATAACGACGA
AGTCGTCGCCACCTATAAGCATATGTACTTTTTTTTACTAATATTCTTTTTTCCACCGCC
TCAGCAGCGGTGGATATTCGTATACATGAAAAAAAATGATTATAAGAAAAAAGGTGGCGG
GGAACCAGGTAGTCATCAACATATATGCGACGTGGAACTAATACGACTGACGACTCCGCG
CCTTGGTCCATCAGTAGTTGTATATACGCTGCACCTTGATTATGCTGACTGCTGAGGCGC
GCAGCACCCAGCAGCGTCGCCGTGACTCCCCGGGAGTTTAACCGGGGACGATA
CGTCGTGGGTCGTCGCAGCGGCACTGAGGGGCCCTCAAATTGGCCCCTGCTAT
360
Appendix 5 Sequence map showing the putative T. brucei PMSl ORF
A map showing the DNA sequence of the 5.5 kb EcoK\ fragment sub-cloned from an 
ILTat 1.2 genomic lambda clone into pBluescript II KS to form the plasmid pJB400, which 
contains the entire putative T. brucei PMSl ORF along with its processing flanks (see 
sections 2.10.2 and 3.4.3). The conceptual translation of the PMSl ORF is shown in red 
beneath the DNA sequence and restriction sites are shown above the sequence in black. 
Half arrows denote primer sequences: those used to amplify the PMSl internal fragment 
{PMS1\J\ and PMSIDX) are indicated in turquoise; those used to amplify the 460 bp PMSl 
probe {PMS1\J2 and PMSl 3’(2)) are indicated in dark red; and those used to confirm the 
linkage of the putative PMSl contigs {PMSl 5’(2) and PMSl 3’(2)) are shown in purple.
EcoRI
GAATTCCTGGCGTTGTTCCATGAGGCACATGTCACGTCGGTCACGTCGATGGGATCCCTG
CTTAAGGACCGCAACAAGGTACTCCGTGTACAGTGCAGCCAGTGCAGCTACCCTAGGGAC
GTGCCACCTGTCTCCCACTTCCCCGTTTGCGAGCCCTTTGTCATCTTCCCCTCGTTGAAC
CACGGTGGACAGAGGGTGAAGGGGCAAACGCTCGGGAAACAGTAGAAGGGGAGCAACTTG
TGGTCAAAAAACCCGCCCTACCGTCTGTAGCATAATGATGAGTTGTCTCTCTGCGACGTC
ACCAGTTTTTTGGGCGGGATGGCAGACATCGTATTACTACTCAACAGAGAGACGCTGCAG
ATAGAACTGCCTTACTCGCGTTTGTGATGTGTAAACTCGTGGGTGTTTTTGCTCTGTGAT
TATCTTGACGGAATGAGCGCAAACACTACACATTTGAGCACCCACAAAAACGAGACACTA
TTCCTAGGAAGCAAACTGTTTCCCACTCCCTCTTACATTATTTCACGGCTCCCTCTACTG
AAGGATCCTTCGTTTGACAAAGGGTGAGGGAGAATGTAATAAAGTGCCGAGGGAGATGAC
TGTAACCGAAGTGTTTCTAGGTGTGAGCTATGGTTGGCATCAAGTGCAGGAACCGCCGAA
ACATTGGCTTCACAAAGATCCACACTCGATACCAACCGTAGTTCACGTCCTTGGCGGCTT
AGGCCCGTCGCGCACACTTCCAAGCGCCCAGTCATGTCCGCCGCATCCTCATGAGTGCCC
TCCGGGCAGCGCGTGTGAAGGTTCGCGGGTCAGTACAGGCGGCGTAGGAGTACTCACGGG
CACTCTCTAAGGAGCTACGCGCCAAGTACAACGTGCGCTCGATGCCTGTGCGCAAGGACG
GTGAGAGATTCCTCGATGCGCGGTTCATGTTGCACGCGAGCTACGGACACGCGTTCCTGC
ACGAGGTGCGTGTTAAGCGTGGGAAGTTCAAGGGCCGTGAGGGCAGAGTCACCGCATGCT
TGCTCCACGCACAATTCGCACCCTTCAAGTTCCCGGCACTCCCGTCTCAGTGGCGTACGA
ACCGCCTCAAGTGGGTTATTCACATTGACAAGGTGAGTTGCGAGAAGGCGAACGGCACCA
TGGCGGAGTTCACCCAATAAGTGTAACTGTTCCACTCAACGCTCTTCCGCTTGCCGTGGT
361
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CCGTTCCCGTCGGTGTACACACCTCCAACGTGGAAATCACGAAACTGAAGCTCAACACCA
601  +---------+--------+-------- +-------- +-------- + 660GGCAAGGGCAGCCACATGTGTGGAGGTTGCACCTTTAGTGCTTTGACTTCGAGTTGTGGT
GGCGGAAGGCAATCCTCGAGCGCAAGGACCGCAGCACGAAGACCGACAAATCAAAGGGAA
661-- 1--------- 1-------- +-------- H-------- +------------ 720
CCGCCTTCCGTTAGGAGCTCGCGTTCCTGGCGTCGTGCTTCTGGCTGTTTAGTTTCCCTT
AGGTGACCGCTGCTGAGAAGGCCATGCAGCAGATGGACTAAAGAAGACGGGGGTCTACGG
721  +---------+--------+-------- +-------- +-------- + 780TCCACTGGCGACGACTCTTCCGGTACGTCGTCTACCTGATTTCTTCTGCCCCCAGATGCC
AGCCACCGAGGTTTACCGACTTCTTTACCTGCTGTTTCACTTAGGAACACCTCGTGATAT
TCGGTGGCTCCAAATGGCTGAAGAAATGGACGACAAAGTGAATCCTTGTGGAGCACTATA
840
P M S l 5' (2)
TTCTGACGTTTATTCTTCATTTTTCTGTGCTAACGTCTCTTTTTACGACTCGATGTGGAG
AAGACTGCAAATAAGAAGTAAAAAGACACGATTGCAGAGAAAAATGCTGAGCTACACCTC
900
CCACACTGCTGCCCCCCCCCCACACGTGCACCATTGCGCGCTTGTTGCCGAACCCTGGTC
GGTGTGACGACGGGGGGGGGGTGTGCACGTGGTAACGCGCGAACAACGGCTTGGGACCAG
960
TCGGTTTGAGAAAGAGGATCAAACATTTATTTTCGTTTCCCCCTGATCTTTCTTTCCTTT
AGCCAAACTCTTTCTCCTAGTTTGTAAATAAAAGCAAAGGGGGACTAGAAAGAAAGGAAA
1020
CCTCCAAGCTTTCTATTTCTTCCGCCACTCAGTCGGAGAAACCTTTCTATGATCCTGAGA
GGAGGTTCGAAAGATAAAGAAGGCGGTGAGTCAGCCTCTTTGGAAAGATACTAGGACTCT
1080
CACCAAAGACTTCAATTTCCTCCTTGCGGAATTGAAACAGCGTATAAATTTGAAGATAGA
GTGGTTTCTGAAGTTAAAGGAGGAACGCCTTAACTTTGTCGCATATTTAAACTTCTATCT
1140
GCAACGCCCATAGTGGGGGGAGAAGGTTGTGAAGAAAGAGGTAAGCAAGGGGCATGATTA
CGTTGCGGGTATCACCCCCCTCTTCCAACACTTCTTTCTCCATTCGTTCCCCGTACTAATM I T
CCCTTTTGGACGAGGGAAGTTCGCGCAAGTTGAGTGCAGGGCAGGTAATTACGAATCTTT
GGGAAAACCTGCTCCCTTCAAGCGCGTTCAACTCACGTCCCGTCCATTAATGCTTAGAAA
L L D E G S S R K L S A G Q V I T N L S
CCAGCGTCGTGAAAGAGTTGGTAGAGAATAGCCTAGATGCCGGTGCCCGTACCGTTGCAA
GGTCGCAGCACTTTCTCAACCATCTCTTATCGGATCTACGGCCACGGGCATGGCAACGTT
S V V K E L V E N S L D A G A R T V A I
3 0 2
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TACGTGTGGAGGATAGCGGCGCTGGAAATATTACCGTGGAAGATGATGGAAGTGGCATGG
ATGCACACCTCCTATCGCCGCGACCTTTATAATGGCACCTTCTACTACCTTCACCGTACCR V E D S G A G N I T V E D D G S G M D
ACTTATCTTATCTGCTAGACAGCGAGGGCCGACTGAAAGAGGATGCTTCCCTGCCCCTGC
TGAATAGAATAGACGATCTGTCGCTCCCGGCTGACTTTCTCCTACGAAGGGACGGGGACGL S Y L L D S E G R L K E D A S L P L L
TAGCCTCGAGGGCGACAACAAAACGAAGGGGGGGCGACAGTGGTCTTTCGTCGCAGGCGG
ATCGGAGCTCCCGCTGTTGTTTTGCTTCCCCCCCGCTGTCACCAGAAAGCAGCGTCCGCCA S R A T T K R R G G D S G L S S Q A A
CGCAAACACTGGGTTTTCGTGGCGAAGCGCTCCACTCTTTGGCTCACCTTAGCGAGTTGT
GCGTTTGTGACCCAAAAGCACCGCTTCGCGAGGTGAGAAACCGAGTGGAATCGCTCAACA
Q T L G F R G E A L H S L A H L S E L S
CCATATGCACAATGTCAGAATCAACCCGACCTACTGCACTACTGATCGCGTACGACAGTA
1561  +--------- K---------+---------H--------- 4--------- + 1620
GGTATACGTGTTACAGTCTTAGTTGGGCTGGATGACGTGATGACTAGCGCATGCTGTCAT
I C T M S E S T R P T A L L I A Y D S N
ATTCCCGCCGTACGACTGTAAAGGTAACGAGTGAACGGAGGGACGTAGGCACAACCGTTG
1621  + + + + + + 1680
TAAGGGCGGCATGCTGACATTTCCATTGCTCACTTGCCTCCCTGCATCCGTGTTGGCAACS R R T T V K V T S E R R D V G T T V V
TCGTTAGCAAACTCTTTGCGGCTCTTCCGGTGCGTCACAAGGATTTCGTACGGGGTAGGA
1681  +---------+---------+---------+---------+---------+ 1740
AGCAATCGTTTGAGAAACGCCGAGAAGGCCACGCAGTGTTCCTAAAGCATGCCCCATCCT
V S K L F A A L P V R H K D F V R G R K
AGAAGCAGCTTCTCGCTGCTACCCTACTGATGAAGCAGTACGCCCTTTCACACCCCCACG
1741  +---------+---------+---------+---------+---------+ 1800
TCTTCGTCGAAGAGCGACGATGGGATGACTACTTCGTCATGCGGGAAAGTGTGGGGGTGCK Q L L A A T L L M K Q Y A L S H P H V
TGCGCTTGTTGATGACCCATCGTGCGGGACCTGACAGTGCCCCCGTTACTCTGGTGTCGT
1801  +---------+---------+---------+---------+--------- + I860
ACGCGAACAACTACTGGGTAGCACGCCCTGGACTGTCACGGGGGCAATGAGACCACAGCA
R L L M T H R A G P D S A P V T L V S L
TGACGGGGACGGGCGACCCCCAGCGAGCCCTTGCTGAGGCGTACGGTGGACGTGTTATCG
1861  +---------+---------+-------- +---------+--------- + 1920
ACTGCCCCTGCCCGCTGGGGGTCGCTCGGGAACGACTCCGCATGCCACCTGCACAATAGC
T G T G D P Q R A L A E A Y G G R V I A
CCAACATGGAGCGTGTGGAGTGGGAACTGACTTTTGGGACAATTACGGGTTATGTTTCGA
1921  +---------+---------+---------+---------+---------+ 1980
GGTTGTACCTCGCACACCTCACCCTTGACTGAAAACCCTGTTAATGCCCAATACAAAGCT
N M E R V E W E L T F G T I T G Y V S K
AGGGGAATGCCGGCAGACTTTCCTCCGATATGCAAGTGTTTGCACTGGATGGGAGGCTTG
1981  +---------+---------+---------+---------+--------- + 2040
TCCCCTTACGGCCGTCTGAAAGGAGGCTATACGTTCACAAACGTGACCTACCCTCCGAACG N A G R L S S D M Q V F A L D G R L V
363
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TTGACCTCCCCATGATGGCCAAGGCGGTTAACGATGCCTACGCCGAATCCCTGCCAAACG
AACTGGAGGGGTACTACCGGTTCCGCCAATTGCTACGGATGCGGCTTAGGGACGGTTTGCD L P M M A K A V N D A Y A E S L P N A
PMS 71 n ^
CCGCGCAGCGCACATTTCCTGCCTTCTTCCTGCATGTCAGCTCTGGTGAGTCACTTCCCT
GGCGCGTCGCGTGTAAAGGACGGAAGAAGGACGTACAGTCGAGACCACTCAGTGAAGGGA
A Q R T F P A F F L H V S S G E S L P Y
ACGATGTGAATTTAGTTCCTGACAAACGCAAAGTTCTCATTTCGGATGAGGAGAGACATG
TGCTACACTTAAATCAAGGACTGTTTGCGTTTCAAGAGTAAAGCCTACTCCTCTCTGTAC
D V N L V P D K R K V L I S D E E R H A
CTGGGGAGGTTCGTACATGCGGTCTTCGAACGTTCCAGGCATCAACTGACGGAATAGATC
GACCCCTCCAAGCATGTACGCCAGAAGCTTGCAAGGTCCGTAGTTGACTGCCTTATCTAG
G E V R T C G L R T F Q A S T D G I D L
TGCCCGTGCGCAACGAAGGCGGATGGAGACACGTACCGGAGCGCAGGAACACACAGGAGA
2281  +---------+---------+---------+---------+--------- + 2340
ACGGGCACGCGTTGCTTCCGCCTACCTCTGTGCATGGCCTCGCGTCCTTGTGTGTCCTCT
P V R N E G G W R H V P E R R N T Q E T
CAATGCCTACACAAACGCCTCTTTCTGCTACATCTATTGCACAGTTCATCTATCAGCGGC
2341  +---------+---------+---------+---------+--------- + 2400
GTTACGGATGTGTTTGCGGAGAAAGACGATGTAGATAACGTGTCAAGTAGATAGTCGCCGM P T Q T P L S A T S I A Q F I Y Q R R
GGGAAACATCGCAGGGAGACAACCTTATTGACAATGCTGCGGTGGCGCAGGTGCAGCCCT
2401  +---------+---------+---------+---------+--------- + 2460
CCCTTTGTAGCGTCCCTCTGTTGGAATAACTGTTACGACGCCACCGCGTCCACGTCGGGA
E T S Q G D N L I D N A A V A Q V Q P S
CCGTTTGCTTAAGTCAACTGTTGTCTGGAAGCTCGCCTATTGGACGGACATCCTCCCCTG
2461  +---------+---------+---------+---------+--------- + 2520
GGCAAACGAATTCAGTTGACAACAGACCTTCGAGCGGATAACCTGCCTGTAGGAGGGGACV C L S Q L L S G S S P I G R T S S P D
ATGCTACCGCTTCCCCAACCAGCACCACCAACCGTGCACCATCGGAGCGTTCTGCAGGTT
2521  +---------+---------+---------+---------+--------- + 2580
TACGATGGCGAAGGGGTTGGTCGTGGTGGTTGGCACGTGGTAGCCTCGCAAGACGTCCAA
A T A S P T S T T N R A P S E R S A G S
^  rf-T.s 7rn
CTGTTGAATCAGTCTTGGAGTATCCCTTGACCTTTGAGCCAACCCAGAAGAGGCAGCGGT
2581-- 1--------- 1---------4--------- 1--------- 1---------4- 264 0
GACAACTTAGTCAGAACCTCATAGGGAACTGGAAACTCGGTTGGGTCTTCTCCGTCGCCA
V E S V L E Y P L T F E P T Q K R Q R L
TGGAGTCCTCAGCGGAAGAAGGAAATACCGGTGACACTGATGGTAGCAGCTGGGGTGAAG
2641  +---------4--------- 4--------- 4--------- 4--------- + 2700
ACCTCAGGAGTCGCCTTCTTCCTTTATGGCCACTGTGACTACCATCGTCGACCCCACTTCE S S A E E G N T G D T D G S S W G E E
364
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AAGATCCCCGGGAGCTCGGACCGGAAGAGATGATGGGGACTGATGATGCAGTTGTGAATT
TTCTAGGGGCCCTCGAGCCTGGCCTTCTCTACTACCCCTGACTACTACGTCAACACTTAAD P R E L G P E E M M G T D D A V V N Y
ACGTTACCGACGATACGAATCAACAGCGACCCGGTCCCCCTCGCTCTTCTGTGAGGTTTC
TGCAATGGCTGCTATGCTTAGTTGTCGCTGGGCCAGGGGGAGCGAGAAGACACTCCAAAGV T D D T N Q Q R P G P P R S S V R F P
CTCCATTTTCAGTTTTGGCTGAGATGCCACTGGTTCACTCCCTTGGAGAATGGGCGGCTC
GAGGTAAAAGTCAAAACCGACTCTACGGTGACCAAGTGAGGGAACCTCTTACCCGCCGAGP F S V L A E M P L V H S L G E W A A P
CGTCCCAACCTTCCGATGGGGGAGGTGTTCGAAAGTTTTCGAGGCTTCAGAAACAAACCG
GCAGGGTTGGAAGGCTACCCCCTCCACAAGCTTTCAAAAGCTCCGAAGTCTTTGTTTGGCS Q P S D G G G V R K F S R L Q K Q T E
AGGAGGAGCTCACGTTGTATTTGGGGAAGGAGTCGTTCAAAAATATGGTTGTACATGGTC
2941  +---------+---------+---------+---------+--------- + 3000
TCCTCCTCGAGTGCAACATAAACCCCTTCCTCAGCAAGTTTTTATACCAACATGTACCAGE E L T L Y L G K E S F K N M V V H G Q
AGTTCAACCATGGCTTCATTGTAACTTCACTGGACGACAACATCTTTGTGATCGACCAGC
3001  +---------+---------+---------+---------+---------+ 3060
TCAAGTTGGTACCGAAGTAACATTGAAGTGACCTGCTGTTGTAGAAACACTAGCTGGTCGF N H G F I V T S L D D N I F V I D Q H
ACGCTGCCGATGAGAAAGGCAACTATGAACATCTAATGAGTCATTATGTAGCCAGGCCAC
3061  +---------+---------+---------+---------+---------+ 3120
TGCGACGGCTACTCTTTCCGTTGATACTTGTAGATTACTCAGTAATACATCGGTCCGGTGA A D E K G N Y E H L M S H Y V A R P Q
AACCCCTCTTTTCTCCAGTACCTGTGTCGATGGAGCCCCAGGCTGTGGATTTGGCTGTTG
3121  4----------+---------4--------- 4--------- 4--------- 4- 3180
TTGGGGAGAAAAGAGGTCATGGACACAGCTACCTCGGGGTCCGACACCTAAACCGACAACP L F S P V P V S M E P Q A V D L A V D
ATCATGCTGAAGAACTGCGGCAACACGGCTTCATCGTGCAGCGGAGTGACGACACCAATA
3181  4---------------------4--------------------- 4---------------------+ -------------------- +  4- 3240
TAGTACGACTTCTTGACGCCGTTGTGCCGAAGTAGCACGTCGCCTCACTGCTGTGGTTATH A E E L R Q H G F I V Q R S D D T N K
PM S1U 2 ^
AGTTGCTGGTGCTATCAGTGCCTGTGATTCCTTACGAGGTTGTGGACCCGCAGAACGTCG
3241  +---------4----------4----------4--------------------- 4- 4- 3300
TCAACGACCACGATAGTCACGGACACTAAGGAATGCTCCAACACCTGGGCGTCTTGCAGC L L V L S V P V I  P Y E V V D P Q N V V
TAGAGCTGATTAGGCAGTTAGTGCATTACAATACGATCAGTAAACCGATGCGATGTGTGT
3301  4--------- 4--------- 4--------- 4--------- 4--------- 4- 3360
ATCTCGACTAATCCGTCAATCACGTAATGTTATGCTAGTCATTTGGCTACGCTACACACAE L I R Q L V H Y N T I S K P M R C V W
365
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GGCACTCAATGGCAACTAAGGCATGCCGTTCTAGCATTATGGTTGGAACGATGCTTAGTG
CCGTGAGTTACCGTTGATTCCGTACGGCAAGATCGTAATACCAACCTTGCTACGAATCACH S M A T K A C R S S I M V G T M L S E
AGAAGAAAATGCGGTCAGTCGTGGACCGAATGGGTGAGCTGGAACAGCCGTGGAACTGTC
TCTTCTTTTACGCCAGTCAGCACCTGGCTTACCCACTCGACCTTGTCGGCACCTTGACAGK K M R S V V D R M G E L E Q P W N C P
CACACGGGCGACCGACCGTGCGGCACGTCTCCAAGATTTCTTCGTTGGTTTCCTTAATGA
GTGTGCCCGCTGGCTGGCACGCCGTGCAGAGGTTCTAAAGAAGCAACCAAAGGAATTACTH G R P T V R H V S K I S S L V S L M T
CGAAGTCCCGCCGTGCGTGAGTTTCACTTATTTATCTGGGCACCACCAAACCTTATGTTT
GCTTCAGGGCGGCACGCACTCAAAGTGAATAAATAGACCCGTGGTGGTTTGGAATACAAA K S R R A
GCTTTTTTTCTTAGTTTTCGTCATTGCTGTTGTTGTTTCTTTGATATGCTTTTTTCCCGT
CGAAAAAAAGAATCAAAAGCAGTAACGACAACAACAAAGAAACTATACGAAAAAAGGGCA
P M S l 3' (2)
GCTTTTGCGTCGCTTTTTCTACACGGAACCTAATGCTCGTCATTGTTCTCTTGCTCCCGT
CGAAAACGCAGCGAAAAAGATGTGCCTTGGATTACGAGCAGTAACAAGAGAACGAGGGCA
P M S l 3' (2)
GCTTTTCCACTCACTGATTTCGGTATTGTTGTTCTTCATTTTTCTCTAAACTGATTTTCC
3721  +---------+---------+---------+---------+ + 3780
CGAAAAGGTGAGTGACTAAAGCCATAACAACAAGAAGTAAAAAGAGATTTGACTAAAAGG
ATTGCGCGACTTGATCTATTTTCTTTCCTTGGTTCATCTGCCTGACGGTAAAGGGAAGGA
3781  +--------- +---------+-------- +---------+--------- + 3840
TAACGCGCTGAACTAGATAAAAGAAAGGAACCAAGTAGACGGACTGCCATTTCCCTTCCT
AGGAAACGAAATCCAGCGGCAGCAGCTGTGCGGTGTCGGTGGCGACCACCTGAACAAACC
TCCTTTGCTTTAGGTCGCCGTCGTCGACACGCCACAGCCACCGCTGGTGGACTTGTTTGG
TTGTAGGTTTCATTTGAGGAAGACGGCGTAGTTTGGCATGGATGTGTGTGAGGGATTGAG
3901  +--------- +---------+-------- +---------+--------- + 3960
AACATCCAAAGTAAACTCCTTCTGCCGCATCAAACCGTACCTACACACACTCCCTAACTC
GGTTCCAGTTGGACATATGTCAGGAACTGGTGGGTTGGGGTTGACGGCAGGGGGTGGAGG3961  +--------- +---------+-------- +---------+--------- + 4020
CCAAGGTCAACCTGTATACAGTCCTTGACCACCCAACCCCAACTGCCGTCCCCCACCTCC
AACCGCGACTAGTAGTGTTTTTTCCGACCTCAGGGAGCTTAACGAGGCAAAGGTGTCGAA
4021  +--------- +---------+-------- +---------+--------- + 4080
TTGGCGCTGATCATCACAAAAAAGGCTGGAGTCCCTCGAATTGCTCCGTTTCCACAGCTT
3 0 0
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CATTCTTTCATACCTAGATGACGTTGTTTCTACGAGACCCCCGTTTCCCGCATCATTTGG
4081  +---------+---------+---------+---------+--------- + 4140
GTAAGAAAGTATGGATCTACTGCAACAAAGATGCTCTGGGGGCAAAGGGCGTAGTAAACC
CCCTTCAGCGTGCCGTGACGTATACATGCCAGCAAATATTTCGGATGGTGGTGTGGCGTT
4141  +---------+---------+---------+---------+---------+ 4200
GGGAAGTCGCACGGCACTGCATATGTACGGTCGTTTATAAAGCCTACCACCACACCGCAA
GGCACCGTCGGCTGACCTACTACAGCCTTCTACGCAGTTACCACCGTTTGGCGGTTCGGC
4201  +---------+---------+---------+---------+--------- + 4260
CCGTGGCAGCCGACTGGATGATGTCGGAAGATGCGTCAATGGTGGCAAACCGCCAAGCCG
TTCATGTCTTACGTCGCACATAATAGGGTGTGGACCCGACGTTCGCAACGATGTTTACCA
AAGTACAGAATGCAGCGTGTATTATCCCACACCTGGGCTGCAAGCGTTGCTACAAATGGT
CGGTATCAAGGCTAAAATATCTGCCTTACAGTTCAGCAATGATGAGCTGAGGGCTGAAAA
GCCATAGTTCCGATTTTATAGACGGAATGTCAAGTCGTTACTACTCGACTCCCGACTTTT
CGAAGAACTGAAGGAGCGAGTCAAGATGGCGCGGGAGAGGGAAGCGGAGCGTCTTGGAAG
GCTTCTTGACTTCCTCGCTCAGTTCTACCGCGCCCTCTCCCTTCGCCTCGCAGAACCTTC
CCAGGAAGCCGCGGCTCGCAACGAGCTGGAAGGGCTCCGCAAGAAGCTACGGGAGACGGA
GGTCCTTCGGCGCCGAGCGTTGCTCGACCTTCCCGAGGCGTTCTTCGATGCCCTCTGCCT
GCGCAACTACGAACGCGTGGTGCAAGAGTTTCAGCGCGAAAGGTCGCAGTTGACCCAGGC
CGCGTTGATGCTTGCGCACCACGTTCTCAAAGTCGCGCTTTCCAGCGTCAACTGGGTCCG
AGTGGAGTCTGTTACGTCTCAACTACGGCAAGAGATGTCTCGGCGGGAGGAGGAGATCGC
TCACCTCAGACAATGCAGAGTTGATGCCGTTCTCTACAGAGCCGCCCTCCTCCTCTAGCG
CAGACTTGAGTCTGCGAACGCGACCGCCATAGCGCAACTTAAGACCCGGTGGCAAGCTCA
GTCTGAACTCAGACGCTTGCGCTGGCGGTATCGCGTTGAATTCTGGGCCACCGTTCGAGT
GGAGAAGGCTGCTCGCGAGAAGTGGAGGATAGCCGAGGCGAAACGCATAAAGGAGAACAC
CCTCTTCCGACGAGCGCTCTTCACCTCCTATCGGCTCCGCTTTGCGTATTTCCTCTTGTG
CCTCCAGTCGTTAGAGCCTGATATCGTGTTGTTGTTGAACAGGCACAAGGCGGAAAAGGC
GGAGGTCAGCAATCTCGGACTATAGCACAACAACAACTTGTCCGTGTTCCGCCTTTTCCG
GCGTATGCGGGAAGAGTTCGAGAACGAACTACGnCAGCGGGATGAGGTTATTGCGGCAAA
CGCATACGCCCTTCTCAAGCTCTTGCTTGATGCnGTCGCCCTACTCCAATAACGCCGTTT
GGAGGCGCCACTCGCAGAGTCCAGGGCGCGGTTGGAGCGTGAGGCATCTGCAACTCGGGC
4861  +---------+---------+---------+---------+---------+ 4920
CCTCCGCGGTGAGCGTCTCAGGTCCCGCGCCAACCTCGCACTCCGTAGACGTTGAGCCCG
367
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EcoRIIT CG AG AGC AACAGGAGTT CCGGGAT CG AGAAT T C 
AGCTCTCGTTGTCCTCAAGGCCCTAGCTCTTAAG
3 0 8
Appendix 6 Multiple alignment of the pHygro-Tub, pHYGWT, pHYGOlj pHYGOl,
pHYGOS, pHYGOS, pHYG07, pHYG09 and pH YG ll
Multiple alignment of the pHygro-Tub, pHYGWT, pHYGOl, pHYG02, pHYGOS, pHYG05, 
pHYGOl, pHYG09 and pHYG ll DNA sequences. Only the region of the pHygro-Tub 
sequence which aligns with the pHYGWT sequence is shown. Numbers in italics indicate 
the percentage of sequence divergence of the HYG flanks of that construct from the 
pHYGWT sequence rounded to the nearest integer. Sequences were aligned using Multalin 
(http://prodes.toulouse.inra.fr/multalin/multalin.html; Corpet, 1988) and shaded using the 
BOXSHADE server (http://www.ch.embnet.org/software/BOX_form.html): identical 
residues are shown in black; residues that differ from the pHYGWT sequence are shown in 
red. The sequence of the HYGVov primer is indicated in blue, and the sequence 
complementary to the //TGRev primer is indicated in green. The sequence corresponding 
to the Nde\ restriction site is shown in purple. Missing bases as shown as dots.
p H y g r o - T u b  1.................................AG CC TG A AC TCA CCGCGACGTCTGTCGAGAAGTTTCTGATCGAAAAG TTC
pHYG W T 1 AAGGCGCGCCAGCCTGAACTCACCGCGACGTCTGTCGAGAAGTTTCTGATCGAAAAGTTC
pHYGOl  1 AAGGCGCGCCAGCCTGAACTCACCGCGACGTCTGTCGAGAAGTTTCTGATCGAAAAGTTC
pHYG02  1 AAGGCGCGCCAGC. TG AACTCACCG CG ACG TCTG TCG AG AAG TTTCTG ATCG AAAAG TTC
pHYG03  1 AAGGCGCGCCAGCCTGAACTCACCGCGACGTCTGTCGAGAAGCTTCTGATCGAAAAGTTC
pHYGOS  1 AAGGCGCGCCAGCCTGAACTCACCGCGACGTCTGTCGAGAAGTCTCTGATCGAAAAGTTC
pHYG07  1 AAGGCGCGCCAGCCTGAACTCACCGCGACGCCTGTCGAGAAGTTTCTGGTTGAAAGGTCC
p H Y G 0 9  1 AAGGCGCGCCAGCCTGAACTCACCGCGACGTCTGCCGAGGCGCTCCTGACCGAGAAGCTC
pHYGll  1 AAGGCGCGCCAGCCTGAACTCACCGCGACGTCTGCCGAGAAGTCCCTGATTGAAAAGTCC
p H y g r o - T u b  5 1  GACAGCGTCTCCGACCTGATGCAGCTCTCG GAGGGCGAAGAATCTCGTGCTTTCAGCTTC
pHYGWT  6 1  G A C AG C G TCTCCGACCTGATGCAGCTCTCG GAGGGCGAAGAATCTCGTGCTTTCA6CTTC
pHYGOl  6 1  GACAGCGTCTCCGACCTGATGCAGCTCTCG GAGGGCGAAGAATCTCGTGCTTTCAGCTTC
pHYG02  6 0  GACAGCGTCTCCGACCTGATGCAGCTCTCG GAGGGCGAAGAATCTCGTGCTTTCAGCTTC
pHYG03  6 1  GACAGCGTCTCCGACCTGATGCAGCTCTCG GAGGGCGAAGAATCTCGTGCTTTCAGCTCC
pHYGOS  6 1  G ACAG CGTCTCCGACCTGGTGCAGCTCTCGGAGGGCGAAGAATCTCGTGCTTTCAGCTTC
pHYGOJ  6 1  GACAGCGTCTCCGGCCTGATGCAGCTCTCGGAGGGCGGAGGACCTCGTGCTTTCAGCCTC
p H Y G 0 9  6 1  G ACAG CG TCCCCGACCTGACGCAGCTCTCGAAGG6CGAAGAATTTCGTGCCTTCAGCCTC
pHYGll  6 1  GGCAGCGTCTCCGACCCGATGCAACTCTCGAAGGGCGGCGAATCTCGTGCTCTCAGCTCC
p H y g r o - T u b  1 1 1  CATGTAGGAGGGCGTG GATATGTCCTGCGGGTAAATAGCTGCGCCGATG GTTTCTACAAA
pHYGWT  1 2 1  CATGTAGGAGGGCGTG GATATGTCCTGCGGGTAAATAGCTGCGCCGATG GTTTCTACAAA
pHYGOl  1 2 1  GATGCAGGAGGGCGTGGATAGGTCCTGCGGGTAAATAGCTGCGCCGATGGTTTCTACAAA
pHYG02  1 2 0  G ATG TAGGAGGGCGTGGATATGTCCTGCGGG TAAATAGCTGCGCCGATGGTTTCTACAAA
pHYG03  1 2 1  GATGTAGGAGGGCGTGGATATGTCCTGCGGG TAAATAGCTGTGCCGATGGTTTCTACAAA
pHYGOS  1 2 1  GATGTAGGAGGGCGTGGATATGTCCTGCGGG TAAATAGCTGCGCCGATGGTTTCTACGAA
pHYGOl  1 2 1  GATGTAGGAGGGCGTGGGTATGTCCTGCGGGTGAATAGCTGCGCCGATAGTTTCTGCAAG
p H Y G 0 9  1 2 1  GGTGTAGGAGGGCGTAGATATGTCCTGCGGGTAAGTGGCTGCGCCGGTGGTTTCTACGAA
pHYGll  1 2 1  GATG TAGGGGAGCGTGGGTACGTCCTGCGGGCAAATAGCTGCGCCGATGGTCTCTACAGA
p H y g r o -T io b  1 7 1  G A TC G TTA TG TTTATC G G CA CTTTG C A TCG G CCG C G C TC CCG A TTCC G G A AG TG CTTG AC
pHYGWT  1 8 1  G A TC G TTATG TTTATCG G C AC TTTG CA TC G G CC G CG C TCCC G ATTC CG G A AG TG CTTG A C
pHYGOl  1 8 1  GATCGTTATG TG TATCG G CACTTTG CATCG G CCG CG CTCCCG ATTCCG G AAG TG CTTG G C
pHYG02  1 8 0  GATCATTACGTTTA TCG G CG CTTTG CA TCG G CC G CG C TC CC G ATTC CG G AAG TG C TTG AC
pHYG03  1 8 1  GATCG CTATG TTTATCG G CACTCTG CATCG G CCG CG CTCCCG ATTCCG G AAG TG CTTG AC
pHYGOS  1 8 1  GATCGTTATG TTTATCG G CG CTTTG CATCG G CCG CG CTCCCG G TTCCG G AAG TG CCTG AC
pHYGOl  1 8 1  G ATC G CTATG TTTA TCGGCGCTTCGCATCGGCCGCGCTCCCGATTCCGGAAGTGCTTG AC
p H Y G 0 9  1 8 1  GACCGTTATGCTTATCGGCACTCTGCACCGGCCG . GCTCCCGATTCCGGAAGTGCTTGAC
pHYGll  1 8 1  GGTCGTTATGTTTATC G G CA CTTTG CAC C G G CC G CG C TC CC G ATTC CG G A AG TAC TTG AC
369
Appendix 6 continued
p H y g r o - T u b  2 3 1  A TT G G G G A A TTC A G C G A G A G C C TG A C C TA TT6C A TC TC C C G C C G T6C A C A 666TG TC A C 6
pHYGWT  2 4 1  ATTG GGGAATTCAGCGAGAGCCTGACCTATTGCATCTCCCGCCGTGCACAGGGTGTCACG
pHYGOl  2 4 1  ATTG G G G AA TTCAGCGAGAGCCTGACCTATTGCATCTCCCGCCGTGCACA6GG TGTCACG
pHYG02  2 4 0  ATTGGGGAGCTCAGCGAGAGCCTGACCTATTGCATCTCCCGCCGTGCACAGGGTGTCACG
pHYG03  2 4 1  ATCGGGGAATTCAGCGAGAGCCTGGCCTATTGCACCTCCCGCCGCGCACAGGGTGTCACG
pHYGOS  2 4 1  ATTGGGGAACTCAGCGAGGGCCTGACCTATTGCATCTCCCGCCGCGCACAGGGTGTCACG
pHYGOl  2 4 1  GTTGGGGAGTTCAGCGAGAGCCTGACCTGTTGCATCTCCCGCCGTGCACAGGGTGTCACG
pHYGOS 2 4 0  AGTG GGGAATTCAGCGGGAGCCTGACTTATTGCGTCTCCCGCCGTGCACAGGGTGTCACG
pHYGll  2 4 1  ATTGGGGAACCCAGCGAGGGCCCGACCTACTGCGTCTCCCGCCGTGCACGGGGTGTCACG
p H y g r o - T u b  2 9 1  TTGCAAGACCTGCCTGAAACCGAACTGCCCGCTGTTCTGCAGCCGGTCGCGGAGGCCATG
pHYGWT  3 0 1  TTGCAAGACCTGCCTGAAACCGAACTGCCCGCTGTTCTGCAGCCGGTCGCGGAGGCCATG
pHYGOl  3 0 1  TTGCAAGACCTGCCTGAAACCGAACTGCCCGCTGTTCTGCAGCCGGTCGCGGAGGCCATG
pHYG02  3 0 0  TTGCAAGACCTGCCTGAAACCGAACTGCCCGCTGTTCTGCAGCCGGTCGCGGAGGCCATG
pHYG03  3 0 1  TTGCAAGACCTGCCTGAAACCGAACTGCCCGCTGTTCTGCAGCCGGTCGCGGAGGCCATG
pHYGOS  3 0 1  TTGTAAGACCTGCCTGAAACCGAACTGCCCGCTGCTCTGCAGCCGGTCGCGGGG6CCATG
pHYGOl  3 0 1  TTGCAAGACCTGCCTGAAACCGAACCGCCCGCTGTCCTGCAGCCGGCCGCGGAGGCCGTG
p H Y G 0 9  3 0 0  TTGTAAGACCTGCCTGGAACCGAACTGCCCGCTGCTCTGCAGCTGGTCGCGGAGGCCATG
pHYGll  3 0 1  CTGCAAGACCTGCCTGAGACCGAACTGCCCGCTGCTTTGCAGCCGGCCGCGGAGGCCCTG
p H y g r o - T u b  3 5 1  GATGCGATCGCTGCGGCCGATCTTAGCCAGACGAGCGGGTTCGGCCCATTCGGACCGCAA
pHYGWT  3 6 1  GATGCGATCGCTGCGGCCGATCTTAGCCAGACGAGCGGGTTCGGCCCATTCGGACCGCAA
pHYGOl  3 6 1  GATGCGATCGCTGCGGCCGATCTTAGCCAGACGAGCGGGTTCGGCCCATTCGGACCGCAA
pHYG02  3 6 0  GAT6CGACCGCTGCGGCCGATCTTAGCCAGACG AG C6G6TTCGGCCCATTCGG ACCGCAA
pHYG03  3 6 1  GATG CG ACCGCTGCGGCCGATCTTAGCCAGACGAGCGGGTTTGGCCCATTCGGACCGCAA
pHYGOS  3 6 1  G ACGC6GTCGCTGCGGCCGGTCTTAGCTAGACG AG CG GGTTC66CCCACTCGGACCGCAA
pHYGOl  3 6 1  GGTGCGACCG CCGCGGCCGGTCTTAGCCAGACGAGCGGATTCG6CCCACTCG6GCCGCAA
p H Y G 0 9  3 6 0  GATGCGATCGCCGCGGCCGATCTCAGCCAGGCGAGTGGGCTCGGCCCACTCGGACCGCAA
pHYGll  3 6 1  GATGCGACCGCCGCGGCCGATCTTAGCCAGACGAGCGGGTCCGGCCCATCCGGACCGTAA
p H y g r o - T u b  4 1 1  G G A ATC G G TCA ATA C AC TAC ATG G CG TG A TTTC A TA TG C G CG ATTG C TG A TC CC CA TG TG
pHYGWT  4 2 1  G G A ATC G G TCA ATAC AC TAC ATG G CG TG A TTTCA TATG C G C G ATTG C TG A TC CC CATG TG
pHYGOl  4 2 1  GGAATCGG TCAATACA CTA C ATG G C G TG ATTC C ATATG CG C G A TTG CTG A TCC CC A TG TG
pHYG02  4 2 0  G G AA TCG G TCAG TACACTACATG G CG TG ATTTCATATG CG CG ATTG CTG ATCCCCACG TG
pHYG03  4 2 1  G G A ATCG G TCAATACACCACACGGCGTGATCTCATATGCGCGATTGCTGATCCCCATGTG
pHYGOS  4 2 1  GGAATCG G CCAATACACTACATG ACG TG ATTTCATATG CG CG ATTG CTG G TCCCCATG CG
p H Y G 0 7  4 2 1  G G A A TC G G TCA ATA TAC TA CA TG G CA TG ATTTC ATA TG CG C G A TTG CTG ATC C CC AC G TG
p H Y G 0 9  4 2 0  G G AATCG G TCAATACACTACATG G CG TG ATTTCATATG CG CG ATTG CCG G TCCCCATG TG
pHYGll  4 2 1  G G G ATCG G TCG ATACACTACATG G CG TG ATTCCATATG CG CG G TTG CTG ATCCCTATG TG
p H y g r o - T u b  4 7 1  TATCACTGGCAAACTGTGATGGACGACACCGTCAGTGCGTCCG TCGCGCAGGCTCTCGAT
pHYGWT  4 8 1  TA TC ACTGGCAAACTGTGATGGACGACACCGTCA6TGCGTCCGTCGCGCAGGCTCTCGAT
pHYGOl  4 8 1  TATCACTGGCAAACTGTGATGGACGACACCGTCA6TGCGTCCGTCGCGCAGGCTCTCGAT
pHYG02  4 8 0  TATCACTGGCAGACTGTGATGGACGACACCGTCAGTGCGTCCGTCGCGCAGGCTCTCGAT
pHYG03  4 8 1  TATCACTGGCGAACTGTGACGGACGACACCGCCAGTACGTCCGTCGCGCAGGCTCTCGGT
pHYGOS  4 8 1  TATCACTGGCAAACTGTGATGGACAACACCGTCAGTGCGTCCGTCGCGCAG GCTCTCGGT
pHYGOl  4 8 1  TATCACTGGCAGGCCGTGATGGACGACACCGTCAGTGCGCCCGTCGCGCAGGCTCTCGAT
p H Y G 0 9  4 8 0  TATCACTAGCAAACTGCGATGGACGACACCGCCAGTGTGTCCGTCGCGCAGGCTCCCGAT
pHYGll  4 8 1  CATCACTGGCAAACCGCGATGGGCGACACCGTCAGTGCGCCCGTCGCGCAGGCCCTCGGC
p H y g r o - T u b  5 3 1  GAGCTGATGCTTTGGGCCGAGGACTGCCCCGAAGTCCGGCACCTCGTGCACGCGGATTTC
pHYGWT  5 4 1  GAGCTGATGCTTTGGGCCGAGGACTGCCCCGAAGTCCGGCACCTCGTGCACGCGGATTTC
pHYGOl  5 4 1  GAGCTGATGCTTTGGGCCGAGGACTGCCCCGAAGTCCGGCACCTCGTGCACGCGGATTTC
pHYG02  5 4 0  GAGCTGATGCTTTGGGCCGAGGACGGCCCCGAAGTCCGGCACCCCGTGCACGCGGATTTC
p H Y G 0 3  5 4 1  GAGTTGATGCTTTGGGCCGAGGACTGCCCCGAAGTCCGGCACCTCGTGCACGCGGATTTC
pHYGOS  5 4 1  GAGCTGATGCTTTGGGCCGAGGACTGCCCCGAGGTCCGGCACCTCGCGCACGCGGATCTC
pHYGOl  5 4 1  GGGCTGGTGCTTTGGGCCGAGGACTGCCCCGAGGCCCGGCACCTCGTGCACGCGGATTCC
p H Y G 0 9  5 4 0  GGGTTAATGCTTTGGGCCGAGGGCTGCCCCGAGGTCCGGCACCCCGTGCACGCGGACTTC
pHYGll  5 4 1  GAGCTGACGCCTTGGGCCGAGGACTGCCCTGAAGTCCGGCACCCCGTGCATGCGGACTCC
370
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p H y g r o - T u b  5 9 1  G G C TCC A AC AA T6TC CTG A CG G AC AA T6G C C6CA TA ACA G CG 6TC ATTG AC TG G A G CG A6
pHYGWT  6 0 1  6G C TC CA A C A A T6TC C TG A C G G A C A A T66C C G C A TA A C A G C6G TC A TTG A C TG G A G C G A 6
pHYGOl  6 0 1  G G CTCC A ACAAT6TCCTGACGGACAATGGCCGCATAACAGC66TCATTG ACTGGAGCGAG
pHYG02  6 0 0  GGCTCCAACAATGTCCTGACGGACAATGGCCGCATAACAGCGGTCATTGACTGGAGCGAG
pHYG03  6 0 1  GGCTCCAACAATGCCCTGACGGACAATGGCCGCATAACAGCGGTCATCGGCTGGAGCGAG
pHYGOS  6 0 1  GGCTCCAGCAATGTCCTAACGGACAATGGCCGCATAGCGGCGGTCATTGACTGGAGCGAG
pHYGOl  6 0 1  GGCCTCAACAATGTCCTGACGGACAATGGCCGCATAACAGCGGCCACTGACCGGAGCGAG
p H Y G 0 9  6 0 0  GGCTCCGACAGTGCCCCGACGGACAGTGGTCACATAGTAGCGGTCATTGACCGGAGCGAG
pHYGll  6 0 1  GGCTCCAGCAACGTCCTGGCGGACAATGGCCACATAGCAGCGGCCGCTGGCTGGGGCGAG
p H y g r o - T u b  6 5 1  G CG A TG TTCG G G GATTCCCAATACGAGGTCGCCAACATCTTCTTCTGGAGGCCGTGGTTG
pHYGWT  6 6 1  G C G A TG TTCG G G GATTCCCAATACGAGGTCGCCAACATCTTCTTCTGGAGGCCGTGGTTG
pHYGOl  6 6 1  G CG ATG TTC G G G GATTCCCAATACGAGGTCGCCAACATCTTCTTCTGGAGGCCGTGGTTG
pHYG02  6 6 0  G CG A TG TTCG G G GATTCCCAATACGAGGTCGCCAACATCTTCTTCTGGAGGCCGTGGTTG
pHYG03  6 6 1  GCGATGTTCGGG GATTCCCAATACGAGGTCGCCAACATCTTCTTCTGGAGGCCGTGGCTG
pHYGOS  6 6 1  G CG ATG TTCGGG GATTCCCAACACG AG GTCGCCAACATCTTCTTCCGGAGGCCGTGGTTG
pHYGOl  6 6 1  GCGATG TTCGGGGATTCCCAATGCGAGGTCGCCAACATCCTCCTCTGGAGGCCGCGGTTG
pHYG09  6 6 0  GCGGTGTTCGGGGGTTCCCAATACGGGGTCGCCAACGCCCTCTTCTGGAGGCCGTGGTTG
pHYGll  6 6 1  GCGATGTCCGGGGATCCCCAATACGAGGTCGCCAACATCTCCTTCTGGAGGCCGCGGTTG
p H y g r o - T u b  7 1 1  GCTTGTATGGAGCAGCAGACGCGCTACTTCGAGCGGAGGCATCCGGAGCTTGCAGGATCG
pHYG W T 7 2 1  GCTTGTATGGAGCAGCAGACGCGCTACTTCGAGCGGAGGCATCCGGAGCTTGCAGGATCG
pHYGOl  7 2 1  GCTTGTATGGAGCAGCAGACGCGCTACTTCGAGCGGAGGCATCCGGAGCTTGCAGGATCG
pHYG02  7 2 0  GCTTGTATGGAGCAGCAAACGCGCTACTCCGAGCGGAGGCATCCGGGGCGTGCAGGATCG
pHYG03  7 2 1  GCTTGTATGGAGCAGCAGGCGCGCTACTTCGGGCGGAGGCATCCGGAGCTTGCAGGATCG
pHYGOS  7 2 1  GCTCGTATGGAGCAGCAGACGCGCTACCTCGGGCGGAGGCATCCGGGGCTTGCAGGGTCG
pHYGOl  7 2 1  GCTTGCATGGAGCAGCAGACGCGCTATTCCGAGCGGAGGCATCCGGAGCTTGCAGGATCG
p H Y G 0 9  7 2 0  GCTTGTATGGAGCAGCGGACGCGCTGCTTTGAGCGGAGGCACCCGGAGCTTGCAGGACCG
pHYGll  7 2 1  GCTTGTGCGGAGCAGCAGACGCGCTACTCCGAGTGGAGGCATCCGGAGCCTGCAGGGCCG
p H y g r o - T u b  7 7 1  CCGCGGCTCCG G G C G TATA TG CTC CG CATTG G TCTTG A CCA AC TCTA TCA G AG C TTG G TT
pHYGWT  7 8 1  CCGCGGCTCC G G G CG TA TATG CTCC G CATTG G TC TTG AC CA A CTC TA TC AG A G CTTG G TT
pHYGOl  7 8 1  CCGCGGCTCCG G G C G TA TA TG CTC CG CATTG G TC TTG A C CAA CTC TATC AG A G C TTG G TT
pHYG02  7 8 0  CCGCGG CTCCG G G CG TG TATG CTCCG CATTG G TCTTG ACCAACTCTATCAG G G CTTG G TT
pHYG03  7 8 1  CCGCGGCTCCG G G C G TATA TG CCC CG TATTG G TC TTG AC CAA CTC TATC AG AG C TTG G TT
pHYGOS  7 8 1  C CG TG G CTCCGGGCGTACATG CTCCGCATTGG CCTTGACCAACTCTATCAGAGCTTGGCT
pHYGOl  7 8 1  CCGCGGCCCCGGGCGTACATGCTCCGCACTGGCCCTGACCAACTCTATCAGAGCTTGGTT
p H Y G 0 9  7 8 0  TCGCGG CCCCG G G CG TG TATG CTCCG TATTG G CCTTG ACCAG CTCTATCAG AG CTTG G TT
pHYGll  7 8 1  C CG C GGTTCCGGGCGTATATGTCCCGTAGTGGTCCTGACTGACTCTATCAGGGCTTGGCC
p H y g r o - T u b  8 3 1  GACGGCAATTTCAATGATGCAGCTTGGGCGCAGGGTCGATGCGACGCAATCGTCCGATCC
pHYGWT  8 4 1  GACGGCAATTTCAATGATGCAGCTTGGGCGCAGGGTCGATGCGACGCAATCGTCCGATCC
pHYGOl  8 4 1  g a c g g c a a t t t c g a t g a t g c a g c t t g g g c g c a g g g t c g a t g c g a c g c a a t c g t c c g a t c c
pHYG02  8 4 0  GACGGCAATTTCGATGATGCAGCTTGGGCGCAGGGTCGATGCGACGCAATCGTCCGATCC
pHYG03  8 4 1  GACGGCAATTTCGATGATGCAGCTTGGGCGCAGGGTCGATGCGACGCAATCGTCCGATCC
pHYGOS  8 4 1  GACGGCAATTTCGGTGATACAGCCTGGGCGCAGGGTCGATGCGACGCAATCGTCCGATCC
pHYGOl  8 4 1  g a c g g c g a c t t c g g t g a t g c a g c t t g g g c g c a g g g t c g a t g c g a c g c a a t c g t c c g a t c c
p H Y G 0 9  8 4 0  AACGGCAATTTCGATGGTGCAGCTTGGGCGCAGGGTCGATGCGACGCAATCGTCCGATCC
pHYGll  8 4 1  GGCGGCAATTTCGACGGTGCAGCCTGGGCGCAGGGTCGGTACGACGCAATCGTCCGATCC
p H y g r o - T u b
pHYGWT
pHYGOl
pHYG02
pHYG03
pHYGOS
pHYGOl
pHYG09
pHYGll
8 9 1  GGAG..........
9 0 1  GGAGGGCGCGCCAT 
9 0 1  GGAGGGCGCGCCAT
9 0 0  GGAGGGCGCGCCAT
9 0 1  GGAGGGCGCGCCAT 
9 0 1  GGAGGGCGCGCCAT 
9 0 1  GGAGGGCGCGCCAT
9 0 0  GGAGGGCGCGCCAT
9 0 1  GGAGGGCGCGCCAT
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